| Gene ID |
Gene Name |
Sequence Strain (Species/Organism) |
VO ID |
NCBI Gene ID |
NCBI Nucleotide GI |
NCBI Protein GI |
Locus Tag |
Genbank Accession |
Protein Accession |
3D structure: PDB ID |
Other Database IDs |
Protein Name |
Molecule Role |
Vaccines Involving this Gene |
|
372
|
11C5 |
Babesia bovis T2Bo |
|
|
|
156086656
|
BBOV_IV008150 |
|
XP_001610737 |
|
|
|
Protective antigen |
|
|
371
|
12D3 |
Babesia bovis T2Bo |
VO_0011027
|
5478971
|
|
156086656
|
BBOV_IV008150 |
AAXT01000002 |
XP_001610737 |
|
|
|
Protective antigen |
B. bovis GST-12D3
|
|
1619
|
18H6 synthetic E protein |
synthetic construct |
|
|
73915390
|
73915391
|
|
|
AAZ92557.1 |
|
CDD:279241
CDD:280922
CDD:213897 |
chimeric Dengue envelope antigen 18H6 |
Protective antigen |
Dengue virus DNA vaccine sB encoding E
Dengue virus DNA vaccine sABC encoding prM and E
|
|
1664
|
1D |
Foot-and-mouth disease virus - type Asia 1 |
|
|
|
148800633
|
|
|
|
|
CDD:301302
CDD:119412 |
1D protein |
Protective antigen |
Foot-and-Mouth Disease Virus Cationic Microparticle-coated DNA Vaccine
Foot-and-Mouth Disease Virus DNA Vaccine pSinCMV-Vac-MEG990
|
|
1699
|
1D |
Foot-and-mouth disease virus - type O |
|
|
|
56675803
|
|
|
|
|
GOA:Q9DJ81
InterPro: IPR004080
UniProtKB/TrEMBL: Q9DJ81 |
VP1 |
Protective antigen |
Foot-and-Mouth Disease Virus DNA Vaccine pSinCMV-Vac-MEG990
|
|
1700
|
1D |
Foot-and-mouth disease virus - type A |
|
|
|
13399192
|
|
|
|
|
CDD:301302
CDD:119412
GOA:Q98VZ6
InterPro: IPR001676
InterPro: IPR004080
UniProtKB/TrEMBL: Q98VZ6 |
VP1 |
Protective antigen |
Foot-and-Mouth Disease Virus DNA Vaccine pSinCMV-Vac-MEG990
|
|
373
|
21B4 |
Babesia bovis |
VO_0011028
|
|
|
1246924
|
|
|
|
|
|
21B4 |
Protective antigen |
|
|
1409
|
26S |
Western equine encephalomyelitis virus |
|
|
|
7330241
|
|
|
|
|
CDD:279312
CDD:279849
CDD:279311
CDD:279870 |
structural polyprotein |
Protective antigen |
WEE virus DNA vaccine pVHX-6 encoding 26S
|
|
593
|
26S mRNA |
Venezuelan equine encephalitis virus |
|
2652924
|
|
9626528
|
VEEVgp3 |
AY973944 |
NP_040824 |
|
|
mRNA |
Protective antigen |
VEE virus DNA vaccine encoding 26S
|
|
165
|
26S mRNA from VEEV |
Venezuelan equine encephalitis virus |
|
2652924
|
|
9626528
|
VEEVgp3 |
NC_001449.1 |
NP_040824.1 |
|
|
structural polyprotein precursor |
|
Multivalent DNA vaccine for B. anthracis, Ebola virus, Marburg virus, and VEE virus
|
|
1695
|
2A |
Foot-and-mouth disease virus - type O |
|
|
|
25121634
|
|
|
|
|
|
2A |
Protective antigen |
FMDV DNA Vaccine encoding P1 and non-structural proteins 2A, 3C, and 3D
|
|
463
|
3-1E |
Eimeria tenella |
VO_0011066
|
|
|
126362934
|
|
|
|
|
CDD:320770
CDD:238085 |
sporozoite antigen 3-1E |
Protective antigen |
E. tenella DNA vaccine proIE
|
|
1689
|
3-1E |
Eimeria acervulina strain QH |
|
|
|
51234119
|
|
|
|
|
CDD:294086
CDD:238085 |
3-1E protein |
Protective antigen |
E. acervulina DNA vaccine 3-1E
|
|
1046
|
3a |
Feline infectious peritonitis virus |
|
10040181
|
|
315192965
|
FIPV_gp03 |
AY994055 |
YP_004070195 |
|
|
putative 3a protein |
Virmugen |
Feline infectiour peritonitis virus 3abc mutant vaccine
|
|
1047
|
3b |
Feline infectious peritonitis virus |
|
10040182
|
|
315192966
|
FIPV_gp04 |
AY994055 |
YP_004070196 |
|
|
putative 3b protein |
Virmugen |
Feline infectiour peritonitis virus 3abc mutant vaccine
|
|
1048
|
3c |
Feline infectious peritonitis virus |
|
10040183
|
|
|
FIPV_gp05 |
|
|
|
|
|
Virmugen |
Feline infectiour peritonitis virus 3abc mutant vaccine
|
|
1696
|
3C |
Foot-and-mouth disease virus - type O |
|
|
|
25121639
|
|
|
|
|
CDD:201298 |
3C |
Protective antigen |
FMDV DNA Vaccine encoding P1 and non-structural proteins 2A, 3C, and 3D
|
|
1697
|
3D |
Foot-and-mouth disease virus - type O |
|
|
|
25121640
|
|
|
|
|
CDD:73158 |
3D |
Protective antigen |
FMDV DNA Vaccine encoding P1 and non-structural proteins 2A, 3C, and 3D
|
|
4216
|
5'-nucleotidase family protein |
Streptococcus agalactiae |
|
|
|
ASZ01629
|
|
|
|
|
CDD:326311
CDD:277317
CDD:308488 |
5'-nucleotidase family protein |
Protective antigen |
|
|
775
|
6K |
Western equine encephalomyelitis virus |
VO_0011307
|
|
|
29611993
|
|
|
|
|
CDD:279870 |
6K protein |
Protective antigen |
WEEV DNA Vaccine encoding 6K-E1 Protein
|
|
4632
|
7299 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1049
|
7a |
Feline infectious peritonitis virus |
|
10040187
|
|
315192970
|
FIPV_gp09 |
AY994055 |
YP_004070200 |
|
|
non-structural protein 7a |
Virmugen |
Feline infectious peritonitis virus 7ab mutant vaccine
|
|
1050
|
7b |
Feline infectious peritonitis virus |
|
10040188
|
|
315192971
|
FIPV_gp10 |
AY994055 |
YP_004070201 |
|
|
non-structural protein 7b |
Virmugen |
Feline infectious peritonitis virus 7ab mutant vaccine
|
|
2393
|
85-B |
Mycobacterium bovis strain 1173P2 |
|
|
|
44168
|
|
|
|
|
CDD:223700
GOA:A1KJU9
InterPro: IPR000801
UniProtKB/UniProt: A1KJU9 |
protein or antigen 85-B |
Protective antigen |
M. bovis DNA vaccine pCI-Ag85B
|
|
1100
|
9GL |
African swine fever virus Mal |
|
|
|
6759635
|
|
|
|
|
CDD:194250 |
Mal-9GL protein |
Virmugen |
African Swine Fever Virus 9GL mutant vaccine
|
|
563
|
A2 |
Leishmania donovani |
VO_0011153
|
|
|
30385439
|
|
|
|
|
|
stage-specific S antigen-like protein |
Protective antigen |
Leishmania vaccine using recombinant L. tarentolae strain expressing A2 antigen
|
|
68
|
A21L |
Vaccinia virus |
VO_0012363
|
3707670
|
|
66275937
|
VACWR140 |
AY603355 |
YP_233022 |
|
|
IMV membrane protein |
Protective antigen |
LC16m8
|
|
29
|
A27L |
Monkeypox virus (strain: Zaire-96-I-16) |
|
928973
|
|
|
MPXVgp137 |
|
|
|
|
|
|
Smallpox DNA Vaccine
|
|
1404
|
A27L |
Vaccinia virus |
|
3707680
|
|
66275947
|
VACWR150 |
AY160184 |
YP_233032 |
|
|
IMV surface protein |
Protective antigen |
Vaccinia virus DNA vaccine 4pox
Vaccina Virus Vaccine A27/B5/CpG7909
|
|
1624
|
A27L |
Vaccinia virus strain Connaught |
|
|
|
58177828
|
|
|
|
|
CDD:111257 |
A27L |
Other |
|
|
4261
|
A30L |
Variola virus |
|
|
|
CAA47504
|
|
|
|
|
CDD:283633
InterPro: IPR009257
UniProtKB/UniProt: P68597 |
A30L |
Protective antigen |
|
|
1399
|
A33R |
Vaccinia virus |
|
3707686
|
|
66275953
|
VACWR156 |
AF226618 |
YP_233038 |
|
|
EEV membrane phosphoglycoprotein |
Protective antigen |
Vaccinia virus DNA vaccine A33R from strain IHD-J
|
|
1626
|
A33R |
Vaccinia virus strain Connaught |
|
|
|
7546900
|
|
|
|
|
CDD:222979 |
A33R |
Protective antigen |
Vaccinia virus DNA vaccine 4pox
|
|
30
|
A33R from Monkeypox virus (strain: Zaire-96-I-16) |
Monkeypox virus (strain: Zaire-96-I-16) |
|
928961
|
|
|
MPXVgp143 |
|
|
|
|
|
|
Smallpox DNA Vaccine
|
|
57
|
A33R from Vaccinia virus (strain: WR (Western Reserve)) |
Vaccinia virus (strain: WR (Western Reserve)) |
|
3707686
|
|
|
VACWR156 |
NC_006998 |
|
|
|
|
|
IMV-EEV
LC16m8
|
|
59
|
A34R |
Vaccinia virus (strain: WR (Western Reserve)) |
|
3707687
|
|
|
VACWR157 |
NC_006998 |
|
|
|
|
|
IMV-EEV
LC16m8
|
|
1400
|
A34R |
Vaccinia virus |
|
3707687
|
|
66275954
|
VACWR157 |
A19583 |
YP_233039 |
|
|
IEV and EEV membrane glycoprotein |
Protective antigen |
|
|
60
|
A36R |
Variola virus |
|
3707689
|
|
|
VACWR159 |
|
|
|
|
|
|
IMV-EEV
LC16m8
|
|
1401
|
A36R |
Vaccinia virus |
|
3707689
|
|
66275956
|
VACWR159 |
D11079 |
YP_233041 |
|
|
IEV transmembrane phosphoprotein |
Protective antigen |
|
|
1406
|
A4L |
Vaccinia virus |
|
3707521
|
|
66275920
|
VACWR123 |
S71673 |
YP_233005 |
|
|
39kDa core protein |
Protective antigen |
|
|
66
|
A56R |
Vaccinia virus (strain: WR (Western Reserve)) |
|
3707652
|
|
|
VACWR181 |
|
|
|
|
|
|
LC16m8
|
|
4527
|
AAV2gp02 |
Adeno-associated virus - 2 |
|
1489608
|
|
110645918
|
AAV2gp02 |
AF043303 |
YP_680423 |
|
|
Rep 78 protein |
Protective antigen |
|
|
4672
|
ABALON |
Homo sapiens |
|
103021294
|
|
|
|
AL160175 |
|
|
|
apoptotic BCL2L1-antisense long non-coding RNA |
Protective antigen |
|
|
4460
|
ABL2 |
Homo sapiens |
|
27
|
|
209862772
|
|
AL139132 |
NP_001129472 |
|
|
transcript variant X4 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
|
|
137
|
ABRA |
Plasmodium falciparum Camp |
VO_0010926
|
811329
|
|
160047
|
|
|
|
|
swissprot:: P22620; GI:113005 |
p101/acidic basic repeat antigen |
Protective antigen |
Recombinant ABRA protein vaccine
|
|
4562
|
ACP3 |
Homo sapiens |
|
55
|
|
6382064
|
|
AC020633 |
NP_001090 |
|
|
transcript variant X2 |
Protective antigen |
MVA-PSA/PAP Prostate Cancer Vaccine
Sipuleucel-T Vaccine
|
|
702
|
ACPP |
Homo sapiens |
|
55
|
|
6382064
|
|
AC020633 |
NP_001090 |
1CVI
|
|
transcript variant 2 |
Protective antigen |
PSA-PAP/KLH-pulsed Autologous Dendritic Cell Vaccine
APC8015F
|
|
921
|
actA |
Listeria monocytogenes EGD-e |
|
987035
|
|
16802250
|
lmo0204 |
AL591974 |
NP_463735 |
1EVH
|
|
actin-assembly inducing protein precursor |
Virmugen |
Listeria monocytogenes actA mutant vaccine
Listeria monocytogenes actA/plcB mutant vaccine
|
|
4459
|
ADAM17 |
Homo sapiens |
|
6868
|
|
1843978386
|
|
AB034151 |
NP_001369706 |
|
|
transcript variant 1 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
IMT-1012 Immunotherapeutic Vaccine
|
|
3869
|
ADP,ATP carrier protein |
Rickettsia prowazekii str |
|
|
|
NP_221091
|
|
|
|
|
CDD:281244 |
ADP,ATP carrier protein |
Protective antigen |
|
|
3872
|
adr2 |
Rickettsia prowazekii str. |
|
|
|
ADE30402
|
|
|
|
|
CDD:226163 |
Rickettsia adhesin |
Protective antigen |
|
|
315
|
AFP |
Homo sapiens |
|
174
|
|
4501989
|
|
AC108157 |
NP_001125 |
|
|
transcript variant 1 |
Protective antigen |
Alpha Fetoprotein Plasmid DNA Vaccine
AFP Gene Hepatocellular Carcinoma Vaccine
Alpha Fetoprotein Adenoviral Vector Vaccine
Autologous Colorectal Tumor Antigen-pulsed Dendritic Cell Vaccine
Cytokine-Induced Killer Cells
Alpha-fetoprotein Peptide-Pulsed Autologous Dendritic Cell Vaccine
|
|
3822
|
AFP from human-Obsolete |
Homo sapiens |
|
174
|
|
4501989
|
|
AC108157 |
NP_001125 |
|
|
transcript variant 1 |
Protective antigen |
|
|
4464
|
ag85A |
Mycobacterium tuberculosis H37Rv |
|
23489907
|
|
489997754
|
RVBD_RS20065 |
AL123456 |
WP_003900759 |
|
|
diacylglycerol acyltransferase/mycolyltransferase Ag85A |
Protective antigen |
TICE BCG
|
|
118
|
Ag85B from M. tuberculosis H37Rv |
Mycobacterium tuberculosis H37Rv |
VO_0012364
|
885785
|
|
15609023
|
Rv1886c |
AL123456 |
NP_216402 |
|
EMBL: AE000516
EMBL: AF198032
EMBL: BX842578
EMBL: U38939
EMBL: X62398
GenomeReviews: AE000516_GR
GenomeReviews: AL123456_GR
InterPro: IPR000801
KEGG: mtc:MT1934
KEGG: mtu:Rv1886c
PDB: 1F0N
PDB: 1F0P
Pfam: PF00756
PIR: C70516
TIGR: MT1934
TubercuList: Rv1886c
UniProt: P31952 |
diacylglycerol acyltransferase/mycolyltransferase Ag85B |
Protective antigen |
Arabinomannan-tetanus toxoid conjugate
Ag85B and ESAT-6 fusion protein
M. tuberculosis DNA Vaccine encoding Ag85B Protein
MVA/IL-15/5Mtb vaccine
M. tuberculosis DNA vaccine encoding Ag85B, MPT64 and MPT83
rBCG-Ag85A/ Ag85B
LT-BCG- Ag85B /Rv3425
|
|
4451
|
AIM2 |
Homo sapiens |
|
9447
|
|
1134787082
|
|
AL035403 |
NP_001335176 |
|
|
transcript variant X2 |
Protective antigen |
AIM2(-1)/HT001(-1)/TAF1B(-1) Frameshift Peptide Vaccine
Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
|
|
4385
|
Ak1 |
Schistosoma japonicum |
|
|
|
CAX82987
|
|
|
|
|
CDD:130427
CDD:238713
GOA:Q86BY2
HSSP: 3ADK
InterPro: IPR000850
UniProtKB/TrEMBL: Q86BY2 |
adenylate kinase 1 |
Protective antigen |
|
|
4763
|
AKAP4 |
Homo sapiens |
|
8852
|
|
21493037
|
|
AC235789 |
NP_003877 |
|
|
transcript variant 1 |
Protective antigen |
Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine
|
|
4601
|
AKT1 |
Homo sapiens |
|
207
|
|
62241013
|
|
A62733 |
NP_001014431 |
|
|
transcript variant X1 |
Protective antigen |
RCAS-Akt Vaccine
|
|
4210
|
aldehyde dehydrogenase |
Streptococcus agalactiae |
|
|
|
OZV86763
|
|
|
|
|
|
aldehyde dehydrogenase |
Protective antigen |
|
|
4678
|
ALDH1A1 |
Homo sapiens |
|
216
|
|
21361176
|
|
AH002598 |
NP_000680 |
|
|
aldehyde dehydrogenase 1 family member A1 |
Protective antigen |
Autologous Pluripotent ALDHbr Stem Cells ALD-451
Allogeneic Melanoma Vaccine AGI-101H
|
|
4679
|
ALDH2 |
Homo sapiens |
|
217
|
|
25777732
|
|
AC002996 |
NP_000681 |
|
|
transcript variant 1 |
Protective antigen |
Autologous Pluripotent ALDHbr Stem Cells ALD-451
|
|
3884
|
algE |
Pseudomonas aeruginosa |
|
|
|
NP_252234
|
|
|
|
|
CDD:315937 |
alginate production protein AlgE |
Protective antigen |
|
|
3926
|
Alkyl hydroperoxide reductase(AhpC) |
Helicobacter pylori |
|
|
|
EIE30837
|
|
|
|
|
|
Alkyl hydroperoxide reductase |
Protective antigen |
|
|
4218
|
alp1 |
Streptococcus agalactiae |
|
|
|
AAR08144
|
|
|
|
|
CDD:282500
CDD:204077
CDD:131384
CDD:298076 |
alpha-like protein 1 |
Protective antigen |
|
|
4219
|
alp3 |
Streptococcus agalactiae |
|
|
|
AKI94854
|
|
|
|
|
CDD:309682
CDD:312387
CDD:131384
CDD:307064 |
Alpha-like protein 3 |
Protective antigen |
|
|
4843
|
alpha-enolase |
Homo sapiens |
|
2023
|
|
319996655
|
|
AL139415 |
NP_001188412 |
|
|
transcript variant 1 |
Protective antigen |
|
|
4842
|
alpha1-giardin |
Giardia intestinalis |
|
5697168
|
|
159108073
|
GL50803_0011654 |
AACB03000003 |
XP_001704310 |
|
|
|
Protective antigen |
G. lamblia bivalent DNA vaccine encoding a1-giardin and CWP2
|
|
640
|
AMA-1 from P. berghei |
Plasmodium berghei |
VO_0011224
|
55149604
|
|
1438889
|
|
|
|
|
CDD:280571 |
apical membrane antigen-1 |
Protective antigen |
|
|
653
|
AMA-1 from P. chabaudi |
Plasmodium chabaudi |
VO_0011237
|
3488885
|
|
1469500
|
|
|
|
|
CDD:302876 |
apical membrane antigen 1 |
Protective antigen |
P. chabaudi AMA1 Protein Vaccine
|
|
139
|
AMA1 from P. falciparum 3D7 |
Plasmodium falciparum 3D7 |
VO_0010923
|
810891
|
|
124804478
|
PF3D7_1133400 |
LN999945 |
XP_001348015 |
1Z40
|
UniProt: P22621 |
Apical membrane antigen 1 (AMA1); PF11_0344; AMA-1, Pf83, RMA1, RMA 1, rhoptry membrane antigen |
Protective antigen |
FMP1/AS02A
ChAd63-MVA AMA1
AMA1-C1Alhydrogel + CPG 7909
AMA1-C1Alhydrogel
NYVAC-Pf7
AMA 49-CPE
PfAMA1-FVO/ Alhydrogel
|
|
1745
|
AMA1 from P. knowlesi |
Plasmodium knowlesi strain H |
|
7320803
|
|
221056402
|
|
|
|
|
CDD:240241
EnsemblGenomes-Gn:PKH_093110
EnsemblGenomes-Tr:PKH_093110
GOA:B3L5E1
InterPro: IPR003298
InterPro: IPR024056
UniProtKB/TrEMBL: B3L5E1 |
apical merozoite antigen 1 |
Protective antigen |
P. knowlesi DNA vaccine encoding PkCSP, PkSSP2, PkAMA1, and PkMSP1p42
|
|
752
|
amastigote surface protein-2 |
|
VO_0011289
|
3537357
|
|
284180153
|
|
|
|
|
CDD:240366
CDD:271234 |
amastigote surface protein-2 |
Protective antigen |
T. cruzi vaccine using Sendai virus vector expressing amastigote surface protein-2
T. cruzi DNA vaccine encoding TSA-1, ASP-1, ASP-2
T. cruzi DNA vaccine encoding ASP-2
T. cruzi DNA vaccine pUB-ASP-2
T. cruzi Vaccine encoding ASP2 with Rapamycin
|
|
797
|
AMN1 |
Coccidioides posadasii |
VO_0011328
|
|
|
76786276
|
|
|
|
|
CDD:279825 |
alpha-mannosidase 1 |
Protective antigen |
|
|
494
|
ANDVsSgp1 |
Andes orthohantavirus |
VO_0011092
|
991232
|
|
19744950
|
ANDVsSgp1 |
AF004660 |
NP_604471 |
|
|
nucleocapsid protein |
Protective antigen |
Andes virus vaccine using adenovirus viral vector expressing ANDV NP
|
|
687
|
Angpt1 |
Mus musculus |
|
11600
|
|
555290158
|
|
AC100734 |
NP_001272991 |
|
|
transcript variant 2 |
Protective antigen |
|
|
4024
|
ankyrin repeat domain protein |
Coxiella burnetii Q321] |
|
|
|
EDR36478
|
|
|
|
|
|
ankyrin repeat domain protein |
Protective antigen |
|
|
300
|
ANTXR1 |
Homo sapiens |
|
84168
|
|
16933553
|
|
AC112230 |
NP_060623 |
|
|
transcript variant 1 |
Protective antigen |
|
|
4084
|
aopX |
Aeromonas salmonicida subsp. |
|
|
|
ACK98975
|
|
|
|
|
|
putative T3SS effector AopX |
Protective antigen |
|
|
588
|
Apa |
Mycobacterium tuberculosis H37Rv |
VO_0011175
|
885896
|
|
57116926
|
Rv1860 |
AL123456 |
YP_177849 |
|
|
hypothetical protein |
Protective antigen |
M. tuberculosis DNA Vaccine APADNA priming and APAMVA boosting
|
|
4092
|
apfA |
Actinobacillus pleuropneumoniae |
|
|
|
AAO64346
|
|
|
|
|
CDD:331644 |
major type IV fimbrial subunit precursor |
Protective antigen |
A. pleuropneumoniae apfA vaccine
|
|
940
|
apxIA |
Actinobacillus pleuropneumoniae L20 |
|
4850247
|
|
126208908
|
APL_1444 |
CP000569 |
YP_001054133 |
|
|
RTX-I toxin determinant A |
Virmugen |
Actinobacillus pleuropneumoniae apxIA mutant vaccine
|
|
358
|
apxIA |
Actinobacillus pleuropneumoniae |
VO_0011019
|
|
|
312899
|
|
|
|
|
CDD:308152
CDD:225483
CDD:311996
GOA:P55128
InterPro: IPR001343
InterPro: IPR003995
InterPro: IPR011049
InterPro: IPR013550
InterPro: IPR018504
InterPro: IPR018511
UniProtKB/UniProt: P55128 |
|
Protective antigen |
A. pleuropneumoniae ApxIA protein vaccine
A. pleuropneumoniae ApxIa and ApxIIa protein vaccine
A. pleuropneumoniae DNA vaccine pcDNA-apxIA/pcDNA-apxIIA
HS93Tox-/pIG-T1K
rS.C-APP-ApxI/ApxII
mixture of Salmonella strains delivering ApxIA, ApxIIA, ApxIIIA and OmpA of A. pleuropneumoniae
|
|
402
|
ApxIC |
Actinobacillus pleuropneumoniae |
|
|
|
1477456
|
|
|
|
|
CDD:154216 |
|
Virmugen |
Actinobacillus pleuropneumoniae ApxIC mutant vaccine
|
|
360
|
apxIIA |
Actinobacillus pleuropneumoniae |
VO_0011020
|
|
|
52630374
|
|
|
|
|
CDD:280531
CDD:225483
CDD:305016
CDD:285531 |
ApxIIA |
Protective antigen |
A. pleuropneumoniae ApxIa and ApxIIa protein vaccine
A. pleuropneumoniae DNA vaccine pcDNA-apxIA/pcDNA-apxIIA
rS.C-APP-ApxI/ApxII
mixture of Salmonella strains delivering ApxIA, ApxIIA, ApxIIIA and OmpA of A. pleuropneumoniae
|
|
1037
|
apxIIA |
Actinobacillus pleuropneumoniae serotype 2 |
|
|
|
255959000
|
APL_0956 |
CP000569 |
YP_001053657 |
|
CDD:111291
CDD:116920 |
RTX-II toxin determinant A |
Virmugen |
Actinobacillus pleuropneumoniae ureC and apxIIA double mutant deletion vaccine
rS.C-APP-ApxIIA
|
|
401
|
ApxIIC |
Actinobacillus pleuropneumoniae |
|
|
|
52630373
|
|
|
|
|
CDD:154216 |
ApxIIC |
Virmugen |
A. pleuropneumoniae HS93C-Ampr
Actinobacillus pleuropneumoniae apxIIC and apxIVA double deletion mutant vaccine
|
|
4088
|
apxIIIA |
Actinobacillus pleuropneumoniae |
|
|
|
CAA48711
|
|
|
|
|
CDD:308152
CDD:225483
CDD:311996
GOA:P55131
InterPro: IPR001343
InterPro: IPR003995
InterPro: IPR011049
InterPro: IPR013550
InterPro: IPR018504
InterPro: IPR018511
UniProtKB/UniProt: P55131 |
ApxIIIA |
Protective antigen |
mixture of Salmonella strains delivering ApxIA, ApxIIA, ApxIIIA and OmpA of A. pleuropneumoniae
|
|
975
|
apxIIIB |
Actinobacillus pleuropneumoniae serovar 2 |
|
|
470686
|
|
|
|
|
|
CDD:30270
CDD:162558
CDD:186074
CDD:73011 |
RTX toxin |
Virmugen |
Actinobacillus pleuropneumoniae apxIIIB and apxIIID double mutant vaccine
|
|
977
|
apxIIID |
Actinobacillus pleuropneumoniae serovar 2 |
|
|
470687
|
|
|
|
|
|
CDD:130902 |
RTX toxin |
Virmugen |
Actinobacillus pleuropneumoniae apxIIIB and apxIIID double mutant vaccine
|
|
405
|
ApxIVA |
Actinobacillus pleuropneumoniae |
|
|
|
6671152
|
|
|
|
|
CDD:164328
CDD:116920 |
ApxIVA |
Virmugen |
Actinobacillus pleuropneumoniae apxIIC and apxIVA double deletion mutant vaccine
|
|
4724
|
AR |
Homo sapiens |
|
367
|
|
21322252
|
|
AF159087 |
NP_000035 |
|
|
transcript variant 1 |
Protective antigen |
Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118
|
|
4215
|
argF |
Streptococcus agalactiae |
|
|
|
AMQ15599
|
|
|
|
|
CDD:235269 |
Ornithine carbamoyltransferase |
Protective antigen |
|
|
188
|
aroA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
197
|
AroA |
Shigella flexneri 2a str. 2457T |
|
1077373
|
|
30062442
|
S0967 |
NC_004741.1 |
NP_836613.1 |
|
|
3-phosphoshikimate 1-carboxyvinyltransferase |
Virmugen |
S. flexneri 2a strain CVD 1203
S. dysenteriae 1 strain WRSd1
S. sonnei strain WRSS1
CVD 1204(pGA1-CS2)
S. flexneri EcSf2a-1 containing shigella plasmid in E. Coli vector
|
|
878
|
aroA |
Staphylococcus aureus subsp. aureus ED98 |
|
8614197
|
|
269203089
|
SAAV_1451 |
CP001781 |
YP_003282358 |
|
|
3-phosphoshikimate 1-carboxyvinyltransferase |
Virmugen |
Staphylococcus aureus aroA mutant vaccine
|
|
889
|
aroA |
Salmonella enterica subsp. enterica serovar Typhi str. Ty2 |
|
1068996
|
|
29142379
|
t1956 |
AE014613 |
NP_805721 |
|
|
3-phosphoshikimate 1-carboxyvinyltransferase |
Virmugen |
Salmonella typhi aroA mutant vaccine
|
|
897
|
aroA |
|
|
|
|
15420539
|
|
|
|
|
CDD:179423
CDD:30129 |
5-enolpyruvylshikimate-3-phosphate synthase |
Virmugen |
Yersinia ruckeri aroA mutant vaccine
|
|
898
|
aroA |
|
|
|
|
144037
|
|
|
|
|
CDD:179423
CDD:30129 |
|
Virmugen |
Bordetella pertussis aroA mutant vaccine
|
|
900
|
aroA |
Yersinia enterocolitica subsp. enterocolitica 8081 |
|
4713234
|
|
123441850
|
YE1538 |
AM286415 |
YP_001005833 |
|
|
3-phosphoshikimate 1-carboxyvinyltransferase |
Virmugen |
Yersinia enterocolitica aroA mutant vaccine
|
|
902
|
aroA |
Bordetella bronchiseptica RB50 |
|
2659145
|
|
33602442
|
BB3469 |
BX640447 |
NP_890002 |
|
|
3-phosphoshikimate 1-carboxyvinyltransferase |
Virmugen |
Bordetella bronchiseptica aroA mutant vaccine (strain BBS18)
Bordetella bronchiseptica aroA/trpE mutant vaccine
|
|
916
|
aroA |
|
|
|
|
581456
|
|
|
|
|
CDD:179423
CDD:30129
GOA:Q04570
InterPro: IPR001986
InterPro: IPR006264
InterPro: IPR013792
InterPro: IPR023193
UniProtKB/UniProt: Q04570 |
|
Virmugen |
Pasteurella multocida aroA mutant vaccine
|
|
920
|
aroA |
M. haemolytica NADC-D60 |
|
|
|
451485
|
|
|
|
|
CDD:179423
CDD:30129 |
5-enolpyruvylshikimate 3-phosphate synthase |
Virmugen |
Mannheimia haemolytica aroA mutant vaccine
|
|
942
|
aroA |
Aeromonas salmonicida subsp. salmonicida A449 |
|
4997369
|
|
145298842
|
ASA_1859 |
CP000644 |
YP_001141683 |
|
|
3-phosphoshikimate 1-carboxyvinyltransferase |
Virmugen |
A. salmonicida live-attenuated vaccine encoding AroA
|
|
333
|
aroa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
366
|
aroA |
Aeromonas salmonicida |
VO_0011024
|
|
|
512545
|
|
|
|
|
GOA:Q03321
UniProtKB/UniProt: Q03321 |
|
Protective antigen |
A. salmonicida live-attenuated vaccine encoding AroA
|
|
689
|
AroA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1060
|
aroA |
Aeromonas hydrophila subsp. hydrophila ATCC 7966 |
|
4489425
|
|
117619998
|
AHA_1979 |
CP000462 |
YP_856510 |
|
|
3-phosphoshikimate 1-carboxyvinyltransferase |
Virmugen |
Aeromonas hydrophila aroA mutant vaccine
|
|
182
|
AroC |
Salmonella enterica subsp. enterica serovar Typhi Ty2 |
|
1069415
|
|
29140996
|
t0480 |
NC_004631.1 |
NP_804338.1 |
|
|
chorismate synthase |
Virmugen |
Aro-deleted S. Typhi
CVD 908-htrA
|
|
918
|
aroC |
Burkholderia pseudomallei 1106a |
|
4899749
|
|
126453136
|
BURPS1106A_1713 |
CP000572 |
YP_001065984 |
|
|
chorismate synthase |
Virmugen |
Burkholderia pseudomallei aroC deletion mutant vaccine
|
|
1091
|
aroC |
Edwardsiella tarda EIB202 |
|
8608790
|
|
269139790
|
ETAE_2445 |
CP001135 |
YP_003296491 |
|
|
chorismate synthase |
Virmugen |
Edwardsiella tarda aroC mutant vaccine
Edwardsiella tarda aroC/esrC mutant vaccine
|
|
181
|
AroD |
Salmonella enterica subsp. enterica serovar Typhi Ty2 |
|
1070649
|
|
29141695
|
t1231 |
NC_004631.1 |
NP_805037.1 |
1QFE
|
|
3-dehydroquinate dehydratase |
Virmugen |
Aro-deleted S. Typhi
|
|
198
|
AroD |
Shigella flexneri 2a str. 2457T |
|
1078189
|
|
30063207
|
S1855 |
NC_004741.1 |
NP_837378.1 |
|
|
3-dehydroquinate dehydratase |
Virmugen |
S. flexneri strain Sfl 124
Shigella flexneri aroD mutant vaccine
|
|
4379
|
ARP2 |
Entamoeba histolytica |
|
|
|
AAF21857
|
|
|
|
|
CDD:100111 |
acidic ribosomal protein P2 |
Protective antigen |
|
|
367
|
asaP1 |
Aeromonas salmonicida subsp. salmonicida A449 |
VO_0011025
|
23570045
|
|
AAN63381
|
ASA_RS08320 |
|
|
|
CDD:296129
CDD:199915 |
toxic extracellular endopeptidase |
Protective antigen |
|
|
956
|
asd |
Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S |
|
|
|
267995764
|
|
|
|
|
CDD:180636
CDD:189205
CDD:145758 |
aspartate-semialdehyde dehydrogenase |
Virmugen |
Salmonella Typhimurium asd mutant vaccine
Salmonella Typhimurium asd/rfc mutant vaccine
|
|
1090
|
asd |
Burkholderia pseudomallei 1026b |
|
|
|
2358232
|
|
|
|
|
CDD:200773
CDD:162144 |
aspartate beta-semialdehyde dehydrogenase |
Virmugen |
Burkholderia pseudomallei asd mutant vaccine
|
|
4940
|
asdfaf asf |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1103
|
AsnC |
Brucella abortus 2308 |
|
3788213
|
|
489054600
|
BAB_RS24000 |
JMRZ01000003 |
WP_002964767 |
|
|
ArsR family transcriptional regulator |
Protective antigen |
Recombinant B. abortus AsnC protein with CFA/IFA adjuvant
|
|
1605
|
ASP-2 |
Trypanosoma cruzi strain Brazil |
|
|
1684906
|
1684907
|
|
|
AAC47720.1 |
|
CDD:240366
CDD:271234 |
amastigote surface protein-2 |
Protective antigen |
|
|
1607
|
ASP-2 from strain Tulahuen |
Trypanosoma cruzi strain Tulahuen |
|
|
284180152
|
284180153
|
|
|
ADB82626.1 |
|
CDD:240366
CDD:271234 |
amastigote surface protein-2 |
Protective antigen |
|
|
1606
|
ASP-2 from the Y strain |
Trypanosoma cruzi strain Y |
|
|
|
30313709
|
|
|
|
|
CDD:240366
CDD:271234
CDD:304605 |
surface protein-2 |
Protective antigen |
|
|
1604
|
ASP1 |
Trypanosoma cruzi strain Sylvio X-10/4 |
|
|
1658194
|
1658195
|
|
|
AAB18265.1 |
|
CDD:271234
CDD:304605 |
surface protein-1 |
Protective antigen |
T. cruzi DNA vaccine encoding TSA-1, ASP-1, ASP-2
|
|
997
|
asp24 |
|
|
|
2352999
|
2353000
|
|
|
AAB69346.1 |
|
CDD:151121 |
acid shock protein |
Virmugen |
B. abortus and B. melitensis mutants with unmarked deletion of asp24, virB2, or manBA
|
|
4735
|
ASTE1 |
Homo sapiens |
|
28990
|
|
572881924
|
|
AC055733 |
NP_001275879 |
|
|
transcript variant 3 |
Protective antigen |
AIM2(-1)/HT001(-1)/TAF1B(-1) Frameshift Peptide Vaccine
|
|
4665
|
ATL1 |
Homo sapiens |
|
51062
|
|
189181742
|
|
AL118556 |
NP_001121185 |
|
|
transcript variant 3 |
Protective antigen |
Dendritic Cell Tumor Cell Lysate Vaccine
|
|
1020
|
atpA |
Salmonella enterica subsp. enterica serovar Typhimurium SL1344 |
|
|
|
301160399
|
STM3867 |
AE006468 |
NP_462766 |
|
CDD:181753
CDD:199133
CDD:29998
CDD:144044
UniProtKB/TrEMBL: E1WDU3 |
ATP synthase alpha subunit |
Virmugen |
Salmonella Typhimurium atpA mutant vaccine
|
|
4049
|
atpA |
Chlamydia muridarum str. Nigg |
|
|
|
AAF39416
|
|
|
|
|
CDD:235248 |
ATP synthase, subunit A |
Protective antigen |
|
|
114
|
B. abortus strain 19 L7/L12 |
Strain 19 |
VO_0010928
|
|
|
304271
|
|
L19101 |
|
|
CDD:234671
CDD:100102 |
ribosomal protein L7/L12 |
Protective antigen |
B. abortus subunit vaccine using L7/L12
B. abortus DNA vaccine expressing BCSP31, SOD and L7/L12
B. abortus DNA vaccine pcDNA3.1-p39-L7/L12 encoding p39-L7/L12 fusion protein
|
|
110
|
B. melitensis M5 P39 |
B. melitensis strain M5 |
VO_0010948
|
|
|
122892474
|
|
EF189139 |
ABM67295 |
|
CDD:224567
CDD:304360 |
immunogenic 39-kDa protein |
Protective antigen |
B. melitensis P39 protein vaccine
|
|
886
|
B14R |
|
|
8384129
|
|
|
|
|
|
|
|
|
|
|
|
4546
|
B4GALNT1 |
Homo sapiens |
|
2583
|
|
451172101
|
|
AC025165 |
NP_001263397 |
|
|
transcript variant X4 |
Protective antigen |
Monoclonal Antibody A1G4 Anti-Idiotype Vaccine
|
|
1402
|
B5R |
Vaccinia virus |
|
3707658
|
|
66275984
|
VACWR187 |
A22016 |
YP_233069 |
|
|
EEV membrane glycoprotein |
Protective antigen |
Vaccinia virus DNA vaccine B5R
Vaccina Virus Vaccine A27/B5/CpG7909
|
|
1623
|
B5R |
Vaccinia virus strain IHD-J |
|
|
|
63002626
|
|
|
|
|
CDD:165263
CDD:200988
CDD:153056 |
EEV type-I membrane glycoprotein |
Other |
|
|
1627
|
B5R |
Vaccinia virus strain Connaught |
|
|
|
29029576
|
|
|
|
|
CDD:165263
CDD:278512
CDD:153056 |
B5R |
Protective antigen |
Vaccinia virus DNA vaccine 4pox
|
|
31
|
B5R from Monkeypox virus (strain: Zaire-96-I-16) |
Monkeypox virus (strain: Zaire-96-I-16) |
|
928916
|
|
|
MPXVgp166 |
|
|
|
|
|
|
Smallpox DNA Vaccine
|
|
55
|
B5R from Vaccinia virus (strain: WR (Western Reserve)) |
Vaccinia virus (strain: WR (Western Reserve)) |
|
3707658
|
|
|
VACWR187 |
|
|
|
|
|
|
LC16m8
IMV-EEV
|
|
1644
|
BAB1_0278 |
Brucella melitensis biovar Abortus 2308 |
|
|
|
82615279
|
|
|
|
|
CDD:264424
EnsemblGenomes-Gn:BAB1_0278
EnsemblGenomes-Tr:CAJ10234
InterPro: IPR011681
UniProtKB/TrEMBL: Q2YPC5 |
conserved hypothetical protein |
Protective antigen |
B. abortus DNA vaccine pVF278
|
|
4223
|
bac |
Streptococcus agalactiae |
|
|
|
BAC98831
|
|
|
|
|
CDD:273479
CDD:301352
CDD:214653
CDD:285864
CDD:293433
CDD:282865
CDD:283799
CDD:279132 |
c protein beta antigen |
Protective antigen |
|
|
1317
|
BAX |
Homo sapiens |
|
581
|
|
612149787
|
|
AB183034 |
NP_001278357 |
|
|
transcript variant X1 |
Protective antigen |
Autoimmune diabetes DNA vaccine pND2-GAD65-BAX encoding GAD and BAX
|
|
4457
|
BCAP31 |
Homo sapiens |
|
10134
|
|
213511012
|
|
CH471172 |
NP_001132913 |
|
|
transcript variant X2 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
|
|
4671
|
BCL2L1 |
Homo sapiens |
|
598
|
|
4502381
|
|
AL117381 |
NP_001182 |
|
|
transcript variant 6 |
Protective antigen |
Bcl-Xs Adenovirus Vaccine
|
|
1676
|
BCSP31 |
Brucella abortus |
|
|
144104
|
144105
|
|
|
AAA22993.1 |
|
CDD:273982 |
cell surface protein |
Protective antigen |
B. abortus DNA vaccine expressing BCSP31, SOD and L7/L12
|
|
1299
|
bcsp31 from Brucella |
Brucella |
|
|
|
361049819
|
|
|
|
|
CDD:32505
CDD:212369 |
TRAP transporter solute receptor, TAXI family precursor |
Other |
|
|
565
|
Beta-tubulin |
Leishmania donovani |
VO_0011155
|
|
|
262233287
|
|
|
|
|
CDD:276956
CDD:240228 |
beta tubulin |
Protective antigen |
L. donovani Beta-tubulin Protein Vaccine
|
|
681
|
Bfr from B. abortus S19 |
Brucella abortus S19 |
VO_0010907
|
6326162
|
|
189022832
|
BAbS19_II06320 |
CP000888 |
YP_001932573 |
|
|
Bacterioferritin |
Protective antigen |
|
|
255
|
Bfr from B. melitensis biovar Abortus 2308 |
Brucella abortus 2308 |
VO_0010968
|
3828133
|
|
489055925
|
BAB_RS29555 |
JMRZ01000012 |
WP_002966069 |
3FVB
|
|
bacterioferritin |
Protective antigen |
|
|
1829
|
bfrA |
Mycobacterium tuberculosis H37Rv |
|
885767
|
|
15609013
|
Rv1876 |
AL123456 |
NP_216392 |
|
|
bacterioferritin BfrA |
Protective antigen |
BCG-DHTM
|
|
4224
|
bibA |
Streptococcus agalactiae |
|
|
|
AHJ88300
|
|
|
|
|
|
BibA |
Protective antigen |
|
|
627
|
binding protein Eag |
Streptococcus equi subsp. equi 4047 |
VO_0011211
|
7696154
|
|
225870123
|
SEQ_0721 |
FM204883 |
YP_002746070 |
|
CDD:144825 |
Ig, alpha2-macroglobulin and albumin binding protein Eag |
Protective antigen |
S. equi Subunit EAG, FNZ and SFS Protein Vaccine
|
|
4351
|
BiP |
Toxoplasma gondii |
|
7896014
|
|
AAF23321
|
|
|
|
|
CDD:331774 |
heat shock protein 70 precursor |
Protective antigen |
|
|
869
|
BipA |
Streptococcus agalactiae |
|
|
|
255961211
|
|
|
|
|
CDD:310807
CDD:114603
CDD:307064 |
BibA |
Protective antigen |
S. agalactiae BipA Protein Vaccine
|
|
4072
|
bipB |
Burkholderia pseudomallei |
|
|
|
ABO26356
|
|
|
|
|
CDD:332605 |
BipB |
Protective antigen |
|
|
4068
|
BipD |
Burkholderia pseudomallei |
|
|
|
ABL67521
|
|
|
|
|
CDD:297251 |
BipD |
Protective antigen |
|
|
4081
|
BmpA |
Borrelia burgdorferi N40 |
|
|
|
AAG00584
|
|
|
|
|
CDD:280728
CDD:107349 |
BmpA |
Protective antigen |
|
|
4082
|
BmpB |
Borrelia burgdorferi N40 |
|
|
|
AAG00585
|
|
|
|
|
CDD:299141 |
BmpB |
Protective antigen |
|
|
4083
|
BmpD |
Borrelia burgdorferi N40 |
|
|
|
AAG00582
|
|
|
|
|
CDD:280728
CDD:107349 |
BmpD |
Protective antigen |
|
|
4229
|
bont |
Clostridium botulinum |
|
|
|
AII82280
|
|
|
|
|
CDD:307728
CDD:311759
CDD:311760
CDD:285226 |
botulinum neurotoxin type E variant E1 |
Protective antigen |
|
|
445
|
BoNT/A1 from C. botulinum |
|
VO_0010900
|
|
|
241183337
|
|
|
|
3NF3
|
CDD:307728
CDD:311759
CDD:311760
CDD:285226 |
Bont/A1 |
Protective antigen |
|
|
448
|
BoNT/A1 from C. botulinum A str. Hall |
Clostridium botulinum A str. Hall |
VO_0010903
|
5398487
|
|
153936924
|
CLC_0862 |
CP000727 |
YP_001386738 |
3NF3
|
|
botulinum neurotoxin type A1 |
Protective antigen |
C. botulinum DNA vaccine pSCARSA/BHc
|
|
449
|
BoNT/B |
Clostridium botulinum B1 str. Okra |
VO_0010904
|
6030102
|
|
169834607
|
CLD_A0068 |
AB232927 |
YP_001693307 |
1S0F
|
CDD:279999
CDD:285227
CDD:285228
CDD:285226 |
botulinum neurotoxin type B |
Protective antigen |
C. botulinum DNA vaccine pSCARSBHc
C. botulinum DNA vaccine pSCARSA/BHc
|
|
450
|
BoNT/C(Hc50) |
|
VO_0010905
|
|
|
217781
|
|
|
BAA14235.1 |
|
CDD:307728
CDD:311759
CDD:328935
CDD:285226 |
botulinum C1 neurotoxin |
Protective antigen |
|
|
4232
|
BoNT/D |
Clostridium botulinum |
|
|
|
BAE53579
|
|
|
|
|
|
botulinum neurotoxin type D precursor |
Protective antigen |
|
|
4069
|
bopE |
Burkholderia pseudomallei |
|
|
|
CRY24974
|
|
|
|
|
|
type III secretion target BopE |
Protective antigen |
|
|
4077
|
Borrelia Burgdorferi Outer Surface Lipoprotein Bba64 |
Borrelia burgdorferi |
|
|
|
4ALY_B
|
|
|
|
|
CDD:283392 |
Borrelia Burgdorferi Outer Surface Lipoprotein Bba64 |
Protective antigen |
|
|
447
|
botA |
|
VO_0010902
|
|
|
733429
|
|
|
|
|
CDD:285228
CDD:285226 |
botulinum neurotoxin serotype A Hc fragment |
Protective antigen |
|
|
4352
|
bov57 |
Babesia bovis |
|
|
|
BBA45742
|
|
|
|
|
|
BOV57 |
Protective antigen |
|
|
232
|
Bp26 |
Brucella melitensis bv. 1 str. 16M |
VO_0010962
|
1196247
|
|
17986819
|
BMEI0536 |
AE008917 |
NP_539453 |
|
|
immunogenic protein |
Protective antigen |
|
|
1053
|
bp26 |
Brucella melitensis bv. 1 str. Rev.1 |
|
|
|
265991532
|
|
|
|
|
CDD:194028 |
outer membrane protein Bp26 |
Virmugen |
Brucella melitensis bp26 mutant vaccine
|
|
4214
|
Branched-chain alpha-keto acid dehydrogenase subunit E2 |
Streptococcus agalactiae |
|
|
|
AFV72219
|
|
|
|
|
CDD:237001
CDD:308457 |
Branched-chain alpha-keto acid dehydrogenase subunit E2 |
Protective antigen |
|
|
383
|
brkA |
Bordetella pertussis |
VO_0011036
|
|
|
562026
|
|
|
|
|
CDD:332715
CDD:238653
CDD:273608 |
BrkA |
Protective antigen |
B. pertussis BrkA protein vaccine
|
|
1066
|
bscN |
Bordetella bronchiseptica RB50 |
|
2662485
|
|
33600613
|
BB1628 |
BX640441 |
NP_888173 |
|
|
type III secretion system ATPase |
Virmugen |
Bordetella bronchiseptica bscN and cyaA double mutant vaccine
|
|
570
|
BT1 |
Leishmania donovani |
VO_0011160
|
13387967
|
|
703123
|
|
|
|
|
CDD:273268
CDD:281135 |
unknown |
Protective antigen |
|
|
924
|
C protein |
Tick-borne encephalitis virus |
|
|
|
206570298
|
|
|
|
|
CDD:110034 |
capsid protein |
Virmugen |
Tick-borne Encephalitis Virus C protein mutant vaccine
|
|
925
|
C protein |
West Nile virus |
|
|
|
158516889
|
|
|
|
|
CDD:144552
VBRC:36387 |
capsid protein |
Virmugen |
West Nile virus C protein mutant vaccine
|
|
4243
|
C protein |
Eastern Equine Encephalitis Virus |
|
|
|
NP_740644
|
|
|
|
|
CDD:279312 |
C protein |
Protective antigen |
|
|
4222
|
C protein alpha-antigen |
Streptococcus agalactiae |
|
|
|
AIF88081
|
|
|
|
|
CDD:273479
CDD:204077
CDD:298076
CDD:279132 |
C protein alpha-antigen |
Protective antigen |
|
|
1736
|
C-E3-E2-E1-6K |
Venezuelan equine encephalitis virus (strain TC-83) |
|
|
|
130559
|
|
|
|
|
CDD:279312
CDD:279849
CDD:279311
CDD:279870 |
Structural polyprotein |
Protective antigen |
VEE virus DNA vaccine pSTU-TRDF encoding VEEV E3–E2–6K
|
|
283
|
C0393 |
Escherichia coli CFT073 |
VO_0010989
|
1034958
|
|
26246291
|
c0393 |
AE014075 |
NP_752330 |
|
|
hemoglobin protease |
Protective antigen |
E. coli vaccine based on recombinant protein CO393
|
|
4230
|
c2I |
Clostridium botulinum |
|
|
|
ADD91305
|
|
|
|
|
CDD:238144 |
C2I |
Protective antigen |
|
|
4231
|
c2II |
Clostridium botulinum |
|
|
|
ADD91306
|
|
|
|
|
CDD:214807
CDD:281492 |
C2II |
Protective antigen |
|
|
284
|
C4424 |
Escherichia coli CFT073 |
VO_0010990
|
1038067
|
|
26250246
|
c4424 |
AE014075 |
NP_756286 |
|
|
adhesin |
Protective antigen |
E. coli C4424 protein vaccine
|
|
4550
|
CA9 |
Homo sapiens |
|
768
|
|
169636420
|
|
AL133410 |
NP_001207 |
|
|
transcript variant X2 |
Protective antigen |
mRNA-electroporated dendritic cells encoding gp100 and tyrosinase as melanoma vaccine
|
|
419
|
CAB049 putative penicillin-binding protein |
Chlamydophila abortus |
VO_0011059
|
|
|
62184696
|
|
|
|
|
CDD:332066 |
penicillin-binding protein |
Protective antigen |
C. abortus DNA vaccine encoding CAB049
|
|
421
|
CAB613 putative peptidase |
Chlamydophila abortus |
VO_0011061
|
|
|
62185225
|
|
|
|
|
CDD:189015 |
peptidase |
Protective antigen |
C. abortus DNA vaccine encoding CAB613
|
|
396
|
cadF |
Campylobacter jejuni |
VO_0011044
|
|
|
WP_002851185
|
|
|
|
|
CDD:275358
CDD:225439
CDD:143586 |
fibronectin-binding outer membrane protein CadF |
Protective antigen |
C. jejuni DNA vaccine pcDNA3.1(+)-cadF
|
|
355
|
caf1 |
Yersinia pestis |
VO_0011017
|
|
|
48621
|
|
|
|
|
CDD:286355
GOA:P26948
InterPro: IPR008966
InterPro: IPR015335
PDB: 1P5U
PDB: 1P5V
PDB: 1Z9S
PDB: 3DOS
PDB: 3DPB
PDB: 3DSN
UniProtKB/UniProt: P26948 |
F1 capsule antigen |
Protective antigen |
Y. pestis DNA vaccine encoding dfF1 Protein
|
|
23
|
Caf1 from Y. pestis biovar Microtus str. 91001 |
Yersinia pestis biovar Microtus str. 91001 |
VO_0010870
|
2767670
|
|
45478667
|
YP_pMT082 |
AE017045 |
NP_995523 |
|
|
F1 capsule antigen |
Protective antigen |
Y. pestis F1 protein vaccine
Y. pestis DNA vaccine F1-V DNA
|
|
3922
|
cagA |
Helicobacter pylori |
|
|
|
WP_130778457
|
|
|
|
|
CDD:302624 |
type IV secretion system oncogenic effector CagA |
Protective antigen |
Epivac vaccine
|
|
3917
|
cagL |
Helicobacter pylori |
|
|
|
APP94146
|
|
|
|
|
|
cag pathogenicity island protein CagL |
Protective antigen |
|
|
1734
|
calpain |
Schistosoma mansoni strain Puerto Rico |
|
|
|
353230291
|
|
|
|
|
CDD:279042
CDD:238004
CDD:279416
CDD:238132
CDD:290234
CDD:238008 |
calpain (C02 family) |
Protective antigen |
S. mansoni DNA vaccine Sm-p80-pcDNA3 encoding the large subunit of S. mansoni calpain
|
|
4281
|
cap |
Porcine circovirus 2 |
|
|
|
AAF35305
|
|
|
|
|
CDD:280582 |
putative capsid protein |
Protective antigen |
|
|
933
|
capB |
Francisella tularensis subsp. holarctica LVS |
|
3952402
|
|
89256709
|
FTL_1416 |
AM233362 |
YP_514071 |
|
|
capsule biosynthesis protein capB |
Virmugen |
Francisella tularensis capB mutant vaccine
|
|
3963
|
capB |
Francisella tularensis |
|
|
|
ABD95977
|
|
|
|
|
CDD:188527 |
CapB |
Protective antigen |
|
|
1327
|
capsule biosynthesis protein |
Bacillus anthracis |
|
|
|
WP_000409765
|
|
|
|
|
CDD:311953
CDD:332959
CDD:282847
CDD:99910 |
capsule synthesis positive regulator AcpB |
Other |
|
|
953
|
carA |
Escherichia coli str. K-12 substr. MG1655 |
|
949025
|
|
16128026
|
b0032 |
U00096 |
NP_414573 |
1Q15
|
|
carbamoyl phosphate synthetase small subunit, glutamine amidotransferase |
Virmugen |
Escherichia coli carAB mutant vaccine
|
|
954
|
carB |
Escherichia coli str. K-12 substr. MG1655 |
|
944775
|
|
16128027
|
b0033 |
U00096 |
NP_414574 |
2A81
|
|
carbamoyl-phosphate synthase large subunit |
Virmugen |
Escherichia coli carAB mutant vaccine
|
|
4382
|
cathepsin B1 (SmCB1) |
Schistosoma mansoni |
|
|
|
4I07_A
|
|
|
|
|
CDD:239111 |
cathepsin B1 (SmCB1) |
Protective antigen |
|
|
4388
|
cathepsin B2 |
Trichinella spiralis |
|
|
|
ARG41449
|
|
|
|
|
CDD:312252
CDD:239111 |
cathepsin B2 |
Protective antigen |
|
|
972
|
cbiA |
Salmonella enterica subsp. enterica serovar Gallinarum str. 287/91 |
|
6923268
|
|
205353181
|
SG2061 |
AM933173 |
YP_002226982 |
|
|
cobyrinic acid a,c-diamide synthase |
Virmugen |
Salmonella Gallinarum cbiA/cobS mutant vaccine
|
|
619
|
CbpA |
Streptococcus pneumoniae D39 |
VO_0011203
|
4441159
|
|
116515359
|
SPD_2017 |
CP000410 |
YP_817402 |
1W9R
|
|
choline binding protein A |
Protective antigen |
S. pneumoniae CbpA Protein Vaccine
|
|
4691
|
CCL21 |
Homo sapiens |
|
6366
|
|
4506835
|
|
AF030572 |
NP_002980 |
|
|
C-C motif chemokine ligand 21 |
Protective antigen |
Autologous Dendritic Cell-Adenovirus CCL21 Vaccine
|
|
1390
|
Ccl21a |
Mus musculus |
|
18829
|
|
14547891
|
RP23-411B7.4 |
AF035684 |
NP_035254 |
|
|
chemokine (C-C motif) ligand 21A (serine) |
Protective antigen |
|
|
4948
|
CCNG1 |
Homo sapiens |
|
900
|
|
1395168480
|
|
AC112205 |
NP_001350944 |
|
|
transcript variant X3 |
Protective antigen |
Retrovector Encoding Mutant Anti-Cyclin G1 Vaccine
|
|
4495
|
CCNI |
Homo sapiens |
|
10983
|
|
1130413436
|
|
AC104771 |
NP_001335061 |
|
|
transcript variant 1 |
Protective antigen |
IMT-1012 Immunotherapeutic Vaccine
|
|
4540
|
CCR5 |
Homo sapiens |
|
1234
|
|
4502639
|
|
AB182982 |
NP_000570 |
|
|
transcript variant A |
Protective antigen |
Mesothelioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
|
|
4718
|
CCR7 |
Homo sapiens |
|
1236
|
|
683523912
|
|
AC004585 |
NP_001288643 |
|
|
transcript variant 2 |
Protective antigen |
|
|
4723
|
CD19 |
Homo sapiens |
|
930
|
|
296010921
|
|
AB052799 |
NP_001171569 |
|
|
transcript variant X3 |
Protective antigen |
|
|
4714
|
CD1D |
Homo sapiens |
|
912
|
|
982742445
|
|
AF142668 |
NP_001306074 |
|
|
transcript variant X3 |
Protective antigen |
|
|
4642
|
CD22 |
Homo sapiens |
|
933
|
|
297374825
|
|
AB012995 |
NP_001172028 |
|
|
transcript variant 4 |
Protective antigen |
EF-2 Peptide Vaccine
|
|
699
|
Cd276 |
Mus musculus |
|
102657
|
|
19527206
|
|
CH466522 |
NP_598744 |
|
|
CD276 antigen |
Protective antigen |
|
|
4319
|
CD2v |
African Swine Fever Virus |
|
|
|
AJB28435
|
|
|
|
|
|
CD2v |
Protective antigen |
|
|
4738
|
CD33 |
Homo sapiens |
|
945
|
|
130980072
|
|
AC063977 |
NP_001076087 |
|
|
transcript variant X2 |
Protective antigen |
Allogeneic AML Antigen-expressing Dendritic Cell Vaccine
|
|
4693
|
CD38 |
Homo sapiens |
|
952
|
|
38454326
|
|
AC005798 |
NP_001766 |
|
|
transcript variant 2 |
Protective antigen |
Autologous Dendritic Cell-Tumor Fusion Vaccine
|
|
4733
|
CD3D |
Homo sapiens |
|
915
|
|
4502669
|
|
AH002612 |
NP_000723 |
|
|
transcript variant 2 |
Protective antigen |
|
|
4446
|
CD40 |
Homo sapiens |
|
958
|
|
4507581
|
|
AL035662 |
NP_001241 |
|
|
transcript variant 7 |
Protective antigen |
Adenovirus 5-CD40 Ligand
Prostate Cancer Vaccine ONY-P1
Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003
Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101
Allogeneic Dendritic Cell-Myeloma Idiotype Vaccine
Autologous Dendritic Cell Vaccine ACT2001
Cancer DNA Vaccine pSURV encoding Survivin
|
|
305
|
Cd40lg |
Mus musculus |
|
21947
|
|
15011846
|
RP23-153G22.3 |
AH006031 |
NP_035746 |
|
|
CD40 ligand |
Protective antigen |
Cancer Retroviral Vector Vaccine encoding Cd40lg
|
|
4698
|
CD40LG |
Homo sapiens |
|
959
|
|
4557433
|
|
AB897731 |
NP_000065 |
|
|
CD40 ligand |
Protective antigen |
Ad-sig-hMUC-1/ecdCD40L Vaccine
Autologous Ad-CD154-Transduced CLL B Cells
Allogeneic Renal Cell Carcinoma Vaccine MGN1601
Autologous CD40L-expressing B-CLL Vaccine
Autologous TriMix-DC Melanoma Vaccine
|
|
4734
|
CD44 |
Homo sapiens |
|
960
|
|
48255935
|
|
AB462491 |
NP_000601 |
|
|
transcript variant X1 |
Protective antigen |
|
|
4542
|
CD55 |
Homo sapiens |
|
1604
|
|
10835143
|
|
AB003312 |
NP_000565 |
|
|
transcript variant 8 |
Protective antigen |
Monoclonal Antibody 105AD7 Anti-idiotype Vaccine
|
|
4613
|
CD58 |
Homo sapiens |
|
965
|
|
221316575
|
|
AL355794 |
NP_001138294 |
|
|
transcript variant 3 |
Protective antigen |
Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
Recombinant Fowlpox-TRICOM Vaccine
Rilimogene-galvacirepvec Vaccine
ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine
Brain Tumor Initiating Cell Vaccine
|
|
4748
|
CD70 |
Homo sapiens |
|
970
|
|
4507605
|
|
AC008760 |
NP_001243 |
|
|
transcript variant 2 |
Protective antigen |
Autologous TriMix-DC Melanoma Vaccine
|
|
311
|
Cd80 |
Mus musculus |
|
12519
|
|
1331037341
|
|
AC154425 |
NP_001346827 |
|
|
transcript variant X1 |
Protective antigen |
Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
Recombinant Fowlpox-TRICOM Vaccine
Recombinant Vaccinia-MUC1-B7 Vaccine
Rilimogene-galvacirepvec Vaccine
Autologous IL-2-expressing B-CLL Vaccine
|
|
4702
|
CD80 |
Homo sapiens |
|
941
|
|
4885123
|
|
AB033124 |
NP_005182 |
|
|
CD80 molecule |
Protective antigen |
Adenovirus B7-1
Allogeneic Renal Cell Carcinoma Vaccine MGN1601
ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine
ALVAC-B7-CEA
ALVAC-CEA (6D)-B7.1 Vaccine
Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine
CD80 Breast Cancer Vaccine
ALVAC-CEA B7.1 Vaccine
Brain Tumor Initiating Cell Vaccine
Newcastle disease virus lysate
Recombinant Vaccinia-Multiepitope Melanoma Peptides-B7.1-B7.2 Vaccine
Recombinant Fowlpox-B7.1 Vaccine
|
|
304
|
Cd86 |
Mus musculus |
|
12524
|
|
161484599
|
|
AC117662 |
NP_062261 |
|
|
transcript variant X2 |
Protective antigen |
Cancer DNA Vaccine pLXSHDmB7-2 encoding Cd86
Recombinant Vaccinia-Multiepitope Melanoma Peptides-B7.1-B7.2 Vaccine
|
|
693
|
Cd86 |
Rattus norvegicus |
|
56822
|
|
11464989
|
|
AABR07034349 |
NP_064466 |
|
|
transcript variant X1 |
Protective antigen |
|
|
1304
|
CD86 |
Homo sapiens |
|
942
|
|
332634950
|
|
AC068630 |
NP_001193853 |
|
|
transcript variant 1 |
Other |
Autologous IL-2-expressing B-CLL Vaccine
Autologous Tumor Cell Vaccine
AUT-OV-ALVAC-hB7.1 Vaccine
|
|
4439
|
CD8A |
Homo sapiens |
|
925
|
|
225007536
|
|
AC064848 |
NP_001139345 |
|
|
transcript variant 4 |
Protective antigen |
Brachyury-expressing Modified Vaccinia Ankara-TRICOM Vaccine
|
|
4591
|
CD90 |
Homo sapiens |
|
7070
|
|
902967471
|
|
AP003396 |
NP_001298089 |
|
|
transcript variant 5 |
Protective antigen |
Allogeneic Glioblastoma Stem-like Cell Line Lysate-pulsed Autologous Dendritic Cell Vaccine
|
|
4759
|
CDH3 |
Homo sapiens |
|
1001
|
|
953953841
|
|
AC099314 |
NP_001304124 |
|
|
transcript variant X1 |
Protective antigen |
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
|
|
4496
|
CDK1 |
Homo sapiens |
|
983
|
|
281427278
|
|
AC022390 |
NP_001163877 |
|
|
transcript variant 6 |
Protective antigen |
IMT-1012 Immunotherapeutic Vaccine
|
|
4868
|
CDPK1 |
Toxoplasma gondii ME49 |
|
7896758
|
|
1084942668
|
TGME49_301440 |
CM002038 |
XP_018637931 |
|
|
|
Protective antigen |
T. gondii DNA vaccine pVAX-CDPK1 with pVAX-IL21-IL15
T. gondii DNA vaccine pVAX-CDPK1 with pVAX-IL7-IL15
|
|
4937
|
CDPK2 |
Toxoplasma gondii ME49 |
|
7895412
|
|
237833849
|
TGME49_225490 |
KE138836 |
XP_002366222 |
|
|
|
Virmugen |
|
|
4904
|
CDPK6 |
Toxoplasma gondii ME49 |
|
7893531
|
|
1085164115
|
TGME49_218720 |
KE138840 |
XP_002370646 |
|
|
|
Protective antigen |
rCDPK6 + rROP18 + PLG
|
|
4471
|
cdsR |
Chlamydia trachomatis A/HAR-13 |
|
45091589
|
|
497557743
|
CTA_RS03050 |
CP000051 |
WP_009871927 |
|
|
SctR family type III secretion system export apparatus subunit CdsR |
Protective antigen |
Vaccinia Virus DD-CDSR Vaccine
|
|
413
|
CDVgp5 |
Canine morbillivirus |
VO_0011053
|
1489793
|
|
9630650
|
CDVgp5 |
AF014953 |
NP_047205 |
|
|
fusion protein F |
Protective antigen |
Canine distemper virus DNA vaccine encoding F and HA
ALVAC- CDV-H/F
NYVAC- CDV-H/F
|
|
412
|
CDVgp6 haemagglutinin protein H |
Canine morbillivirus |
VO_0011052
|
1489792
|
|
9630651
|
CDVgp6 |
AB472690 |
NP_047206 |
|
|
haemagglutinin protein H |
Protective antigen |
Canine distemper virus DNA vaccine encoding F and HA
Canine distemper virus DNA vaccine encoding HA
NYVAC- CDV-H/F
ALVAC- CDV-H/F
|
|
4436
|
Cea-Mouse |
Mus musculus |
|
111518
|
|
|
|
|
|
|
|
carcinoembryonic antigen gene family |
Protective antigen |
Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine
|
|
4535
|
CEACAM1 |
Homo sapiens |
|
634
|
|
68161541
|
|
A43165 |
NP_001020083 |
|
|
transcript variant 5 |
Protective antigen |
Mammaglobin-A DNA Vaccine
Fowlpox Virus Vaccine
|
|
316
|
CEACAM3 |
Homo sapiens |
|
1084
|
|
461496471
|
|
AC022516 |
NP_001264092 |
|
|
transcript variant 3 |
Protective antigen |
|
|
1351
|
CEACAM5 (CEA) |
Homo sapiens |
|
1048
|
|
612407802
|
|
AC008999 |
NP_001278413 |
|
|
transcript variant 1 |
Protective antigen |
Cancer Subunit DC (Tat-CEA) vaccine
Colorectal cancer DNA vaccine pCEA/HBsAg encoding carcinoembryonic antigen and hepatitis B surface antigen
Monoclonal Antibody 3H1 Anti-Idiotype Vaccine
Adenoviral Vector Ad5-CEA(6D) Vaccine
Indium In 111-Labeled Autologous Peripheral Blood Mononuclear Cells Vaccine
Inalimarev Vaccine
Fowlpox Virus Vaccine Vector
Falimarev Vaccine
Algenpantucel-L
Anti-CEA TCR Retroviral Vector-Transduced Autologous Peripheral Blood Lymphocytes
ALVAC-CEA Vaccine
ALVAC-CEA (VCP248)
ALVAC-B7-CEA
ALVAC-CEA (6D)-B7.1 Vaccine
Allogeneic Cellular Vaccine 1650-G
Carcinoembryonic Antigen Peptide 1-6D
Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine
Carcinoembryonic Antigen Peptide-1 Vaccine
Carcinoembryonic Antigen RNA-pulsed DC Cancer Vaccine
CEA RNA-pulsed Autologous Human Cultured Dendritic Cells
CEA/Tetanus Toxoid T Helper Epitope Fusion Protein-Expressing DNA Plasmid Vaccine
Dendritic Cell-CEA Peptide Vaccine
Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207
|
|
4568
|
CEACAM5 - obsolete |
Homo sapiens |
|
1048
|
|
612407802
|
|
AC008999 |
NP_001278413 |
|
|
transcript variant 1 |
Protective antigen |
EP-2101 Vaccine
Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
Recombinant Vaccinia-CEA Vaccine
|
|
795
|
CEL-170/4 |
Entamoeba histolytica |
VO_0011326
|
|
|
401088
|
|
|
|
|
|
170 kDa surface lectin |
Protective antigen |
E. histolytica CEL-170/4 protein vaccine
|
|
4195
|
cell surface protein |
Streptococcus equi |
|
|
|
WP_043026814
|
|
|
|
|
CDD:303769
CDD:293650
CDD:302792
CDD:293879
CDD:295219
CDD:279132 |
cell surface protein |
Protective antigen |
|
|
923
|
cen1 |
|
|
|
|
15488542
|
|
|
|
|
CDD:185503
CDD:28933 |
centrin |
Virmugen |
Leishmania donovani cen1 mutant vaccine
|
|
3970
|
CFA/I |
Escherichia coli |
|
|
|
AAB22177
|
|
|
|
|
CDD:282325 |
colonization factor antigen I |
Protective antigen |
|
|
4342
|
Chain A, Eimeria Tenella Microneme Protein 3 Mar_b Domain |
Eimeria tenella |
|
|
|
2LBO_A
|
|
|
|
|
CDD:287526 |
Chain A, Eimeria Tenella Microneme Protein 3 Mar_b Domain |
Protective antigen |
|
|
4652
|
CHI3L1 |
Homo sapiens |
|
1116
|
|
144226251
|
|
AC105940 |
NP_001267 |
|
|
chitinase 3 like 1 |
Protective antigen |
DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
|
|
133
|
cjaA |
Campylobacter jejuni RM1221 |
VO_0010955
|
3231573
|
|
1813949
|
CJE1064 |
CP000025 |
YP_179057 |
|
CDD:270412
GOA:P94643
InterPro: IPR001638
UniProtKB/TrEMBL: P94643 |
surface antigen, CjaA |
Protective antigen |
Avirulent Salmonella vaccine strain carrying C. jejuni cjaA gene
|
|
141
|
cjaA |
P. vivax SouthernMex-62 isolate |
VO_0010957
|
|
|
|
|
|
|
1Z27
|
CDD:270412
GOA:P94643
InterPro: IPR001638
UniProtKB/TrEMBL: P94643 |
|
Protective antigen |
|
|
4777
|
CLEC3B |
Homo sapiens |
|
7123
|
|
817473757
|
|
AC104165 |
NP_001295323 |
|
|
transcript variant X1 |
Protective antigen |
Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine
|
|
4415
|
CLEC4C |
Homo sapiens |
|
170482
|
|
1701108502
|
|
AC006517 |
NP_001358319 |
|
|
transcript variant X3 |
Protective antigen |
Plasmacytoid Dendritic Cell Vaccine
|
|
847
|
ClfA |
Staphylococcus aureus subsp. aureus str. Newman |
VO_0012390
|
5330438
|
|
151220968
|
NWMN_0756 |
AP009351 |
YP_001331790 |
1N67
|
|
clumping factor A |
Protective antigen |
S. aureus ClfA Protein Vaccine
S. aureus DNA vaccine pClfaSrtD13
S. aureus DNA vaccine encoding Efb, FnbpA, ClfA, Cna
|
|
4183
|
clfB |
Staphylococcus aureus |
|
|
|
SIN33476
|
|
|
|
|
CDD:309682
CDD:313621
CDD:307064 |
Fibrinogen-binding protein B |
Protective antigen |
|
|
1004
|
clpB |
Francisella tularensis subsp. tularensis SCHU S4 |
|
3192509
|
|
56708764
|
FTT_1769c |
AJ749949 |
YP_170660 |
3P2L
|
|
ClpB protein |
Virmugen |
Francisella tularensis clpB mutant vaccine
|
|
608
|
ClpP |
Streptococcus pneumoniae D39 |
VO_0011193
|
4441476
|
|
WP_000613477
|
SPD_0650 |
CP000410 |
YP_816144 |
1Y7O
|
CDD:178955
CDD:132928 |
ATP-dependent Clp protease proteolytic subunit |
Protective antigen |
S. pneumoniae ClpP protein Vaccine
|
|
1089
|
clpP |
Salmonella enterica subsp. enterica serovar Enteritidis str. P125109 |
|
6950532
|
|
207855928
|
SEN0430 |
AM933172 |
YP_002242579 |
|
|
ATP-dependent Clp protease proteolytic subunit |
Virmugen |
Salmonella Enteritidis guaBA/clpP mutant vaccine
|
|
1003
|
clpP from S. typhimurium str. LT2 |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1251968
|
|
16763829
|
STM0448 |
AE006468 |
NP_459444 |
|
|
ATP-dependent Clp protease proteolytic subunit |
Virmugen |
Salmonella Typhimurium clpP mutant vaccine
Salmonella Typhimurium guaBA/clpP mutant vaccine
Salmonella Typhimurium guaBA/clpP/fliD mutant vaccine
|
|
846
|
cna |
Staphylococcus aureus |
VO_0012389
|
|
387879
|
WP_001039420
|
|
|
AAA20874.1 |
2F68
|
CDD:283410
CDD:283411
CDD:301706
CDD:212461 |
Cna B-type domain-containing protein |
Protective antigen |
S. aureus CNA Protein Vaccine
S. aureus DNA vaccine encoding Efb, FnbpA, ClfA, Cna
|
|
1102
|
cobB |
Brucella abortus 2308 |
|
3787893
|
|
489054238
|
BAB_RS22225 |
JMRZ01000005 |
WP_002964414 |
|
|
hydrogenobyrinate a,c-diamide synthase |
Protective antigen |
Recombinant B. abortus CobB protein with CFA/IFA adjuvant
|
|
971
|
cobS |
Salmonella enterica subsp. enterica serovar Gallinarum str. 287/91 |
|
6923296
|
|
205353166
|
SG2041 |
AM933173 |
YP_002226967 |
|
|
cobalamin synthase |
Virmugen |
Salmonella Gallinarum cbiA/cobS mutant vaccine
|
|
4360
|
cofactor-independent phosphoglycerate mutase |
Leishmania donovani |
|
13386661
|
|
ADG96010
|
|
|
|
|
CDD:215295
CDD:293734 |
cofactor-independent phosphoglycerate mutase |
Protective antigen |
|
|
1613
|
COL2A1 |
Gallus gallus |
|
|
15546069
|
15546070
|
|
|
AAK98621.1 |
|
CDD:189968
CDD:279718 |
alpha 1 type IIA collagen precursor |
Protective antigen |
|
|
629
|
collagen binding, ancillary pilus subunit Cne |
Streptococcus equi subsp. equi 4047 |
VO_0011213
|
7695900
|
|
225870316
|
SEQ_0935 |
FM204883 |
YP_002746263 |
|
CDD:283410
CDD:212461
CDD:273478 |
collagen binding, ancillary pilus subunit Cne |
Protective antigen |
S. equi Subunit CNE Protein Vaccine
|
|
1321
|
Collagen type II |
Gallus gallus |
|
395069
|
|
45383309
|
|
AADN05000742 |
NP_989757 |
|
|
transcript variant X1 |
Protective antigen |
Adjuvant arthritis DNA vaccine pcDNA-CCOL2A1 encoding type II collagen
|
|
1674
|
Collagen type II |
Mus musculus |
|
12824
|
|
169658375
|
|
AC113444 |
NP_001106987 |
|
|
transcript variant 2 |
Protective antigen |
Adjuvant arthritis DNA vaccine CII encoding type II collagen
|
|
4017
|
com1 |
Coxiella burnetii |
|
|
|
AAG41990
|
|
|
|
|
CDD:224565
CDD:239321 |
27kDa outer membrane protein |
Protective antigen |
|
|
4055
|
COMC |
Chlamydia trachomatis |
|
|
|
CRH78535
|
|
|
|
|
|
COMC family |
Protective antigen |
|
|
1228
|
Complete genome |
Murine leukemia virus |
|
|
378404894
|
53749063
|
|
|
BAD52415.1 |
|
|
GAG polyprotein precursor |
Other |
|
|
429
|
copN |
Chlamydophila pneumoniae |
VO_0010884
|
|
|
33241669
|
|
|
|
|
CDD:274206 |
CopN |
Protective antigen |
C. pneumoniae CopN protein vaccine
|
|
1267
|
Core protein |
Simian immunodeficiency virus |
|
|
|
54312018
|
|
|
|
|
CDD:109591
CDD:201337
CDD:199156 |
core protein |
Other |
SIV DNA vaccine pSIVgag and pmacIL-15 encoding SIV core protein
|
|
1289
|
Core protein |
Hepatitis C virus |
|
|
|
349623451
|
|
|
|
|
CDD:144947 |
core |
Other |
|
|
758
|
CP cysteine proteinase |
Leishmania amazonensis |
VO_0011295
|
|
30142041
|
30142042
|
|
|
AAN34826.1 |
|
CDD:185513
CDD:214853
CDD:278538
CDD:239068 |
cysteine proteinase |
Protective antigen |
L. amazonensis CP Protein Vaccine
|
|
4847
|
Cp12 |
Cryptosporidium parvum Iowa II |
|
3372891
|
|
66357286
|
cgd4_2330 |
AAEE01000008 |
XP_625821 |
|
|
|
Protective antigen |
pVAX1-C-Cp12-Cp21
|
|
4386
|
CP1412 |
Schistosoma japonicum |
|
|
|
AAS68246
|
|
|
|
|
CDD:238512 |
egg protein CP1412 |
Protective antigen |
|
|
4849
|
CP15 |
|
|
|
|
ABO61338.1
|
|
|
|
|
CDD:185442 |
15 kDa sporozoite surface antigen |
Protective antigen |
pVAX-15-23
Cp15-23
|
|
777
|
CP15/60 |
Cryptosporidium parvum |
VO_0011309
|
3371947
|
170676501
|
170676502
|
|
|
ACB30404.1 |
|
|
sporozoite surface antigen CP15/60 |
Protective antigen |
C. parvum DNA vaccine encoding CP15/60
|
|
4378
|
CP15/60 |
Cryptosporidium parvum |
|
|
|
AAA28294
|
|
|
|
|
|
CP15/60 |
Protective antigen |
|
|
4315
|
CP204L |
African Swine Fever Virus |
|
|
|
AGL93215
|
|
|
|
|
|
p32 |
Protective antigen |
|
|
4318
|
CP204L |
African Swine Fever Virus |
|
|
|
AHN94305
|
|
|
|
|
|
p30 |
Protective antigen |
|
|
4848
|
Cp21 |
Cryptosporidium parvum Iowa II |
|
3373643
|
|
66358562
|
cgd2_2570 |
AAEE01000005 |
XP_626459 |
|
|
|
Protective antigen |
pVAX1-C-Cp12-Cp21
|
|
776
|
CP23 |
Cryptosporidium parvum |
VO_0011308
|
3372811
|
U34390
|
AAB17724.1
|
|
|
|
|
|
Cp23 antigen |
Protective antigen |
C. parvum DNA vaccine encoding CP23
pVAX-15-23
Cp15-23
|
|
1301
|
cp24 from Brucella melitensis |
Brucella melitensis |
|
|
|
1674445
|
|
|
|
|
CDD:178850
CDD:29621 |
CP24 |
Other |
|
|
4380
|
CP3 |
Entamoeba histolytica |
|
|
|
CAA60673
|
|
|
|
|
CDD:214853
CDD:278538
CDD:239068
GOA:P36184
InterPro: IPR000169
InterPro: IPR000668
InterPro: IPR013128
InterPro: IPR013201
UniProtKB/UniProt: P36184 |
cysteine proteinase |
Protective antigen |
|
|
4317
|
CP530R |
African Swine Fever Virus |
|
|
|
AHN94308
|
|
|
|
|
CDD:295006 |
pp62 |
Protective antigen |
|
|
737
|
Cpa |
Leishmania major |
VO_0011275
|
5651252
|
71084305
|
71084306
|
|
|
AAZ23598.1 |
|
CDD:185513
CDD:285458
CDD:278538
CDD:239068 |
cysteine protease |
Protective antigen |
L. major DNA Vaccine encoding LACKp24, TSA, LmSTI1 and CPa
|
|
4043
|
CPAF |
Chlamydia trachomatis |
|
|
|
WP_009873463
|
|
|
|
|
CDD:321971
CDD:214582 |
protease-like activity factor CPAF |
Protective antigen |
|
|
744
|
cpb |
Leishmania major |
VO_0011281
|
5649389
|
|
54287314
|
|
|
|
|
CDD:278538
CDD:239068
GOA:Q5ZQK2
InterPro: IPR000169
InterPro: IPR000668
InterPro: IPR013128
UniProtKB/TrEMBL: Q5ZQK2 |
cysteine proteinase b |
Protective antigen |
|
|
382
|
cpn60 |
Bordetella pertussis |
VO_0011035
|
|
|
968920
|
|
|
|
|
CDD:234573
CDD:239460 |
Cpn60 (GroEL) |
Protective antigen |
B. pertussis Cpn60 protein vaccine
|
|
4844
|
CpP2 |
Cryptosporidium parvum |
|
3372370
|
|
AAF21857.1
|
|
|
|
|
CDD:100111 |
acidic ribosomal protein P2 |
Protective antigen |
C. parvum DNA vaccine encoding CpP2
|
|
892
|
cps |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1035
|
cpxA |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1255585
|
|
16767324
|
STM4058 |
AE006468 |
NP_462939 |
|
|
two-component sensor protein |
Virmugen |
Salmonella Typhimurium gyrA/cpxA/rpoB mutant vaccine
|
|
4096
|
cpxD |
Actinobacillus pleuropneumoniae serovar 2 str. S1536 |
|
|
|
AAB64442
|
|
|
|
|
CDD:132072
CDD:280687 |
CpxD |
Protective antigen |
|
|
959
|
cpxR |
Salmonella enterica subsp. enterica serovar Gallinarum str. 287/91 |
|
6923307
|
|
205354363
|
SG3362 |
AM933173 |
YP_002228164 |
|
|
DNA-binding transcriptional regulator CpxR |
Virmugen |
Salmonella Gallinarum cpxR/Ion mutant vaccine
|
|
958
|
crp |
Salmonella enterica subsp. enterica serovar Gallinarum |
|
|
46811320
|
46811321
|
|
|
AAT01929.1 |
|
|
cAMP receptor protein |
Virmugen |
Salmonella Gallinarum crp mutant vaccine
|
|
327
|
crp |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1099
|
crp |
Edwardsiella ictaluri 93-146 |
|
7962173
|
|
238921513
|
NT01EI_3665 |
CP001600 |
YP_002935028 |
|
|
cAMP-regulatory protein |
Virmugen |
E. ictaluri crp mutant vaccine
|
|
1101
|
crp from S. Typhimurium |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1254989
|
|
16766754
|
STM3466 |
AE006468 |
NP_462369 |
|
|
cAMP-regulatory protein |
Virmugen |
Salmonella Typhimurium cya/crp mutant vaccine
|
|
760
|
CRP-10 |
Escherichia coli str. K-12 substr. MG1655 |
VO_0011297
|
947867
|
|
16131236
|
b3357 |
U00096 |
NP_417816 |
|
CDD:271234
CDD:290570 |
DNA-binding transcriptional dual regulator CRP |
Protective antigen |
T. cruzi DNA Vaccine encoding CRP-10 Protein
|
|
1386
|
CRTC |
Homo sapiens |
|
|
|
1905911
|
|
|
|
|
CDD:306718 |
calreticulin |
Protective antigen |
Human papillomavirus DNA vaccine hCRTE6E7L2 DNA encoding CRT linked to E6, E7 and L2
|
|
756
|
Cruzipain |
Trypanosoma cruzi |
VO_0011293
|
3550848
|
|
71663165
|
|
AAHK01000135 |
XP_818579 |
|
CDD:185513
CDD:214853
CDD:278538
CDD:239068
CDD:288946 |
cruzipain |
Protective antigen |
T. cruzi vaccine using attenuated Salmonella expressing T. cruzi Cruzipain
|
|
4656
|
CRY2 |
Arabidopsis thaliana |
|
839529
|
|
15219720
|
AT1G04400 |
CP002684 |
NP_171935 |
|
|
|
Protective antigen |
|
|
633
|
CS from P. berghei str. ANKA |
Plasmodium berghei ANKA |
VO_0011217
|
3428738
|
|
AAA29577.1
|
PBANKA_040320 |
LK023119 |
XP_022712148 |
|
|
|
Protective antigen |
P. berghei CS Protein Subunit Vaccine
P. berghei DNA vaccine encoding PbCSP
P. berghei DNA vaccine CSP-3p28
|
|
634
|
CS from P. falciparum |
Plasmodium falciparum 3D7 |
VO_0011218
|
814364
|
|
552191
|
|
|
|
|
CDD:278517 |
circumsporozoite protein |
Protective antigen |
P. falciparum CS expressed in irradiated P. berghei as Vaccine
RTS,S/AS01
Pb(PfCS@UIS4)
NYVAC-Pf7
|
|
4825
|
CS from P. vivax |
|
|
|
|
AAA29526.1
|
|
|
|
|
CDD:237171
CDD:395043 |
circumsporozoite protein |
Protective antigen |
PvCS/Montanide ISA-51
|
|
635
|
CS from P. yoelii |
Plasmodium yoelii |
VO_0011219
|
3800426
|
|
1844509887
|
PY17X_0405400 |
LM993658 |
XP_728216 |
|
|
|
Protective antigen |
P. yoelii DNA vaccine pDIP/PyCSP. 1
|
|
79
|
CS1 |
Escherichia coli 536 |
VO_0010941
|
4188469
|
|
110643341
|
ECP_3188 |
CP000247 |
YP_671071 |
|
|
CS1 type fimbrial major subunit |
Protective antigen |
Live attenuated ETEC vaccine ACAM2017
EHEC O157 subunit vaccine using his-tagged N-terminal intimin
Stx I B-subunit-expressing Vibrio cholerae vaccine strain [CVD 103-HgR(pDA60)]
Shiga Toxin 1-B subunit and EaeA coexpression from E. Coli in Vibrio cholerae
Shiga Toxin 2 B Subunit Vaccine
CVD 103-HgR Live Oral Cholera Vaccine with E. Coli Cross Protection
S. Typhi engineered to stably express ETEC colonization factor antigen I (CFA/I) vaccine
|
|
4180
|
Csa1A |
Staphylococcus aureus |
|
|
|
4BIH_B
|
|
|
|
|
CDD:282376 |
Csa1A |
Protective antigen |
|
|
4653
|
CSF1R |
Homo sapiens |
|
1436
|
|
569026720
|
|
AC011382 |
NP_001275634 |
|
|
transcript variant 3 |
Protective antigen |
|
|
4686
|
Csf2-Mouse |
Mus musculus |
|
12981
|
|
110625658
|
|
AL596103 |
NP_034099 |
|
|
transcript variant X1 |
Protective antigen |
Vaccinia-GM-CSF Vaccine
|
|
3956
|
csgG |
Haemophilus parasuis SH0165 |
|
|
|
ACL33081
|
|
|
|
|
CDD:224379 |
putative lipoprotein, curli production assembly/transport component CsgG |
Protective antigen |
|
|
4783
|
CSH1 |
Homo sapiens |
|
1442
|
|
4503083
|
|
AC040958 |
NP_001308 |
|
|
chorionic somatomammotropin hormone 1 |
Protective antigen |
hTERT/Survivin/CMV Multipeptide Vaccine
|
|
4820
|
CSP from P. falciparum |
|
|
|
|
|
|
|
|
|
|
|
|
UK39
|
|
1743
|
CSP from P. knowlesi |
Plasmodium knowlesi strain H |
|
7322927
|
|
221060580
|
|
|
|
|
CDD:319368
EnsemblGenomes-Gn:PKH_134120
EnsemblGenomes-Tr:PKH_134120
GOA:B3LAV3
InterPro: IPR001841
InterPro: IPR013083
UniProtKB/TrEMBL: B3LAV3 |
circumsporozoite protein, putative |
Protective antigen |
P. knowlesi DNA vaccine encoding PkCSP, PkSSP2, PkAMA1, and PkMSP1p42
|
|
3971
|
cssA |
Escherichia coli |
|
16833872
|
|
543130020
|
D616_p104124 |
AB702969 |
YP_008531445 |
|
CDD:293436 |
CS6 structural subunit A |
Protective antigen |
|
|
4563
|
CTAG1B |
Homo sapiens |
|
1485
|
|
4503119
|
|
AC244107 |
NP_001318 |
|
|
cancer/testis antigen 1B |
Protective antigen |
Cancer Subunit NY-ESO-1 Protein Vaccine
Recombinant NY-ESO-1 Protein vaccine adjuvanted with Imiquimod
ALVAC(2) Melanoma Multi-antigen Vaccine
NA-17/MAGE-3.A2/NY-ESO-1 Peptide Vaccine
NY-ESO-1 Peptide Vaccine
NY-ESO-1 Plasmid DNA Cancer Vaccine
NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine
NY-ESO-1/GLA-SE Vaccine ID-G305AmN
NY-ESO-1/LAGE-1 Peptide Vaccine
NY-ESO-1/MART-1 Peptide-pulsed Dendritic Cell Vaccine
NY-ESO-1b Peptide Vaccine
NY-ESO-B Vaccine
Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623
Recombinant NY-ESO-1 ISCOMATRIX Vaccine
Recombinant Vaccinia-NY-ESO-1 Vaccine
short overlapping peptides and full-length recombinant protein
12 Melanoma Peptide Vaccine
MAGE-A1/MAGE-A3/NY-ESO-1 Peptides Vaccine
|
|
4567
|
CTAG2 |
Homo sapiens |
|
30848
|
|
543583752
|
|
AC244107 |
NP_066274 |
|
|
transcript variant 1 |
Protective antigen |
NY-ESO-1/LAGE-1 Peptide Vaccine
Anti-NY-ESO1 TCR-transduced Autologous CD62L+-derived T-Lymphocytes
|
|
710
|
CTLA4 |
Homo sapiens |
|
1493
|
|
83700231
|
|
AC010138 |
NP_001032720 |
1AH1
|
|
transcript variant 1 |
Protective antigen |
Anti-CTLA4 MoAb RNA-transfected Autologous Dendritic Cell Vaccine
Sargramostim Plasmid DNA Melanoma Vaccine Adjuvant
Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine
Anti-CTLA4 MoAb RNA/GITRL RNA-transfected Autologous Dendritic Cell Vaccine
ALVAC-hB7.1
GVAX Pancreatic Cancer Vaccine
GVAX Cancer Vaccine
|
|
731
|
ctxB |
|
VO_0011270
|
|
|
110264635
|
|
|
|
|
CDD:279687 |
cholera toxin B |
Protective antigen |
V. cholerae CTB DNA Vaccine
|
|
3832
|
ctxB |
Vibrio cholerae |
|
|
|
AET14210
|
|
|
|
|
CDD:279687 |
CtxB |
Protective antigen |
|
|
4432
|
cupB5 |
Pseudomonas aeruginosa PAO1 |
|
878708
|
|
15599277
|
PA4082 |
AE004091 |
NP_252771 |
|
|
adhesive protein CupB5 |
Protective antigen |
|
|
479
|
CWP2 |
Giardia lamblia ATCC 50803 |
VO_0011080
|
5703171
|
|
159120052
|
GL50803_5435 |
AACB02000001 |
XP_001710242 |
|
|
|
Protective antigen |
G. duodenalis DNA vaccine encoding CWP2
|
|
4840
|
CWP2 |
Giardia intestinalis |
|
5703171
|
|
159120052
|
GL50803_005435 |
AACB03000003 |
XP_001710242 |
|
|
|
Protective antigen |
G. lamblia bivalent DNA vaccine encoding a1-giardin and CWP2
|
|
1001
|
cya |
Salmonella enterica subsp. enterica serovar Typhimurium |
|
|
|
581756
|
|
|
|
|
CDD:193111
GOA:P0A1A7
InterPro: IPR000274
UniProtKB/UniProt: P0A1A7 |
adenylate cyclase |
Virmugen |
Salmonella Typhimurium cya/crp mutant vaccine
|
|
376
|
CyaA |
Bordetella pertussis |
VO_0011031
|
|
|
580668
|
|
|
|
2COL
|
CDD:281494
CDD:280531
CDD:225483
CDD:305016 |
adenylate cyclase |
Protective antigen |
B. pertussis CyaA protein vaccine
|
|
1065
|
cyaA |
Bordetella bronchiseptica RB50 |
|
2661688
|
|
33599313
|
BB0324 |
BX640437 |
NP_886873 |
|
|
bifunctional hemolysin-adenylate cyclase precursor |
Virmugen |
Bordetella bronchiseptica bscN and cyaA double mutant vaccine
|
|
4936
|
CyP |
Toxoplasma gondii ME49 |
|
7895236
|
|
237841307
|
TGME49_221210 |
CM002036 |
XP_002369951 |
|
|
|
Protective antigen |
rBCGpMV361-TgCyP
|
|
1353
|
CYP1B1 |
Homo sapiens |
|
1545
|
|
189491763
|
|
ABBA01074989 |
NP_000095 |
|
|
cytochrome P450, family 1, subfamily B, polypeptide 1 |
Other |
|
|
483
|
D15 |
Haemophilus influenzae 86-028NP |
VO_0011083
|
3430379
|
|
68249503
|
NTHI1084 |
CP000057 |
YP_248615 |
|
|
protective surface antigen D15 |
Protective antigen |
H. influenzae D15 protein vaccine
|
|
42
|
D8L |
Vaccinia virus (strain: WR (Western Reserve)) |
|
3707569
|
|
|
VACWR113 |
|
|
|
|
|
|
IMV-EEV
|
|
1405
|
D8L |
Vaccinia virus |
|
3707569
|
|
66275910
|
VACWR113 |
DQ121394 |
YP_232995 |
|
|
IMV membrane protein |
Protective antigen |
Vaccinia virus DNA vaccine wtD8L
Vaccinia virus DNA vaccine tPA-D8L
|
|
322
|
dasd |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
841
|
DbpA |
Borrelia burgdorferi 297 |
VO_0012387
|
8319341
|
|
256041910
|
Bbu297_A24 |
U75866 |
YP_003110629 |
|
|
decorin binding protein A |
Protective antigen |
B. burgdorferi DbpA Protein Vaccine
B. burgdorferi DbpA and OspA Protein Vaccine
|
|
4078
|
dbpA |
Borrelia burgdorferi |
|
|
|
ABD95792
|
|
|
|
|
CDD:280507 |
DbpA |
Protective antigen |
|
|
1355
|
DCT |
Homo sapiens |
|
1638
|
|
193788640
|
|
AL139318 |
NP_001123361 |
|
|
transcript variant 1 |
Protective antigen |
Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
Murine TYRP2 Plasmid DNA Vaccine
|
|
4685
|
DCT |
Homo sapiens |
|
1638
|
|
193788640
|
|
AL139318 |
NP_001123361 |
|
|
transcript variant X2 |
Protective antigen |
Autologous Lymphoma Cell/Allogeneic Dendritic Cell Electrofusion Hybrid Vaccine
|
|
4462
|
DDR1 |
Homo sapiens |
|
780
|
|
321400059
|
|
AB088102 |
NP_001189450 |
|
|
transcript variant X8 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine
|
|
4009
|
degP |
Edwardsiella tarda |
|
|
|
ADB84596
|
|
|
|
|
CDD:236802
CDD:290102
CDD:238487 |
DegP |
Protective antigen |
|
|
4557
|
DEPDC1 |
Homo sapiens |
|
55635
|
|
166295188
|
|
AL138789 |
NP_001107592 |
|
|
transcript variant 2 |
Protective antigen |
Multipeptide Vaccine S-588210
DEPDC1/MPHOSH1 Peptide Vaccine
|
|
4644
|
DItox |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4063
|
DNA-binding protein |
Campylobacter jejuni |
|
|
|
WP_002867076
|
|
|
|
|
CDD:223854
CDD:153102 |
DNA starvation/stationary phase protection protein |
Protective antigen |
|
|
3867
|
dnaE |
Rickettsia prowazekii str |
|
|
|
NP_221128
|
|
|
|
|
CDD:235554
CDD:213988
CDD:285034
CDD:291259
CDD:239931 |
DNA polymerase III subunit alpha |
Protective antigen |
|
|
728
|
DnaJ |
Salmonella enterica subsp. enterica serovar Typhi str. CT18 |
VO_0011268
|
1246524
|
|
16759006
|
STY0013 |
AL513382 |
NP_454623 |
|
|
DnaJ protein |
Protective antigen |
S. typhi DnaJ Protein Vaccine
|
|
4402
|
DnaJ |
|
|
|
|
WP_001035362
|
|
|
|
|
CDD:331332
CDD:227588
CDD:332379 |
hypothetical protein |
Protective antigen |
S. pneumoniae DnaJ Protein Vaccine
|
|
426
|
dnaK |
Chlamydophila abortus |
VO_0010882
|
|
|
26006347
|
|
|
|
|
CDD:234715 |
DnaK |
Protective antigen |
C. abortus DNA vaccine encoding DnaK
|
|
257
|
DnaK |
Brucella abortus bv. 1 str. 9-941 |
VO_0010970
|
3341115
|
|
62290965
|
BruAb1_2100 |
AE017223 |
YP_222758 |
|
|
molecular chaperone DnaK |
Protective antigen |
|
|
866
|
DnaK |
Mycobacterium tuberculosis H37Rv |
VO_0012408
|
885946
|
|
15607491
|
Rv0350 |
AL123456 |
NP_214864 |
|
|
chaperone protein DnaK |
Protective antigen |
BCG-DHTM
|
|
3961
|
dnaK |
Francisella tularensis |
|
|
|
AAA69561
|
|
|
|
|
CDD:234715
CDD:302596
CDD:212657 |
DnaK |
Protective antigen |
|
|
4012
|
dnaK |
Edwardsiella tarda |
|
|
|
AKH90009
|
|
|
|
|
CDD:234715 |
molecular chaperone DnaK |
Protective antigen |
|
|
416
|
dnaX |
Chlamydophila abortus |
VO_0011056
|
|
|
62148024
|
|
|
|
|
CDD:180523
EnsemblGenomes-Gn:CAB327
EnsemblGenomes-Tr:CAH63776
GOA:Q5L6F0
InterPro: IPR003593
InterPro: IPR008921
InterPro: IPR012763
InterPro: IPR027417
UniProtKB/TrEMBL: Q5L6F0 |
DNA polymerase III subunit gamma/tau |
Protective antigen |
C. abortus DNA vaccine encoding DnaX
|
|
948
|
dnt |
Bordetella pertussis Tohama I |
|
2666936
|
|
33594321
|
BP3439 |
BX640421 |
NP_881965 |
|
|
dermonecrotic toxin |
Virmugen |
Bordetella pertussis dnt mutant vaccine
|
|
1038
|
dnt |
Bordetella bronchiseptica RB50 |
|
2661538
|
|
33602952
|
BB3978 |
BX640449 |
NP_890512 |
|
|
dermonecrotic toxin |
Virmugen |
Bordetella bronchiseptica dnt mutant vaccine
|
|
909
|
drrC |
Mycobacterium tuberculosis H37Rv |
|
888491
|
|
15610075
|
Rv2938 |
BX842581 |
NP_217454 |
|
|
daunorubicin-DIM-transport integral membrane protein ABC transporter DrrC |
Virmugen |
Mycobacterium tuberculosis drrC mutant vaccine
|
|
334
|
dsd |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
554
|
E |
Japanese encephalitis virus |
VO_0011145
|
|
|
16445023
|
|
|
|
|
CDD:279241
CDD:213392
CDD:213897 |
envelope protein |
Protective antigen |
Japanese encephalitis virus vaccine BV-G-E
Japanese encephalitis virus DNA vaccine encoding E protein
Japanese encephalitis virus DNA Vaccine P-JEV
Japanese encephalitis virus DNA Vaccine pCJ-3/E encoding E
NYVAC-JEV- prM/E/ NS1
|
|
669
|
E |
Yellow fever virus Senegal/Ko/HD117294/1995 |
VO_0011252
|
|
|
262283879
|
|
|
|
|
CDD:279241
CDD:280922
CDD:213897 |
envelope glycoprotein |
Protective antigen |
vP869
|
|
4275
|
E |
Yellow fever virus |
|
|
|
AAA92706
|
|
|
|
|
CDD:279241
CDD:280922
CDD:213897 |
envelope protein |
Protective antigen |
|
|
4276
|
E |
Tick-borne Encephalitis Virus (TBEV) |
|
|
|
CAC94472
|
|
|
|
|
CDD:279241
CDD:213392
CDD:213897
GOA:Q8UYS5
HSSP: 1SVB
InterPro: IPR000336
InterPro: IPR011998
InterPro: IPR011999
InterPro: IPR013755
InterPro: IPR013756
InterPro: IPR014756
UniProtKB/TrEMBL: Q8UYS5 |
E protein |
Protective antigen |
Encepur
|
|
1381
|
E from Dengue virus 1 |
Dengue virus 1 |
|
|
|
148372385
|
|
|
|
|
CDD:279241
CDD:332896
CDD:213392
CDD:213897 |
envelope protein |
Protective antigen |
Dengue virus DNA vaccine D1ME encoding prM and E
Dengue Virus DNA Vaccine D1ME-VRP
V180 - Aluminum Hydroxide Alhydrogelâ„¢ Adjuvant
Dengvaxia
rMV-TDV
|
|
1382
|
E from Dengue virus 3 |
Dengue virus 3 |
|
|
|
166092240
|
|
|
|
|
CDD:279241
CDD:280922
CDD:213897 |
envelope |
Protective antigen |
V180 - Aluminum Hydroxide Alhydrogelâ„¢ Adjuvant
Dengvaxia
rMV-TDV
|
|
1383
|
E from Dengue virus 4 |
Dengue virus 4 |
|
|
|
369726339
|
|
|
|
|
CDD:279241
CDD:213392
CDD:213897 |
envelope protein |
Protective antigen |
Dengue Virus DNA Vaccine expressing prM/E proteins
V180 - Aluminum Hydroxide Alhydrogelâ„¢ Adjuvant
Dengvaxia
rMV-TDV
|
|
590
|
E protein |
|
VO_0011177
|
|
|
111145461
|
|
|
|
2I69
|
CDD:279241
CDD:213392
CDD:213897 |
E protein |
Protective antigen |
West Nile virus DNA vaccine pCBWN encoding prM and E
ALVAC-WNV-PrM/E (dogs and cats)
|
|
780
|
E protein from Dengue Virus 2 |
|
VO_0011311
|
|
|
202078796
|
|
|
|
1OAN
|
CDD:279241
CDD:213392
CDD:213897 |
envelope protein |
Protective antigen |
Dengue Subunit E Protein Vaccine
Dengue virus DNA vaccine sA encoding prM and E from Dengue Virus 4
Dengue virus DNA vaccine sC encoding prM and E
Dengue virus DNA vaccine sABC encoding prM and E
Dengue virus DNA vaccine pE1D2 encoding E from Dengue Virus 2 strain New Guinea C
Dengue virus DNA vaccine 1040D2MEL encoding dengue-2 prM-E-LAMP chimeric protein
Dengue virus DNA vaccine p1012D2ME encoding prM and E from DEN 2 New Guinea C strain
V180 - Aluminum Hydroxide Alhydrogelâ„¢ Adjuvant
Dengvaxia
rMV-TDV
|
|
1324
|
E protein from West Nile Virus |
West Nile virus NY99 |
|
5714902
|
|
158516888
|
WNVNY99_gp1 |
DQ211652 |
YP_001527877 |
|
|
polyprotein |
Other |
|
|
966
|
E(rns) |
Classical swine fever virus - Brescia |
|
|
|
130457
|
|
|
|
|
CDD:147625
CDD:152325
CDD:185828
CDD:29472
CDD:152822
CDD:114308
CDD:31829
CDD:28927
CDD:73158 |
Genome polyprotein |
Virmugen |
Classical swine fever virus E(rns) mutant vaccine
|
|
443
|
E0 |
|
VO_0010898
|
|
|
115343287
|
|
|
|
|
CDD:294141
CDD:238220 |
envelope glycoprotein E0 |
Protective antigen |
Classical swine fever virus vaccine VAC-E0
|
|
965
|
E1 |
Classical swine fever virus - Brescia |
|
|
325460
|
325461
|
|
|
AAA43843.1 |
|
|
envelope glycoprotein E1 |
Virmugen |
Classical swine fever virus E1 mutant vaccine
|
|
774
|
E1 |
Western equine encephalomyelitis virus |
VO_0011306
|
|
17148716
|
17148717
|
|
|
AAL35792.1 |
|
CDD:279870 |
glycoprotein |
Protective antigen |
WEEV DNA Vaccine encoding 6K-E1 Protein
Western equine encephalomyelitis virus PE2/E1 mutant vaccine
|
|
4272
|
E1 |
Rubella virus |
|
|
|
BAB88324
|
|
|
|
|
CDD:283418 |
E1 |
Protective antigen |
|
|
4332
|
E1 |
Hepatitis C virus |
|
|
|
AAO46051
|
|
|
|
|
CDD:110536
CDD:110557 |
E1 |
Protective antigen |
|
|
727
|
E1 glycoprotein |
Venezuelan equine encephalitis virus |
VO_0011267
|
|
|
798795
|
|
|
|
|
CDD:201874 |
E1 glycoprotein |
Protective antigen |
VEE Virus PE2/E1 mutant vaccine
VEE virus DNA vaccine VEEV IA/B parent encoding structural genes
|
|
4246
|
E1 protein |
Eastern Equine Encephalitis Virus |
|
|
|
NP_740648
|
|
|
|
|
CDD:279870 |
E1 protein |
Protective antigen |
|
|
4285
|
E1 protein |
Western equine encephalomyelitis virus |
|
|
|
NP_818942
|
|
|
|
|
CDD:279870 |
E1 protein |
Protective antigen |
|
|
4659
|
E1B |
Human mastadenovirus C |
|
2652981
|
|
9626162
|
HAdVC_gp02 |
JX173077 |
NP_040510 |
|
|
control protein E1B 19K |
Protective antigen |
|
|
442
|
E2 |
Classical swine fever virus strain LPC |
VO_0010897
|
|
|
50403916
|
|
|
|
|
CDD:292945 |
E2 protein |
Protective antigen |
Classical swine fever virus vaccine VAC-E2
|
|
773
|
E2 |
Western equine encephalomyelitis virus |
VO_0011305
|
|
|
29611992
|
|
|
|
|
CDD:279311 |
E2 protein |
Protective antigen |
WEEV Subunit E2 Protein Vaccine
Western equine encephalomyelitis virus PE2/E2 mutant virus
|
|
1032
|
E2 |
Classical swine fever virus |
|
920146
|
|
12657942
|
PestiV2gp1 |
AF326963 |
NP_075354 |
|
|
polyprotein |
Virmugen |
Classical swine fever virus E2 mutant vaccine
Classical swine fever virus DNA vaccine pCI-gp55
DNA vaccine expressing the E2 protein
Classical Swine Fever Virus DNA Vaccine pcDNA/E2 with TRIF
rORFV-CSFV-E2
|
|
1410
|
E2 |
Sindbis virus |
|
|
|
20257395
|
|
|
|
|
CDD:279311 |
polyprotein |
Protective antigen |
Sindbis virus DNA vaccine encoding E2
|
|
1662
|
E2 |
Classical swine fever virus strain Shimen |
|
|
|
221063268
|
|
|
|
|
CDD:292945 |
E2 glycoprotein |
Protective antigen |
|
|
1679
|
E2 |
Bovine viral diarrhea virus 2 TC Shinozaki NCP/92 |
|
|
|
49614538
|
|
|
|
|
CDD:292945 |
structural glycoprotein E2 |
Protective antigen |
BVDV DNA vaccine encoding E2
|
|
4267
|
E2 |
Human Papillomavirus |
|
|
|
ATD50852
|
|
|
|
|
CDD:278909
CDD:317681
CDD:278912 |
E2 protein |
Protective antigen |
|
|
4331
|
E2 |
Hepatitis C virus |
|
|
|
AAB30986
|
|
|
|
|
CDD:110557 |
E2 |
Protective antigen |
|
|
725
|
E2 envelope protein |
Venezuelan equine encephalitis virus |
VO_0011265
|
|
|
25140296
|
|
|
|
|
CDD:279311 |
E2 envelope protein |
Protective antigen |
VEE virus DNA vaccine VEEV IA/B parent encoding structural genes
|
|
4245
|
E2 protein |
Eastern Equine Encephalitis Virus |
|
|
|
AAL09089
|
|
|
|
|
CDD:279311 |
E2 protein |
Protective antigen |
|
|
4257
|
E2 protein |
Bovine viral diarrhea virus 1 |
|
|
|
ABW24687
|
|
|
|
|
CDD:292945 |
E2 protein |
Protective antigen |
|
|
4335
|
E2 protein |
chikungunya virus |
|
|
|
AEJ18140
|
|
|
|
|
CDD:279311 |
E2 protein |
Protective antigen |
|
|
1684
|
E2A |
Mus musculus |
|
21423
|
|
255918153
|
|
AB095606 |
NP_001157619 |
|
|
transcript variant 8 |
Protective antigen |
Carcinoma DNA vaccine pVAX/E2A
|
|
4244
|
E3 protein |
Eastern Equine Encephalitis Virus |
|
|
|
NP_740645
|
|
|
|
|
CDD:279849 |
E3 protein |
Protective antigen |
|
|
4286
|
E3 protein |
Western equine encephalomyelitis virus |
|
|
|
NP_818939
|
|
|
|
|
CDD:279849 |
E3 protein |
Protective antigen |
|
|
4489
|
E6 |
Human papillomavirus type 16 |
|
1489078
|
|
9627104
|
HpV16gp1 |
AB663688 |
NP_041325 |
|
|
transforming protein E6 |
Protective antigen |
Amolimogene Bepiplasmid
Human Papillomavirus Tumor Antigen Vaccine
HPV DNA Plasmids Therapeutic Vaccine VGX-3100
Recombinant Vaccinia Viral Vector RO5217790 Vaccine
rMVTT- HPV16-E6/E7
Synthetic Long E6/E7 Peptides Vaccine HPV-01
DNA Vaccine VB10.16
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112
HPV 16 E6 (18-26) Peptide Vaccine
Host Dendritic Cell Vaccine-001 MSSM/BIIR
|
|
4268
|
E6 HPV 18 |
Human Papillomavirus |
|
|
|
AAP20594
|
|
|
|
|
CDD:332494 |
E6 protein |
Protective antigen |
MEDI0457
|
|
511
|
E6 Type 16 |
Human papillomavirus type 16 |
VO_0011107
|
1489078
|
|
9627104
|
HpV16gp1 |
AB663688 |
NP_041325 |
|
|
transforming protein E6 |
Protective antigen |
Human papillomavirus DNA vaccine pNGVL4a-E6/opt
Human papillomavirus DNA vaccine hCRTE6E7L2 DNA encoding CRT linked to E6, E7 and L2
|
|
4490
|
E7 |
Human papillomavirus type 16 |
|
1489079
|
|
9627105
|
HpV16gp2 |
AB663783 |
NP_041326 |
|
|
transforming protein E7 |
Protective antigen |
Amolimogene Bepiplasmid
Human Papillomavirus Tumor Antigen Vaccine
HPV DNA Plasmids Therapeutic Vaccine VGX-3100
HPV 16 E7:86-93 Peptide Vaccine
HPV 16 E7:12-20 Peptide Vaccine
Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
pNGVL4a-CRT/E7(detox) DNA Vaccine
pNGVL4a-Sig/E7(detox)/HSP70 DNA Vaccine
Recombinant Vaccinia Viral Vector RO5217790 Vaccine
rMVTT- HPV16-E6/E7
Synthetic Long E6/E7 Peptides Vaccine HPV-01
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112
Cancer Vaccine using E7 protein of human papillomavirus 16 and Quil-A
Cancer Vaccine using E7 protein of human papillomavirus 16 and Algammulin
attenuated Listeria expressing cancer antigen vaccine
DNA Vaccine VB10.16
Human Papillomavirus 16 E7 Peptide/Padre 965.10 Vaccine
Verpasep Caltespen Vaccine
|
|
4269
|
E7 HPV 18 |
Human Papillomavirus |
|
|
|
AAP20595
|
|
|
|
|
CDD:295537 |
E7 protein |
Protective antigen |
|
|
509
|
E7 Type 16 |
Human papillomavirus type 16 |
VO_0011105
|
1489079
|
|
9627105
|
HpV16gp2 |
AB663783 |
NP_041326 |
|
|
transforming protein E7 |
Protective antigen |
Human papillomavirus E7 protein vaccine
Human papillomavirus DNA vaccine Pe7(pcDNA3-Sig/sE7/LAMP) encoding E7
Human papillomavirus DNA vaccine CRT/E7 DNA
Human papillomavirus DNA vaccine E7IR
Human papillomavirus DNA vaccine E7SH DNA
Human papillomavirus DNA vaccine hCRTE6E7L2 DNA encoding CRT linked to E6, E7 and L2
LM1-2-E7
ADXS11-001
MEDI0457
|
|
93
|
eae |
Escherichia coli O157:H7 str. EDL933 |
VO_0010944
|
960862
|
|
WP_129935252
|
Z5110 |
AE005174 |
NP_290259 |
1E5U
|
|
intimin |
Protective antigen |
E. coli vaccine using intimin polypeptide
E. coli subunit vaccine based on intimin and Efa-1 polypeptides
|
|
835
|
eba-175 |
Plasmodium falciparum 3D7 |
VO_0012382
|
2654998
|
|
296004911
|
PF3D7_0731500 |
AL844506 |
XP_001349207 |
|
|
|
Protective antigen |
P. falciparum DNA Vaccine encoding EBA-175
|
|
4561
|
EBNA-1 |
Human gammaherpesvirus 4 |
|
3783709
|
|
82503233
|
HHV4_EBNA-1.1 |
AB850647 |
YP_401677 |
|
|
mRNA |
Protective antigen |
MVA-EBNA1/LMP2 Vaccine
|
|
11
|
EBOV NP |
Reston ebolavirus |
VO_0010859
|
955194
|
|
22789223
|
REBOVgp1 |
AF522874 |
NP_690580 |
|
|
mRNA |
Protective antigen |
NP-VRP
|
|
1326
|
EF |
Bacillus anthracis |
|
|
|
142813
|
|
|
|
|
CDD:149028
CDD:202671 |
edema factor |
Other |
|
|
85
|
efa1 |
Escherichia coli O157:H7 |
|
916316
|
|
WP_001239095
|
ECs3860 |
NC_002695 |
NP_311887 |
|
CDD:315573
CDD:327708 |
cytotoxin |
Protective antigen |
E. coli subunit vaccine based on intimin and Efa-1 polypeptides
E. coli subunit vaccine based on Efa-1 polypeptide
|
|
1732
|
efb |
Staphylococcus aureus subsp. aureus VRS11b |
|
|
|
387748005
|
|
|
|
|
CDD:192953 |
extracellular fibrinogen-binding protein Efb |
Protective antigen |
S. aureus DNA vaccine encoding Efb, FnbpA, ClfA, Cna
|
|
4413
|
EGFR |
Homo sapiens |
|
1956
|
|
1100818972
|
|
AB221348 |
NP_001333826 |
|
|
transcript variant 1 |
Protective antigen |
PF-04948568 Vaccine
Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623
Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1
Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623
PEP-3-KLH Conjugate Vaccine
Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701
EGFRvIII Peptide Vaccine
|
|
798
|
ELI-Ag1 |
Coccidioides immitis |
VO_0011329
|
|
|
37779128
|
|
|
|
|
|
expression library immunization antigen 1 |
Protective antigen |
|
|
92
|
eltB |
Escherichia coli |
VO_0010943
|
|
|
157021162
|
|
|
|
1PZI
|
CDD:279687 |
LTB |
Protective antigen |
soybean-expressed E. coli LTB vaccine
|
|
4791
|
Emb |
Mus musculus |
|
13723
|
|
226437629
|
|
AC123935 |
NP_034460 |
|
|
embigin |
Protective antigen |
|
|
4107
|
emm |
Streptococcus pyogenes |
|
|
|
AAN04081
|
|
|
|
|
CDD:235600
CDD:274008 |
M24 |
Protective antigen |
|
|
854
|
emm1 |
Streptococcus pyogenes |
VO_0012397
|
|
311757
|
311758
|
|
|
CAA44062.1 |
2OTO
|
CDD:273479
CDD:291694
CDD:295219
CDD:279132
GOA:Q10372
HSSP: 1IC2
InterPro: IPR001899
InterPro: IPR005877
InterPro: IPR019931
InterPro: IPR019948
InterPro: IPR019950
UniProtKB/TrEMBL: Q10372 |
M protein type 1 |
Protective antigen |
S. pyogenes M Protein Vaccine
|
|
4112
|
emm12 mutant |
Streptococcus pyogenes |
|
|
|
BAD14986
|
|
|
|
|
ATCC:12353
CDD:273479
CDD:302792
CDD:303051
CDD:287450
CDD:295219 |
M12 mutant protein precursor |
Protective antigen |
|
|
4115
|
emm3 |
Streptococcus pyogenes |
|
|
|
CAA56449
|
|
|
|
|
CDD:273479
CDD:303051
CDD:287450
CDD:287215
CDD:279132
GOA:Q54835
InterPro: IPR001899
InterPro: IPR005877
InterPro: IPR019931
InterPro: IPR019948
InterPro: IPR019950
UniProtKB/TrEMBL: Q54835 |
M3 protein |
Protective antigen |
|
|
4157
|
endopeptidase O(PepO) |
Streptococcus pneumoniae |
|
|
|
EJG73599
|
|
|
|
|
|
endopeptidase O |
Protective antigen |
|
|
721
|
Eng |
Mus musculus |
|
13805
|
|
226437649
|
RP23-17P12.4 |
AL772271 |
NP_001139820 |
|
|
transcript variant 2 |
Protective antigen |
Cancer DNA Vaccine encoding Endoglin Boosted with Recombinant Endoglin Protein
|
|
4756
|
ENG |
Homo sapiens |
|
2022
|
|
4557555
|
|
AF035753 |
NP_000109 |
|
|
transcript variant 2 |
Protective antigen |
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
|
|
4025
|
enhA1 |
Coxiella burnetii Q321] |
|
|
|
EDR35563
|
|
|
|
|
|
enhanced entry protein EnhA |
Protective antigen |
|
|
4044
|
eno |
Chlamydia trachomatis |
|
|
|
AKR39796
|
|
|
|
|
CDD:213580 |
enolase |
Protective antigen |
|
|
4209
|
eno |
Streptococcus agalactiae |
|
|
|
AFV72009
|
|
|
|
|
CDD:234617 |
Enolase |
Protective antigen |
|
|
4035
|
enolase |
Chlamydophila pneumoniae |
|
|
|
AAP98758
|
|
|
|
|
CDD:213580
CDD:239429 |
enolase |
Protective antigen |
|
|
4191
|
entA_1 |
Staphylococcus aureus subsp. aureus SK1585 |
|
|
|
KFD31781
|
|
|
|
|
|
sea |
Protective antigen |
|
|
153
|
env |
Human immunodeficiency virus 1 |
VO_0010937
|
|
|
8218033
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369
GOA:Q9IBN3
HSSP: 1MEQ
InterPro: IPR000328
InterPro: IPR000777
UniProtKB/TrEMBL: Q9IBN3 |
ENV (gp160) |
Protective antigen |
HIV priming with DNA vaccine expressing HIV gp160 protein and boosted with Ad5/35 vector expressing the same protein
DNA vaccine expressing multiple HIV epitopes
|
|
1240
|
env |
Human immunodeficiency virus 1 |
|
155971
|
|
9629363
|
HIV1gp8 |
AF033819 |
NP_057856 |
|
|
Envelope surface glycoprotein gp160, precursor |
Protective antigen |
HIV DNA vaccine env-pcDNA3.1 encoding env
Combination of HIV DNA vaccine pCMV HIV gag and pCMV HIV gp120 and gp140
HIV DNA vaccine ALVAC-HIV encoding env, gag, and pro
HIV adnenovirus vector vaccine Ad28 encoding env, gag, and pro
HIV DNA vaccine Ad26/Ad5HVR48 encoding HIV or SIV env or gag
HIV DNA vaccine HIV DNA encoding gp160
HIV DNA vaccine pHIS-SHIV-B
HIV recombinant vector vaccine MVA.HIVA encoding env and rev
HIV priming with DNA vaccine expressing HIV gp160 protein and boosted with Ad5/35 vector expressing the same protein
ALVAC-HIV-2- env/gag/pol
|
|
1243
|
env |
Simian immunodeficiency virus |
|
|
|
532231
|
|
|
|
|
CDD:109567
CDD:197369 |
envelope glycoprotein |
Other |
SIV DNA vaccine pVacc4 encoding env from mac239
SabRV-SIV
|
|
1251
|
env |
Human immunodeficiency virus 1 |
|
|
|
169641099
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
envelope glycoprotein |
Protective antigen |
|
|
1261
|
env |
Human immunodeficiency virus 1 MN |
|
|
|
3342812
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
envelope glycoprotein |
Protective antigen |
HIV DNA vaccine APL 400–003 encoding env and rev
HIV DNA vaccine pCMN160
|
|
1266
|
env |
Human immunodeficiency virus 1 |
|
|
|
58043865
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
envelope glycoprotein |
Protective antigen |
|
|
1273
|
env |
Human immunodeficiency virus 1 |
|
|
|
1129018
|
|
|
|
|
CDD:278917 |
envelope glycoprotein gp120 |
Protective antigen |
|
|
1708
|
env |
Simian-Human immunodeficiency virus strain SHIV89.6P |
|
|
|
72398919
|
|
|
|
|
CDD:278917 |
envelope protein |
Protective antigen |
DNA and poxvirus priming-boosting SHIV vaccine
HIV DNA vaccine SIVmac239 Gag-Pol-Nef and mock Env with rAd5 boost
|
|
1711
|
env |
Simian-Human immunodeficiency virus strain SHIV-89.6 |
|
|
|
2828045
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
env |
Protective antigen |
HIV DNA vaccine SHIV-89.6 DNA (DNA/89.6)
|
|
1720
|
env |
Human immunodeficiency virus 2 |
|
|
|
1845209
|
|
|
|
|
CDD:278917
CDD:278918
CDD:197369 |
envelope polyprotein |
Protective antigen |
HIV-2 DNA vaccine
ALVAC-HIV-2
|
|
1738
|
env |
Reticuloendotheliosis virus strain APC-566 |
|
|
|
88605105
|
|
|
|
|
CDD:278837
CDD:197368 |
env protein |
Protective antigen |
REV DNA vaccine VP22/gag and VP22/env
REV gp90 Vaccine
|
|
1747
|
env |
Human immunodeficiency virus 1 isolate 715 from Baltimore clone 6 |
|
|
|
475647
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
envelope glycoprotein |
Protective antigen |
SHIV DNA vaccine encoding env and gag
SHIV(Ba-L) DNA vaccine encoding env and gag
|
|
1748
|
env |
Human immunodeficiency virus 1 strain Ba-L subtype B |
|
|
326367
|
326371
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
|
Protective antigen |
SHIV DNA vaccine encoding env and gag
SHIV(Ba-L) DNA vaccine encoding env and gag
|
|
1749
|
env |
Human immunodeficiency virus 1 strain 96ZM651 |
|
|
|
13569225
|
|
|
|
|
CDD:278917
CDD:197369 |
envelope glycoprotein |
Protective antigen |
SHIV DNA vaccine encoding env and gag
SHIV(Ba-L) DNA vaccine encoding env and gag
|
|
1750
|
env |
Human immunodeficiency virus 1 strain 976 clone 17 |
|
|
|
475668
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
envelope glycoprotein |
Protective antigen |
SHIV DNA vaccine encoding env and gag
SHIV(Ba-L) DNA vaccine encoding env and gag
|
|
1752
|
env |
Human immunodeficiency virus 1 isolate 037 clone 08 |
|
|
|
487257
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
envelope glycoprotein |
Protective antigen |
SHIV(Ba-L) DNA vaccine encoding env and gag
|
|
1753
|
env |
Simian-Human immunodeficiency virus |
|
|
|
343533448
|
|
|
|
|
CDD:278917
CDD:295533
CDD:197369 |
envelope glycoprotein |
Protective antigen |
|
|
4249
|
env |
Feline herpesvirus 1 |
|
|
|
BAA12690
|
|
|
|
|
CDD:150302 |
env, partial [Feline immunodeficiency virus] |
Protective antigen |
|
|
4280
|
env |
Bovine Leukemia virus |
|
|
|
BAV53924
|
|
|
|
|
|
gp51 |
Protective antigen |
|
|
4709
|
env |
Human immunodeficiency virus 1 |
|
155971
|
|
9629363
|
HIV1gp8 |
AF033819 |
NP_057856 |
|
|
Envelope surface glycoprotein gp160, precursor |
Protective antigen |
HIVgP160 Vaccine
AUT-OV-ALVAC-hB7.1 Vaccine
|
|
1411
|
env from FeLV-A/Glasgow |
Feline leukemia virus |
|
|
|
546071
|
|
|
|
|
CDD:278837 |
gp70 |
Protective antigen |
FeLV DNA vaccine gag/pol and env
ALVAC-FL- env/gag
|
|
1250
|
env from SIV |
Simian immunodeficiency virus |
|
1490007
|
|
9627208
|
SIVgp6 |
M58410 |
NP_054372 |
|
|
envelope protein |
Protective antigen |
HIV DNA vaccine Ad26/Ad5HVR48 encoding HIV or SIV env or gag
rMVTT-SIV-gpe
|
|
465
|
Env from strain FRA |
Feline leukemia virus |
VO_0011068
|
1491868
|
|
9630709
|
FeLVgp2 |
AF052723 |
NP_047256 |
|
|
Env polyprotein |
Protective antigen |
EURIFEL FeLV
|
|
1254
|
env HIV |
Human immunodeficiency virus 1 |
|
155971
|
|
9629363
|
HIV1gp8 |
AF033819 |
NP_057856 |
|
|
Envelope surface glycoprotein gp160, precursor |
Other |
|
|
1244
|
env receptor binding subunit |
Simian immunodeficiency virus |
|
|
|
603752
|
|
|
|
|
CDD:109567 |
envelope glycoprotein gp120 receptor binding subunit |
Other |
SabRV-SIV
|
|
411
|
Env/Rex/Tax |
Bovine leukemia virus |
VO_0011051
|
2760849
|
|
9626230
|
BLVgp05 |
AF033818 |
NP_056898 |
|
|
p18 |
Protective antigen |
Bovine leukemia virus DNA vaccine encoding Env
|
|
496
|
envelope |
Hepatitis B virus |
VO_0011094
|
|
|
113207330
|
|
|
|
|
CDD:279085
GOA:Q0KG42
InterPro: IPR000349
UniProtKB/TrEMBL: Q0KG42 |
preS2 middle surface protein |
Protective antigen |
Hepatitis B virus DNA vaccine pVAX-PS
|
|
4809
|
envelope (E) protein |
Severe acute respiratory syndrome coronavirus 2 |
|
43740570
|
|
1796318600
|
GU280_gp04 |
LC528232 |
YP_009724392 |
|
|
envelope protein |
Protective antigen |
|
|
4262
|
envelope (E) proteins |
Japanese encephalitis virus |
|
|
|
P27395
|
|
|
|
|
CDD:250285
CDD:279856
CDD:279358
CDD:279241
CDD:213392
CDD:213897
CDD:279316
CDD:279359
CDD:279357
CDD:279317
CDD:214692
CDD:284962
CDD:238005
CDD:304359
CDD:238034
CDD:279666
CDD:279665
CDD:279986
CDD:279336 |
Genome polyprotein |
Protective antigen |
|
|
1242
|
Envelope polyprotein from HXB2 |
Human immunodeficiency virus 1 |
|
|
|
1906385
|
|
|
|
|
CDD:278917
CDD:278918
CDD:197369 |
|
Protective antigen |
|
|
915
|
envelope protein (E) gene of SARS-CoV |
Severe acute respiratory syndrome-related coronavirus |
|
1489671
|
|
29836499
|
sars4 |
|
NP_828854 |
|
|
protein E |
Virmugen |
SARS-CoV E gene mutant vaccine
rMA15-ΔE vaccine
|
|
1287
|
Envelope proteins |
Hepatitis B virus |
|
|
|
1510158
|
|
|
|
|
CDD:109739 |
envelope proteins |
Other |
Hepatitis B DNA vaccine pS encoding major envelope proteins
|
|
1072
|
envZ |
Shigella flexneri 5 str. 8401 |
|
4207729
|
|
110807236
|
SFV_3409 |
CP000266 |
YP_690756 |
2LFR
|
|
osmolarity sensor protein |
Virmugen |
Shigella flexneri envZ mutant vaccine
|
|
4320
|
EP153R |
African Swine Fever Virus |
|
|
|
AJZ77151
|
|
|
|
|
CDD:214480 |
EP153R |
Protective antigen |
|
|
317
|
EPCAM |
Homo sapiens |
|
4072
|
|
218505670
|
|
AC079775 |
NP_002345 |
|
|
epithelial cell adhesion molecule |
Protective antigen |
Cancer EPCAM protein vaccine
KSA-KLH Conjugate Vaccine
Recombinant Colorectal cancer antigen GA733 Vaccine
|
|
4525
|
EPHA2 |
Homo sapiens |
|
1969
|
|
1041818018
|
|
AL451042 |
NP_001316019 |
|
|
transcript variant 2 |
Protective antigen |
HLA-A*0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide Vaccine
DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
|
|
296
|
ERBB2 |
Homo sapiens |
|
2064
|
|
54792098
|
RP23-355L10.8 |
AB025285 |
NP_001005862 |
|
|
transcript variant 3 |
Protective antigen |
Cancer Her-2/neu Protein Subunit Vaccine
Adenovirus HER2-Transduced Autologous Dendritic Cell Vaccine
AE37 Peptide/GM-CSF Vaccine
HLA-A*0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide Vaccine
HER2-pulsed Autologous Type-1 Polarized Dendritic Cell Vaccine
HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901
Monoclonal Antibody 4B5 Anti-Idiotype Vaccine
Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
MVF-HER-2(597-626)/MVF-HER-2 (266-296) Peptide Vaccine
Nelipepimut-S Plus GM-CSF Vaccine
EP-2101 Vaccine
pNGVL3-hICD Vaccine
Poly Microsphere Encapsulated HER2/neu Oral Vaccine
Recombinant dHER2 Vaccine
Survivin/p53/HER2 Antigen-loaded Autologous Dendritic Cell Vaccine
Allogeneic GM-CSF-Secreting Breast Cancer Vaccine
Autologous GM-CSF-Secreting Breast Cancer Vaccine
Autologous Ovarian Tumor Cell Lysate-Pulsed Dendritic Cell Vaccine
Lapuleucel-T Vaccine
CD80 Breast Cancer Vaccine
Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine
Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
Mammaglobin-A DNA Vaccine
|
|
4731
|
Erbb2 |
Rattus norvegicus |
|
24337
|
|
77020289
|
|
AABR07030444 |
NP_058699 |
|
|
erb-b2 receptor tyrosine kinase 2 |
Protective antigen |
Adenovirus Encoding Rat HER-2/neu
|
|
1693
|
esa1 |
Edwardsiella tarda strain TX1 |
|
|
|
302136428
|
|
|
|
|
CDD:236834
CDD:284624
CDD:279448 |
putative surface antigen |
Protective antigen |
E. tarda DNA vaccine pCEsa1
|
|
4003
|
eseC |
Edwardsiella tarda EIB201 |
|
|
|
AAV69404
|
|
|
|
|
CDD:237952 |
EseC |
Protective antigen |
|
|
4008
|
eseD |
Edwardsiella tarda |
|
|
|
AAV69405
|
|
|
|
|
CDD:185259 |
EseD |
Protective antigen |
|
|
3977
|
espA |
Escherichia coli O157:H7 |
|
|
|
EIP05353
|
|
|
|
|
|
espA |
Protective antigen |
EspA-Tir-M novel fusion protein vaccine
|
|
3987
|
espB |
Escherichia coli O157:H7 |
|
|
|
EIP05354
|
|
|
|
|
|
espB |
Protective antigen |
|
|
1057
|
esrB |
Edwardsiella tarda EIB202 |
|
8607237
|
|
269138242
|
ETAE_0886 |
CP001135 |
YP_003294942 |
|
|
two-component response regulator EsrB, LuxR family |
Virmugen |
Edwardsiella tarda esrB mutant vaccine
|
|
1092
|
esrC |
Edwardsiella tarda EIB202 |
|
8607212
|
|
269138217
|
ETAE_0861 |
CP001135 |
YP_003294917 |
|
|
putative transcriptional regulator EsrC |
Virmugen |
Edwardsiella tarda aroC/esrC mutant vaccine
|
|
4176
|
esxA |
Staphylococcus aureus |
|
|
|
A0A0H2XI99
|
|
|
|
|
CDD:227179 |
ESAT-6 secretion system extracellular protein A |
Protective antigen |
|
|
104
|
EsxA (ESAT-6) |
Mycobacterium tuberculosis H37Rv |
VO_0010919
|
886209
|
|
57117165
|
Rv3875 |
AL123456 |
YP_178023 |
|
EMBL: AE000516
EMBL: AF004671
EMBL: AF420491
EMBL: BX842584
EMBL: X79562
GenomeReviews: AE000516_GR
GenomeReviews: AL123456_GR
InterPro: IPR010310
KEGG: mtc:MT3989
KEGG: mtu:Rv3875
PDB: 1WA8
Pfam: PF06013
PIR: A70803
TIGR: MT3989
TubercuList: Rv3875
UniProt: P0A564 |
ESAT-6 protein EsxA |
Protective antigen |
recombinant S. typhimurium secreting M. tuberculosis ESAT-6
Ag85B and ESAT-6 fusion protein
MVA/IL-15/5Mtb vaccine
|
|
121
|
EsxB |
Mycobacterium tuberculosis H37Rv |
VO_0010951
|
886194
|
|
15611010
|
Rv3874 |
AF004671 |
NP_218391 |
3FAV
|
EMBL: AE000516
EMBL: AF004671
EMBL: AF419854
EMBL: BX842584
GenomeReviews: AE000516_GR
GenomeReviews: AL123456_GR
InterPro: IPR010310
KEGG: mtc:MT3988
KEGG: mtu:Rv3874
Pfam: PF06013
PIR: H70802
SMR: P0A566
TIGR: MT3988
TubercuList: Rv3874
UniProt: P0A566 |
ESAT-6-like protein EsxB |
Protective antigen |
|
|
4177
|
esxB |
Staphylococcus aureus |
|
|
|
A0A0H2XIE9
|
|
|
|
|
CDD:310537 |
ESAT-6 secretion system extracellular protein B |
Protective antigen |
|
|
4396
|
esxV |
Mycobacterium tuberculosis H37Rv |
|
|
|
NP_218136
|
|
|
|
|
CDD:310537 |
ESAT-6 like protein EsxV |
Protective antigen |
ID93/GLA-SE
|
|
4397
|
esxW |
Mycobacterium tuberculosis H37Rv |
|
|
|
NP_218137
|
|
|
|
|
CDD:310537 |
ESAT-6 like protein EsxW |
Protective antigen |
ID93/GLA-SE
|
|
1691
|
et18 |
Edwardsiella tarda |
|
|
|
74474893
|
|
|
|
|
CDD:182907 |
antigenic protein Et 18 |
Protective antigen |
E. tarda DNA vaccine pCE18
|
|
4015
|
eta21 |
Edwardsiella tarda |
|
|
|
ACY64541
|
|
|
|
|
CDD:223685 |
putative peptidase |
Protective antigen |
|
|
1692
|
eta6 |
Edwardsiella tarda strain TX1 |
|
|
|
262223754
|
|
|
|
|
CDD:320798
CDD:153074 |
hypothetical protein Eta6 |
Protective antigen |
E. tarda DNA vaccine pCE6
|
|
4007
|
eta81 |
Edwardsiella tarda |
|
|
|
AFM47374
|
|
|
|
|
|
putative adhesin |
Protective antigen |
|
|
3980
|
etpA |
Escherichia coli |
|
|
|
AAX13509
|
|
|
|
|
CDD:289765
CDD:297026
CDD:225751 |
EtpA |
Protective antigen |
|
|
3965
|
etsC |
Escherichia coli |
|
|
|
YP_444081
|
|
|
|
|
CDD:332259 |
EtsC |
Protective antigen |
|
|
4774
|
EWSR1 |
Homo sapiens |
|
2130
|
|
253970502
|
|
AB005538 |
NP_001156757 |
|
|
transcript variant X34 |
Protective antigen |
EF-1 Peptide Vaccine
|
|
4954
|
exa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
601
|
ExbB |
Neisseria meningitidis MC58 |
VO_0011186
|
903370
|
|
15677575
|
NMB1729 |
AE002098 |
NP_274732 |
|
|
biopolymer transport protein |
Protective antigen |
N. meningitidis ExbB Protein Vaccine
|
|
1307
|
Exported protein 1 from Plasmodium falciparum |
Plasmodium falciparum |
|
|
|
39843114
|
|
|
|
|
CDD:174853 |
exported protein 1 |
Protective antigen |
|
|
934
|
exsA |
Brucella melitensis biovar Abortus 2308 |
|
3787220
|
|
82699354
|
BAB1_0468 |
AM040264 |
YP_413928 |
|
|
ABC transporter ATPase |
Virmugen |
Brucella abortus exsA mutant vaccine
|
|
1601
|
F |
Newcastle disease virus strain D26/76 |
|
|
|
549308
|
|
|
|
|
CDD:278924 |
Fusion glycoprotein F0 |
Protective antigen |
|
|
1666
|
F |
Bovine respiratory syncytial virus strain Snook |
|
|
|
3451386
|
|
|
|
|
CDD:278924
GOA:O90698
HSSP: 1G2C
InterPro: IPR000776
InterPro: IPR013055
UniProtKB/TrEMBL: O90698 |
F protein |
Protective antigen |
BRSV DNA vaccine VCL-Fb
|
|
4265
|
F |
Mumps virus |
|
|
|
AJD08938
|
|
|
|
|
CDD:278924 |
fusion protein |
Protective antigen |
|
|
4311
|
F |
Human metapneumovirus |
|
|
|
AAU12148
|
|
|
|
|
CDD:278924 |
F protein |
Protective antigen |
|
|
578
|
F fusion protein |
Measles morbillivirus |
VO_0011167
|
1489800
|
|
9626950
|
MeVgp4 |
AB016162 |
NP_056922 |
|
|
mRNA |
Protective antigen |
Measles Virus vaccine VEE/SIN-H+F
ALVAC-MV-HA/F
|
|
624
|
F fusion protein |
Newcastle disease virus B1 |
VO_0011208
|
912271
|
|
11545723
|
NDVgp4 |
AF309418 |
NP_071469 |
3MAW
|
|
fusion protein |
Protective antigen |
Newcastle disease virus DNA vaccine pCAGF encoding the F protein
HVT-ND
rAPMV3-F (newcastle disease)
|
|
783
|
F fusion protein |
Nipah virus |
VO_0011314
|
|
8164021
|
8164022
|
|
|
AAF73956.1 |
|
CDD:306910 |
fusion protein |
Protective antigen |
NIpah Virus G and F Proteins Subunit Vaccine
ALVAC-NiV-G
ALVAC-NiV-F
|
|
1670
|
F protein |
Human respiratory syncytial virus |
|
|
|
306438651
|
|
|
|
|
CDD:278924
GOA:E0WLR1
InterPro: IPR000776
UniProtKB/TrEMBL: E0WLR1 |
F protein |
Protective antigen |
HRSV DNA vaccine DRF-412
Respiratory syncytal virus bivalent prefusion F vaccine
RSV/ΔNS2/Δ1313/I1314
rB/HPIV3- RSV-F
rPIV3-RSV-hMPV
MEDI-534
|
|
564
|
F1-ATPase |
Leishmania donovani |
VO_0011154
|
|
|
722242
|
|
|
|
|
CDD:304359
CDD:238540
CDD:278722 |
F1-ATPase beta subunit |
Protective antigen |
L. donovani LD31 Protein Vaccine
|
|
67
|
F13L |
Vaccinia virus (strain: WR (Western Reserve)) |
|
3707509
|
|
|
VACWR052 |
|
|
|
|
|
|
LC16m8
|
|
4247
|
F9 |
Feline calicivirus |
|
|
|
AAB23553
|
|
|
|
|
CDD:279283 |
capsid protein |
Protective antigen |
|
|
1081
|
FabB/FabF |
Plasmodium falciparum 3D7 |
|
3885996
|
|
296004726
|
PFF1275c |
AL844505 |
XP_966246 |
1OB1
|
|
|
Virmugen |
Plasmodium FabB/FabF mutant vaccine
|
|
440
|
FabD |
Chlamydophila pneumoniae CWL029 |
VO_0010895
|
894994
|
|
15618217
|
CPn0297 |
AE001363 |
NP_224502 |
|
|
malonyl CoA-acyl carrier protein transacylase |
Protective antigen |
C. pneumoniae DNA vaccine encoding FabD
|
|
1363
|
FABP |
Schistosoma japonicum |
|
|
|
349804
|
|
|
|
|
CDD:278490 |
fatty acid binding protein |
Protective antigen |
Chinese S. japonicum DNA vaccine pVAX/SjFABP encoding FABP
|
|
323
|
fad |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
906
|
fadD26 |
Mycobacterium tuberculosis H37Rv |
|
887603
|
|
57117038
|
Rv2930 |
BX842581 |
NP_217446 |
|
|
acyl-CoA synthetase |
Virmugen |
Mycobacterium tuberculosis fadD26 mutant vaccine
|
|
91
|
FaeG |
Escherichia coli |
|
|
|
|
|
|
|
|
|
|
|
E. coli FaeG DNA vaccine
soybean-expressed E. coli LTB vaccine
|
|
289
|
faeG |
Escherichia coli SE11 |
VO_0010993
|
7003192
|
|
WP_000751752
|
ECSE_P3-0034 |
AP009243 |
YP_002295988 |
|
CDD:308182 |
F4 fimbrial adhesin subunit FaeG |
Protective antigen |
|
|
696
|
Fas |
Mus musculus |
|
14102
|
|
226443053
|
|
AC102285 |
NP_001140180 |
|
|
transcript variant 1 |
Protective antigen |
|
|
302
|
Fasl |
Mus musculus |
|
14103
|
|
327478405
|
|
AC164414 |
NP_001192172 |
|
|
transcript variant 2 |
Protective antigen |
|
|
301
|
FASLG |
Homo sapiens |
|
356
|
|
4557329
|
|
AB013303 |
NP_000630 |
|
|
transcript variant 1 |
Protective antigen |
|
|
853
|
fbaA |
Streptococcus pyogenes SSI-9 |
VO_0012396
|
|
|
14915682
|
|
|
|
|
CDD:273479
CDD:320995
CDD:273478 |
fibronectin-binding protein |
Protective antigen |
S. pyogenes FbaA Protein Vaccine
|
|
4127
|
fbaA |
Streptococcus pyogenes |
|
|
|
AMY98237
|
|
|
|
|
CDD:273479
CDD:331285
CDD:273478 |
Fibronectin-binding protein |
Protective antigen |
|
|
632
|
Fbp |
Streptococcus equi subsp. equi 4047 |
VO_0011216
|
7697172
|
|
225871286
|
SEQ_2017 |
FM204883 |
YP_002747233 |
|
|
antiphagocytic cell surface-anchored fibrinogen-and IgG Fc-binding protein SeM |
Protective antigen |
|
|
4152
|
fbp54 |
Streptococcus pyogenes |
|
|
|
AAR18990
|
|
|
|
|
CDD:224212
CDD:283353 |
fibronectin/fibrinogen-binding protein |
Protective antigen |
S. pyogenes FBP54 Protein Vaccine
|
|
1414
|
fbpA |
Mycobacterium marinum |
|
|
|
13431282
|
|
|
|
|
CDD:304388 |
Diacylglycerol acyltransferase/mycolyltransferase Ag85A |
Protective antigen |
M. marinum pCMV-85A
|
|
122
|
FbpA (Ag85A) |
Mycobacterium tuberculosis H37Rv |
VO_0010952
|
886132
|
|
15610940
|
Rv3804c |
AL123456 |
NP_218321 |
1SFR
|
EMBL: AE000516
EMBL: BX842584
EMBL: M27016
EMBL: U47335
GenomeReviews: AE000516_GR
GenomeReviews: AL123456_GR
InterPro: IPR000801
KEGG: mtc:MT3911
KEGG: mtu:Rv3804c
PDB: 1SFR
Pfam: PF00756
PIR: H70887
TIGR: MT3911
TubercuList: Rv3804c
UniProt: P0A4V2 |
diacylglycerol acyltransferase/mycolyltransferase Ag85A |
Protective antigen |
MVA85A prime and BCG boost
rBCG-Ag85A[Tokyo]
DNA vaccine co-expressing A85A and caspase-3
MVA/IL-15/5Mtb vaccine
M. tuberculosis DNA vaccine pcDNA3.1+/Ag85A DNA encoding Ag85A
M. tuberculosis DNA vaccine DNAAg85A encoding a single immunogenic M.tb Ag
rBCG-Ag85A/ Ag85B
|
|
814
|
FbpD |
Mycobacterium bovis BCG str. Tokyo 172 |
VO_0012366
|
7562680
|
|
224992215
|
JTY_3867 |
AP010918 |
YP_002646905 |
1R88
|
|
MPT51/MPB51 antigen protein |
Protective antigen |
|
|
645
|
FCR3S1.2-var1 |
Plasmodium falciparum |
VO_0011229
|
810160
|
|
2961468
|
|
|
|
|
CDD:292087
CDD:283158
CDD:281064
CDD:114603
CDD:292085 |
erythrocyte membrane protein 1 |
Protective antigen |
|
|
4625
|
FCY1 |
Saccharomyces cerevisiae S288C |
|
856175
|
|
6325319
|
YPR062W |
BK006949 |
NP_015387 |
|
|
|
Protective antigen |
rMeV- SCD
|
|
3992
|
FdeC |
Escherichia coli |
|
|
|
WP_000092542
|
|
|
|
|
CDD:314749
CDD:329065
CDD:214751 |
intimin-like adhesin FdeC |
Protective antigen |
|
|
3976
|
fedA |
Escherichia coli |
|
|
|
WP_119805777
|
|
|
|
|
CDD:321493 |
F18 fimbrial major subunit FedA |
Protective antigen |
|
|
3975
|
fedF |
Escherichia coli |
|
|
|
CAA81288
|
|
|
|
|
UniProtKB/TrEMBL: Q47212 |
FedF |
Protective antigen |
|
|
4447
|
FGF2 |
Homo sapiens |
|
2247
|
|
1371565425
|
|
AC021205 |
NP_001348594 |
|
|
transcript variant 1 |
Protective antigen |
Adenovirus 5-Fibroblast Growth Factor 2
|
|
4430
|
FGF5 |
Homo sapiens |
|
2250
|
|
620597367
|
|
AC021127 |
NP_001278741 |
|
|
transcript variant 1 |
Protective antigen |
117-126:FGF-5 Peptide
HLA-A2, A3-Restricted FGF-5 Peptides/Montanide ISA-51 Vaccine
|
|
375
|
fhaB |
Bordetella pertussis |
VO_0011030
|
|
|
3980256
|
|
|
|
1RWR
|
CDD:289765
CDD:283510
CDD:293785
CDD:290071
CDD:292650
GOA:Q45365
InterPro: IPR008619
InterPro: IPR008638
InterPro: IPR010069
InterPro: IPR011050
InterPro: IPR011102
InterPro: IPR012334
UniProtKB/TrEMBL: Q45365 |
filamentous hemagglutinin |
Protective antigen |
B. pertussis FhaB and 69 kDa OMP protein vaccine
|
|
446
|
FHc |
|
VO_0010901
|
|
|
166236883
|
|
|
|
|
CDD:285228
CDD:285226 |
recombinant botulinum toxin F Hc domain |
Protective antigen |
C. botulinum FHc protein vaccine
|
|
4099
|
fhuA |
Actinobacillus pleuropneumoniae |
|
|
|
AAM69431
|
|
|
|
|
CDD:237595
CDD:238657 |
outer membrane ferric hydroxamate receptor FhuA |
Protective antigen |
|
|
4179
|
Fhud2 |
Staphylococcus aureus |
|
|
|
4B8Y_A
|
|
|
|
|
CDD:223687
CDD:294188
CDD:238347 |
ferrichrome ABC transporter substrate-binding protein |
Protective antigen |
|
|
4654
|
FIM3 |
Homo sapiens |
|
2279
|
|
|
|
|
|
|
|
Friend-murine leukemia virus integration site 3 homolog |
Protective antigen |
|
|
4010
|
fimA |
Edwardsiella tarda |
|
|
|
ABK57121
|
|
|
|
|
CDD:226069 |
major fimbrial subunit protein |
Protective antigen |
|
|
3978
|
fimH |
Escherichia coli |
|
|
|
AGA03820
|
|
|
|
|
CDD:198456
CDD:312615
CDD:321493 |
FimH |
Protective antigen |
|
|
281
|
FimH from E. coli str. K-12 substr. MG1655 |
Escherichia coli str. K-12 substr. MG1655 |
VO_0010987
|
948847
|
|
16132141
|
b4320 |
CP009685 |
NP_418740 |
|
|
type 1 fimbriae D-mannose specific adhesin |
Protective antigen |
KLH-s-FimH1-25 with CFA and then IFA
E. coli FimH with CFA and then IFA
|
|
263
|
FimH from E. coli UTI89 |
Escherichia coli UTI89 |
VO_0010945
|
3992235
|
|
91213965
|
UTI89_C5017 |
CP000243 |
YP_543951 |
1TR7
|
|
type 1 fimbiral adhesin FimH |
Protective antigen |
|
|
3983
|
FimH/MrpH fusion protein |
Escherichia coli |
|
|
|
AHW46359
|
|
|
|
|
CDD:198456
CDD:286270
CDD:294848 |
FimH/MrpH fusion protein |
Protective antigen |
|
|
4775
|
FL1 |
Homo sapiens |
|
100306940
|
|
|
|
|
|
|
|
Follicular lymphoma, susceptibility to, 1 |
Protective antigen |
EF-1 Peptide Vaccine
|
|
1075
|
fla |
Borrelia burgdorferi HB19 |
|
|
|
435009
|
|
|
|
|
CDD:183758
CDD:144315
CDD:144340
GOA:Q44895
HSSP: 1ORY
InterPro: IPR001029
InterPro: IPR001444
InterPro: IPR001492
InterPro: IPR019776
UniProtKB/TrEMBL: Q44895 |
flagellin |
Virmugen |
Borrelia burgdorferi fla mutant vaccine
|
|
3925
|
flaA chimeric flagellin |
Helicobacter pylori |
|
|
|
AGI42755
|
|
|
|
|
CDD:237146
CDD:279061
CDD:284584
CDD:279090 |
FlaA |
Protective antigen |
|
|
398
|
FlaA from C. jejuni 81-176 |
Campylobacter jejuni subsp. jejuni 81-176 |
VO_0011046
|
4682159
|
|
121612545
|
CJJ81176_1339 |
AY102622 |
YP_001000997 |
|
|
flagellin |
Protective antigen |
C. jejuni MBP-FlaA protein vaccine
|
|
87
|
FlaA from C. jejuni NCTC 11168 |
Campylobacter jejuni subsp. jejuni NCTC 11168 = ATCC 700819 |
VO_0010942
|
905631
|
|
218562948
|
Cj1339c |
AL111168 |
YP_002344727 |
|
BioCyc: CJEJ192222:CJ1339C-MONOMER
EMBL: AL139078
InterPro: IPR001029
InterPro: IPR001492
InterPro: IPR010810
KEGG: cje:Cj1339c
Pfam: PF00669
Pfam: PF00700
Pfam: PF07196
PIR: H81277
PRINTS: PR00207
ProDom: PD000316
UniProt: P56963
|
flagellin A |
Protective antigen |
MBP fused on Campylobacter FlaA (MBP-FlaA)
|
|
400
|
FlaC |
Campylobacter jejuni subsp. jejuni 81-176 |
VO_0011048
|
4682885
|
|
121612344
|
CJJ81176_0743 |
CP000538 |
YP_001000416 |
|
|
flagellin subunit protein FlaC |
Protective antigen |
C. jejuni FlaC protein vaccine
|
|
3998
|
flagellar hook assembly protein FlgD |
Edwardsiella tarda |
|
|
|
WP_035598485
|
|
|
|
|
CDD:235847 |
flagellar hook assembly protein FlgD |
Protective antigen |
|
|
3877
|
flagellin |
Pseudomonas aeruginosa |
|
|
|
CAA67105
|
|
|
|
|
CDD:279061
CDD:284584
CDD:224263
CDD:279090
GOA:P72127
HSSP: 1ORY
InterPro: IPR001029
InterPro: IPR001492
InterPro: IPR010810
UniProtKB/TrEMBL: P72127 |
flagellin |
Protective antigen |
|
|
4014
|
flagellin FliC |
Edwardsiella tarda |
|
|
|
ATI65365
|
|
|
|
|
CDD:235867 |
flagellin FliC |
Protective antigen |
|
|
4071
|
flgK |
Burkholderia pseudomallei |
|
|
|
AIV80017
|
|
|
|
|
CDD:235895 |
flagellar hook-associated protein FlgK |
Protective antigen |
|
|
927
|
fliC |
Salmonella enterica subsp. enterica serovar Enteritidis |
|
|
|
119351647
|
|
|
|
|
CDD:181201 |
FliC |
Virmugen |
Salmonella enterica fliC/guaB mutant vaccine
|
|
770
|
fliC |
|
VO_0011303
|
|
|
1929918
|
|
|
|
|
CDD:236344 |
flagellin |
Protective antigen |
B. pseudomallei DNA vaccine encoding Flagellin Protein
|
|
1690
|
fliC |
Edwardsiella tarda strain TX1 |
|
|
|
262223752
|
|
|
|
|
CDD:235867
CDD:279061
CDD:279090 |
flagellin |
Protective antigen |
E. tarda DNA vaccine pCE18
E. tarda DNA vaccine pCE6
|
|
3886
|
fliC |
Pseudomonas aeruginosa |
|
|
|
AAP34195
|
|
|
|
|
CDD:236344 |
FliC |
Protective antigen |
|
|
3890
|
fliC |
Pseudomonas aeruginosa |
|
|
|
AAB69135
|
|
|
|
|
CDD:279061
CDD:284584
CDD:279090 |
flagellin |
Protective antigen |
|
|
3979
|
fliC |
Escherichia coli |
|
|
|
429545217
|
|
|
|
|
CDD:236140
CDD:279061
CDD:289230
CDD:279090 |
FliC |
Protective antigen |
|
|
1087
|
fliD |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1253481
|
|
16765298
|
STM1960 |
AE006468 |
NP_460913 |
|
|
flagellar capping protein |
Virmugen |
Salmonella Typhimurium guaBA/clpP/fliD mutant vaccine
|
|
3887
|
FliD |
Pseudomonas aeruginosa |
|
|
|
EAZ56903
|
|
|
|
|
CDD:224264 |
flagellar cap; FliD |
Protective antigen |
|
|
4477
|
FLT1 |
Homo sapiens |
|
2321
|
|
229892220
|
|
AL138712 |
NP_001153392 |
|
|
transcript variant X1 |
Protective antigen |
VEGFR1-1084 Peptide Vaccine
|
|
298
|
Flt3 |
Mus musculus |
|
14255
|
|
122937353
|
|
AC127549 |
NP_034359 |
|
|
transcript variant X2 |
Protective antigen |
|
|
701
|
Flt3 |
Mus musculus |
|
14255
|
|
122937353
|
|
AC127549 |
NP_034359 |
|
|
transcript variant X2 |
Protective antigen |
|
|
4507
|
FLT3LG |
Homo sapiens |
|
2323
|
|
325197197
|
|
AC010619 |
NP_001191431 |
|
|
transcript variant X16 |
Protective antigen |
HPV E6/E7 DNA Vaccine GX-188E
|
|
3993
|
flu |
Escherichia coli |
|
|
|
49176177
|
|
|
|
|
CDD:315649
CDD:225999
CDD:328937
UniProtKB/UniProt: P39180
ASAP:ABE-0006642
ECOCYC:G7080
EcoGene:EG12686 |
CP4-44 prophage; self recognizing antigen 43 (Ag43) autotransporter |
Protective antigen |
|
|
1698
|
FMDV A12 genome |
Foot-and-mouth disease virus - type A strain A12-119 |
|
|
46810760
|
46810761
|
|
|
|
|
CDD:283147
CDD:286076
CDD:278501
CDD:119412
CDD:301302
CDD:279280
CDD:278947
CDD:279070
CDD:238843 |
polyprotein |
Protective antigen |
Foot and mouth disease DNA vaccine pWRMHX encoding a minimal self-cleaving ribozyme
|
|
849
|
fnbA |
Staphylococcus aureus subsp. aureus NCTC 8325 |
VO_0012392
|
|
|
120457
|
|
|
|
|
CDD:309682
CDD:331378
CDD:313621
CDD:308566
CDD:307064 |
Fibronectin-binding protein A |
Protective antigen |
S. aureus FnbA Protein Vaccine
S. aureus DNA vaccine encoding Efb, FnbpA, ClfA, Cna
|
|
4173
|
FnbpA |
Staphylococcus aureus |
|
|
|
EEV76353
|
|
|
|
|
CDD:287406 |
fibrinogen-binding protein A |
Protective antigen |
|
|
630
|
Fnz |
Streptococcus equi subsp. zooepidemicus |
VO_0011214
|
7695217
|
|
754170878
|
SZO_RS08670 |
FM204884 |
WP_041790586 |
|
|
thioester-forming surface-anchored protein |
Protective antigen |
S. equi Subunit EAG, FNZ and SFS Protein Vaccine
|
|
4203
|
fnz |
Streptococcus equi subsp. zooepidemicus MGCS10565] |
|
|
|
ACG61689
|
|
|
|
|
CDD:285533
CDD:274864
CDD:281046 |
fibronectin-binding protein Fnz |
Protective antigen |
|
|
3950
|
FOG |
Haemophilus parasuis SH0165 |
|
|
|
ACL32772
|
|
|
|
|
CDD:276809
CDD:290160
CDD:285020
CDD:304382 |
possible outer membrane protein, FOG: TPR repeat protein |
Protective antigen |
|
|
4622
|
FOLH1 |
Homo sapiens |
|
2346
|
|
62548858
|
|
AC110742 |
NP_001014986 |
|
|
transcript variant X5 |
Protective antigen |
PSA/PSMA DNA Plasmid INO-5150 Vaccine
|
|
4452
|
FOLR1 |
Homo sapiens |
|
2348
|
|
4758400
|
|
AP000812 |
NP_000793 |
|
|
transcript variant 7 |
Protective antigen |
Multi-epitope Folate Receptor Alpha Peptide Vaccine
Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
Folate-FITC Vaccine
Retroviral Vector MFGS-MOv18-gamma Vaccine
|
|
476
|
FopA |
Francisella tularensis subsp. holarctica OSU18 |
VO_0011078
|
4306351
|
|
115315051
|
FTH_1293 |
CP000437 |
YP_763774 |
|
|
outer membrane protein FopA |
Protective antigen |
|
|
468
|
FopB |
Francisella novicida U112 |
VO_0011070
|
4547777
|
|
118496734
|
FTN_0119 |
CP000439 |
YP_897784 |
|
|
hypothetical protein |
Protective antigen |
F. tularensis FopB Protein Vaccine
|
|
1388
|
Fosl1 |
Mus musculus |
|
14283
|
|
6753896
|
|
AC122861 |
NP_034365 |
|
|
fos-like antigen 1 |
Protective antigen |
|
|
4572
|
FOXO1 |
Homo sapiens |
|
2308
|
|
9257222
|
|
AL133318 |
NP_002006 |
|
|
transcript variant X1 |
Protective antigen |
PAX3/FKHR Peptide Vaccine
|
|
186
|
Frag C |
Escherichia coli O157:H7 EDL933 |
|
958167
|
|
15803220
|
Z4009 |
NC_002655.2 |
NP_289252.1 |
|
|
PTS system, glucitol/sorbitol-specific IIB component and second of two IIC components; frag |
|
CVD 915
|
|
1332
|
Fragment C from tetanus toxin |
Clostridium tetani |
|
|
|
8132375
|
|
|
|
|
CDD:285228
CDD:285226 |
tetanus toxin |
Protective antigen |
Cancer DNA vaccine p.DOM-AH1 encoding fragment C
Lymphoma DNA vaccine VαVβVβ-FrC
|
|
324
|
fsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
331
|
fsd |
|
|
|
|
|
|
|
|
|
|
|
Defense factor |
|
|
399
|
fspA1 |
Campylobacter jejuni |
VO_0011047
|
|
|
116292649
|
|
|
|
|
CDD:330552 |
FspA1 |
Protective antigen |
C. jejuni FspA1 protein vaccine
|
|
409
|
fspA2 |
Campylobacter jejuni |
VO_0011049
|
|
|
116292677
|
|
|
|
|
|
FspA2 |
Protective antigen |
C. jejuni FspA2 protein vaccine
|
|
1006
|
FTL0552 |
Francisella tularensis subsp. holarctica LVS |
|
3952730
|
|
89255956
|
FTL_0552 |
AM233362 |
YP_513318 |
|
|
two-component response regulator |
Virmugen |
Francisella tularensis FTL0552 mutant vaccine
|
|
985
|
FTT0918 |
Francisella tularensis subsp. tularensis SCHU S4 |
|
3191684
|
|
56708019
|
FTT_0918 |
AJ749949 |
YP_169915 |
|
|
hypothetical protein |
Virmugen |
Francisella tularensis FTT0918 mutant vaccine
|
|
4668
|
FUS |
Homo sapiens |
|
2521
|
|
283135201
|
|
AC009088 |
NP_001164105 |
|
|
transcript variant 2 |
Protective antigen |
Canarypox-hIL-12 Melanoma Vaccine
|
|
1630
|
Fusion protein |
Avian metapneumovirus isolate 1b |
|
|
|
6018112
|
|
|
|
|
CDD:278924 |
fusion protein |
Protective antigen |
Avian pneumovirus DNA Vaccine expressing the F gene
|
|
247
|
FyuA |
Escherichia coli APEC O1 |
VO_0010965
|
4492541
|
|
117624167
|
APECO1_1063 |
CP000468 |
YP_853080 |
|
|
pesticin/yersiniabactin receptor protein |
Protective antigen |
E. coli vaccine based on recombinant protein FyuA
|
|
4965
|
fyuA |
|
|
|
|
WP_142468275
|
|
|
|
|
CDD:273805
CDD:238657 |
siderophore yersiniabactin receptor FyuA |
Protective antigen |
Klebesiella FuyA protein vaccine
|
|
647
|
G |
Rabies virus |
VO_0011231
|
|
|
56384945
|
|
|
|
|
CDD:279337 |
glycoprotein |
Protective antigen |
Rabies DNA Vaccine encoding Rabies virus Glycoprotein
Rabies virus DNA vaccine pCMV-intA-rabies encoding glycoprotein G
AdC68- rabies virus glycoprotein
Rabies Virus Vaccine pAlpha-Rab-G
|
|
1671
|
G |
Human respiratory syncytial virus A strain Long |
|
|
|
1353203
|
|
|
|
|
CDD:144411
CDD:224196 |
Major surface glycoprotein G |
Protective antigen |
HRSV DNA vaccine pND-G
rBPIV3-RSV-G
VSV-RSV(F/G)
|
|
1376
|
G from BRSV |
Bovine orthopneumovirus |
|
1489813
|
|
9631274
|
BovRSVgp07 |
AF092942 |
NP_048054 |
|
|
mRNA |
Protective antigen |
Bovine herpesvirus 1 recombinant vector vaccine BHVl/BRSVG
|
|
513
|
G glycoprotein |
Infectious hematopoietic necrosis virus |
VO_0011109
|
1489848
|
|
9628086
|
IHNVgp4 |
KP216199 |
NP_042679 |
|
|
glycoprotein |
Protective antigen |
IHNV DNA vaccine pIHNw-G
IHNV DNA vaccine pCMV4-G
IHNV DNA vaccine pCDNA-G encoding G
IHNV DNA vaccine pIHN-G encoding glycoproteins
|
|
779
|
G glycoprotein |
Hendra henipavirus |
VO_0011310
|
1446471
|
|
29468607
|
Hvgp5 |
AF017149 |
NP_047112 |
2X9M
|
|
glycoprotein |
Protective antigen |
Hendra virus G protein vaccine
|
|
782
|
G glycoprotein |
Nipah henipavirus |
VO_0011313
|
920955
|
|
13559814
|
Nvgp5 |
AF212302 |
NP_112027 |
2VWD
|
|
attachment glycoprotein |
Protective antigen |
NIpah Virus G and F Proteins Subunit Vaccine
rMV-Ed-G
ALVAC-NiV-G
ALVAC-NiV-F
Nipah Virus Vaccine rVSVΔG-NiVBG
|
|
1661
|
G glycoprotein |
Hirame novirhabdovirus |
|
2559534
|
|
34610118
|
HIRRVgp4 |
AF104985 |
NP_919033 |
|
|
glycoprotein |
Protective antigen |
H. rhabdovirus DNA Vaccine encoding N and G
H. rhabdovirus DNA vaccine pHRV-G encoding HIRRV and VHSV G proteins
H. rhabdovirus DNA Vaccine encoding G
|
|
1059
|
G protein |
Human metapneumovirus CAN97-83 |
|
|
|
75549950
|
|
|
|
|
CDD:118131 |
Major surface glycoprotein G |
Virmugen |
Human metapneumovirus G protein mutant vaccine
|
|
487
|
G1 |
Sin Nombre virus |
VO_0011086
|
|
|
1113859
|
|
|
|
2K9H
|
CDD:279853 |
envelope glycoprotein G1 |
Protective antigen |
Sin Nombre virus DNA vaccine encoding G1
|
|
762
|
G2 |
Trypanosoma cruzi |
VO_0011299
|
3543901
|
|
71424025
|
|
AAHK01000586 |
XP_812654 |
|
|
protein G2 |
Protective antigen |
T. cruzi DNA Vaccine encoding G2 Protein
T. cruzi vaccine encoding TcG2 and TcG4
T. cruzi Vaccine TcVac4
T. cruzi Vaccine TcVac3 encoding TcG2 and TcG4
T. cruzi Vaccine TcVac2
T. cruzi DNA-prime/MVA-boost vaccine encoding TcG2 and TcG4
T. cruzi DNA prime/Protein-boost vaccine encoding TcG2 and TcG4
|
|
4584
|
GAA |
Homo sapiens |
|
2548
|
|
119393891
|
|
AC087741 |
NP_000143 |
|
|
transcript variant 4 |
Protective antigen |
Glioma-Associated Antigen Peptide-Pulsed Autologous Dendritic Cell Vaccine
|
|
1318
|
Gad65 |
Mus musculus |
|
14417
|
|
124517709
|
RP23-407K8.5 |
AB032757 |
NP_032104 |
|
|
transcript variant X1 |
Protective antigen |
Insulin-dependent diabetes mellitus DNA vaccine JwGAD65 + IL-4
|
|
1658
|
gad65 |
Rattus norvegicus |
|
24380
|
|
6978871
|
|
AABR07028859 |
NP_036695 |
|
|
glutamate decarboxylase 2 |
Protective antigen |
Autoimmune diabetes DNA vaccine pCMV–1/rGAD65 encoding GAD
|
|
1659
|
GAD65 |
Homo sapiens |
|
2572
|
|
4503875
|
RP11-420F12.2 |
AL162503 |
NP_000809 |
|
|
transcript variant 1 |
Protective antigen |
Autoimmune diabetes DNA vaccine pND2-SGAD55
Autoimmune diabetes DNA vaccine pND2-GAD65-BAX encoding GAD and BAX
|
|
466
|
gag |
Feline leukemia virus |
VO_0011069
|
|
|
323916
|
|
|
|
|
CDD:307339
CDD:307969
CDD:197667 |
gag-p15 polyprotein |
Protective antigen |
EURIFEL FeLV
ALVAC-FL- env/gag
|
|
1259
|
gag |
Simian immunodeficiency virus SIV-mnd 2 |
|
956108
|
|
27311167
|
Siv2gp1 |
AF367411 |
NP_758886 |
|
|
gag protein |
Other |
rBCG-SIVgag
|
|
1268
|
gag |
Human immunodeficiency virus 1 |
|
|
|
5081475
|
|
|
|
|
CDD:249943
CDD:279002
CDD:197667
CDD:285867 |
gag |
Protective antigen |
|
|
1272
|
gag |
Human immunodeficiency virus 1 |
|
|
|
1537051
|
|
|
|
|
CDD:249943
CDD:279002
CDD:278525
CDD:197667
CDD:285867 |
gag |
Protective antigen |
|
|
1709
|
gag |
Simian-Human immunodeficiency virus strain SHIV-89.6 |
|
|
|
2828037
|
|
|
|
|
CDD:249943
CDD:279002
CDD:331526 |
gag |
Protective antigen |
HIV DNA vaccine SHIV-89.6 DNA (DNA/89.6)
rBCG-SIVgag and rDIsSIVgag Prime-boost SHIV vaccine
|
|
1717
|
gag |
Human immunodeficiency virus 2 |
|
|
|
1845205
|
|
|
|
|
CDD:249943
CDD:279002
CDD:197667 |
gag polyprotein |
Protective antigen |
HIV-2 DNA vaccine
ALVAC-HIV-2- env/gag/pol
ALVAC-HIV-2
|
|
1737
|
gag |
Reticuloendotheliosis virus strain APC-566 |
|
|
|
88605103
|
|
|
|
|
CDD:307339
CDD:307969
CDD:197667 |
gag protein |
Protective antigen |
REV DNA vaccine VP22/gag and VP22/env
|
|
4279
|
gag |
Bovine Leukemia virus |
|
|
|
AGV74358
|
|
|
|
|
CDD:279002 |
P24 |
Protective antigen |
|
|
713
|
Gag from HIV 1 |
Human immunodeficiency virus 1 |
VO_0011263
|
155030
|
|
9629360
|
HIV1gp2 |
AF033819 |
NP_057850 |
|
|
Pr55(Gag) |
Protective antigen |
Combination of HIV DNA vaccine pCMV HIV gag and pCMV HIV gp120 and gp140
HIV DNA vaccine ALVAC-HIV encoding env, gag, and pro
HIV adnenovirus vector vaccine Ad28 encoding env, gag, and pro
HIV DNA vaccine Ad26/Ad5HVR48 encoding HIV or SIV env or gag
HIV DNA vaccine (HIV)-1 gagDNA encoding gag
HIV DNA vaccine pHIV-1gag encoding gag
HIV DNA vaccine Ad5 HIV-1 gag encoding gag
HIV DNA vaccine DNA-CRL1005 with Ad5-gag
HIV recombinant vector vaccine MVA-gag encoding gag
HIV DNA vaccine aroC+Gag encoding gag
DNA vaccine expressing multiple HIV epitopes
L. T -HIV-1 Gag
|
|
1751
|
gag from HIV-1 vector pNL4-3 |
HIV-1 vector pNL4-3 |
|
|
|
12831136
|
|
|
|
|
CDD:249943
CDD:279002
CDD:331526
CDD:312289 |
gag polyprotein |
Protective antigen |
SHIV DNA vaccine encoding env and gag
SHIV(Ba-L) DNA vaccine encoding env and gag
|
|
1265
|
gag from HXB2 |
Human immunodeficiency virus 1 HXB2 |
|
|
|
328450
|
|
|
|
|
CDD:249943 |
gag protein |
Protective antigen |
|
|
98
|
Gag protein from SIV-mnd 2 |
Simian immunodeficiency virus SIV-mnd 2 |
VO_0010949
|
956108
|
|
27311167
|
Siv2gp1 |
AF367411 |
NP_758886 |
|
|
gag protein |
Protective antigen |
HIV DNA and adenoviral vector Ad5 expressing SIV gag protein
Adenoviral vector Ad5 expressing SIV gag protein
HIV DNA vaccine Ad26/Ad5HVR48 encoding HIV or SIV env or gag
HIV recombinant vector vaccine FPV-SIVgag/pol-IFN-γ encoding SIV gag and pol
DNA and poxvirus priming-boosting SHIV vaccine
HIV DNA vaccine pHIS-SHIV-B
HIV DNA vaccine SIVmac239 Gag-Pol-Nef and mock Env with rAd5 boost
|
|
1252
|
gag-pol |
Human immunodeficiency virus 1 |
|
155348
|
|
28872819
|
HIV1gp1 |
AF033819 |
NP_057849 |
|
|
Gag-Pol |
Protective antigen |
HIV DNA vaccine APL 400-047 encoding HIV gag/pol
HIV DNA vaccine pCMN160
|
|
1253
|
gag-pol |
Simian immunodeficiency virus |
|
1490009
|
|
22535297
|
SIVgp1 |
M66437 |
NP_687035 |
|
|
Gag-Pol |
Other |
SabRV-SIV
|
|
1255
|
gag-pol SIV |
Simian immunodeficiency virus |
|
1490009
|
|
22535297
|
SIVgp1 |
M29973 |
NP_687035 |
|
|
Gag-Pol |
Protective antigen |
|
|
792
|
Gal/GalNAc lectin |
Entamoeba histolytica HM-1:IMSS |
VO_0011323
|
3404842
|
|
67469085
|
EHI_046650 |
DS571321 |
XP_650534 |
|
|
|
Protective antigen |
E. histolytica Gal/GalNAc lectin protein vaccine
|
|
4798
|
GALC |
Homo sapiens |
|
2581
|
|
83281450
|
|
AH003226 |
NP_000144 |
|
|
transcript variant 4 |
Protective antigen |
Alpha-Galactosylceramide-Pulsed Autologous Dendritic Cells
|
|
964
|
galE |
Salmonella enterica subsp. enterica serovar Typhi str. Ty2 |
|
1067209
|
|
29142526
|
t2111 |
AE014613 |
NP_805868 |
|
|
UDP-galactose-4-epimerase |
Virmugen |
Salmonella Typhi galE mutant vaccine
|
|
1097
|
galU |
Francisella tularensis subsp. tularensis SCHU S4 |
|
3191600
|
|
56707872
|
FTT_0757 |
AJ749949 |
YP_169768 |
|
|
UTP--glucose-1-phosphate uridylyltransferase |
Virmugen |
Francisella tularensis galU mutant vaccine
|
|
1632
|
gam56 |
Eimeria maxima |
|
25336657
|
AY129951.2
|
25989587
|
|
|
|
|
|
56 kDa gametocyte antigen |
Protective antigen |
E. maxima DNA vaccine pcDNA-Gam56
|
|
4372
|
gam56 |
Eimeria maxima |
|
|
|
AAN05087
|
|
|
|
|
|
56 kDa gametocyte antigen |
Protective antigen |
|
|
457
|
gam82 |
Eimeria maxima |
VO_0011062
|
25336658
|
|
38565038
|
|
|
|
|
|
82 kDa gametocyte antigen |
Protective antigen |
E. maxima Gam82 protein vaccine
|
|
4373
|
gam82 |
Eimeria maxima |
|
|
|
AAO47083
|
|
|
|
|
|
82 kDa gametocyte antigen |
Protective antigen |
|
|
823
|
Gap |
Brucella abortus bv. 1 str. 9-941 |
VO_0012375
|
3340207
|
|
62290600
|
BruAb1_1713 |
AE017223 |
YP_222393 |
|
|
glyceraldehyde-3-phosphate dehydrogenase |
Protective antigen |
|
|
1628
|
gapA |
Haemophilus parasuis SH0165 |
|
7278596
|
|
498484148
|
HAPS_RS00005 |
CP001321 |
WP_010785946 |
|
|
type I glyceraldehyde-3-phosphate dehydrogenase |
Protective antigen |
Haemophilus Parasuis Avirulent Live Culture Vaccine (USDA: 19J1.00)
pCgap DNA vaccine encoding glyceraldehyde-3-phosphate dehydrogenase
|
|
3904
|
gapA |
Mycoplasma gallisepticum |
|
|
|
AAS65542
|
|
|
|
|
CDD:332876 |
GapA |
Protective antigen |
|
|
4181
|
gapC |
Staphylococcus aureus |
|
|
|
AAR13672
|
|
|
|
|
CDD:278473
CDD:273675
CDD:280894 |
GapC |
Protective antigen |
|
|
4002
|
GAPDH |
Edwardsiella tarda |
|
|
|
AGO59148
|
|
|
|
|
CDD:185323
CDD:278473
CDD:280894 |
glyceraldehyde-3-phosphate dehydrogenase |
Protective antigen |
|
|
422
|
gatA |
Chlamydophila abortus |
VO_0010879
|
|
|
62184918
|
|
|
|
|
CDD:234572 |
aspartyl/glutamyl-tRNA amidotransferase subunit A |
Protective antigen |
C. abortus DNA vaccine encoding GatA/GatB
|
|
424
|
gatB |
Chlamydophila abortus |
VO_0010880
|
|
|
62147986
|
|
|
|
|
CDD:235489
EnsemblGenomes-Gn:CAB287
EnsemblGenomes-Tr:CAH63737
GOA:Q5L6I8
InterPro: IPR003789
InterPro: IPR004413
InterPro: IPR006075
InterPro: IPR017958
InterPro: IPR017959
InterPro: IPR018027 |
aspartyl/glutamyl-tRNA amidotransferase subunit B |
Protective antigen |
C. abortus DNA vaccine encoding GatA/GatB
|
|
417
|
gatC |
Chlamydophila abortus |
VO_0011057
|
|
|
62184917
|
|
|
|
|
CDD:178810 |
aspartyl/glutamyl-tRNA amidotransferase subunit C |
Protective antigen |
C. abortus DNA vaccine encoding GatC
|
|
654
|
gB |
Suid herpesvirus 1 |
VO_0011238
|
|
|
4138504
|
|
|
|
|
UniProtKB/TrEMBL: Q9WJ33 |
envelope glycoprotein B |
Protective antigen |
Pseudorabies Subunit gB Protein Vaccine
|
|
1221
|
gB |
Bovine herpesvirus 1 |
|
|
|
349734084
|
|
|
|
|
CDD:223014 |
glycoprotein B |
Protective antigen |
Bovine herpesvirus 1 DNA vaccine pMASIAtgB encoding a truncated, secreted form of gB
|
|
1614
|
gB |
Human herpesvirus 1 strain KOS |
|
|
|
1353200
|
|
|
|
|
CDD:223014 |
Envelope glycoprotein B |
Protective antigen |
Herpes simplex virus DNA vaccine pCI-gB encoding gB
pRP-RSV-HSV-1-gB
|
|
1724
|
gB |
Gallid herpesvirus 1 isolate CG |
|
|
|
110676569
|
|
|
|
|
CDD:223014 |
glycoprotein B |
Protective antigen |
Laryngotracheitis DNA Vaccine encoding gB
|
|
4334
|
gB |
infectious laryngotracheitis virus |
|
|
|
Q02409
|
|
|
|
|
CDD:223014 |
Envelope glycoprotein B |
Protective antigen |
|
|
486
|
Gc |
Seoul virus |
VO_0011085
|
|
|
284157806
|
|
|
|
|
CDD:144961 |
Gc glycoprotein |
Protective antigen |
Seoul virus vaccine rCAV-2-Gc
|
|
3945
|
gcp |
Haemophilus parasuis |
|
|
|
EQA95212
|
|
|
|
|
|
putative tRNA threonylcarbamoyladenosine biosynthesis protein Gcp |
Protective antigen |
|
|
935
|
gD |
|
|
|
|
19548971
|
|
|
|
1L2G
|
CDD:177571
CDD:186820 |
glycoprotein D |
Virmugen |
Herpes simplex virus 1 gD mutant vaccine
Herpes Simplex Virus Type 1 DNA Vaccine pRSC-gD-IL-21
Herpes Simplex Virus Type 1 DNA Vaccine encoding 5gP
|
|
1291
|
gD |
Human herpesvirus 2 |
|
1487358
|
|
9629336
|
HHV2gp69 |
AY779751 |
NP_044536 |
|
|
envelope glycoprotein D |
Other |
Herpes simplex virus DNA vaccine gD-2 encoding gD
Herpes simplex virus DNA vaccine encoding gD and gB from HSV-2 strain Curtis
Herpes Simplex Virus 2 DNA Vaccine Vaxfectin-gD2
Herpes Simplex Virus 2 DNA Vaccine encoding gD
Herpes Simplex Virus 2 DNA Vaccine encoding gD with CD40L
HSV 2 DNA vaccine pVAX–HSV–2gD–Hsp70
rOka-gD2- HSV-2
|
|
4250
|
gD protein |
Feline herpesvirus 1 |
|
|
|
AHZ31390
|
|
|
|
|
CDD:223029
CDD:279830
CDD:288690 |
gD protein |
Protective antigen |
|
|
984
|
gE |
Equid herpesvirus 1 |
|
|
|
330789
|
|
|
|
|
CDD:177575
CDD:145558 |
glycoprotein E |
Virmugen |
Equid herpesvirus gE mutant vaccine
|
|
791
|
gEh29 |
Entamoeba histolytica |
VO_0011322
|
|
399673
|
399674
|
|
|
CAA50324.1 |
|
CDD:223527
CDD:239313
GOA:P19476
InterPro: IPR000866
InterPro: IPR012335
InterPro: IPR012336
InterPro: IPR017936
InterPro: IPR019479
UniProtKB/UniProt: P19476 |
alkyl hydroperoxide reductase |
Protective antigen |
E. histolytica Eh29 protein vaccine
|
|
799
|
GEL1 |
Coccidioides posadasii |
VO_0011330
|
|
|
14582416
|
|
|
|
|
CDD:304882 |
glucanosyltransferase |
Protective antigen |
C. posadasii Subunit GEL1 Protein Vaccine
|
|
3921
|
ggt |
Helicobacter pylori |
|
|
|
ADN80237
|
|
|
|
|
CDD:129176 |
Gamma-glutamyl transpeptidase |
Protective antigen |
|
|
962
|
gH |
|
|
|
|
138315
|
|
|
|
|
CDD:177579 |
Envelope glycoprotein H |
Virmugen |
Herpes simplex virus 1 gH mutant vaccine
|
|
4322
|
gH |
Murine Cytomegalovirus |
|
|
|
P30673
|
|
|
|
|
CDD:223036 |
Envelope glycoprotein H |
Protective antigen |
|
|
668
|
GI |
Suid herpesvirus 1 |
VO_0011251
|
|
|
255957222
|
|
|
|
|
CDD:177577
CDD:165547 |
envelope glycoprotein gI |
Protective antigen |
Pseudorabies Subunit gI Protein Vaccine
|
|
983
|
gI |
Equid herpesvirus 1 |
|
|
|
330788
|
|
|
|
|
CDD:177577 |
glycoprotein I |
Virmugen |
Equid herpesvirus gI mutant vaccine
|
|
665
|
GII |
Suid herpesvirus 1 |
VO_0011249
|
|
|
1335775
|
|
|
|
|
CDD:223014 |
glycoprotein gII |
Protective antigen |
Pseudorabies recombinant vector vaccine encoding gp50 and gII protein
NYVAC-PRV- gII/ gp50
|
|
667
|
GIII |
Suid herpesvirus 1 |
VO_0011250
|
|
|
334050
|
|
|
|
|
CDD:223030
CDD:280317 |
glycoprotein gIII mature peptide |
Protective antigen |
|
|
1220
|
gIV |
Bovine herpesvirus 1 |
|
|
|
330746
|
|
|
|
|
CDD:223029 |
glycoprotein gIV |
Protective antigen |
Bovine herpesvirus 1 DNA vaccine pRSVgIV
|
|
4321
|
gL |
Murine Cytomegalovirus |
|
|
|
P52514
|
|
|
|
|
CDD:280049 |
Envelope glycoprotein L |
Protective antigen |
|
|
4302
|
GL protein |
Equine arteritis virus |
|
|
|
AAK37632
|
|
|
|
|
CDD:292603
CDD:109986 |
GL protein |
Protective antigen |
Equine Arteritis Virus EAV-VRPs (
|
|
4713
|
Gla |
Mus musculus |
|
11605
|
|
133778924
|
|
BX004852 |
NP_038491 |
|
|
transcript variant X1 |
Protective antigen |
Alpha-1,3-galactosyltransferase-expressing Allogeneic Renal Cell Carcinoma Vaccine
|
|
4705
|
GLIPR1 |
Homo sapiens |
|
11010
|
|
110825980
|
|
AC022507 |
NP_006842 |
|
|
transcript variant X1 |
Protective antigen |
AdRTVP-1-Transduced Prostate Cancer Cell-Based Vaccine
|
|
856
|
GlpQ |
Treponema pallidum subsp. pallidum str. Nichols |
VO_0012399
|
2611763
|
|
499184166
|
TP_RS01315 |
AE000520 |
WP_010881706 |
|
|
glycerophosphoryl diester phosphodiesterase |
Protective antigen |
T. pallidum GlpQ Protein Vaccine
|
|
827
|
gltA |
Helicobacter pylori |
VO_0012379
|
|
|
NP_206828
|
|
|
|
|
CDD:180164
CDD:99867 |
type II citrate synthase |
Protective antigen |
H. pylori GltA Protein Vaccine
|
|
617
|
GltX |
Streptococcus pneumoniae TIGR4 |
VO_0011201
|
931970
|
|
WP_000031087
|
SP_2069 |
AE005672 |
NP_346492 |
|
CDD:234953 |
glutamate--tRNA ligase |
Protective antigen |
S. pneumoniae GtS Protein Vaccine
|
|
812
|
GLURP |
Plasmodium falciparum 3D7 |
VO_0011343
|
810501
|
|
124802897
|
PF3D7_1035300 |
LN999944 |
XP_001347628 |
|
|
glutamate-rich protein |
Protective antigen |
|
|
4389
|
Glutathione-S-transferase (GST) |
Trichinella spiralis |
|
|
|
ABA42914
|
|
|
|
|
CDD:294274
CDD:173353
CDD:295467
CDD:198286 |
glutathione-S-transferase |
Protective antigen |
|
|
4194
|
Glyceraldehyde-3-phosphate dehydrogenase GAPDH |
Streptococcus equi subsp. zooepidemicus SzS31A1 |
|
|
|
EQB24294
|
|
|
|
|
|
glyceraldehyde-3-phosphate dehydrogenase |
Protective antigen |
|
|
1229
|
glycoprotein |
Rabies virus ERA |
|
|
|
156446052
|
|
|
|
|
CDD:110007 |
glycoprotein |
Other |
Rabies virus DNA vaccine pSG5rab.gp
Rabies virus DNA vaccine encoding the ERA glycoprotein
|
|
1237
|
Glycoprotein |
Viral hemorrhagic septicemia virus Danish isolate DK-3592B |
|
|
|
299444
|
|
Y18263 |
NP_049548 |
|
CDD:279337 |
envelope glycoprotein |
Protective antigen |
VHSV DNA vaccine pCMV-vhsG encoding glycoprotein G
VHSV DNA vaccine pVHS-G encoding glycoproteins
VHSV DNA vaccine pCMV-vhsN encoding nucleocapsid protein N and glycoprotein G
|
|
4288
|
glycoprotein |
Rift Valley Fever virus |
|
|
|
ARW71759
|
|
|
|
|
CDD:148701
CDD:311284
CDD:148700 |
glycoprotein |
Protective antigen |
|
|
4324
|
glycoprotein |
Viral haemorrhagic septicaemia virus |
|
|
|
CAB07737
|
|
|
|
|
CDD:279337
GOA:O42008
InterPro: IPR001903
InterPro: IPR002417
UniProtKB/TrEMBL: O42008 |
glycoprotein |
Protective antigen |
|
|
1239
|
Glycoprotein B |
Human betaherpesvirus 5 |
|
3077424
|
|
52139241
|
HHV5wtgp060 |
AY446894 |
YP_081514 |
|
|
envelope glycoprotein B |
Protective antigen |
Human cytomegalovirus DNA vaccine VCL-CB01 encoding phosphoprotein 65 and gB
Human cytomegalovirus DNA vaccine pcGB
|
|
1018
|
glycoprotein E |
Suid herpesvirus 1 |
|
|
|
307634504
|
|
|
|
|
CDD:177575
CDD:190321 |
glycoprotein E |
Virmugen |
Pseudorabies virus glycoprotein E/G/UL23 mutant vaccine
|
|
1017
|
glycoprotein G |
Suid herpesvirus 1 |
|
|
|
15422177
|
|
|
|
|
CDD:186820 |
glycoprotein G |
Virmugen |
Pseudorabies virus glycoprotein E/G/UL23 mutant vaccine
|
|
1033
|
Glycoprotein G |
Rabies virus |
|
1489856
|
|
9627201
|
RABVgp4 |
M13215 |
NP_056796 |
|
|
mRNA |
Virmugen |
Rabies virus glycoprotein G mutant vaccine
RCN-rabies-G
BV-RVG/RVG
rLSDV-Rabies-gP
|
|
1055
|
glycoprotein G |
Bovine respiratory syncytial virus |
|
1489813
|
|
9631274
|
BovRSVgp07 |
AF092942 |
NP_048054 |
1BRV
|
|
mRNA |
Virmugen |
Bovine respiratory syncytial virus glycoprotein G mutant vaccine
Bovine Respiratory Syncytial Virus recombinant vector vaccine BHVl/BRSVG encoding the G protein
|
|
1026
|
glycoprotein M |
|
|
|
|
1478255
|
|
|
|
|
CDD:177566
GOA:Q85041
InterPro: IPR000785
UniProtKB/UniProt: Q85041 |
UL10 |
Virmugen |
Psuedorabies virus glycoprotein M mutant vaccine
|
|
1728
|
gM |
Murid betaherpesvirus 1 |
|
3293854
|
|
61660210
|
MuHV1_gp093 |
GU305914 |
YP_214101 |
|
|
Glycoprotein M or integral membrane protein |
Protective antigen |
Murine cytomegalovirus DNA vaccine pgM-pgN
|
|
1648
|
GM-CSF |
Equus caballus |
|
100033981
|
|
126352688
|
|
AAWR02002535 |
NP_001075351 |
|
|
granulocyte-macrophage colony-stimulating-factor |
Protective antigen |
|
|
4473
|
GM-CSF |
Papio anubis |
|
100137216
|
|
281182592
|
|
DP000485 |
NP_001162225 |
|
|
granulocyte-macrophage colony-stimulating factor |
Protective antigen |
Sargramostim Plasmid DNA Pancreatic Tumor Cell Vaccine
|
|
4449
|
GM-CSF (human) |
Homo sapiens |
|
1437
|
|
27437030
|
|
AC004511 |
NP_000749 |
|
|
colony stimulating factor 2 |
Protective antigen |
Pexastimogene-devacirepvec Vaccine
Oncolytic Adenovirus Encoding GM-CSF Vaccine
AE37 Peptide/GM-CSF Vaccine
Allogeneic GM-CSF-Based Myeloma Cell Vaccine
Allogeneic GM-CSF-Secreting Breast Cancer Vaccine
Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo
Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo
GVAX Lung Cancer Vaccine
PSA/IL-2/GM-CSF Vaccine
Recombinant Fowlpox GM-CSF Vaccine Adjuvant
Autologous GM-CSF-Secreting Lethally Irradiated Leukemia Cell Vaccine
|
|
1338
|
GM-CSF (Mus musculus) |
Mus musculus |
|
12981
|
|
110625658
|
RP23-309E16.1 |
AL596103 |
NP_034099 |
|
|
transcript variant X1 |
Protective antigen |
Melanoma DNA vaccine pNL3-MAGE-1-GM
Melanoma DNA vaccine pN4a-MAGE-1-GM
|
|
4586
|
GM2A |
Homo sapiens |
|
2760
|
|
39995109
|
|
AC008385 |
NP_000396 |
|
|
transcript variant 1 |
Protective antigen |
GM2/GD2/GD3 Lactone-KLH Conjugate Trivalent Vaccine
Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine
Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine
|
|
1729
|
gN |
Murine cytomegalovirus (strain Smith) |
|
|
|
190358890
|
|
|
|
|
CDD:281543 |
Envelope glycoprotein N |
Protective antigen |
Murine cytomegalovirus DNA vaccine pgM-pgN
|
|
275
|
GNA1030 |
Neisseria meningitidis MC58 |
VO_0010983
|
903167
|
|
15676917
|
NMB1030 |
AE002098 |
NP_274064 |
|
|
hypothetical protein |
Protective antigen |
|
|
268
|
GNA1162 |
Neisseria meningitidis MC58 |
VO_0010976
|
903582
|
|
15677037
|
NMB1162 |
AE002098 |
NP_274189 |
|
|
hypothetical protein |
Protective antigen |
|
|
267
|
GNA1220 |
Neisseria meningitidis MC58 |
VO_0010975
|
903642
|
|
15677093
|
NMB1220 |
AE002098 |
NP_274245 |
|
|
hypothetical protein |
Protective antigen |
|
|
273
|
GNA1870 |
Neisseria meningitidis MC58 |
VO_0010981
|
904318
|
|
15677705
|
NMB1870 |
AE002098 |
NP_274866 |
1YS5
|
|
hypothetical protein |
Protective antigen |
|
|
266
|
GNA1946 |
Neisseria meningitidis MC58 |
VO_0010974
|
904205
|
|
15677776
|
NMB1946 |
AE002098 |
NP_274940 |
3GXA
|
|
outer membrane lipoprotein |
Protective antigen |
|
|
265
|
GNA2001 |
Neisseria meningitidis MC58 |
VO_0010947
|
904124
|
|
15677829
|
NMB2001 |
AE002098 |
NP_274993 |
|
|
hypothetical protein |
Protective antigen |
|
|
274
|
GNA2091 |
Neisseria meningitidis MC58 |
VO_0010982
|
903958
|
|
15677911
|
NMB2091 |
AE002098 |
NP_275079 |
|
|
hemolysin |
Protective antigen |
|
|
264
|
GNA2132 |
Neisseria meningitidis MC58 |
VO_0010946
|
903357
|
|
15677945
|
NMB2132 |
AE002098 |
NP_275117 |
|
|
transferrin-binding protein-like protein |
Protective antigen |
|
|
270
|
GNA33 |
Neisseria meningitidis MC58 |
VO_0010978
|
902136
|
|
15675973
|
NMB0033 |
AE002098 |
NP_273099 |
|
|
membrane-bound lytic murein transglycosylase A |
Protective antigen |
|
|
269
|
GNA992 (hsf) |
Neisseria meningitidis MC58 |
VO_0010977
|
903112
|
|
15676883
|
NMB0992 |
AE002098 |
NP_274028 |
|
|
adhesin |
Protective antigen |
|
|
622
|
Gnd |
Streptococcus pneumoniae D39 |
VO_0011206
|
4441177
|
|
WP_000158781
|
SPD_0343 |
CP000410 |
YP_815856 |
|
CDD:236453 |
NADP-dependent phosphogluconate dehydrogenase |
Protective antigen |
S. pneumoniae 6PGD Protein Vaccine
|
|
4721
|
GNRH1 |
Homo sapiens |
|
2796
|
|
395394022
|
|
AC091185 |
NP_000816 |
|
|
transcript variant 1 |
Protective antigen |
|
|
4741
|
Gnrh1 |
Mus musculus |
|
14714
|
|
51093849
|
|
AC093020 |
NP_032171 |
|
|
transcript variant 2 |
Protective antigen |
Anti-GnRH Vaccine PEP223
|
|
1602
|
gp |
Rabies virus strain CVS |
|
|
|
22553076
|
|
|
|
|
CDD:279337
GOA:Q8JJY8
InterPro: IPR001903
UniProtKB/TrEMBL: Q8JJY8 |
glycoprotein |
Protective antigen |
|
|
1655
|
GP |
Zaire ebolavirus isolate EBOV/H.sapiens-tc/COD/1995/13625 Kikwit |
|
|
|
1695253
|
|
|
|
|
CDD:279888
CDD:333284
CDD:197367 |
virion spike glycoprotein |
Protective antigen |
Marburg virus recombinant vector vaccine CAdVax-Panfilo
|
|
1668
|
GP |
Hantaan virus 76-118 |
|
|
|
138339
|
|
|
|
|
CDD:279853
CDD:119058
CDD:144961 |
Envelopment polyprotein |
Protective antigen |
Hantavirus DNA vaccine pWRG/HTN-M
|
|
4886
|
GP from Angola Marburg Virus |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1297
|
GP from Cote d'Ivoire Ebola virus |
Cote d'Ivoire ebolavirus |
|
9487535
|
|
302315373
|
CIEBOVp4 |
FJ217162 |
YP_003815426 |
|
|
mRNA |
Other |
rVSV-EBOV
|
|
148
|
GP from Marburg virus Ci67 |
Lake Victoria marburgvirus |
|
|
|
305862101
|
AF005735 |
|
|
|
CDD:110602
CDD:197426
CDD:197370 |
GP |
Other |
Adenovirus vectors expressing Marburg virus glycoprotein
Marburg virus recombinant vector vaccine CAdVax-Panfilo
cAdVaxM(fus)
CAdVa-Filoviruses (EbMarburg viruses)
|
|
149
|
GP from Marburg virus Ravn |
M/Kenya/Kitum Cave/1987/Ravn |
|
|
|
2459878
|
|
|
|
|
CDD:110602
CDD:197426
CDD:197370 |
glycoprotein precursor |
Other |
Adenovirus vectors expressing Marburg virus glycoprotein
Multivalent DNA vaccine for B. anthracis, Ebola virus, Marburg virus, and VEE virus
Marburg virus DNA vaccine MARV GP encoding GP
Marburg virus recombinant vector vaccine CAdVax-Panfilo
cAdVaxM(fus)
CAdVa-Filoviruses (EbMarburg viruses)
Marburg Virus Vaccine mVLP Poly I:C Adjuvant
|
|
4920
|
GP from Marburgvirus |
Marburg marburgvirus |
|
920945
|
|
158539112
|
MARV_gp4 |
|
YP_001531156 |
|
|
mRNA |
Protective antigen |
Marburg Virus Vaccine PHV01
Marburg Virus Vaccine rVSV-N4CT1-MARV-GP
|
|
150
|
GP from Musoke Marburgvirus |
Lake Victoria marburgvirus - Musoke |
VO_0010961
|
|
|
77543430
|
|
|
|
|
CDD:279888
CDD:197367 |
glycoprotein |
Protective antigen |
Marburg virus-like particles
Adenovirus vectors expressing Marburg virus glycoprotein
Marburg virus glycoprotein expressed by baculovirus recombinants
Recombinant VEE Replicons expressing MBGV GP
VSV-based vaccine expressing MBGV GP
Heterologous MARV Protein VLP
Marburg virus recombinant vector vaccine CAdVax-Panfilo
Marburg virus DNA prime/boost vaccine DNA/rAd5-GP encoding GP from strain Angola
Marburg virus DNA vaccine DNA-GP encoding GP
Marburg virus recombinant vector vaccine MBGV GP
Marburg virus recombinant vector vaccine MBGV GP/MBGV NP
cAdVaxM(fus)
CAdVa-Filoviruses (EbMarburg viruses)
Marburg Virus Vaccine Ad26.Filo, MVA-BN-Filo
Marburg Virus Vaccine mVLP QS-21 Adjuvant
|
|
10
|
GP from Reston ebolavirus |
Reston ebolavirus |
VO_0010858
|
955190
|
|
22789230
|
REBOVgp4 |
AF522874 |
NP_690583 |
|
|
mRNA |
Protective antigen |
GP-VRP
DNA vaccine expressing sGP
|
|
453
|
GP from Sudan ebolavirus |
Sudan ebolavirus |
VO_0010911
|
3160774
|
|
55770812
|
SEVgp4 |
AY316199 |
YP_138523 |
|
|
mRNA |
Protective antigen |
Ebola virus DNA vaccine encoding ZEBOV GP and SEBOV GP
Ebola virus recombinant vector vaccine EBO7 encoding GP from SEBOV and ZEBOV
Ebola virus DNA vaccine DNA/rAd5 encoding ZEBOV and SEBOV antigens
cAdVax-based bivalent ebola virus vaccine (Sudan and Zaire species)
cAd3-EBO S
|
|
452
|
GP from Zaire ebolavirus |
Zaire ebolavirus |
VO_0010910
|
911829
|
|
10313995
|
ZEBOVgp4 |
AF272001 |
NP_066246 |
|
|
mRNA |
Protective antigen |
Ebola virus DNA vaccine encoding ZEBOV GP and SEBOV GP
Ebola virus DNA vaccine GP DNA
Ebola virus recombinant rAD-GP encoding GP
Ebola virus recombinant VSVΔG-GP encoding GP
Ebola virus recombinant vector vaccine EBO7 encoding GP from SEBOV and ZEBOV
Ebola virus recombinant vector vaccine pVSVXN2∆G/ZEBOVsGP encoding GP
Ebola virus DNA vaccine EBOV GP
Ebola virus recombinant adenovirus vector vaccine ADV−GP/NP
Ebola virus recombinant adenovirus vaccine AdC7-ZGP encoding GP
Ebola virus recombinant vector vaccine Ad-CMVZGP encoding the glycoprotein
Ebola virus recombinant vector vaccine Ad-CAGoptZGP encoding the envelope glycoprotein
Ebola virus DNA vaccine DNA/rAd5 encoding ZEBOV and SEBOV antigens
cAdVax-based bivalent ebola virus vaccine (Sudan and Zaire species)
rAd-GP (Ebola virus)
rVSV-EBOV
cAd3-EBO S
|
|
173
|
GP from Zaire ebolavirus |
Zaire ebolavirus (ZEBOV) |
VO_0010932
|
|
|
21702651
|
AAM76034 |
|
|
|
CDD:279888
CDD:333284
CDD:197367 |
surface glycoprotein GP precursor |
Protective antigen |
Multivalent DNA vaccine for B. anthracis, Ebola virus, Marburg virus, and VEE virus
Marburg Virus Vaccine Ad26.Filo, MVA-BN-Filo
|
|
4888
|
GP protein [Marburg marburgvirus] |
|
|
|
|
CAA82539.1
|
|
|
|
|
CDD:279888
CDD:165513
CDD:197367
GOA:P35254
InterPro: IPR002050
InterPro: IPR002561
InterPro: IPR014625
UniProtKB/UniProt: P35254 |
GP protein |
Protective antigen |
Marburg Virus Vaccine pVAKS-GPVM
|
|
4887
|
GP Sudan ebolavirus |
Sudan ebolavirus |
|
3160774
|
|
55770812
|
SEVgp4 |
AY316199 |
YP_138523 |
|
|
mRNA |
Protective antigen |
Marburg Virus Vaccine Ad26.Filo, MVA-BN-Filo
|
|
1341
|
gp100 (PMEL) |
Homo sapiens |
|
6490
|
|
318037593
|
|
AC025162 |
NP_001186982 |
|
|
transcript variant 3 |
Protective antigen |
Melanoma DNA vaccine hugp100 encoding gp100
ALVAC(2) Melanoma Multi-antigen Vaccine
HLA-A2-Binding TYR/MART-1/gp100 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
MART-1/gp100/Tyrosinase/MAGE-A3 Peptides-loaded Irradiated Allogeneic Plasmacytoid Dendritic Cells Vaccine
MART-1:26-35(27L) Peptide Vaccine
Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
gp100:209-217 Peptide Vaccine
gp100:154-162 Peptide Vaccine
gp100: ES209-217(210M) Peptide Vaccine
gp100-Reactive Autologous Peripheral Blood Lymphocyte Vaccine
gp100-Pulsed Peripheral Blood Mononuclear Cell Vaccine
gp100-Fowlpox Vaccine
gp100 Vaccinia Vaccine
gp100 Protein (184V) Vaccine
gp100 and GM-CSF DNA/Gold Vaccine
gp100 Adenovirus Vaccine
DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
Dendritic Cell-gp100-MART-1 Antigen Vaccine
Autologous TriMix-DC Melanoma Vaccine
Autologous Lymphoma Cell/Allogeneic Dendritic Cell Electrofusion Hybrid Vaccine
Autologous Anti-gp100:154-162 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307
Alpha-type-1 Polarized Dendritic Cells
Antigen-targeted Personalized Breast Cancer Vaccine
Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine
27-35(27L):MART-1 peptide vaccine
Autologous Dendritic Cell-Autologous Tumor mRNA-Human CD40L Vaccine
MELITAC 12.1 Peptide Vaccine
Recombinant Vaccinia-Multiepitope Melanoma Peptides-B7.1-B7.2 Vaccine
Multivalent immunotherapeutic vaccine
NA17.A2 Peptide Vaccine
NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine
Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine
gp100:280-288 Peptide Vaccine
Recombinant Fowlpox-gp100p209 Vaccine
Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
Recombinant Vaccinia-gp100:209-217 Vaccine
Recombinant Vaccinia-Mgp100 Vaccine
ALVAC gp100 Vaccine
|
|
1249
|
gp120 |
Human immunodeficiency virus 1 |
|
|
|
2326505
|
|
|
|
|
CDD:278917
GOA:O40515
InterPro: IPR000777
UniProtKB/TrEMBL: O40515 |
|
Protective antigen |
HIV recombinant canarypox vector vaccine (ALVAC-HIV [vCP1521] for priming and AIDSVAX B/E for boostering
HIV adenovirus vector vaccine Ad35 encoding env gp120
HIV DNA vaccine gp120
HIV DNA vaccine VlJns-tPA-gp120
|
|
1260
|
gp120 |
Human immunodeficiency virus 1 |
|
|
|
7769646
|
|
|
|
|
CDD:278917 |
gp120 |
Protective antigen |
|
|
1730
|
gp120 |
Human immunodeficiency virus 1 |
|
|
|
2326505
|
|
|
|
|
CDD:278917
GOA:O40515
InterPro: IPR000777
UniProtKB/TrEMBL: O40515 |
|
Protective antigen |
N. meningitidis DNA vaccine P3A
|
|
4788
|
gp160 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4295
|
GP3 |
Porcine respiratory and reproductive syndrome virus |
|
|
|
ABW91095
|
|
|
|
|
CDD:250739 |
GP3 |
Protective antigen |
|
|
4294
|
GP4 |
Porcine respiratory and reproductive syndrome virus |
|
|
|
ACV91353
|
|
|
|
|
CDD:111400 |
GP4 |
Protective antigen |
|
|
755
|
Gp46 |
Leishmania amazonensis |
VO_0011292
|
|
159320
|
159321
|
|
|
AAA29234.1 |
|
CDD:178695
CDD:275380 |
surface membrane glycoprotein GP46/M-2 |
Protective antigen |
L. amazonensis DNA vaccine encoding GP46
|
|
1422
|
GP5 |
Porcine reproductive and respiratory syndrome virus YA1 |
|
|
|
71152867
|
|
|
|
|
CDD:109986 |
major envelope glycoprotein |
Protective antigen |
PRRSV DNA vaccine pCI-ORF5/ORF6
|
|
4300
|
GP5 |
Equine arteritis virus |
|
|
|
AFU74047
|
|
|
|
|
CDD:292603
CDD:109986 |
GP5 |
Protective antigen |
|
|
963
|
GP5 protein |
Porcine reproductive and respiratory syndrome virus strain HUN4 |
|
|
|
149389584
|
|
|
|
|
CDD:109986 |
GP5 |
Virmugen |
Porcine respiratory and reproductive syndrome virus GP5 protein mutant vaccine
PRRSV DNA vaccine GST-ORF5 encoding GP5
|
|
664
|
gp50 |
Suid herpesvirus 1 |
VO_0011248
|
|
|
2440155
|
|
|
|
|
CDD:279830
InterPro: IPR002896
UniProtKB/TrEMBL: O41201 |
glycoprotein gp50 |
Protective antigen |
Pseudorabies recombinant vector vaccine encoding gp50 protein
Pseudorabies recombinant vector vaccine encoding gp50 and gII protein
|
|
1039
|
gp50 |
Suid herpesvirus 1 |
|
2952548
|
|
51557533
|
SuHV1_gp50 |
BK001744 |
YP_068367 |
|
|
|
Virmugen |
Pseudorabies virus gp50/gp63 mutant vaccine
NYVAC-PRV- gII/ gp50
|
|
444
|
gp55 |
|
VO_0010899
|
|
|
1763691
|
|
|
|
|
CDD:292945 |
glycoprotein |
Protective antigen |
Classical swine fever virus E1 protein vaccine
|
|
741
|
Gp63 |
Leishmania major |
VO_0011278
|
5649645
|
|
259011719
|
|
|
|
1LML
|
CDD:279761 |
GP63 |
Protective antigen |
L. major DNA Vaccine encoding Gp63
|
|
1040
|
gp63 |
Suid herpesvirus 1 |
|
2952540
|
|
51557548
|
SuHV1_gp63 |
BK001744 |
YP_068382 |
|
|
transcriptional regulator ICP4 |
Virmugen |
Pseudorabies virus gp50/gp63 mutant vaccine
|
|
4282
|
gp70 protein |
Feline leukemia virus |
|
|
|
NP_955581
|
|
|
|
|
CDD:278837
CDD:pfam00429 |
gp70 protein |
Protective antigen |
|
|
4493
|
gp72 |
Human herpesvirus 4 type 2 |
|
5176180
|
|
139424541
|
HHV4tp2_gp72 |
|
YP_001129507 |
|
|
BALF5 |
Protective antigen |
Interleukin-2 Anti-Idiotype Vaccine
|
|
1295
|
GPC |
Lassa virus strain AV |
|
|
|
354681511
|
|
|
|
|
CDD:279177 |
GPC protein |
Protective antigen |
Lassa fever virus recombinant vector vaccine YFV17D/LASV-GPC encoding the glycoprotein precursor
Lassa fever Virus Vaccine MOPEVAC (Modified Mopeia virus expressing antigens of pathogenic arenaviruses)
|
|
1357
|
GPC3 |
Homo sapiens |
|
2719
|
|
257471006
|
AC002420.1 |
AC002420 |
NP_001158089 |
|
|
transcript variant 4 |
Protective antigen |
|
|
3841
|
gpd |
Treponema pallidum |
|
|
|
2352433
|
|
|
|
|
CDD:236859 |
glycerophosphodiester phosphodiesterase |
Protective antigen |
|
|
4689
|
GPR183 |
Homo sapiens |
|
1880
|
|
4826706
|
|
AL160155 |
NP_004942 |
|
|
transcript variant X1 |
Protective antigen |
Autologous Epstein-Barr Virus-Transformed B-Lymphoblastoid Cell Vaccine
|
|
4434
|
GPT |
Homo sapiens |
|
2875
|
|
1843419814
|
|
AC084125 |
NP_001369593 |
|
|
transcript variant 4 |
Protective antigen |
Ad CMV I kappaB alpha
|
|
1733
|
GPX1 |
Schistosoma mansoni |
|
|
|
212287928
|
|
|
|
|
CDD:238207
CDD:278975 |
Glutathione peroxidase |
Protective antigen |
S. mansoni DNA vaccine pcDNA/GPXbb encoding glutathione-S-peroxidase, GPX
|
|
1361
|
GRA1 |
Toxoplasma gondii |
|
7896994
|
|
301750620
|
|
|
|
|
|
P24 granule antigen |
Protective antigen |
T. gondii DNA vaccine pVR1020-GRA1
|
|
4932
|
GRA16 |
Toxoplasma gondii ME49 |
|
7896580
|
|
237840711
|
TGME49_208830 |
CM002035 |
XP_002369653 |
|
|
|
Protective antigen |
T. gondii DNA vaccine pVAX-GRA16
|
|
4934
|
GRA17 |
|
|
|
|
EPR58489.1
|
|
|
|
|
|
dense-granule antigen DG32 |
Protective antigen |
T. gondii DNA vaccine pVAX-TgGRA17 + pVAX-TgGRA23
T. gondii DNA vaccine pVAX-TgGRA17
T. gondii GRA17 mutant vaccine
|
|
4348
|
GRA2 |
Toxoplasma gondii |
|
7897424
|
|
EPT27242
|
|
|
|
|
|
dense granule protein GRA2 |
Protective antigen |
|
|
4935
|
GRA23 |
|
|
|
|
EPR58349.1
|
|
|
|
|
|
dense granule protein DG32 |
Protective antigen |
T. gondii DNA vaccine pVAX-TgGRA17 + pVAX-TgGRA23
T. gondii DNA vaccine pVAX-TgGRA23
|
|
4923
|
GRA24 |
|
|
|
|
EPR64168.1
|
|
|
|
|
CDD:223021 |
hypothetical protein |
Protective antigen |
T. gondii DNA vaccine pVAX-GRA24 + pVAX-GRA25 + pVAX-MIC6
|
|
4861
|
GRA41 |
Toxoplasma gondii |
|
|
|
CEL76947.1
|
|
|
|
|
|
hypothetical protein |
Protective antigen |
T. gondii DNA vaccine pEGFP-C1/GRA41
|
|
4349
|
GRA5 |
Toxoplasma gondii |
|
7898187
|
|
EPT31025
|
|
|
|
|
|
dense granule protein GRA5 |
Protective antigen |
|
|
4930
|
GRA6 |
Toxoplasma gondii ME49 |
|
7895853
|
|
237845283
|
TGME49_275440 |
CM002045 |
XP_002371939 |
|
|
|
Protective antigen |
T. gondii DNA vaccine pcDNA3.1-HisGRA6
|
|
4939
|
GRA6 |
Neospora caninum Liverpool |
|
13446567
|
|
401410886
|
NCLIV_052880 |
FR823391 |
XP_003884891 |
|
|
|
Protective antigen |
RB51--MIC3/GRA2/GRA6/MIC1/SRS2
|
|
4357
|
GRA7 |
Neospora caninum |
|
|
|
AFB77190
|
|
|
|
|
|
dense granule protein |
Protective antigen |
|
|
4908
|
GRA7 |
Toxoplasma gondii ME49 |
|
7894037
|
|
237836631
|
TGME49_203310 |
CM002041 |
XP_002367613 |
|
|
|
Protective antigen |
GRA7(20–28)SAPN
T. gondii DNA vaccine pVitro-SAG1-GRA7
|
|
4929
|
GRA8 |
Toxoplasma gondii ME49 |
|
7894224
|
|
237840457
|
TGME49_254720 |
CM002037 |
XP_002369526 |
|
|
|
Protective antigen |
|
|
4587
|
GRDX |
Homo sapiens |
|
117189
|
|
|
|
|
|
|
|
Graves disease, susceptibility to, X-linked |
Protective antigen |
GM2/GD2/GD3 Lactone-KLH Conjugate Trivalent Vaccine
|
|
4649
|
GRIN1 |
Homo sapiens |
|
2902
|
|
11496971
|
|
AL929554 |
NP_000823 |
|
|
transcript variant X1 |
Protective antigen |
DNA Plasmid Encoding Interleukin-12 INO-9012
|
|
320
|
GroEL |
Salmonella enterica subsp. enterica serovar Typhi str. Ty2 |
VO_0010998
|
1068458
|
|
29144631
|
t4382 |
AE014613 |
NP_807973 |
|
|
molecular chaperone GroEL |
Protective antigen |
S. typhi GroEL Protein Vaccine
|
|
473
|
groEL |
Francisella tularensis |
VO_0011075
|
|
|
282159959
|
|
|
|
|
CDD:234573
CDD:239460 |
chaperonin GroEL |
Protective antigen |
F. tularensis GroEL protein vaccine
|
|
3902
|
groEL |
Bacillus anthracis |
|
|
|
KHA39277
|
|
|
|
|
|
molecular chaperone GroEL |
Protective antigen |
|
|
4001
|
groEL |
Edwardsiella tarda |
|
|
|
AGN29187
|
|
|
|
|
CDD:295468 |
GroEL |
Protective antigen |
|
|
4029
|
GroEL |
Chlamydophila pneumoniae |
|
|
|
WP_010883533
|
|
|
|
|
CDD:223535
CDD:295468 |
chaperonin GroEL |
Protective antigen |
C. pneumoniae DNA vaccine pHSP-60
|
|
4036
|
groEL |
Chlamydophila abortus |
|
|
|
AAL14265
|
|
|
|
|
CDD:234573
CDD:239460 |
GroEL |
Protective antigen |
|
|
4074
|
groEL |
Burkholderia pseudomallei |
|
|
|
AAO46033
|
|
|
|
|
CDD:237231
CDD:234573
CDD:239460 |
GroEL |
Protective antigen |
|
|
1300
|
groEL from Brucella abortus |
Brucella abortus bv. 1 str. 9-941 |
|
3341925
|
|
62317142
|
BruAb2_0190 |
AE017224 |
YP_222995 |
|
|
molecular chaperone GroEL |
Other |
|
|
4042
|
groEL_3 |
Chlamydia trachomatis D/UW-3/CX |
|
|
|
AAC68350
|
|
|
|
|
CDD:223535 |
HSP60 |
Protective antigen |
|
|
1686
|
GRP |
Homo sapiens |
|
2922
|
|
60498997
|
|
AC067859 |
NP_001012530 |
|
|
transcript variant X3 |
Protective antigen |
Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP
|
|
561
|
GRP-78 |
Leishmania donovani |
VO_0011152
|
13386966
|
|
16797868
|
|
|
|
|
CDD:240227
CDD:212681 |
glucose-regulated protein 78 |
Protective antigen |
L. donovani GRP-78 Protein Vaccine
|
|
4189
|
gst |
Staphylococcus aureus |
|
|
|
EES94142
|
|
|
|
|
|
glutathione S-transferase |
Protective antigen |
|
|
888
|
guaA |
Yersinia pestis KIM 10 |
|
1146310
|
|
22125262
|
y1363 |
AE009952 |
NP_668685 |
|
|
GMP synthase |
Virmugen |
Yersinia pestis guaBA mutant vaccine
|
|
913
|
guaA |
Francisella tularensis subsp. holarctica LVS |
|
3951701
|
|
89256406
|
FTL_1071 |
AM233362 |
YP_513768 |
|
|
GMP synthase |
Virmugen |
Francisella tularensis guaA mutant vaccine
|
|
1088
|
guaA |
Salmonella enterica subsp. enterica serovar Enteritidis str. P125109 |
|
6948075
|
|
207857920
|
SEN2490 |
AM933172 |
YP_002244571 |
|
|
GMP synthase |
Virmugen |
Salmonella Enteritidis guaBA/clpP mutant vaccine
|
|
1085
|
guaA from S. typhimurium str. LT2 |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1254032
|
|
16765830
|
STM2510 |
AE006468 |
NP_461445 |
|
|
GMP synthase |
Virmugen |
Salmonella Typhimurium guaBA/clpP mutant vaccine
Salmonella Typhimurium guaBA/clpP/fliD mutant vaccine
|
|
196
|
GuaB |
Shigella flexneri 5 str. 8401 |
|
4207514
|
|
110806439
|
SFV_2555 |
CP000266 |
YP_689959 |
|
|
inosine 5'-monophosphate dehydrogenase |
Protective antigen |
S. flexneri 2a strain CVD 1205
|
|
887
|
guaB |
Yersinia pestis KIM 10 |
|
1146309
|
|
22125261
|
y1362 |
AE009952 |
NP_668684 |
|
|
inosine 5'-monophosphate dehydrogenase |
Virmugen |
Yersinia pestis guaBA mutant vaccine
|
|
914
|
guaB |
Francisella tularensis subsp. holarctica FTNF002-00 |
|
5523917
|
|
156502929
|
FTA_1563 |
CP000803 |
YP_001428994 |
|
|
inosine-5'-monophosphate dehydrogenase |
Virmugen |
Francisella tularensis guaB mutant vaccine
|
|
1086
|
guaB |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1254033
|
|
16765831
|
STM2511 |
AE006468 |
NP_461446 |
|
|
inosine 5'-monophosphate dehydrogenase |
Virmugen |
Salmonella Typhimurium guaBA/clpP mutant vaccine
Salmonella Typhimurium guaBA/clpP/fliD mutant vaccine
|
|
926
|
guaB from S. enteritidis str. P125109 |
Salmonella enterica subsp. enterica serovar Enteritidis str. P125109 |
|
6949287
|
|
207857921
|
SEN2491 |
AM933172 |
YP_002244572 |
|
|
inosine 5'-monophosphate dehydrogenase |
Virmugen |
Salmonella enterica fliC/guaB mutant vaccine
Salmonella Enteritidis guaBA/clpP mutant vaccine
|
|
4730
|
GUCY2C |
Homo sapiens |
|
2984
|
|
222080083
|
|
AC007545 |
NP_004954 |
|
|
transcript variant X1 |
Protective antigen |
Adenovirus 5-Human Guanylyl Cyclase C-PADRE Vaccine
|
|
464
|
GX3262 |
Eimeria tenella |
VO_0011067
|
|
|
102304
|
|
|
|
|
|
sporozoite antigen |
Protective antigen |
E. tenella GX3262 protein vaccine
|
|
1034
|
gyrA |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1253794
|
|
16765599
|
STM2272 |
AE006468 |
NP_461214 |
|
|
DNA gyrase subunit A |
Virmugen |
Salmonella Typhimurium gyrA/cpxA/rpoB mutant vaccine
|
|
577
|
H hemagglutinin protein |
Measles morbillivirus |
VO_0011166
|
1489801
|
|
9626951
|
MeVgp5 |
AB016162 |
NP_056923 |
2RKC
|
|
mRNA |
Protective antigen |
Measles Virus vaccine VEE/SIN-H+F
Measles Virus vaccine VEE/SIN-H
Measles virus DNA-HA vaccine
ALVAC-MV-HA/F
|
|
4339
|
H protein |
rinderpest virus |
|
|
|
YP_087125
|
|
|
|
|
CDD:271231
GOA:Q629I1
InterPro: IPR000665
InterPro: IPR011040
UniProtKB/TrEMBL: Q629I1 |
H protein |
Protective antigen |
RPV ISCOM Vaccine
|
|
748
|
H1 |
Leishmania infantum |
VO_0011285
|
5070063
|
78146499
|
78146500
|
|
|
ABB22792.1 |
|
|
histone H1 |
Protective antigen |
L. infantum H1 protein vaccine
|
|
292
|
H2-K1 |
Mus musculus |
|
14972
|
|
133922588
|
|
AB114280 |
NP_001001892 |
|
|
transcript variant X11 |
Protective antigen |
Cancer recombinant vector vaccine encoding H-2Kb
Poliovirus vector expressing model antigen H2-Kb-restricted CTL epitope
|
|
739
|
H2B |
Leishmania major |
VO_0011277
|
|
|
13384083
|
|
|
|
|
CDD:304987 |
histone H2B |
Protective antigen |
L. major H2B Protein Vaccine
|
|
62
|
H3L |
Vaccinia virus |
VO_0010935
|
3707557
|
|
66275898
|
VACWR101 |
KT184691 |
YP_232983 |
|
|
IMV heparin binding surface protein |
Protective antigen |
IMV-EEV
|
|
1407
|
H5R |
Vaccinia virus |
|
3707559
|
|
66275900
|
VACWR103 |
AY603355 |
YP_232985 |
|
|
late transcription factor VLTF-4 |
Protective antigen |
|
|
516
|
HA |
Equine influenza virus H3N8 |
VO_0011112
|
|
|
404517
|
|
|
|
|
CDD:278910 |
hemagglutinin |
Protective antigen |
Influenza virus DNA vaccine encoding HA of Equine influenza virus H3N8
|
|
519
|
HA |
Influenza A virus (A/Puerto Rico/8/1934(H1N1)) |
VO_0011114
|
|
|
126599271
|
|
|
|
|
CDD:278910 |
hemagglutinin |
Protective antigen |
Recombinant baculovirus encoding HA from Influenza A virus (A/Puerto Rico/8/1934(H1N1))
Influenza virus DNA vaccine pCMV/Hl encoding H1
Influenza virus DNA vaccine pIRES/HA encoding HA
Influenza virus DNA vaccine pIRES/HA/IL-2 expressing HA
Influenza virus DNA vaccine pIRES/HA/GM-CSF encoding HA
Influenza virus DNA vaccine pIRES/HA/IL-12p35 + pIRES/NA/IL-12p40
Influenza virus DNA vaccine pBK-SFV-HA
Influenza virus DNA vaccine HA-DNA
Influenza virus DNA vaccine HA DNA
Influenza virus DNA vaccine pcDNA3.1/HA
BV-H5/H7/H9
rVEE-HA(H1N1)
|
|
521
|
ha |
Influenza A virus (A/chicken/Italy/13474/99(H7N1)) |
VO_0011116
|
|
|
32261025
|
|
|
|
|
CDD:278910
GOA:Q7TDW9
HSSP: 1IBN
InterPro: IPR000149
InterPro: IPR001364
InterPro: IPR008980
InterPro: IPR013827
InterPro: IPR013828
InterPro: IPR013829
UniProtKB/TrEMBL: Q7TDW9 |
hemagglutinin |
Protective antigen |
Avian influenza virus DNA vaccine pCMV-HA
|
|
522
|
HA |
Influenza B virus (Strain B/England/222/82) |
VO_0011117
|
|
|
122955
|
|
|
|
|
CDD:278910 |
Hemagglutinin |
Protective antigen |
Recombinant vaccinia virus encoding HA from Influenza B virus (Strain B/England/222/82)
|
|
523
|
HA |
Influenza A virus (A/duck/Badung-Bali/05/2005(H5N1)) |
VO_0011118
|
|
|
190344179
|
|
|
|
|
CDD:278910 |
hemagglutinin |
Protective antigen |
|
|
527
|
HA |
Influenza A virus (A/environment/Hong Kong/156/1997(H5N1)) |
VO_0011121
|
|
|
269826115
|
|
|
|
|
CDD:278910 |
hemagglutinin |
Protective antigen |
Influenza virus DNA vaccine encoding HA from Influenza A virus (A/environment/Hong Kong/156/1997(H5N1))
|
|
531
|
HA |
Influenza A virus (A/Solomon Islands/3/2006(H1N1)) |
VO_0011124
|
|
|
156123416
|
|
|
|
|
CDD:278910 |
hemagglutinin |
Protective antigen |
|
|
533
|
HA |
Influenza A virus (A/Yamagata/120/1986(H1N1)) |
VO_0011126
|
|
|
221344
|
|
|
|
|
CDD:278910 |
hemagglutinin |
Protective antigen |
Influenza virus HA protein vaccine (Influenza A virus (A/Yamagata/120/1986(H1N1)))
|
|
534
|
HA |
Influenza A virus (A/Fukuoka/C29/85(H3N2)) |
VO_0011127
|
|
|
221306
|
|
|
|
|
CDD:278910 |
hemagglutinin |
Protective antigen |
Influenza virus HA protein vaccine (Influenza A virus (A/Fukuoka/C29/85(H3N2)))
|
|
535
|
HA |
Influenza B virus (B/Ibaraki/2/85) |
VO_0011128
|
|
|
122959
|
|
|
|
|
CDD:278910 |
Hemagglutinin |
Protective antigen |
Influenza virus DNA vaccine encoding HA from Influenza B virus (B/Ibaraki/2/85)
|
|
537
|
HA |
Influenza A virus (A/Indonesia/CDC669/2006(H5N1)) |
VO_0011130
|
|
|
113497156
|
|
|
|
|
CDD:278910 |
hemagglutinin |
Protective antigen |
BacHA derived from Influenza A virus (A/Indonesia/CDC669/2006(H5N1))
|
|
538
|
HA |
Influenza A virus (A/Indonesia/CDC594/2006(H5N1)) |
VO_0011131
|
|
|
113495780
|
|
|
|
|
CDD:278910 |
hemagglutinin |
Protective antigen |
BacHA derived from Influenza A virus (A/Indonesia/CDC669/2006(H5N1))
|
|
539
|
HA |
Influenza A virus (A/Hawaii/01/1991(H3N2)) |
VO_0011132
|
|
|
110313990
|
|
|
|
|
CDD:278910 |
haemagglutinin |
Protective antigen |
|
|
540
|
HA |
Influenza A virus (A/chicken/Henan/12/2004(H5N1)) |
VO_0011133
|
|
|
61698018
|
|
|
|
|
CDD:278910 |
hemagglutinin |
Protective antigen |
Influenza virus DNA vaccine encoding HA from Influenza A virus (A/chicken/Henan/12/2004(H5N1))
|
|
546
|
HA |
Influenza A virus (A/chicken/Guangdong/02/2007(H9N2)) |
VO_0011139
|
|
|
206812650
|
|
|
|
|
CDD:278910 |
hemagglutinin |
Protective antigen |
|
|
549
|
HA |
Influenza A virus (A/turkey/Ireland/1378/1983(H5N8)) |
VO_0011141
|
|
|
115279333
|
|
|
|
|
CDD:278910 |
hemagglutinin |
Protective antigen |
Influenza virus DNA vaccine pCMVH5HA
Influenza virus DNA vaccine pβactinH7HA
FP-AI-H5(H5N1)
vFP89-HA (H5N1 HPAI virus)
vFP89-H5
|
|
550
|
HA |
Influenza A virus (A/chicken/Indonesia/7/2003(H5N1)) |
VO_0011142
|
|
|
129282887
|
|
|
|
|
CDD:278910 |
hemagglutinin |
Protective antigen |
FP-AI-H5(H5N1)
Trovac-AI-H5
|
|
551
|
HA |
Influenza A virus (A/Hatay/2004/(H5N1)) |
VO_0011143
|
|
|
56311402
|
|
|
|
|
CDD:278910
GOA:Q5QQ29
InterPro: IPR000149
InterPro: IPR001364
InterPro: IPR008980
InterPro: IPR013827
InterPro: IPR013828
InterPro: IPR013829
UniProtKB/TrEMBL: Q5QQ29 |
hemagglutinin |
Protective antigen |
|
|
553
|
HA |
Influenza A virus (A/whooper swan/Mongolia/3/05(H5N1)) |
VO_0011144
|
|
|
81687119
|
|
|
|
|
CDD:278910 |
hemagglutinin |
Protective antigen |
VSV*ΔG-H5 (H5N1)
|
|
765
|
HA |
Influenza A virus (A/equine/Kentucky/1/1981(H3N8)) |
VO_0011302
|
|
166079523
|
166079524
|
|
|
ABY81481.1 |
|
CDD:278910 |
hemagglutinin |
Protective antigen |
Influenza virus DNA vaccine encoding HA from Influenza A virus (A/equine/Kentucky/1/1981(H3N8))
Influenza virus DNA vaccine BacPAKHA encoding EqfKY HA
|
|
1212
|
HA |
A/seal/Massachusetts/1/1980(H7N7) |
|
|
|
119952175
|
|
|
|
|
CDD:278910 |
haemagglutinin |
Protective antigen |
Influenza virus DNA vaccine pP1/H7 encoding H7
Influenza virus DNA vaccine p188 encoding H7
RSV-H7
Schmidt-Ruppin Rous sarcoma virus-H7 (H7N7)
|
|
1215
|
HA |
A/swine/Taiwan/HL-1125/2009(H1N1) |
|
|
|
317015046
|
|
|
|
|
CDD:278910 |
hemagglutinin |
Protective antigen |
Influenza virus DNA vaccine pJW4303/HI encoding HI (HA)
AcHERV-sH1N1-HA
|
|
1372
|
HA |
Influenza A virus (A/Indonesia/5/2005(H5N1)) |
|
|
|
145284450
|
|
|
|
|
CDD:278910 |
hemagglutinin |
Protective antigen |
Influenza virus DNA vaccine H5 DNA
dVV-HA5(H5N1)
|
|
1433
|
HA |
Influenza A virus (A/chicken/Hubei/489/2004(H5N1)) |
|
|
55233227
|
55233228
|
|
|
AAV48546.1 |
|
CDD:278910 |
hemagglutinin |
Protective antigen |
Influenza virus DNA vaccine pHA/NP147–155 encoding NP147-155
|
|
1620
|
HA |
synthetic construct |
|
|
89994009
|
89994010
|
|
|
ABD83813.1 |
|
CDD:278910 |
codon-optimized hemagglutinin |
Protective antigen |
|
|
1831
|
HA |
|
|
|
516372
|
516373
|
|
|
CAA40729.1 |
|
CDD:278910
GOA:Q67089
HSSP: 1JSD
InterPro: IPR000149
InterPro: IPR001364
InterPro: IPR008980
InterPro: IPR013827
InterPro: IPR013828
UniProtKB/TrEMBL: Q67089 |
haemagglutinin |
Protective antigen |
PrV-HA (swine-origin H1N1)
|
|
4438
|
HA |
Influenza A virus (A/California/07/2009(H1N1)) |
|
23308115
|
|
758899356
|
UJ99_s4gp1 |
FJ969540 |
YP_009118626 |
|
|
hemagglutinin |
Protective antigen |
|
|
1213
|
HA from A/equine/Sao Paulo/1/76(H7N7) |
A/equine/Sao Paulo/1/76(H7N7) |
|
|
|
59208
|
|
|
|
|
CDD:278910
GOA:P26102
InterPro: IPR000149
InterPro: IPR001364
InterPro: IPR008980
InterPro: IPR013827
InterPro: IPR013828
InterPro: IPR013829
UniProtKB/UniProt: P26102 |
heamagglutinin |
Protective antigen |
Influenza virus DNA vaccine pCMV/H7
|
|
520
|
HA from Influenza A virus (A/Aichi/2/1968(H3N2)), (X31) |
Influenza A virus (A/Aichi/2/1968(H3N2)), (X31) |
VO_0011115
|
|
|
324132
|
|
|
|
|
CDD:278910 |
hemagglutinin precursor |
Protective antigen |
|
|
532
|
HA from Influenza A virus (A/Goose/Guangdong/1/96(H5N1)) |
Influenza A virus (A/goose/Guangdong/1/1996(H5N1)) |
VO_0011125
|
3654620
|
|
73852955
|
FLUAVH5N1_s4gp1 |
AF144305 |
YP_308669 |
|
|
hemagglutinin |
Protective antigen |
pCAGGoptiHA
Influenza virus DNA vaccine pHA
Influenza virus DNA vaccine pCAGGoptiHA
Influenza virus DNA vaccine pCAGGHA
|
|
525
|
HA from Influenza A virus (A/Hong Kong/1/68(H3N2)) |
Influenza A virus (A/Hong Kong/1/68(H3N2)) |
VO_0011120
|
|
|
16960108
|
|
|
|
|
|
|
Protective antigen |
Influenza virus DNA vaccine encoding HA from Influenza A virus (A/Hong Kong/1/68(H3N2))
|
|
547
|
HA from Influenza A virus (A/Thailand/1(KAN-1)/2004(H5N1)) |
Influenza A virus (A/Thailand/1(KAN-1)/2004(H5N1)) |
VO_0011140
|
|
46578137
|
46578138
|
|
|
AAS65615.2 |
|
CDD:278910 |
hemagglutinin |
Protective antigen |
Influenza virus DNA vaccine encoding HA from Influenza A virus (A/Thailand/1(KAN-1)/2004(H5N1))
|
|
545
|
HA from Influenza A virus (A/Viet Nam/1203/2004(H5N1)) |
Influenza A virus (A/Viet Nam/1203/2004(H5N1)) |
VO_0011138
|
|
|
159144921
|
|
|
|
2FK0
|
CDD:278910 |
hemagglutinin |
Protective antigen |
Flagellin-based HA globular head fusion vaccine using HA protein from Influenza A virus (A/Viet Nam/1203/2004(H5N1))
Influenza virus DNA vaccine VCL-4785 encoding HA
Influenza virus DNA vaccine VCL-4785 encoding H5
Avian influenza virus DNA vaccine pH5HA
BV-H5/H7/H9
dVV-HA5(H5N1)
|
|
518
|
HA from Influenza A virus (A/WSN/1933(H1N1)) |
Influenza A virus (A/WSN/1933(H1N1)) |
VO_0011113
|
|
|
324200
|
|
|
|
|
CDD:278910 |
hemagglutinin precursor |
Protective antigen |
Recombinant vesicular stomatitis virus encoding HA from Influenza A virus (A/WSN/1933(H1N1))
|
|
147
|
Hanta_G2 |
Andes virus Case T isolate |
|
|
2801763
|
2801763
|
|
AAB97456 |
|
|
Accession:AAB97456; GI:2801763 |
Andes Hantavirus M segment polyprotein |
|
DNA vaccine encoding ANDV glycoproteins
|
|
102
|
hap |
|
VO_0010916
|
|
|
AAB03707
|
|
|
|
|
CDD:280543
CDD:238653
CDD:214872 |
adhesion and penetration protein |
Protective antigen |
Nontypeable H. influenzae Hap Protein Vaccine
H. influenzae Hap protein vaccine
|
|
103
|
hap |
|
VO_0010917
|
|
|
23506944
|
|
AF369380 |
|
|
CDD:280543
CDD:238653
CDD:313027
CDD:214872 |
adhesin |
Protective antigen |
Nontypeable H. influenzae Hap Protein Vaccine
|
|
871
|
HAP |
Streptococcus equi subsp. equi 4047 |
|
|
|
4336671
|
|
|
|
|
CDD:226636
CDD:173869 |
hyaluronate-associated protein precursor |
Protective antigen |
|
|
3960
|
hap |
Haemophilus influenzae |
|
|
|
AAM74936
|
|
|
|
|
CDD:280543
CDD:225999 |
hap |
Protective antigen |
|
|
4361
|
HASPA |
Leishmania donovani |
|
|
|
3724130
|
|
|
|
|
UniProtKB/TrEMBL: O77299 |
HASPA protein |
Protective antigen |
|
|
4366
|
HASPB |
Leishmania infantum |
|
5069221
|
|
XP_001465795
|
|
|
|
|
CDD:332332
UniProtKB/TrEMBL: A4I0F4 |
hydrophilic acylated surface protein b |
Protective antigen |
|
|
572
|
HASPB1 |
Leishmania donovani |
VO_0011162
|
|
|
51847753
|
|
|
|
|
CDD:273344 |
cell surface protein B1 |
Protective antigen |
L. donovani HASPB1 Protein Vaccine
|
|
749
|
HASPB1 |
Leishmania infantum |
VO_0011286
|
5069221
|
3724133
|
3724134
|
|
|
CAA09789.1 |
|
CDD:273344
UniProtKB/TrEMBL: O77301 |
HASPB1 protein |
Protective antigen |
L. infantum HASPB1 protein vaccine
|
|
680
|
HAVgp2 |
Hepatovirus A |
VO_0010906
|
1493919
|
|
9626734
|
HAVgp2 |
M14707 |
NP_041008 |
|
|
hypothetical protein |
Protective antigen |
|
|
4802
|
HBB |
Homo sapiens |
|
3043
|
|
4504349
|
|
A01592 |
NP_000509 |
|
|
hemoglobin subunit beta |
Protective antigen |
DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
|
|
1280
|
HBcAg |
Hepatitis B virus |
|
|
|
560096
|
|
|
|
|
CDD:109943 |
HBcAg |
Other |
|
|
821
|
HBHA |
Mycobacterium tuberculosis H37Ra |
VO_0012373
|
5211814
|
|
148660242
|
MRA_0482 |
CP000611 |
YP_001281765 |
|
|
iron-regulated heparin binding hemagglutinin Hbha |
Protective antigen |
M. tuberculosis HBHA Protein Vaccine
|
|
4090
|
hbpA |
Actinobacillus pleuropneumoniae |
|
|
|
ABN75084
|
|
|
|
|
CDD:223818
CDD:173858 |
Heme-binding protein A |
Protective antigen |
A. pleuropneumoniae HbpA vaccine
|
|
1284
|
HbS |
Hepatitis B virus |
|
|
|
15384573
|
|
|
|
|
CDD:109739 |
HBs antigen |
Other |
Hepatitis B DNA vaccine pRc/CMV-HBs(S) encoding HBsAg
Hepatitis B DNA vaccine pCMV-HBs encoding HBsAg
Hepatitis B DNA vaccine pCEA/HBsAg encoding CEA and HBsAg
|
|
4578
|
HBsAg |
Hepatitis B virus |
|
944569
|
|
941241316
|
HBVgp2 |
AF372622 |
YP_009173869 |
|
|
large envelope protein |
Protective antigen |
|
|
497
|
HBVgp2 pre-S1/pre-S2/S |
Hepatitis B virus |
VO_0011095
|
944569
|
|
941241316
|
HBVgp2 |
AF372622 |
YP_009173869 |
|
CDD:109739 |
large envelope protein |
Protective antigen |
|
|
498
|
HBVgp3 X protein |
Hepatitis B virus |
|
944566
|
|
21326587
|
HBVgp3 |
X04615 |
NP_647606 |
|
|
X protein |
Virmugen |
Hepatitis B virus X protein mutant vaccine
|
|
3889
|
hcp1 |
Pseudomonas aeruginosa |
|
|
|
ARG84223
|
|
|
|
|
CDD:310322 |
Hcp1 |
Protective antigen |
|
|
4253
|
HE |
Infectious salmon anemia virus |
|
|
|
ADT90093
|
|
|
|
|
CDD:283797 |
hemagglutinin-esterase |
Protective antigen |
|
|
899
|
hemA |
|
|
|
|
12656010
|
|
|
|
|
CDD:178819
CDD:133452
CDD:144372 |
glutamyl-tRNA reductase |
Virmugen |
Vibrio cholerae hemA mutant vaccine
|
|
3873
|
hemH |
Rickettsia prowazekii |
|
|
|
NP_221230
|
|
|
|
|
CDD:234585
CDD:239504
CDD:238240 |
ferrochelatase |
Protective antigen |
|
|
644
|
HEP17 |
Plasmodium yoelii |
VO_0011228
|
3790041
|
|
1399353
|
|
|
|
|
CDD:284100 |
hepatocyte erythrocyte protein 17 kDa |
Protective antigen |
P. yoelii DNA vaccine encoding PyHEP17 Protein
|
|
4330
|
Hepatitis E Virus E2s Domain |
Hepatitis E virus |
|
|
|
3RKD_B
|
|
|
|
|
CDD:281067 |
Hepatitis E Virus E2s Domain |
Protective antigen |
|
|
4448
|
HER2-Dupli |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4085
|
hflX |
Actinobacillus pleuropneumoniae |
|
|
|
ASU15836
|
|
|
|
|
CDD:330486 |
GTPase HflX |
Protective antigen |
|
|
950
|
hfq |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1255887
|
|
16767607
|
STM4361 |
AE006468 |
NP_463222 |
2YLB
|
|
RNA-binding protein Hfq |
Virmugen |
Salmonella Typhimurium hfq mutant vaccine
|
|
1247
|
HIV complete genome |
Human immunodeficiency virus 1 |
|
|
388332048
|
388332049
|
|
|
AFK29870.1 |
|
|
gag protein |
Other |
|
|
1274
|
HIV1 ENV |
Human immunodeficiency virus 1 |
|
|
|
1490266
|
|
|
|
|
CDD:197369
GOA:Q76270
InterPro: IPR000328
PDB: 1I5X
PDB: 1I5Y
PDB: 1QR8
PDB: 1QR9
UniProtKB/TrEMBL: Q76270 |
GP41 |
Protective antigen |
|
|
4178
|
hla |
Staphylococcus aureus |
|
|
|
AMQ79365
|
|
|
|
|
CDD:273388 |
hla |
Protective antigen |
|
|
4947
|
HLA-A |
Homo sapiens |
|
3105
|
|
337752170
|
|
AB005048 |
NP_001229687 |
|
|
transcript variant 1 (A*03:01:01:01) |
Protective antigen |
Renal Cell Carcinoma Peptides Vaccine IMA901
|
|
4683
|
HLA-B |
Homo sapiens |
|
3106
|
|
17986001
|
|
AB030573 |
NP_005505 |
|
|
major histocompatibility complex, class I, B |
Protective antigen |
Renal Cell Carcinoma Peptides Vaccine IMA901
|
|
4682
|
HLA-DRB1 |
Homo sapiens |
|
3123
|
|
345461076
|
|
AB007634 |
NP_001230894 |
|
|
transcript variant 1 |
Protective antigen |
Autologous Melanoma Lysate/KLH-Pulsed Autologous Dendritic Cell Vaccine
Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine
|
|
4171
|
hlgB |
Staphylococcus aureus |
|
|
|
AKB00489
|
|
|
|
|
CDD:273388 |
gamma-hemolysin component C precursor, HlgB |
Protective antigen |
|
|
842
|
Hly |
Listeria monocytogenes EGD-e |
VO_0012388
|
987033
|
|
16802248
|
lmo0202 |
AL591824 |
NP_463733 |
|
|
listeriolysin O precursor |
Protective antigen |
L. monocytogenes DNA Vaccine encoding hly
|
|
278
|
Hma |
Escherichia coli CFT073 |
VO_0010984
|
1037732
|
|
26248334
|
c2482 |
AE014075 |
NP_754374 |
|
|
outer membrane receptor for iron compound or colicin |
Protective antigen |
E. coli Hma protein vaccine
|
|
582
|
HN |
Mumps rubulavirus |
VO_0011171
|
1489765
|
|
9695422
|
MuVgp6 |
AB040874 |
NP_054713 |
|
|
hemagglutinin-neuraminidase |
Protective antigen |
Mumps HN Protein Subunit Vaccine
rvOka-HN (mumps virus)
|
|
4323
|
HN |
Parainfluenza virus |
|
|
|
AAL89408
|
|
|
|
|
CDD:278832 |
HN glycoprotein |
Protective antigen |
MEDI-534
|
|
4884
|
HN |
Human respirovirus 1 |
|
935266
|
|
19718372
|
Hpv1gp09 |
|
NP_604441 |
|
|
mRNA |
Protective antigen |
MEDI-534
|
|
625
|
HN hemagglutinin-neuraminidase |
Newcastle disease virus B1 |
VO_0011209
|
912270
|
|
11545724
|
NDVgp5 |
AF309418 |
NP_071470 |
1USR
|
|
hemagglutinin-neuraminidase |
Protective antigen |
Newcastle Disease Virus HN Glycoprotein Subunit Vaccine
rAPMV3-F (newcastle disease)
|
|
3919
|
hpaA |
Helicobacter pylori |
|
|
|
WP_000855917
|
|
|
|
|
CDD:310078 |
neuraminyllactose-binding hemagglutinin |
Protective antigen |
|
|
480
|
hpd |
Haemophilus influenzae |
VO_0011081
|
|
|
148971
|
|
|
|
|
CDD:236859 |
protein D |
Protective antigen |
|
|
4961
|
hPIV3 fusion |
|
|
|
|
|
|
|
|
|
|
|
Protective antigen |
|
|
350
|
HpmB |
Yersinia pestis CO92 |
VO_0011013
|
1176539
|
|
218930726
|
YPO3720 |
AL590842 |
YP_002348601 |
|
|
hemolysin activator protein |
Protective antigen |
|
|
4505
|
HPV6 E6 |
Human papillomavirus type 6 |
|
2829163
|
|
|
|
|
|
|
|
Record to support submission of GeneRIFs for a gene not in Gene (human papillomavirus type 6 HPV-6). |
Protective antigen |
HPV-6-targeting Immunotherapeutic Vaccine INO-3106
|
|
4506
|
HPV6 E6 |
Human papillomavirus type 6 |
|
2829163
|
|
|
|
|
|
|
|
Record to support submission of GeneRIFs for a gene not in Gene (human papillomavirus type 6 HPV-6). |
Protective antigen |
Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
|
|
4944
|
HRAS |
Homo sapiens |
|
3265
|
|
194363762
|
|
AC137894 |
NP_001123914 |
|
|
transcript variant 1 |
Protective antigen |
Racotumomab Vaccine
|
|
3947
|
hsdS |
Haemophilus parasuis |
|
|
|
ACL32369
|
|
|
|
|
CDD:279728
CDD:223804 |
type I restriction enzyme specificity protein HsdS |
Protective antigen |
|
|
726
|
hslU |
Salmonella enterica subsp. enterica serovar Typhimurium |
VO_0011266
|
|
|
9650897
|
|
|
|
|
CDD:235364
GOA:O30911
InterPro: IPR003593
InterPro: IPR004491
InterPro: IPR013093
UniProtKB/UniProt: O30911 |
heat shock protein |
Protective antigen |
|
|
1350
|
HSP47 |
Mus musculus |
|
|
|
51450
|
|
|
|
|
CDD:239001
GOA:P19324
InterPro: IPR000215
UniProtKB/UniProt: P19324 |
heat shock protein |
Protective antigen |
Prostate cancer DNA vaccine PSCA-HSP encoding PSCA and HSP
|
|
805
|
hsp60 |
Helicobacter pylori |
VO_0011336
|
|
|
397869
|
|
|
|
|
CDD:234573
CDD:239460
GOA:P42383
InterPro: IPR001844
InterPro: IPR002423
InterPro: IPR018370
UniProtKB/UniProt: P42383 |
heat shock protein 60 |
Protective antigen |
|
|
1742
|
HSP60 from P. yoelii |
Plasmodium yoelii strain 17X(NL) |
|
3790277
|
|
3885993
|
|
|
|
|
CDD:185455
CDD:239460 |
heat shock protein 60 |
Protective antigen |
P. yoelii DNA vaccine pPyHsp60-VR1012
|
|
1612
|
hsp65 |
Mycobacterium leprae |
|
|
|
34333423
|
|
|
|
|
CDD:295468 |
heat shock protein 65 |
Protective antigen |
Adjuvant arthritis DNA vaccine pCMV3.65 encoding HSP65
Pristane-induced arthritis DNA vaccine DNA-hsp65 encoding Mycobacterium leprae 65-kDa heat shock protein
|
|
566
|
hsp70 |
Leishmania donovani |
VO_0011156
|
|
|
281426606
|
|
|
|
|
CDD:302596
GOA:D2EAU9
InterPro: IPR001023
InterPro: IPR013126
InterPro: IPR018181
UniProtKB/TrEMBL: D2EAU9 |
heat shock protein 70 |
Protective antigen |
L. donovani Hsp70 Protein Vaccine
|
|
1735
|
hsp70 |
Toxoplasma gondii |
|
7895357
|
|
12248795
|
|
|
|
|
CDD:240227
CDD:212675
CDD:295646 |
|
Protective antigen |
T. gondii DNA vaccine T.g.HSP70
|
|
1096
|
HSP70 II |
Leishmania infantum JPCM5 |
|
5073319
|
|
146101862
|
LINJ_35_4220 |
FR796467 |
XP_001469224 |
|
|
|
Virmugen |
Leishmania infantum HSP70 II mutant vaccine
|
|
657
|
Hsp90 |
Plasmodium falciparum |
VO_0011241
|
2655065
|
|
1093612
|
|
|
|
|
CDD:240341
CDD:214643
CDD:238030
CDD:278607 |
|
Protective antigen |
P. falciparum Hsp90 Protein Subunit Vaccine
|
|
4581
|
HSP90B1 |
Homo sapiens |
|
7184
|
|
4507677
|
|
AC078819 |
NP_003290 |
|
|
heat shock protein 90 beta family member 1 |
Protective antigen |
Viagenpumatucel-L Vaccine
gp96-secreting Allogeneic Bladder Cancer Cell Vaccine HS-410
|
|
825
|
hspA |
Helicobacter pylori 85P |
VO_0012377
|
|
|
712830
|
|
|
|
|
CDD:178988
CDD:238197 |
heat shock protein |
Protective antigen |
H. pylori HspA Protein Vaccine
H. pylori DNA vaccine pcDNA3.1-hspA
|
|
4687
|
HSPA4 |
Homo sapiens |
|
3308
|
|
38327039
|
|
AC113410 |
NP_002145 |
|
|
heat shock protein family A (Hsp70) member 4 |
Protective antigen |
Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858
|
|
826
|
hspB |
Helicobacter pylori 85P |
VO_0012378
|
|
|
712831
|
|
|
|
|
CDD:234573
CDD:237231
CDD:239460 |
heat shock protein |
Protective antigen |
H. pylori HspB Protein Vaccine
H. pylori DNA vaccine pcDNA3.1-hspB
|
|
4481
|
HSPD1 |
Homo sapiens |
|
3329
|
|
31542947
|
|
AC010746 |
NP_002147 |
|
|
transcript variant 2 |
Protective antigen |
Verpasep Caltespen Vaccine
|
|
493
|
HTNVsSgp1 |
Hantaan orthohantavirus |
VO_0011091
|
2943078
|
|
38371711
|
HTNVsSgp1 |
M14626 |
NP_941977 |
|
|
hypothetical protein |
Protective antigen |
|
|
175
|
htpB |
Coxiella burnetii |
VO_0010934
|
|
|
197253489
|
AY251297 |
|
|
|
CDD:234573
CDD:237231
CDD:239460 |
heat shock protein B |
Protective antigen |
P1-HspB (fusion of protein 1 and heat-shock protein B)
|
|
345
|
HtpG |
Yersinia pestis CO92 |
VO_0011008
|
1175934
|
|
218930152
|
YPO3119 |
AL590842 |
YP_002348027 |
|
|
heat shock protein 90 |
Protective antigen |
|
|
185
|
HtrA |
Salmonella enterica subsp. enterica serovar Typhi str. CT18 |
|
1246721
|
|
16759200
|
STY0231 |
NC_003198.1 |
NP_454817.1 |
|
|
protease DO precursor; heat shock protein HtrA |
|
CVD 909
|
|
824
|
HtrA |
Haemophilus influenzae NTHi 33 |
VO_0012376
|
|
|
2935168
|
|
|
|
|
CDD:273938 |
HtrA |
Protective antigen |
|
|
996
|
htrA |
Yersinia enterocolitica subsp. enterocolitica 8081 |
|
4715899
|
|
123441096
|
YE0741 |
AM286415 |
YP_001005085 |
|
|
serine endoprotease |
Virmugen |
Yersinia enterocolitica htrA mutant vaccine
|
|
1080
|
htrA |
Salmonella enterica subsp. enterica serovar Typhimurium SL1344 |
|
|
|
301156836
|
STM0209 |
AE006468 |
NP_459214 |
|
CDD:182855
CDD:199257
CDD:29044
UniProtKB/TrEMBL: E1W881 |
protease DO precursor; heat shock protein HtrA |
Virmugen |
Salmonella Typhimurium htrA mutant vaccine
|
|
4054
|
htrA |
Chlamydia muridarum str. Nigg |
|
|
|
AAF39082
|
|
|
|
|
CDD:273938 |
serine protease, HtrA/DegQ/DegS family |
Protective antigen |
|
|
4066
|
htrA |
Campylobacter jejuni |
|
|
|
CAA57948
|
|
|
|
|
CDD:273938
CDD:290102
CDD:238487
GOA:Q46120
HSSP: 1KY9
InterPro: IPR001254
InterPro: IPR001478
InterPro: IPR001940
InterPro: IPR009003
InterPro: IPR011782
UniProtKB/TrEMBL: Q46120 |
serine protease |
Virmugen |
|
|
1343
|
HuD |
Homo sapiens |
|
1996
|
|
221316767
|
|
AL583843 |
NP_001138246 |
|
|
transcript variant 7 |
Protective antigen |
Neuroblastoma DNA vaccine HuDsec
|
|
1235
|
Human metapneumovirus genome |
Human metapneumovirus |
|
|
340008341
|
340008342
|
|
|
AEK26903.1 |
|
|
N |
Other |
|
|
1231
|
Human parainfluenza virus 1 genome |
Human parainfluenza virus 1 |
|
|
19718363
|
19718364
|
|
|
NP_604433.1 |
|
|
nucleoprotein |
Other |
|
|
4669
|
human TP53 (P53) |
Homo sapiens |
|
7157
|
|
120407068
|
|
AB118156 |
NP_000537 |
|
|
transcript variant 2 |
Protective antigen |
ALVAC-P53 Vaccine
Modified Vaccinia Virus Ankara Vaccine Expressing p53
EP-2101 Vaccine
p53 Peptide Vaccine
Autologous Dendritic Cell-Adenovirus P53 Vaccine
Contusugene ladenovec
Adenovirus-p53 Transduced Dendritic Cell Vaccine
Anti-p53 T-Cell Receptor-Transduced Peripheral Blood Lymphocytes Vaccine
Berzofsky Ras/P53 Peptide Vaccine
Long Peptide Vaccine 7
ONYX-015 Vaccine
Recombinant Adenovirus-p53 SCH-58500 Vaccine
|
|
1685
|
HUMGP 75 |
Homo sapiens |
|
|
|
1067130
|
|
|
|
|
CDD:278682
GDB:126337
GOA:P17643
HGNC:HGNC:12450
InterPro: IPR002227
InterPro: IPR008922
InterPro: IPR015559
UniProtKB/UniProt: P17643 |
melanoma antigen gp 75 |
Protective antigen |
Melanoma DNA vaccine gp75 DNA encoding melanosomal membrane glycoproteins, gp75
|
|
3941
|
hxuB |
Haemophilus parasuis |
|
|
|
ACL33615
|
|
|
|
|
CDD:225387
CDD:285653
CDD:279448 |
heme/hemopexin-binding protein B, hemolysin activation/secretion protein |
Protective antigen |
|
|
3942
|
hxuC |
Haemophilus parasuis |
|
|
|
ACL33614
|
|
|
|
|
CDD:273807
CDD:238657 |
heme/hemopexin utilization protein C/outer membrane receptor protein, mostly Fe transport |
Protective antigen |
|
|
4341
|
hypothetical protein |
Eimeria acervulina |
|
|
|
AFB77195
|
|
|
|
|
|
hypothetical protein |
Protective antigen |
|
|
4086
|
hypothetical protein APL_1061 |
Actinobacillus pleuropneumoniae |
|
|
|
ABN74153
|
|
|
|
|
CDD:324543 |
hypothetical protein |
Protective antigen |
|
|
4151
|
hypothetical protein MGAS2096_Spy1592 |
Streptococcus pyogenes M1 GAS |
|
|
|
ABF36644
|
|
|
|
|
|
hypothetical protein |
Protective antigen |
|
|
3870
|
hypothetical protein RP403 |
Rickettsia prowazekii str |
|
|
|
NP_220784
|
|
|
|
|
CDD:288430
CDD:304521
CDD:225441 |
hypothetical protein |
Protective antigen |
|
|
4138
|
hypothetical protein SPy_0130 |
Streptococcus pyogenes |
|
|
|
NP_268519
|
|
|
|
|
CDD:274781 |
hypothetical protein |
Protective antigen |
|
|
4142
|
hypothetical protein SPy_0843 |
Streptococcus pyogenes M1 GAS |
|
|
|
NP_269051
|
|
|
|
|
CDD:315882; CDD:275383 |
hypothetical protein |
Protective antigen |
|
|
4368
|
hypothetical protein [Leishmania braziliensis] |
Leishmania amazonensis |
|
5418250
|
|
AKK31275
|
|
|
|
|
CDD:294530 |
hypothetical protein |
Protective antigen |
|
|
254
|
IalB |
Brucella melitensis bv. 1 str. 16M |
VO_0010967
|
1197295
|
|
17987867
|
BMEI1584 |
AE008917 |
NP_540501 |
|
|
invasion protein B |
Protective antigen |
B. melitensis DNA vaccine p-ialB
|
|
862
|
iap |
Listeria monocytogenes strain L2K3-549C1 |
VO_0012404
|
|
|
215422507
|
|
|
|
|
CDD:333284 |
p60 |
Protective antigen |
L. monocytogenes p60 Protein Vaccine
|
|
4612
|
ICAM1 |
Homo sapiens |
|
3383
|
|
167466198
|
|
AC011511 |
NP_000192 |
|
|
intercellular adhesion molecule 1 |
Protective antigen |
Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
Recombinant Fowlpox-TRICOM Vaccine
Rilimogene-galvacirepvec Vaccine
Autologous IL-2-expressing B-CLL Vaccine
ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine
Brain Tumor Initiating Cell Vaccine
|
|
4026
|
icmO |
Coxiella burnetii CbuK_Q154 |
|
|
|
ACJ20972
|
|
|
|
|
CDD:328724 |
IcmO |
Protective antigen |
|
|
1023
|
ICP0 |
Human herpesvirus 2 |
|
1487289
|
|
109676722
|
HHV2gp61 |
Z86099 |
NP_044528 |
|
|
ubiquitin E3 ligase ICP0 |
Virmugen |
Herpes simplex virus 2 ICP0 mutant vaccine
|
|
504
|
ICP27 |
Herpes simplex virus type 1 |
VO_0011101
|
|
|
75812153
|
|
|
|
|
CDD:293457
CDD:283185 |
ICP27 |
Protective antigen |
Herpes simplex virus DNA vaccine ICP-27 DNA encoding ICP-27
|
|
503
|
ICP27 from Herpes simplex virus type 2 |
Herpes simplex virus type 2 |
VO_0011100
|
|
|
124181
|
|
|
|
|
CDD:293457
CDD:283185 |
mRNA export factor |
Protective antigen |
Herpes simplex virus type 2 DNA vaccine encoding ICP27
|
|
193
|
IcsA/VirG |
Shigella flexneri 2a str. 301 |
|
1238021
|
|
31983529
|
CP0182 |
NC_004851.1 |
NP_858315.1 |
3ML3
|
|
IcsA (VirG), outermembrane protein exposed to the bacterial surface by a C-terminal autotransporter domain and involved in the movement of intracellular bacteria by binding to N-WASP |
Virmugen |
S. flexneri 2a strain CVD 1207
SC602
|
|
4666
|
ID1 |
Homo sapiens |
|
3397
|
|
31317299
|
|
AL110115 |
NP_002156 |
|
|
transcript variant 2 |
Protective antigen |
Dendritic Cell-Idiotype-Keyhole Limpet Hemocyanin Vaccine
|
|
4498
|
IDH1 |
Homo sapiens |
|
3417
|
|
538917488
|
|
AC016697 |
NP_001269315 |
|
|
transcript variant 2 |
Protective antigen |
IDH1R132H-Specific Peptide Vaccine PEPIDH1M
IDH1R132H Mutation-targeting IDH1 Peptide Vaccine
|
|
4804
|
IDO1 |
Homo sapiens |
|
3620
|
|
4504577
|
|
AC007991 |
NP_002155 |
|
|
indoleamine 2,3-dioxygenase 1 |
Protective antigen |
Indoleamine 2,3-dioxygenase Peptide Vaccine
|
|
1227
|
IE1 |
Murine cytomegalovirus |
|
|
|
138479
|
|
|
|
|
|
Immediate-early protein 1 |
Protective antigen |
Murine cytomegalovirus DNA vaccine pcDNA-89 encoding pp89
|
|
658
|
IE180 |
Suid alphaherpesvirus 1 |
VO_0011242
|
2952540
|
|
51557548
|
SuHV1_gp63 |
BK001744 |
YP_068382 |
|
|
transcriptional regulator ICP4 |
Protective antigen |
Psuedorabies DNA vaccine encoding IE180 protein
|
|
4325
|
IE2 |
Human cytomegalovirus |
|
|
|
AAA45953
|
|
|
|
|
|
IE2 |
Protective antigen |
|
|
4603
|
IFNA2 |
Homo sapiens |
|
3440
|
|
11067751
|
|
AL353732 |
NP_000596 |
|
|
interferon alpha 2 |
Protective antigen |
Recombinant Adenovirus-Interferon/Syn3 Vaccine
|
|
4604
|
IFNB1 |
Homo sapiens |
|
3456
|
|
4504603
|
|
AL390882 |
NP_002167 |
|
|
interferon beta 1 |
Protective antigen |
Recombinant Adenovirus-hIFN-beta Vaccine
|
|
1419
|
IFNG |
Sus scrofa |
|
396991
|
|
47522726
|
|
CU694828 |
NP_999113 |
|
|
interferon, gamma |
Other |
|
|
4703
|
IFNG |
Homo sapiens |
|
3458
|
|
56786138
|
|
AC007458 |
NP_000610 |
|
|
interferon gamma |
Protective antigen |
Allogeneic Dendritic Cell Vaccine COMBIG-DC
ALVAC Vaccine
|
|
4716
|
IFNG- Obsolete |
Homo sapiens |
|
3458
|
|
56786138
|
|
AC007458 |
NP_000610 |
|
|
interferon gamma |
Protective antigen |
|
|
4538
|
IFNL3 |
Homo sapiens |
|
282617
|
|
1100961536
|
|
AC011445 |
NP_001333866 |
|
|
transcript variant 2 |
Protective antigen |
Melanoma Theraccine
|
|
4469
|
IGF2BP3 |
Homo sapiens |
|
10643
|
|
30795212
|
|
AC005082 |
NP_006538 |
|
|
transcript variant X1 |
Protective antigen |
URLC10-CDCA1-KOC1 Multipeptide Vaccine
URLC10-TTK-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine
Multipeptide Vaccine S-588210
Recombinant Adenovirus-L523S Vaccine
Recombinant DNA-L523S Vaccine
|
|
4598
|
IGFBP1 |
Homo sapiens |
|
3484
|
|
4504615
|
|
AC091524 |
NP_000587 |
|
|
insulin like growth factor binding protein 1 |
Protective antigen |
pUMVC3-hIGFBP-2 Multi-Epitope Plasmid DNA Vaccine
|
|
1657
|
IgG Fc |
Mus musculus |
|
215384
|
|
169790797
|
|
AC158220 |
NP_001116075 |
|
|
Fc fragment of IgG binding protein |
Protective antigen |
Insulin-dependent diabetes mellitus DNA vaccine JwGAD65 + IL-4
|
|
1688
|
IgG Fc |
Homo sapiens |
|
8857
|
|
154146262
|
|
AC006950 |
NP_003881 |
|
|
Fc fragment of IgG binding protein |
Protective antigen |
Prostate cancer DNA vaccine psig-3P-Fc encoding 3P(hPSM, hPAP, or hPSA)-Fc fusion protein
|
|
4696
|
IGHG1 |
Homo sapiens |
|
3500
|
|
|
|
AL122127 |
|
|
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
Protective antigen |
|
|
469
|
IglB |
Francisella novicida U112 |
VO_0011071
|
4548125
|
|
118497903
|
FTN_1323 |
CP000439 |
YP_898953 |
|
|
intracellular growth locus protein B |
Virmugen |
Francisella tularensis IglB mutant vaccine
|
|
7
|
IglC |
Francisella tularensis subsp. novicida U112 |
|
4548124
|
|
|
FTN_1322 |
|
|
|
|
|
Virmugen |
dsbB, FTT0742, pdpB, fumA, carB
KKF24
|
|
470
|
IglC1 |
Francisella tularensis subsp. tularensis SCHU S4 |
VO_0011072
|
3191591
|
|
56708413
|
FTT_1357c |
AJ749949 |
YP_170309 |
2QWU
|
|
intracellular growth locus subunit C |
Protective antigen |
F. tularensis vaccine rLm/iglC
|
|
471
|
IglC2 |
Francisella tularensis subsp. tularensis SCHU S4 |
VO_0011073
|
3191814
|
|
56708721
|
FTT_1712c |
AJ749949 |
YP_170617 |
|
|
intracellular growth locus subunit C |
Protective antigen |
F. tularensis vaccine rLm/iglC
|
|
4564
|
IL12 |
Sus scrofa |
|
107653060
|
|
|
|
|
|
|
|
Interleukin 12 level |
Protective antigen |
Natural Killer Cells ZRx101 Vaccine
Oncovax-ID/IL-2 Vaccine
PSA/IL-2/GM-CSF Vaccine
SRL172
|
|
1367
|
Il12a |
Mus musculus |
|
16159
|
|
226874945
|
|
AC121306 |
NP_001152896 |
|
|
transcript variant 1 |
Protective antigen |
Chinese S. japonicum DNA vaccine pVIVO2-IL12-Sj23 encoding Sj23 and IL-12
|
|
4744
|
IL12A |
Homo sapiens |
|
3592
|
|
24430219
|
|
AC010370 |
NP_000873 |
|
|
transcript variant 1 |
Protective antigen |
Ad5-yCD/mutTKSR39rep-hIL12
|
|
4699
|
IL12B |
Homo sapiens |
|
3593
|
|
24497438
|
|
AC011418 |
NP_002178 |
|
|
interleukin 12B |
Protective antigen |
Ad5-yCD/mutTKSR39rep-hIL12
Adenovirus-mediated Human Interleukin-12
|
|
4553
|
IL13RA2 |
Homo sapiens |
|
3598
|
|
10834992
|
|
AH012718 |
NP_000631 |
|
|
interleukin 13 receptor subunit alpha 2 |
Protective antigen |
Plasmacytoid Dendritic Cell Vaccine
|
|
694
|
Il18 |
Mus musculus |
|
16173
|
|
1269208322
|
|
AC025500 |
NP_001344150 |
|
|
transcript variant X2 |
Protective antigen |
|
|
1389
|
Il18 |
Mus musculus |
|
16173
|
|
1269208322
|
|
AC025500 |
NP_001344150 |
|
|
transcript variant X2 |
Protective antigen |
|
|
4674
|
IL2 |
Homo sapiens |
|
3558
|
|
28178861
|
|
AC022489 |
NP_000577 |
|
|
interleukin 2 |
Protective antigen |
Autologous Tumor Cell Proteoliposome Chronic Lymphocytic Leukemia Vaccine
Autologous HNSCC DNA-transfected Semi-allogeneic Fibroblasts MRC-5 Vaccine
Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine
|
|
4745
|
IL2-Duplicate |
Homo sapiens |
|
3558
|
|
28178861
|
|
AC022489 |
NP_000577 |
|
|
interleukin 2 |
Protective antigen |
|
|
4445
|
IL24 |
Homo sapiens |
|
11009
|
|
297632401
|
|
AC098935 |
NP_001172085 |
|
|
transcript variant X2 |
Protective antigen |
Adenovector Encoding MDA7
|
|
698
|
Il25 |
Mus musculus |
|
140806
|
|
18141561
|
|
CH466535 |
NP_542767 |
|
|
transcript variant X1 |
Protective antigen |
|
|
697
|
Il33 |
Mus musculus |
|
77125
|
|
257900495
|
|
AC111048 |
NP_001158196 |
|
|
transcript variant 2 |
Protective antigen |
|
|
4414
|
IL3RA |
Homo sapiens |
|
3563
|
|
391224440
|
|
AL683870 |
NP_001254642 |
|
|
transcript variant X3 |
Protective antigen |
Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
|
|
4208
|
immunogenic secreted protein |
Streptococcus agalactiae |
|
|
|
ASI67082
|
|
|
|
|
CDD:332523 |
immunogenic secreted protein |
Protective antigen |
|
|
1683
|
Immunoglobulin |
Homo sapiens |
|
|
|
1945467
|
|
|
|
|
CDD:299845
CDD:214653 |
immunoglobulin heavy chain |
Protective antigen |
B-cell lymphoma DNA vaccine VCL-1642.XXX encoding a chimeric immunoglobulin molecule onsisting of tumor-specific variable (Id) regions
|
|
4057
|
incA |
Chlamydia trachomatis |
|
|
|
ABV03238
|
|
|
|
|
CDD:282066 |
IncA |
Protective antigen |
|
|
4135
|
inlA |
Streptococcus pyogenes M1 GAS |
|
|
|
NP_269467
|
|
|
|
|
CDD:331999
CDD:275380
CDD:227223 |
putative internalin A precursor |
Protective antigen |
|
|
4006
|
invasin |
Edwardsiella tarda |
|
|
|
AKH88306
|
|
|
|
|
CDD:288753
CDD:214751 |
invasin |
Protective antigen |
|
|
307
|
ipaB |
Shigella flexneri 2a |
VO_0010994
|
|
|
22036246
|
|
|
|
|
CDD:293143 |
IpaB |
Protective antigen |
S. flexneri Invaplex 24 Subunit Vaccine
S. flexneri Invaplex 50 Subunit Vaccine
|
|
3862
|
ipaB |
Shigella sonnei |
|
|
|
SJL99262
|
|
|
|
|
|
IpaB |
Protective antigen |
|
|
308
|
IpaC |
Shigella flexneri 2a |
VO_0010995
|
|
|
47056
|
|
|
|
|
CDD:185271
GOA:P18012
InterPro: IPR005427
UniProtKB/UniProt: P18012 |
|
Protective antigen |
S. flexneri Invaplex 24 Subunit Vaccine
S. flexneri Invaplex 50 Subunit Vaccine
|
|
3864
|
ipaC |
Shigella dysenteriae Sd197 |
|
|
|
YP_406166
|
|
|
|
|
CDD:185271 |
IpaC |
Protective antigen |
|
|
309
|
ipaD |
Shigella flexneri 2a |
VO_0010996
|
|
|
22036352
|
|
|
|
2J0O
|
CDD:297251 |
IpaD |
Protective antigen |
S. flexneri Invaplex 24 Subunit Vaccine
S. flexneri Invaplex 50 Subunit Vaccine
|
|
3863
|
ipaD |
Shigella flexneri |
|
|
|
ACS88189
|
|
|
|
|
CDD:297251 |
IpaD |
Protective antigen |
|
|
982
|
IpxM |
Yersinia pestis CO92 |
|
1174901
|
|
218929170
|
YPO2063 |
AL590842 |
YP_002347045 |
|
|
lipid A biosynthesis (KDO)2-(lauroyl)-lipid IVA acyltransferase |
Virmugen |
Yersinia pestis IpxM mutant vaccine
|
|
1313
|
IRBP |
Mus musculus |
|
|
|
4689280
|
|
|
|
|
CDD:143479 |
retinoid-binding protein IRBP |
Other |
|
|
1611
|
IRBP from humans |
Homo sapiens |
|
5949
|
|
4506453
|
|
AH002852 |
NP_002891 |
|
|
retinol binding protein 3 |
Protective antigen |
EAU DNA vaccine IRBP-DNA encoding IRBP
|
|
279
|
ireA |
Escherichia coli CFT073 |
VO_0010985
|
1037614
|
|
AMR36194
|
c5174 |
AE014075 |
NP_757022 |
|
CDD:139605 |
IreA |
Protective antigen |
E. coli IreA protein vaccine
|
|
282
|
IroN |
Escherichia coli |
VO_0010988
|
7379404
|
|
222104801
|
MM1_0014 |
AF449498 |
YP_002539290 |
1FEP
|
|
outer membrane receptor FepA |
Protective antigen |
|
|
318
|
IroN |
Salmonella enterica subsp. enterica serovar Typhimurium |
VO_0010997
|
|
|
259475459
|
|
|
|
|
CDD:237410 |
|
Protective antigen |
Salmonella IroN Protein Vaccine
|
|
343
|
Irp7 |
Yersinia pestis CO92 |
VO_0011006
|
1174753
|
|
218929030
|
YPO1914 |
AL590842 |
YP_002346905 |
|
|
ABC transporter permease |
Protective antigen |
|
|
893
|
isdB |
Staphylococcus aureus subsp. aureus str. Newman |
|
5330644
|
|
151221252
|
NWMN_1040 |
AP009351 |
YP_001332074 |
|
CDD:213844 |
iron-regulated heme-iron binding protein IsdB |
Protective antigen |
|
|
4188
|
IsdH |
Staphylococcus aureus subsp. aureus 71193 |
|
|
|
AFH69961
|
|
|
|
|
CDD:331945 |
IsdH |
Protective antigen |
|
|
4119
|
isp2 |
Streptococcus pyogenes |
|
|
|
NP_269810
|
|
|
|
|
CDD:330579
CDD:226451 |
immunogenic secreted precursor-like protein |
Protective antigen |
|
|
4909
|
ISP3 |
Toxoplasma gondii ME49 |
|
7897539
|
|
1085146070
|
TGME49_316540 |
CM002046 |
XP_018635288 |
|
|
|
Protective antigen |
ISP3 VLP
|
|
240
|
Iss |
Escherichia coli APEC O1 |
VO_0010964
|
5616654
|
|
157418230
|
APECO1_O1CoBM146 |
DQ381420 |
YP_001481302 |
|
|
Iss |
Protective antigen |
APEC vaccine based on Iss protein
APEC vaccine using GST-Iss fusion protein
|
|
4463
|
ITGB8 |
Homo sapiens |
|
3696
|
|
4504779
|
|
AC004130 |
NP_002205 |
|
|
transcript variant X3 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine
|
|
4710
|
ITIH4 |
Homo sapiens |
|
3700
|
|
262050538
|
|
AC006254 |
NP_001159921 |
|
|
transcript variant 1 |
Protective antigen |
|
|
280
|
iutA |
Escherichia coli CFT073 |
VO_0010986
|
1039578
|
|
WP_000079029
|
c3623 |
AE014075 |
NP_755498 |
|
CDD:273805 |
TonB-dependent receptor |
Protective antigen |
E. coli IutA protein vaccine
|
|
4461
|
JUP |
Homo sapiens |
|
3728
|
|
1209185293
|
|
AC109319 |
NP_001339702 |
|
|
transcript variant 4 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine
|
|
808
|
katA |
Helicobacter pylori |
VO_0011339
|
|
|
WP_000247320
|
|
|
|
1QWL
|
CDD:163712 |
catalase |
Protective antigen |
H. pylori catalase protein vaccine
|
|
817
|
KatG |
Mycobacterium tuberculosis H37Rv |
VO_0012369
|
885638
|
|
15609045
|
Rv1908c |
AL123456 |
NP_216424 |
1SJ2
|
|
catalase-peroxidase |
Protective antigen |
M. tuberculosis DNA Vaccine encoding KatG
M. tuberculosis DNA vaccine (containing the ESAT-6, MPT-64, MPT-83, and KatG constructs)
|
|
649
|
Kbeta |
Plasmodium falciparum 3D7 |
VO_0011233
|
813054
|
|
124506397
|
PF3D7_0524000 |
AL844504 |
XP_001351796 |
|
|
|
Protective antigen |
|
|
720
|
KDR |
Homo sapiens |
|
3791
|
|
11321597
|
|
AC021220 |
NP_002244 |
|
|
kinase insert domain receptor |
Protective antigen |
HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 Multipeptide Vaccine
HLA-A*2402-Restricted VEGFR1/2 Multipeptide Vaccine
HLA-A*2402-Restricted VEGFR1 Peptide Vaccine
HLA-A*0201-Restricted VEGFR1 Peptide Vaccine
HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 Multipeptide Vaccine
LY6K/VEGFR1/VEGFR2 Multipeptide Vaccine
VEGFR-2 DNA Vaccine VXM01
|
|
4794
|
Kdr |
Mus musculus |
|
16542
|
|
1388591307
|
|
AC124615 |
NP_001350145 |
|
|
transcript variant 1 |
Protective antigen |
VEGFR2-169 Peptide Vaccine
|
|
4558
|
KIF20B |
Homo sapiens |
|
9585
|
|
546231677
|
|
AL157389 |
NP_001271188 |
|
|
transcript variant 4 |
Protective antigen |
Multipeptide Vaccine S-588210
DEPDC1/MPHOSH1 Peptide Vaccine
|
|
717
|
KLK3 |
Homo sapiens |
|
354
|
|
71834853
|
|
AC011523 |
NP_001025218 |
|
|
transcript variant 3 |
Protective antigen |
MVA-PSA/PAP Prostate Cancer Vaccine
Prostate Tumor Antigen-activated Autologous Dendritic Cell Vaccine
PROSTVAC-Contaminated W/ BVDV
PSA Prostate Cancer Vaccine
PSA-OP Peptide Vaccine
PSA:154-163(155L) Peptide Vaccine
PSMA/TARP Peptide Vaccine
pVAXrcPSAv53l DNA Vaccine
Recombinant Fowlpox-Prostate Specific Antigen Vaccine
Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine
Recombinant Vaccinia DF3/MUC1 Vaccine
Recombinant Vaccinia-Prostate Specific Antigen Vaccine
Recombinant Vaccinia-PSA/PSMA Vaccine
rF-PSA/PSMA/TRICOM Vaccine
Rilimogene-galvacirepvec Vaccine
Fowlpox-PSA-TRICOM Vaccine
GVAX Cancer Vaccine
Prostate cancer DNA vaccine psig-3P-Fc encoding 3P(hPSM, hPAP, or hPSA)-Fc fusion protein
Prostate cancer DNA vaccine pVAX/PSA encoding PSA
APC8015F
Fowlpox Virus Vaccine
PSA RNA-Pulsed Dendritic Cell Vaccine
Recombinant Vaccinia PSA Vaccine
|
|
1334
|
KLK3-Dupli |
Homo sapiens |
|
|
|
20520643
|
|
|
|
|
CDD:238113
GOA:Q546G3
HGNC:HGNC:6364
InterPro: IPR001254
InterPro: IPR001314
InterPro: IPR009003
InterPro: IPR018114
UniProtKB/TrEMBL: Q546G3 |
prostate specific antigen |
Protective antigen |
|
|
567
|
KMP-11 |
Leishmania donovani |
VO_0011157
|
|
|
7579896
|
|
|
|
|
CDD:281087 |
KMP-11 |
Protective antigen |
L. donovani DNA Vaccine encoding KMP-11
SL3261-L. donovani
|
|
1723
|
KMP-11 |
Leishmania donovani |
|
|
|
34922492
|
|
|
|
|
CDD:281087 |
Kinetoplastid membrane protein 11 |
Protective antigen |
Leishmania major DNA vaccine KMP-11
SL3261-L. major
L. major DNA vaccine encoding TSA, LMSTI1, KMP11, and LACK
|
|
4367
|
kmp-11 gene C |
Leishmania infantum |
|
5073121
|
|
CAA64883
|
|
|
|
|
CDD:281087
GOA:Q25298
InterPro: IPR004132
InterPro: IPR013326
UniProtKB/UniProt: Q25298 |
kinetoplastid membrane protein 11 |
Protective antigen |
|
|
4444
|
KRAS |
Homo sapiens |
|
3845
|
|
1621312269
|
|
AC087239 |
NP_001356715 |
|
|
transcript variant d |
Protective antigen |
HCV DNA Vaccine INO-8000
RAS Peptide Cancer Vaccine
RASVAC-C Vaccine
RASVAC-V Vaccine
RCAS-Ras Vaccine
Long Peptide Vaccine 7
Racotumomab Vaccine
|
|
4942
|
KRAS |
Homo sapiens |
|
3845
|
|
1621312269
|
|
AC087239 |
NP_001356715 |
|
|
transcript variant d |
Protective antigen |
|
|
4853
|
L protein |
|
|
|
|
AYC76673
|
|
|
|
|
CDD:395756
CDD:275046 |
L |
Protective antigen |
|
|
4293
|
L1 |
Fowlpox virus |
|
|
|
P15910
|
|
|
|
|
CDD:280581 |
Protein L1 homolog |
Protective antigen |
|
|
4305
|
L1 |
Bovine papillomavirus |
|
|
|
AHB82182
|
|
|
|
|
CDD:305106 |
L1 protein |
Protective antigen |
|
|
4441
|
L1 |
Human papillomavirus |
|
25479185
|
|
922073271
|
AMQ97_gp6 |
KP692117 |
YP_009163896 |
|
|
L1 |
Protective antigen |
HPV 16 L1-VLP Vaccine
Recombinant Human Papillomavirus Nonavalent Vaccine
Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine
|
|
512
|
L1 HPV 16 |
Human papillomavirus type 16 |
VO_0011108
|
1489082
|
|
1046490004
|
HpV16gp8 |
K02718 |
NP_041332 |
2R5H
|
|
major capsid protein L1 |
Protective antigen |
Human papillomavirus DNA vaccine VlJns-Ll encoding L1
Human papillomavirus DNA vaccine pC16-L1 encoding L1
|
|
4832
|
L1 HPV 52 |
|
|
|
|
AAY57811.1
|
|
GQ472848 |
ACX32362 |
|
CDD:420110 |
L1 |
Protective antigen |
11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha)
|
|
1403
|
L1R |
Vaccinia virus |
|
3707544
|
|
66275885
|
VACWR088 |
AF226617 |
YP_232970 |
|
|
IMV membrane protein |
Protective antigen |
Vaccinia virus DNA vaccine pWRG/L1R
|
|
1625
|
L1R |
Vaccinia virus strain Connaught |
|
|
|
7546898
|
|
|
|
|
CDD:280581 |
L1R |
Protective antigen |
Vaccinia virus DNA vaccine 4pox
|
|
28
|
L1R from Monkeypox virus Zaire-96-I-16 |
Monkeypox virus Zaire-96-I-16 |
VO_0010871
|
928938
|
|
17974998
|
MPXVgp085 |
AF380138 |
NP_536512 |
|
|
L1R |
Protective antigen |
Smallpox DNA Vaccine
|
|
56
|
L1R from Vaccinia virus (strain: WR (Western Reserve)) |
Vaccinia virus (strain: WR (Western Reserve)) |
|
3707544
|
|
|
VACWR088 |
|
|
|
|
|
|
IMV-EEV
|
|
4306
|
L2 |
Bovine papillomavirus |
|
|
|
BAF95819
|
|
|
|
|
CDD:165142
CDD:278914 |
L2 protein |
Protective antigen |
|
|
510
|
L2 HPV 16 |
Human papillomavirus type 16 |
VO_0011106
|
1489081
|
|
1046490003
|
HpV16gp7 |
K02718 |
NP_041331 |
|
|
minor capsid protein L2 |
Protective antigen |
Human papillomavirus L2 protein vaccine
Human papillomavirus DNA vaccine hCRTE6E7L2 DNA encoding CRT linked to E6, E7 and L2
AAVLP(HPV16/31L2)
|
|
4266
|
L2 HPV 18 |
Human Papillomavirus 16 |
|
|
|
AAP20600
|
|
|
|
|
CDD:165142
CDD:278914 |
L2 protein |
Protective antigen |
|
|
4910
|
L2 HPV31 |
|
|
|
|
ALT54672
|
|
|
|
|
CDD:332973 |
L2 |
Protective antigen |
AAVLP(HPV16/31L2)
|
|
1677
|
L7/L12 |
Brucella abortus RB51-AHVLA |
|
|
|
479804332
|
|
|
|
|
CDD:100102 |
50S ribosomal protein L7/L12 |
Protective antigen |
Divalent DNA B. abortus Vaccine pcDNA3.1-L7/L12-Omp16
|
|
734
|
LACK |
Leishmania major |
VO_0011260
|
|
1276476
|
1276477
|
|
|
AAA97577.1 |
|
CDD:238121
CDD:225201
CDD:293791 |
LACK |
Protective antigen |
L. major DNA Vaccine encoding LACKp24, TSA, LmSTI1 and CPa
L. major DNA vaccine pcLACK + IL-22
L. major DNA vaccine encoding TSA, LMSTI1, KMP11, and LACK
|
|
4946
|
lacZ |
Escherichia coli str. K-12 substr. MG1655 |
|
945006
|
|
16128329
|
b0344 |
CP009685 |
NP_414878 |
|
|
beta-galactosidase |
Protective antigen |
Recombinant Adenovirus-LacZ Vaccine
|
|
4531
|
LADD-Ag |
|
|
|
|
|
|
|
|
|
|
|
Protective antigen |
Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809
|
|
1276
|
Large HBsAg |
Hepatitis B virus |
|
|
|
18252577
|
|
|
|
|
CDD:109739 |
HBsAg |
Other |
|
|
170
|
Lassa nucleoprotein |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
560
|
LASVsSgp1 nucleoprotein |
Lassa mammarenavirus |
VO_0011151
|
956584
|
|
23343510
|
LASVsSgp1 |
AY628203 |
NP_694869 |
|
|
nucleoprotein |
Protective antigen |
Lassa Virus Nucleoprotein Subunit Vaccine
Lassa fever virus recombinant vector vaccine V-LSG/N encoding the glycoprotein and the nucleoprotein
ML29 L-AttV, rLCMV(IGR/S-S) (Mopiea/Lassa reassortant)
|
|
20
|
LASVsSgp2 glycoprotein |
Lassa mammarenavirus |
VO_0010869
|
956585
|
|
23343511
|
LASVsSgp2 |
AY628203 |
NP_694870 |
|
|
glycoprotein |
Protective antigen |
V-LSGPC
VSV[Delta]G/LVGPC
Lassa fever virus recombinant vector vaccine V-LSG encoding the glycoprotein
Lassa fever virus recombinant vector vaccine V-LSG/N encoding the glycoprotein and the nucleoprotein
ML29 L-AttV, rLCMV(IGR/S-S) (Mopiea/Lassa reassortant)
|
|
428
|
LcrE |
Chlamydophila pneumoniae CWL029 |
VO_0010883
|
895078
|
|
15618244
|
CPn0324 |
AE001363 |
NP_224529 |
|
|
low calcium response protein E |
Protective antigen |
C. pneumoniae LcrE protein vaccine
|
|
790
|
LcrV |
Yersinia enterocolitica |
VO_0011321
|
1449458
|
|
32470278
|
pYVe8081_p09 |
CP009845 |
NP_863514 |
|
|
LcrV |
Protective antigen |
Y. enterocolititica Subunit V Antigen Protein Vaccine
|
|
24
|
LcrV from Y. pestis biovar Microtus str. 91001 |
Yersinia pestis biovar Microtus str. 91001 |
|
2767532
|
|
|
YP_pCD52 |
|
|
1R6F
|
|
|
|
Recombinant Y. pestis V antigen vaccine
Y. pestis DNA vaccine F1-V DNA
|
|
25
|
LcrV from Y. pestis CO92 |
Yersinia pestis CO92 |
|
1172676
|
|
|
YPCD1.31c |
|
|
1R6F
|
|
|
|
VSV vector expressing Y. pestis lcrV
Recombinant Y. pestis YopD protein vaccine
|
|
44
|
LcrV from y. pestis CO92 |
Yersinia pestis CO92 |
VO_0010874
|
1172676
|
|
16082719
|
YPCD1.31c |
AL117189 |
NP_395165 |
1R6F
|
|
secreted effector protein |
Protective antigen |
Recombinant Y. pestis V antigen vaccine
|
|
45
|
LcrV from Y. pestis KIM 10 |
Yersinia pestis |
VO_0010875
|
1149310
|
|
31795491
|
D744_p5047 |
AF053946 |
NP_857946 |
1R6F
|
|
Yop secretion and targeting control protein |
Protective antigen |
Recombinant Y. pestis V antigen vaccine
|
|
600
|
lctP |
Neisseria meningitidis |
VO_0011185
|
|
|
254667969
|
|
|
|
|
CDD:224535
EnsemblGenomes-Gn:NMO_0425
EnsemblGenomes-Tr:CBA04244
GOA:C6S5G4
InterPro: IPR003804
UniProtKB/TrEMBL: C6S5G4 |
L-lactate permease |
Protective antigen |
N. meningitidis LctP Protein Vaccine
|
|
38
|
Lef |
Bacillus anthracis str. 'Ames Ancestor' |
VO_0010873
|
2820148
|
|
47566484
|
GBAA_pXO1_0172 |
AE017336 |
YP_016503 |
1J7N
|
CDD:285037
CDD:286266
CDD:238144 |
lethal factor |
Protective antigen |
pCLF4
B. anthracis DNA vaccine LF pDNA encoding LF
|
|
5
|
Lef from B. anthracis str. A2012 |
Bacillus anthracis str. A2012 |
VO_0010857
|
1158731
|
|
21392848
|
BXA0172 |
AE011190 |
NP_652928 |
1J7N
|
|
lethal factor |
Protective antigen |
DNA vaccine encoding PA83 and LF
B. anthracis DNA vaccine pCLF4
|
|
4828
|
LeIF |
Leishmania major strain Friedlin |
|
12981542
|
|
389592667
|
LMJF_03_0980 |
FR796399 |
XP_003721774 |
|
|
|
Protective antigen |
LEISH-F1+MPL-SE
|
|
929
|
ler |
Escherichia coli O157:H7 str. TW14359 |
|
8219269
|
|
254795663
|
ECSP_4703 |
CP001368 |
YP_003080500 |
|
|
enterocyte effacement (LEE)-encoded regulator |
Virmugen |
Escherichia coli ler mutant vaccine
|
|
951
|
leuD |
Mycobacterium tuberculosis H37Rv |
|
888225
|
|
15610124
|
Rv2987c |
BX842581 |
NP_217503 |
3H5J
|
|
isopropylmalate isomerase small subunit |
Virmugen |
Mycobacterium tuberculosis leuD mutant vaccine
|
|
1398
|
LF |
synthetic construct |
|
|
|
40646955
|
|
|
|
|
CDD:285037
CDD:294115
CDD:238144 |
lethal factor domains I-III |
Protective antigen |
|
|
3905
|
ligA |
Leptospira kirschneri serovar Kambale |
|
|
|
ACH98094
|
|
|
|
|
CDD:214752
CDD:308144
CDD:322060 |
LigA |
Protective antigen |
|
|
4052
|
ligA |
Chlamydia trachomatis |
|
|
|
CRH83817
|
|
|
|
|
|
NAD-dependent DNA ligase LigA |
Protective antigen |
|
|
1650
|
ligB |
Leptospira interrogans serovar Copenhageni str. Fiocruz L1-130 |
|
2771118
|
|
45656362
|
LIC10464 |
AE016823 |
YP_000448 |
|
|
hypothetical protein |
Protective antigen |
Leptospira interrogans DNA vaccine pTARGET/ LigBrep
|
|
3906
|
ligB |
Leptospira interrogans serovar Pomona |
|
|
|
ACH89908
|
|
|
|
|
CDD:295441
CDD:214752
CDD:280521 |
LigB |
Protective antigen |
|
|
4631
|
LILRA2 |
Homo sapiens |
|
11027
|
|
590122028
|
|
AC009892 |
NP_001124389 |
|
|
transcript variant 2 |
Protective antigen |
|
|
4087
|
lip40 |
Actinobacillus pleuropneumoniae |
|
|
|
AKJ32477
|
|
|
|
|
CDD:295696 |
lipoprotein Lip40 |
Protective antigen |
|
|
3910
|
lipL21 |
Leptospira interrogans serovar Copenhageni str. Fiocruz L1-130 |
|
|
|
AAS68648
|
|
|
|
|
|
LipL21 |
Protective antigen |
|
|
3909
|
lipL32 |
Leptospira mayottensis 200901116 |
|
|
|
AEZ53269
|
|
|
|
|
CDD:288920 |
LipL32 |
Protective antigen |
|
|
3911
|
lipL45 |
Leptospira interrogans serovar Lai str. 56601] |
|
|
|
AAN49494
|
|
|
|
|
CDD:309765
CDD:331332 |
LipL45 |
Protective antigen |
|
|
746
|
LIPO-A |
Leishmania infantum |
VO_0011283
|
|
|
730579
|
|
|
|
|
CDD:140267
CDD:240221 |
60S acidic ribosomal protein P0 |
Protective antigen |
pcDNA3-LiP0
|
|
4728
|
LMP-1 |
Human gammaherpesvirus 4 |
|
3783750
|
|
82503278
|
HHV4_LMP-1 |
AB850647 |
YP_401722 |
|
|
mRNA |
Protective antigen |
Ad5F35-LMP1/LMP2-Transduced Autologous Dendritic Cells
|
|
4729
|
LMP-2A |
Human gammaherpesvirus 4 |
|
3783751
|
|
82503189
|
HHV4_LMP-2A |
AJ507799 |
YP_401631 |
|
|
mRNA |
Protective antigen |
Ad5F35-LMP1/LMP2-Transduced Autologous Dendritic Cells
|
|
736
|
LmSTI1 |
Leishmania major |
VO_0011274
|
5649395
|
1698879
|
1698880
|
|
|
AAB37318.1 |
|
CDD:290150
CDD:278916
CDD:276809
CDD:290160
CDD:128966 |
protein antigen LmSTI1 |
Protective antigen |
L. major DNA Vaccine encoding LACKp24, TSA, LmSTI1 and CPa
LEISH-F1+MPL-SE
L. major DNA vaccine encoding TSA, LMSTI1, KMP11, and LACK
|
|
3912
|
loa22 |
Leptospira interrogans serovar Australis |
|
|
|
AIZ46906
|
|
|
|
|
CDD:143586 |
Loa22 |
Protective antigen |
|
|
347
|
LolA |
Yersinia pestis CO92 |
VO_0011010
|
1174218
|
|
218928525
|
YPO1377 |
CP009973 |
YP_002346400 |
|
|
outer-membrane lipoprotein carrier protein |
Protective antigen |
|
|
4073
|
LolC |
Burkholderia pseudomallei |
|
|
|
WP_076874059
|
|
|
|
|
CDD:274034 |
lipoprotein-releasing ABC transporter permease subunit |
Protective antigen |
|
|
768
|
LolC/E |
Burkholderia pseudomallei K96243 |
VO_0010921
|
3093214
|
|
53719887
|
BPSL2277 |
CP009538 |
YP_108873 |
|
|
lipoprotein releasing system transmembrane protein |
Protective antigen |
B. pseudomallei Subunit LolC Protein Vaccine
|
|
960
|
lon |
Salmonella enterica subsp. enterica serovar Gallinarum str. 287/91 |
|
6923289
|
|
205351761
|
SG0461 |
AM933173 |
YP_002225562 |
|
|
DNA-binding ATP-dependent protease La |
Virmugen |
Salmonella Gallinarum cpxR/Ion mutant vaccine
|
|
904
|
lpd |
Mycoplasma gallisepticum str. R(low) |
|
1089767
|
|
31544686
|
MGA_0161 |
AE015450 |
NP_853264 |
|
|
dihydrolipoamide dehydrogenase (E3) component of pyruvate dehydrogenase complex |
Virmugen |
Mycoplasma gallisepticum lpd mutant vaccine
|
|
596
|
lpdA |
Neisseria meningitidis |
VO_0011181
|
|
|
1017430
|
|
|
|
|
CDD:133458
CDD:304358
CDD:180579
CDD:278498
CDD:280934
GOA:Q51191
HSSP: 1OJT
InterPro: IPR000089
InterPro: IPR000815
InterPro: IPR001327
InterPro: IPR003016
InterPro: IPR004099
InterPro: IPR006258
InterPro: IPR011053
InterPro: IPR012999
InterPro: IPR013027
InterPro: IPR016156
UniProtKB/TrEMBL: Q51191 |
outer membrane protein P64k or PM-6 |
Other |
CCPS-P64kR
|
|
609
|
LplA |
Streptococcus pneumoniae R6 |
VO_0011194
|
934072
|
|
15903091
|
spr1047 |
AE007317 |
NP_358641 |
|
|
lipoate-protein ligase |
Protective antigen |
|
|
477
|
LpnA |
Francisella tularensis subsp. tularensis SCHU S4 |
VO_0011079
|
3191792
|
|
56708002
|
FTT_0901 |
AJ749949 |
YP_169898 |
|
|
lipoprotein |
Protective antigen |
|
|
3915
|
lpp20 |
Helicobacter pylori |
|
|
|
AAA50860
|
|
|
|
|
CDD:280351 |
Lpp20 precursor |
Protective antigen |
|
|
980
|
lppA |
Salmonella enterica subsp. enterica serovar Typhimurium |
|
|
|
323129647
|
|
|
|
|
CDD:187093 |
major outer membrane lipoprotein |
Virmugen |
Salmonella Typhimurium IppA/IppB/msbB
|
|
979
|
lppB |
Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S |
|
|
|
267993263
|
|
|
|
|
CDD:187093 |
putative methyl-accepting chemotaxis protein |
Virmugen |
Salmonella Typhimurium IppA/IppB/msbB
Salmonella Typhimurium IppB/msbB mutant vaccine
|
|
3932
|
LppC |
Haemophilus parasuis |
|
|
|
WP_021117166
|
|
|
|
|
CDD:332423 |
lppC lipofamily protein |
Protective antigen |
|
|
484
|
LPS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
686
|
LPS lipopolysaccharide |
Brucella ovis |
|
|
|
|
|
|
|
|
|
|
Protective antigen |
|
|
142
|
LSA-1 from Plasmodium falciparum |
Plasmodium falciparum |
|
|
|
510186
|
|
|
|
|
CDD:183692
HSSP: 1D7M
UniProtKB/TrEMBL: Q25887 |
liver stage antigen-1 |
Other |
P. falciparam liver-stage peptides and lipopeptides
Chimeras of P. falciparum LSA-1 epitope T1 with MS2 bacteriophage capsids
NYVAC-Pf7
|
|
834
|
LSA-3 |
Plasmodium falciparum 3D7 |
VO_0012381
|
812783
|
|
124801463
|
PF3D7_0220000 |
LN999943 |
XP_001349701 |
|
|
Liver stage antigen 3 |
Protective antigen |
P. falciparum LSA-3 Protein Vaccine
|
|
3913
|
lsa21 |
Leptospira interrogans serovar Australis |
|
|
|
ADB11053
|
|
|
|
|
|
Lsa21 |
Protective antigen |
|
|
3958
|
Lsg locus protein 4 |
Haemophilus influenzae |
|
|
|
OKQ05233
|
|
|
|
|
|
Lsg locus protein 4 |
Protective antigen |
|
|
4187
|
lukF |
Staphylococcus aureus |
|
|
|
CRL36945
|
|
|
|
|
CDD:273388 |
leukotoxin LukF |
Protective antigen |
|
|
4186
|
lukS |
Staphylococcus aureus |
|
|
|
CAA51251
|
|
|
|
|
CDD:285242
GOA:Q53746
HSSP: 1PVL
InterPro: IPR001340
InterPro: IPR003963
InterPro: IPR016183
UniProtKB/TrEMBL: Q53746 |
leucocidin S |
Protective antigen |
|
|
4615
|
LV28_RS26095 transcriptional regulator RegF |
Pandoraea pnomenusa |
|
25003478
|
|
560176903
|
LV28_RS26095 |
CABPSO010000005 |
WP_023593906 |
|
|
glutathione S-transferase N-terminal domain-containing protein |
Protective antigen |
Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
|
|
4467
|
LY6K |
Homo sapiens |
|
54742
|
|
237858795
|
|
AC108002 |
NP_001153826 |
|
|
transcript variant X2 |
Protective antigen |
URLC10 Peptide Vaccine
URLC10-CDCA1-KOC1 Multipeptide Vaccine
URLC10-TTK-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine
LY6K/VEGFR1/VEGFR2 Multipeptide Vaccine
Multipeptide Vaccine S-588210
HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 Multipeptide Vaccine
|
|
952
|
lysA |
Mycobacterium tuberculosis H37Rv |
|
886960
|
|
15608433
|
Rv1293 |
BX842576 |
NP_215809 |
1HKW
|
|
diaminopimelate decarboxylase LysA |
Virmugen |
Mycobacterium tuberculosis lysA/secA2 mutant vaccine
|
|
4270
|
M |
Rabies virus |
|
|
|
ANJ04750
|
|
|
|
|
|
M protein |
Protective antigen |
|
|
4312
|
M |
Human metapneumovirus |
|
|
|
CAD28609
|
|
|
|
|
CDD:281396
GOA:Q80IJ6
InterPro: IPR005056
UniProtKB/TrEMBL: Q80IJ6 |
matrix |
Protective antigen |
|
|
1629
|
M gene |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
581
|
M matrix protein |
Measles morbillivirus |
VO_0011170
|
1489803
|
|
9626949
|
MeVgp3 |
AB002686 |
NP_056921 |
|
|
mRNA |
Protective antigen |
Measles Virus Vaccine VVM
|
|
1707
|
M membrane protein |
Infectious bronchitis virus |
|
1489743
|
|
9626542
|
IBVgp4 |
M22014 |
NP_040835 |
|
|
membrane protein |
Protective antigen |
Infectious Bronchitis Virus DNA Vaccine encoding S1, N, and M
IBV DNA vaccine pVAX1-16S1/M/N
|
|
785
|
M protein |
|
VO_0011316
|
|
|
73671170
|
|
|
|
|
CDD:279358 |
membrane (M) protein |
Protective antigen |
Dengue Vaccine using Vaccinia Virus expressing M Protein
|
|
1727
|
M protein |
Japanese encephalitis virus strain TS3306 |
|
|
|
4572323
|
|
|
|
|
CDD:279856 |
M protein |
Protective antigen |
Japanese encephalitis virus DNA Vaccine P-JEV
|
|
4878
|
M protein |
|
|
|
|
AHB33452
|
|
|
|
|
|
M |
Virmugen |
Mnull RSV
|
|
492
|
M Segment |
Hantaan virus |
VO_0011090
|
|
|
1389703
|
|
|
|
|
CDD:144961 |
M polyprotein |
Protective antigen |
|
|
543
|
M1 |
Influenza A virus (A/chicken/Henan/12/2004(H5N1)) |
VO_0011136
|
|
|
61698034
|
|
|
|
|
CDD:278993
CDD:128998 |
matrix protein 1 |
Protective antigen |
Influenza virus DNA vaccine encoding M1 from Influenza A virus (A/chicken/Henan/12/2004(H5N1))
|
|
1417
|
M1 |
Influenza A virus (A/chicken/Italy/5093/99(H7N1)) |
|
|
|
116247898
|
|
|
|
|
CDD:278993
CDD:128998 |
matrix protein 1 |
Protective antigen |
Avian influenza DNA vaccine pCMV-M
|
|
4105
|
M1 |
Streptococcus pyogenes |
|
|
|
AAA85117
|
|
|
|
|
CDD:236892 |
M1 protein |
Protective antigen |
|
|
1217
|
M1 from A/Puerto Rico/8/1934(H1N1) |
Influenza A virus (A/Puerto Rico/8/1934(H1N1)) |
|
956527
|
|
8486123
|
FLUAVs7gp1 |
EF467824 |
NP_040978 |
|
|
matrix protein 1 |
Other |
|
|
4111
|
M14 |
Streptococcus pyogenes |
|
|
|
PHP24645
|
|
|
|
|
|
peptidase M14 |
Protective antigen |
|
|
4116
|
M18 |
Streptococcus pyogenes |
|
|
|
WP_011018277
|
|
|
|
|
CDD:291694
CDD:295219
CDD:279132 |
LPXTG cell wall anchor domain-containing protein |
Protective antigen |
|
|
754
|
M2 |
Leishmania amazonensis |
VO_0011291
|
|
2828562
|
2828563
|
|
|
AAC08302.1 |
|
CDD:240315
CDD:153108 |
ribonucleotide reductase M2 subunit |
Protective antigen |
L. amazonensis M2 protein vaccine
|
|
4237
|
M2 |
Bovine Respiratory Syncytial Virus |
|
|
|
AAL49411
|
|
|
|
|
CDD:214632
CDD:283973 |
M2-1 protein |
Protective antigen |
|
|
524
|
M2 from Influenza A virus (A/Puerto Rico/8/34(H1N1)) |
Influenza A virus (A/Puerto Rico/8/1934(H1N1)) |
VO_0011119
|
956528
|
|
56583270
|
FLUAVs7gp2 |
V01099 |
NP_040979 |
3BKD
|
|
matrix protein 2 |
Protective antigen |
Influenza virus CTA1-3M2e-DD protein vaccine
M2 mutant from Influenza A
Influenza virus DNA vaccine pDNAs VR4759 encoding M2
Influenza virus DNA vaccine pDNA encoding M2 and NP
Influenza virus DNA vaccine M2-DNA/M2-Ad
BPZE1- FHA (H1N1/PR8 influenza A virus)
|
|
4885
|
M2-1 |
|
|
|
|
AIO08080
|
|
|
|
|
CDD:214632
CDD:399442 |
M2-1 |
Protective antigen |
|
|
1058
|
M2-2 |
Human metapneumovirus CAN97-83 |
|
|
|
75549952
|
|
|
|
|
|
Matrix protein M2-2 |
Virmugen |
Human metapneumovirus M2-2 mutant vaccine
|
|
1061
|
M2-2 |
Human respiratory syncytial virus A2 |
|
|
|
81925031
|
|
|
|
|
CDD:116003 |
Matrix M2-2 |
Virmugen |
Human Respiratory Syncytial Virus M2-2 mutant vaccine
D46/NS2/N/ΔM2-2-HindIII
LID/ΔM2-2/1030s
|
|
4117
|
M22 |
Streptococcus pyogenes |
|
|
|
AKI36048
|
|
|
|
|
CDD:224135 |
peptidase M22 |
Protective antigen |
|
|
4114
|
M28 |
Streptococcus pyogenes |
|
|
|
OZS35741
|
|
|
|
|
|
peptidase M28 |
Protective antigen |
|
|
4106
|
M6 |
Streptococcus pyogenes |
|
|
|
AAA26920
|
|
|
|
|
CDD:273479
CDD:287215
CDD:279132 |
M6 mature peptide |
Protective antigen |
|
|
604
|
MAG1 |
Neospora caninum |
VO_0011189
|
13443506
|
EF580924.1
|
147886433
|
|
|
|
|
CDD:274008 |
cyst matrix and cyst wall protein |
Protective antigen |
N. caninum NcMAG1 Protein Vaccine
|
|
1600
|
MAGE-1 |
Homo sapiens |
|
|
|
416115
|
|
|
|
|
CDD:289225
CDD:279759 |
MAGE-1 |
Protective antigen |
MG1-hDCT Vaccine
Tetravalent RNA-lipoplex Cancer Vaccine
Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107
|
|
4786
|
MAGEA1 (MAGE1) |
Homo sapiens |
|
4100
|
|
148276977
|
|
AC152005 |
NP_004979 |
|
|
MAGE family member A1 |
Protective antigen |
HLA-A1-Binding MAGE-1/MAGE-3 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
MAGE-1 Vaccinia Contaminated with BVDV
MAGE-A1/MAGE-A3/NY-ESO-1 Peptides Vaccine
Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
Melanoma DNA vaccine pN4a-MAGE-1-GM
Melanoma DNA vaccine pNL3-MAGE-1-GM
MELITAC 12.1 Peptide Vaccine
|
|
4511
|
MAGEA1-Duplicate |
|
|
|
|
|
|
|
|
|
|
|
|
Multivalent immunotherapeutic vaccine
|
|
4818
|
MAGEA10 |
Homo sapiens |
|
4109
|
|
1890326744
|
|
AC116666 |
NP_001011543 |
|
|
transcript variant 2 |
Protective antigen |
MELITAC 12.1 Peptide Vaccine
|
|
4569
|
MAGEA2 |
Homo sapiens |
|
4101
|
|
542133120
|
|
AC244102 |
NP_001269430 |
|
|
transcript variant X1 |
Protective antigen |
EP-2101 Vaccine
Allogeneic Cellular Vaccine 1650-G
|
|
708
|
MAGEA3 |
Homo sapiens |
|
4102
|
|
4885467
|
|
AC244102 |
NP_005353 |
|
|
transcript variant X2 |
Protective antigen |
Melan-A/MAGE-3.DP4 Peptide Vaccine
Immunotherapeutic GSK1572932A
HLA-A1-Binding MAGE-1/MAGE-3 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
MAGE-3.A1 Peptide Vaccine
MAGE-A1/MAGE-A3/NY-ESO-1 Peptides Vaccine
MAGE-A3 Peptide Vaccine
MAGE-A3-expressing Adenovirus Type 5 Vaccine
MAGE-A3/HPV 16 Peptide Vaccine
MART-1/gp100/Tyrosinase/MAGE-A3 Peptides-loaded Irradiated Allogeneic Plasmacytoid Dendritic Cells Vaccine
NA-17/MAGE-3.A2/NY-ESO-1 Peptide Vaccine
NA17.A2 Peptide Vaccine
NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine
EP-2101 Vaccine
Autologous TriMix-DC Melanoma Vaccine
Allogeneic GM-CSF-Based Myeloma Cell Vaccine
Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine
Autologous-Cell Leukemia Vaccine
MELITAC 12.1 Peptide Vaccine
4-peptide melanoma vaccine
|
|
4732
|
MAGEA6 |
Homo sapiens |
|
4105
|
|
4885469
|
|
AC244102 |
NP_005354 |
|
|
transcript variant 1 |
Protective antigen |
Adenovirus Encoding Tyrosinase/MART-1/MAGEA6-transduced Autologous Dendritic Cell Vaccine
|
|
4637
|
MAGEA9 |
Homo sapiens |
|
4108
|
|
4885473
|
|
AC016939 |
NP_005356 |
|
|
transcript variant X1 |
Protective antigen |
G250 Peptide Vaccine
|
|
4740
|
MAGEC1 |
Homo sapiens |
|
9947
|
|
58530876
|
|
AF064589 |
NP_005453 |
|
|
transcript variant X1 |
Protective antigen |
Allogeneic GM-CSF-Based Myeloma Cell Vaccine
Autologous CT7/MAGE-A3/WT1 mRNA-Electroporated Langerhans-Type Dendritic Cells
|
|
4675
|
MAGEC2 |
Homo sapiens |
|
51438
|
|
7706605
|
|
AF116195 |
NP_057333 |
|
|
MAGE family member C2 |
Protective antigen |
Autologous TriMix-DC Melanoma Vaccine
|
|
4501
|
major capsid protein L1 |
|
|
|
|
|
|
|
|
|
|
|
|
Human Papillomavirus Vaccine V503
|
|
4038
|
major outer membrane protein |
Chlamydia trachomatis |
|
|
|
AAA23141
|
|
|
|
|
CDD:279628 |
major outer membrane protein |
Protective antigen |
|
|
4028
|
major outer membrane protein, MOMP |
Chlamydophila pneumoniae |
|
|
|
WP_010883333
|
|
|
|
|
CDD:279628 |
porin |
Protective antigen |
|
|
4065
|
major outer membrane protein, MOMP |
Campylobacter jejuni |
|
|
|
WP_002910950
|
|
|
|
|
CDD:328846 |
major outer membrane protein |
Protective antigen |
|
|
4149
|
maltodextrin-binding proteinSPy1294 |
Streptococcus pyogenes M1 GAS |
|
|
|
NP_269421
|
|
|
|
|
CDD:328725 |
putative maltose/maltodextrin-binding protein |
Protective antigen |
|
|
1000
|
manA |
Brucella melitensis bv. 1 str. 16M |
|
|
|
260563601
|
BAB1_0562 |
|
|
|
CDD:32765
CDD:29324 |
ManA family protein |
Virmugen |
B. abortus and B. melitensis mutants with unmarked deletion of asp24, virB2, or manBA
|
|
999
|
manB |
Brucella melitensis bv. 1 str. 16M |
|
1198671
|
|
17989244
|
BMEII0899 |
AE008918 |
NP_541877 |
|
|
phosphomannomutase |
Virmugen |
B. abortus and B. melitensis mutants with unmarked deletion of asp24, virB2, or manBA
|
|
803
|
MAPP15 |
|
VO_0011334
|
|
|
777767
|
|
|
|
|
|
microtubule-associated protein |
Protective antigen |
T. brucei Subunit p15 Protein Vaccine
|
|
4636
|
MBL2 |
Homo sapiens |
|
4153
|
|
4557739
|
|
AB025350 |
NP_000233 |
|
|
transcript variant 2 |
Protective antigen |
TBC-CEA-Contaminated W/ BVDV Vaccine
|
|
1610
|
MBP |
Cavia porcellus |
|
|
|
3309629
|
|
|
|
|
CDD:279937 |
myelin basic protein |
Protective antigen |
EAE DNA vaccine pZZ/MBP68–85 encoding MBP
|
|
1339
|
Mcam |
Mus musculus |
|
84004
|
|
1327848422
|
|
AC148328 |
NP_001346459 |
|
|
transcript variant X2 |
Protective antigen |
Melanoma DNA vaccine SINCp c-muMUC18 encoding MCAM/MUC18
|
|
3907
|
mce |
Leptospira borgpetersenii serovar Hardjo-bovis str. JB197 |
|
|
|
ADA57469
|
|
|
|
|
CDD:224380
CDD:280608 |
Mce |
Protective antigen |
|
|
991
|
mce-2 |
Mycobacterium tuberculosis CDC1551 |
|
925014
|
|
15839991
|
MT0618 |
AE000516 |
NP_335028 |
|
|
virulence factor |
Virmugen |
Mycobacterium tuberculosis mce-2 mutant vaccine
|
|
992
|
mce-3 |
Mycobacterium tuberculosis CDC1551 |
|
923491
|
|
15841441
|
MT2018 |
AE000516 |
NP_336478 |
|
|
virulence factor |
Virmugen |
Mycobacterium tuberculosis mce-2 mutant vaccine
Mycobacterium tuberculosis mce-3 mutant vaccine
|
|
4760
|
MDM2 |
Homo sapiens |
|
4193
|
|
223890201
|
|
AC025423 |
NP_001138809 |
|
|
transcript variant X3 |
Protective antigen |
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
|
|
574
|
MDV040 |
Gallid alphaherpesvirus 2 |
VO_0011164
|
4811501
|
|
125745079
|
MD5V_040 |
AF147806 |
YP_001033956 |
|
|
envelope glycoprotein B |
Protective antigen |
Marek's Disease Virus Vaccine rFPV/gB1
|
|
575
|
MDV095 |
Gallid alphaherpesvirus 2 |
VO_0011165
|
4811454
|
|
125745128
|
MD5V_095 |
AF243438 |
YP_001034012 |
|
|
envelope glycoprotein I |
Protective antigen |
Marek's Disease Virus Vaccine rFPV/gI
|
|
848
|
MecA |
Staphylococcus aureus subsp. aureus MRSA252 |
VO_0012391
|
2861157
|
|
49482291
|
SAR0039 |
BX571856 |
YP_039515 |
1VQQ
|
|
penicillin-binding protein 2 prime |
Protective antigen |
S. aureus DNA Vaccine encoding PBP2a Protein
|
|
4290
|
membrane protein (M) gene of SARS-CoV |
SARS-CoV |
|
|
|
ABD75314
|
|
|
|
|
CDD:279907 |
membrane protein |
Protective antigen |
SARS-CoV M protein DNA vaccine
SARS-CoV N + SARS-CoV M DNA vaccine
|
|
947
|
metH |
Neisseria meningitidis MC58 |
|
903064
|
|
15676837
|
NMB0944 |
AE002098 |
NP_273982 |
|
|
5-methyltetrahydropteroyltriglutamate--homocysteine S-methyltransferase |
Virmugen |
Neisseria meningitidis metH/siaD mutant vaccine
|
|
4543
|
MFGE8 |
Homo sapiens |
|
4240
|
|
167830477
|
|
AC067805 |
NP_001108086 |
|
|
transcript variant X2 |
Protective antigen |
Monoclonal Antibody 11D10 Anti-Idiotype Vaccine
|
|
4551
|
MGMT |
Homo sapiens |
|
4255
|
|
1434110720
|
|
AH007347 |
NP_002403 |
|
|
transcript variant X1 |
Protective antigen |
MSCV-MGMT(P140K) Vaccine
|
|
616
|
MIC1 |
Neospora caninum |
VO_0011200
|
13440244
|
|
17226315
|
|
|
|
|
CDD:287526
CDD:151915 |
microneme-associated protein |
Protective antigen |
N. caninum NcMIC1 Protein Vaccine
RB51--MIC3/GRA2/GRA6/MIC1/SRS2
|
|
4926
|
MIC1 |
Toxoplasma gondii ME49 |
|
7896467
|
|
237838467
|
TGME49_291890 |
CM002044 |
XP_002368531 |
|
|
|
Protective antigen |
TgMIC1-4-6
TgMIC1-4
TgMIC1
|
|
614
|
MIC10 |
Neospora caninum |
VO_0011198
|
13445423
|
|
11141617
|
|
|
|
|
|
NcMIC10 precursor |
Protective antigen |
N. caninum MIC10 and p24 protein vaccine
|
|
4922
|
MIC11 |
Toxoplasma gondii ME49 |
|
7901413
|
|
1084997115
|
TGME49_204530 |
CM002041 |
XP_018637299 |
|
|
|
Protective antigen |
T. gondii DNA vaccine pcDNA3.1/MIC11
|
|
1633
|
MIC13 |
Toxoplasma gondii |
|
7899621
|
|
380449403
|
|
|
|
|
CDD:287526 |
microneme protein 13 |
Protective antigen |
T. gondii DNA vaccine pVAX-TgMIC13
|
|
901
|
mic2 |
|
|
|
|
1923217
|
|
|
|
2XGG
|
CDD:29244
CDD:154951 |
micronemal protein MIC2 |
Virmugen |
T. gondii mic2 mutant vaccine
|
|
459
|
MIC2 |
Eimeria tenella |
VO_0011063
|
|
|
225579627
|
|
|
|
|
CDD:115333 |
microneme 2 |
Protective antigen |
E. tenella DNA vaccine EtMIC2
|
|
4370
|
mic2 |
Eimeria maxima |
|
25336734
|
FR718971.1
|
CBX60033
|
|
|
|
|
CDD:115333
InterPro: IPR009556
UniProtKB/TrEMBL: F6IA05 |
Microneme protein 2 |
Protective antigen |
|
|
587
|
MIC3 |
Toxoplasma gondii ME49 |
VO_0011174
|
7901253
|
|
1085201908
|
TGME49_325800 |
KE139555 |
XP_002369833 |
|
|
|
Protective antigen |
T. gondii DNA vaccine pcDNA3-MIC3
|
|
1622
|
MIC3 |
Toxoplasma gondii strain RH(ERP) |
|
|
5931753
|
5931754
|
|
|
CAB56644.1 |
|
CDD:304395
CDD:283826
InterPro: IPR000742
InterPro: IPR006210
UniProtKB/TrEMBL: Q9GRG4 |
MIC3 microneme protein |
Protective antigen |
T. gondii DNA vaccine pMIC3i encoding the complete MIC3-ORF (RH(ERP) strain)
|
|
4356
|
MIC3 |
Neospora caninum |
|
13441624
|
|
CEL65204
|
|
|
|
|
CDD:289699 |
microneme protein MIC3, putative |
Protective antigen |
|
|
4927
|
MIC4 |
Toxoplasma gondii ME49 |
|
7896295
|
|
237840617
|
TGME49_208030 |
CM002035 |
XP_002369606 |
|
|
|
Protective antigen |
TgMIC1-4-6
TgMIC1-4
TgMIC4
|
|
4879
|
MIC6 |
Toxoplasma gondii ME49 |
|
29768960
|
|
1085164641
|
TGME49_218520 |
CM002047 |
XP_018634830 |
|
|
|
Protective antigen |
T. gondii DNA vaccine pIRESneo/MIC6/PLP1
T. gondii DNA vaccine pVAX-GRA24 + pVAX-GRA25 + pVAX-MIC6
TgMIC1-4-6
TgMIC6
|
|
4371
|
mic7 |
Eimeria maxima |
|
|
|
CBX60037
|
|
|
|
|
UniProtKB/TrEMBL: G0LEU8 |
Microneme protein 7 |
Protective antigen |
|
|
876
|
MIC8 |
|
|
7899500
|
13346486
|
13346487
|
|
|
AAK19757.1 |
|
|
microneme protein 8 |
Protective antigen |
T. gondii DNA vaccine encoding MIC8
|
|
4629
|
Mice Gene |
|
|
|
|
|
|
|
|
|
|
|
Protective antigen |
|
|
4021
|
mip |
Coxiella burnetii |
|
|
|
AAA92352
|
|
|
|
|
CDD:279662
CDD:223619
CDD:278674 |
peptidyl propyl cis/trans isomerase |
Protective antigen |
|
|
3982
|
MipA |
Escherichia coli O25b:H5 |
|
|
|
ANK01746
|
|
|
|
|
CDD:226236 |
mipA |
Protective antigen |
|
|
706
|
MLANA |
Homo sapiens |
|
2315
|
|
5031913
|
RP11-546N22.1 |
AL365360 |
NP_005502 |
|
|
melan-A |
Protective antigen |
MART-1:26-35(27L) Peptide Vaccine
MART-1:27-35 Peptide Vaccine
Melan-A VLP Vaccine
Melan-A/MAGE-3.DP4 Peptide Vaccine
27-35(27L):MART-1 peptide vaccine
ALVAC-MART-1 Vaccine
HLA-A2-Binding TYR/MART-1/gp100 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
Multivalent immunotherapeutic vaccine
NA17.A2 Peptide Vaccine
NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine
NY-ESO-1/MART-1 Peptide-pulsed Dendritic Cell Vaccine
gp100-Reactive Autologous Peripheral Blood Lymphocyte Vaccine
Dendritic Cell-MART-1 Peptide Vaccine
Autologous Lymphoma Cell/Allogeneic Dendritic Cell Electrofusion Hybrid Vaccine
Autologous Anti-MART-1 F5 T-Cell Receptor Gene-Engineered Peripheral Blood Lymphocytes
Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307
Alpha-type-1 Polarized Dendritic Cells
Adenovirus Encoding Tyrosinase/MART-1/MAGEA6-transduced Autologous Dendritic Cell Vaccine
Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine
Dendritic Cell-gp100-MART-1 Antigen Vaccine
Autologous-Cell Leukemia Vaccine
Gag:267-274 Peptide Vaccine
MART-1/gp100/Tyrosinase/MAGE-A3 Peptides-loaded Irradiated Allogeneic Plasmacytoid Dendritic Cells Vaccine
|
|
4621
|
MLANA-Dupli |
Homo sapiens |
|
2315
|
|
5031913
|
|
AL365360 |
NP_005502 |
|
|
melan-A |
Protective antigen |
Recombinant Vaccinia-Multiepitope Melanoma Peptides-B7.1-B7.2 Vaccine
Synchrovax SEM Plasmid DNA Vaccine
Autologous Melanoma Lysate-Pulsed Autologous Dendritic Cell Vaccine
MART-1 Adenovirus Vaccine
MART-1 Fowlpox Vaccine
MART-1 Vaccinia Vaccine
Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine
|
|
1056
|
mntA |
Bacillus anthracis str. A0248 |
|
7848141
|
|
229600559
|
BAA_3238 |
CP001598 |
YP_002867390 |
|
|
manganese ABC transporter, manganese-binding protein |
Virmugen |
Bacillus anthracis mntA deletion mutant vaccine
|
|
4169
|
mntC |
Staphylococcus aureus |
|
|
|
AAL50778
|
|
|
|
|
CDD:320865
CDD:238347 |
MntC |
Protective antigen |
|
|
1311
|
Mog |
Mus musculus |
|
17441
|
|
113199771
|
|
AC116130 |
NP_034944 |
|
|
transcript variant X1 |
Protective antigen |
|
|
1359
|
Mog |
Rattus norvegicus |
|
24558
|
|
158262022
|
|
BX883052 |
NP_073159 |
|
|
myelin oligodendrocyte glycoprotein |
Other |
|
|
435
|
MOMP |
|
VO_0010890
|
|
|
1518659
|
|
|
|
|
CDD:279628 |
major outer membrane protein |
Protective antigen |
C. muridarum MOMP protein vaccine
|
|
767
|
MOMP |
Chlamydophila psittaci 89/1051 |
VO_0010925
|
|
144544
|
144545
|
|
|
AAA17396.1 |
|
CDD:279628 |
major outer membrane protein |
Protective antigen |
|
|
771
|
MOMP from C. psittaci 6BC |
Chlamydia psittaci 6BC |
VO_0011304
|
|
40568
|
40569
|
|
|
CAA40300.1 |
|
CDD:279628
GOA:Q46203
InterPro: IPR000604
UniProtKB/UniProt: Q46203 |
major outer membrane protein |
Protective antigen |
|
|
313
|
mouse Trp53 |
Mus musculus |
|
22059
|
|
187960040
|
RP23-56I20.1 |
AF074575 |
NP_001120705 |
|
|
transcript variant 2 |
Protective antigen |
Mutant p53 Peptide Pulsed Dendritic Cell Vaccine
PR-151 Peptide Vaccine
Telomerase Peptide Vaccine GV1001
|
|
4548
|
MOV10 |
Homo sapiens |
|
4343
|
|
194272168
|
|
AL603832 |
NP_001123551 |
|
|
transcript variant X7 |
Protective antigen |
MOv-PBL Vaccine
|
|
589
|
Mpt63 |
Mycobacterium tuberculosis H37Rv |
VO_0011176
|
885334
|
|
15609063
|
Rv1926c |
AL123456 |
NP_216442 |
1LMI
|
|
immunogenic protein Mpt63 |
Protective antigen |
|
|
815
|
MPT64 |
Mycobacterium tuberculosis H37Rv |
VO_0012367
|
885925
|
|
15609117
|
Rv1980c |
A42312 |
NP_216496 |
2HHI
|
|
immunogenic protein Mpt64 |
Protective antigen |
M. tuberculosis DNA vaccine encoding Ag85B, MPT64 and MPT83
M. tuberculosis DNA vaccine (containing the ESAT-6, MPT-64, MPT-83, and KatG constructs)
|
|
867
|
MPT83 |
Mycobacterium tuberculosis H37Rv |
VO_0012409
|
887155
|
|
15610010
|
Rv2873 |
AL123456 |
NP_217389 |
|
|
cell surface lipoprotein |
Protective antigen |
M. tuberculosis DNA vaccine encoding Ag85B, MPT64 and MPT83
M. tuberculosis DNA vaccine (containing the ESAT-6, MPT-64, MPT-83, and KatG constructs)
|
|
4102
|
mrp |
Streptococcus pyogenes |
|
|
|
ANC26187
|
|
|
|
|
CDD:273479
CDD:309295
CDD:330553
CDD:307064 |
Emm-related protein Mrp |
Protective antigen |
|
|
4664
|
MS4A1 |
Homo sapiens |
|
931
|
|
23110987
|
|
AB520824 |
NP_068769 |
|
|
transcript variant 3 |
Protective antigen |
Cyclin B1 Peptide-pulsed Autologous Dendritic Cell Vaccine
Anti-CD3 x Anti-CD20 Bispecific Antibody-Armed Activated T Cells Cancer Vaccine
|
|
4354
|
msa |
Babesia bovis |
|
|
|
ABA06476
|
|
|
|
|
CDD:289042 |
merozoite surface antigen 2 |
Protective antigen |
|
|
4355
|
MSA-1 |
Babesia bovis |
|
|
|
ABR92034
|
|
|
|
|
CDD:289042 |
merozoite surface antigen 1 |
Protective antigen |
|
|
981
|
msbB |
Salmonella enterica subsp. enterica serovar Typhimurium 14028 |
|
|
|
4104731
|
|
|
|
|
ATCC:14028
CDD:153246 |
lipid A acyltransferase |
Virmugen |
Salmonella Typhimurium IppA/IppB/msbB
Salmonella Typhimurium IppB/msbB mutant vaccine
|
|
1070
|
msbB2 |
Shigella sonnei Ss046 |
|
3670926
|
|
74315019
|
SSON_P182 |
CP000039 |
YP_313437 |
|
|
lipid A biosynthesis (KDO)2-(lauroyl)-lipid IVA acyltransferase |
Virmugen |
Shigella sonnei virG/senA/senB/msbB2 mutant vaccine
|
|
4712
|
MSLN |
Homo sapiens |
|
10232
|
|
293651530
|
|
AE006464 |
NP_001170826 |
|
|
transcript variant 1 |
Protective antigen |
Algenpantucel-L
Allogeneic Mesothelioma Tumor Lysate-pulsed Autologous Dendritic Cell Vaccine
Autologous GM-CSF-secreting Lethally Irradiated Colorectal Cancer Cell Vaccine
|
|
143
|
MSP-1 from P. falciparum |
Plasmodium falciparum 3D7 |
VO_0010958
|
813575
|
|
124507147
|
PF3D7_0930300 |
AL844508 |
XP_001352170 |
|
CDD:289698
CDD:304395 |
merozoite surface protein 1 |
Protective antigen |
P. falciparum vaccine Combination B
P. vivax MSP1-19-PADRE
P. falciparum MSP1 from transgenic mice with Freund's adjuvant
ChAd63-MVA MSP1
NYVAC-Pf7
|
|
637
|
msp-8 |
Plasmodium yoelii |
VO_0011221
|
3792405
|
|
58197887
|
|
|
|
|
CDD:315598 |
merozoite surface protein 8 |
Protective antigen |
|
|
641
|
MSP1 from P. berghei |
Plasmodium berghei |
VO_0011225
|
|
|
1762646
|
|
|
|
|
|
merozoite surface protein 1 |
Protective antigen |
P. berghei MSP1 Protein Vaccine
|
|
1746
|
MSP1 from P. knowlesi |
Plasmodium knowlesi strain H |
|
7320035
|
|
XP_002258582.2
|
|
|
|
|
CDD:284802
CDD:289698
CDD:289699
EnsemblGenomes-Gn:PKH_072850
EnsemblGenomes-Tr:PKH_072850
GOA:B3L2X8
InterPro: IPR010901
InterPro: IPR024730
InterPro: IPR024731
UniProtKB/TrEMBL: B3L2X8 |
merozoite surface protein 1, MSP-1 |
Protective antigen |
P. knowlesi DNA vaccine encoding PkCSP, PkSSP2, PkAMA1, and PkMSP1p42
|
|
628
|
MSP1 from P. yoelii str. 17XNL |
Plasmodium yoelii |
VO_0011212
|
3791597
|
|
82596427
|
PY17X_0834400 |
LK934636 |
XP_726257 |
|
|
|
Protective antigen |
P. yoelii DNA vaccine encoding MSP1
rBCGMSP1-15
|
|
646
|
MSP1 from P.vivax |
Plasmodium vivax |
VO_0011230
|
|
AF435639.1
|
26985160
|
|
|
|
2NPR
|
CDD:299863
CDD:284802
CDD:289698
CDD:289699 |
merozoite surface protein 1 |
Protective antigen |
|
|
4924
|
MSP2 |
|
|
812660
|
|
CAA70446.1
|
|
|
|
|
CDD:144541
GOA:O00790
InterPro: IPR001136
UniProtKB/TrEMBL: O00790 |
merozoite surface antigen 2 |
Protective antigen |
P. falciparum MSA-2 subunit vaccine
|
|
636
|
msp3 |
Plasmodium falciparum |
VO_0011220
|
810502
|
|
113207288
|
|
|
|
|
CDD:284533
InterPro: IPR010784
UniProtKB/TrEMBL: Q0KGB6 |
merozoite surface protein 3 |
Protective antigen |
P. falciparum MSP3 Protein Subunit Vaccine
MSP3-CRM-Vac4All/ Alhydrogel®
|
|
4925
|
MSP4 |
Plasmodium falciparum 3D7 |
|
812662
|
|
124801002
|
PF3D7_0207000 |
AF295306 |
XP_001349580 |
|
|
|
Protective antigen |
P. falciparum MSP4 with AFCo1 Adjuvant
|
|
652
|
MSP4/5 |
Plasmodium yoelii |
VO_0011236
|
3800676
|
AY563017.1
|
49798469
|
|
|
|
|
CDD:289699 |
merozoite surface protein 4/5 |
Protective antigen |
P. yoelii MSP1 and MSP4/5 Proteins Subunit Vaccine
|
|
568
|
mspC |
Leishmania donovani |
VO_0011158
|
|
|
21954466
|
|
|
|
|
CDD:302875
GOA:Q8MM48
HSSP: 1LML
InterPro: IPR001577
UniProtKB/TrEMBL: Q8MM48 |
GP63 |
Protective antigen |
L. donovani gp63 Protein Vaccine
|
|
584
|
Mtb72F |
Mycobacterium tuberculosis |
VO_0011173
|
|
|
283801990
|
|
|
|
|
|
|
Protective antigen |
M. tuberculosis Mtb72F Protein Subunit Vaccine
|
|
4139
|
mtsA |
Streptococcus pyogenes |
|
|
|
NP_268747
|
|
|
|
|
CDD:238557 |
metal binding protein of ABC transporter (lipoprotein) |
Protective antigen |
|
|
703
|
MUC1 |
Homo sapiens |
|
4582
|
|
67189007
|
RP11-263K19.2 |
AC234582 |
NP_001018016 |
|
|
transcript variant 14 |
Protective antigen |
Lung metastasis DNA vaccine pCEP4-MUC1 encoding MUC1
Synthetic MUC1 Peptide Vaccine
Anti-idiotype MUC-1 Monoclonal Antibody Vaccine
Inalimarev Vaccine
Liposomal MUC1/PET-lipid A Vaccine
Mammaglobin-A DNA Vaccine
MUC-1 Peptide Vaccine
MUC1 Antigen/SB AS-2 Vaccine
MUC1-KLH Conjugate Vaccine
MUC1-KLH Vaccine/QS21
MUC1-targeted Peptide GO-203-2C Vaccine
MVA-MUC1-IL2 Vaccine
Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine
Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine
PSA:154-163 Peptide Vaccine
Recombinant Human MUC1-Oxidized Polymannose-pulsed Autologous Dendritic Cell Vaccine
Recombinant Vaccinia DF3/MUC1 Vaccine
Recombinant Vaccinia-MUC-1 Vaccine
Recombinant Vaccinia-MUC1-B7 Vaccine
rF-MUC1(DF3)/TRICOM Vaccine
Fowlpox Virus Vaccine Vector
Falimarev Vaccine
Emepepimut-S Vaccine
Autologous Dendritic Cell-Tumor Fusion Vaccine
Ad-sig-hMUC-1/ecdCD40L Vaccine
|
|
1340
|
Muc1 |
Mus musculus |
|
17829
|
|
7305293
|
|
AC132327 |
NP_038633 |
|
|
mucin 1, transmembrane |
Protective antigen |
Lung metastasis DNA vaccine pCEP4-MUC1 encoding MUC1
|
|
4811
|
MUC16 |
Homo sapiens |
|
94025
|
|
83367077
|
|
AC008734 |
NP_078966 |
|
|
transcript variant X12 |
Protective antigen |
Abagovomab
|
|
4552
|
MUC2 |
Homo sapiens |
|
4583
|
|
1083917512
|
|
AC139749 |
NP_002448 |
|
|
mucin 2, oligomeric mucus/gel-forming |
Protective antigen |
MUC-2-Globo H-KLH Conjugate Vaccine
MUC-2-KLH Vaccine
|
|
4537
|
MUC5B |
Homo sapiens |
|
727897
|
|
301172750
|
|
AC061979 |
NP_002449 |
|
|
mucin 5B, oligomeric mucus/gel-forming |
Protective antigen |
Maraba virus MG1 Vaccine
|
|
1084
|
mucR |
Brucella melitensis bv. 1 str. 16M |
|
1197075
|
|
17987647
|
BMEI1364 |
AE008917 |
NP_540281 |
|
|
transcriptional regulatory protein MUCR |
Virmugen |
Brucella melitensis mucR mutant vaccine
|
|
3534
|
Myd88 |
Mus musculus |
|
17874
|
|
6754772
|
|
AAHY01082338 |
NP_034981 |
|
|
myeloid differentiation primary response gene 88 |
Other |
|
|
4234
|
N |
Bovine Respiratory Syncytial Virus |
|
|
|
ARJ54327
|
|
|
|
|
CDD:308720 |
nucleoprotein |
Protective antigen |
|
|
4236
|
N |
Bovine Respiratory Syncytial Virus |
|
|
|
AAL49405
|
|
|
|
|
CDD:281264 |
nucleocapsid protein |
Protective antigen |
|
|
4287
|
N |
Rift Valley Fever virus |
|
|
|
AHL18328
|
|
|
|
|
CDD:253357 |
nucleocapsid protein N |
Protective antigen |
|
|
4291
|
N |
Feline infectious peritonitis virus |
|
|
|
BAC01159
|
|
|
|
|
CDD:279305 |
nucleocapsid |
Protective antigen |
Feline infectious peritonitis virus recombinant N proteins vaccine
|
|
4416
|
N from MERS-CoV |
Middle East respiratory syndrome-related coronavirus |
|
14254601
|
|
667489396
|
G128_gp09 |
|
YP_009047211 |
|
|
nucleoprotein |
Protective antigen |
|
|
1226
|
N gene |
Infectious hematopoietic necrosis virus |
|
1489845
|
|
9628083
|
IHNVgp1 |
L40883 |
NP_042676 |
|
|
nucleocapsid protein |
Other |
IHNV DNA vaccine pCMV4-N encoding the nucleoprotein
|
|
579
|
N nucleocapsid protein |
Measles morbillivirus |
VO_0011168
|
1489804
|
|
9626946
|
MeVgp1 |
AB016162 |
NP_056918 |
|
|
mRNA |
Protective antigen |
Measles Virus Vaccine VVN
|
|
1660
|
N nucleocapsid protein |
Hirame novirhabdovirus |
|
2559538
|
|
34610115
|
HIRRVgp1 |
AF104985 |
NP_919030 |
|
|
nucleocapsid protein |
Protective antigen |
H. rhabdovirus DNA Vaccine encoding N and G
|
|
1672
|
N protein |
Infectious bronchitis virus strain M41 serotype Massachussets |
|
|
|
157058858
|
|
|
|
|
CDD:279305 |
nucleocapsid protein |
Protective antigen |
IBV DNA vaccine pVAX1-N
Infectious Bronchitis Virus DNA Vaccine encoding S1, N, and M
IBV DNA vaccine pVAX1-16S1/M/N
|
|
4872
|
N protein |
18537/Human orthopneumovirus |
|
|
|
BAA00637
|
|
|
|
|
CDD:397378 |
N protein |
Defense factor |
|
|
530
|
NA |
Influenza A virus (A/Aichi/2/1968(H3N2)) |
VO_0011123
|
|
|
46401580
|
|
|
|
|
CDD:271235 |
neuraminidase |
Protective antigen |
|
|
536
|
NA |
Influenza B virus (B/Ibaraki/2/85) |
VO_0011129
|
|
|
53829726
|
|
|
|
|
CDD:278493 |
NA glycoprotein |
Protective antigen |
Influenza virus DNA vaccine encoding NA from Influenza B virus (B/Ibaraki/2/85)
|
|
542
|
NA |
Influenza A virus (A/chicken/Henan/12/2004(H5N1)) |
VO_0011135
|
|
|
61698053
|
|
|
|
2HTY
|
CDD:271235 |
neuraminidase |
Protective antigen |
Influenza virus DNA vaccine encoding NA from Influenza A virus (A/chicken/Henan/12/2004(H5N1))
|
|
1722
|
NA |
Influenza A virus (A/Viet Nam/1203/2004(H5N1)) |
|
|
|
291359313
|
|
|
|
|
CDD:271235 |
neuraminidase |
Protective antigen |
Avian influenza virus DNA vaccine pN1NA encoding N1 neuraminidase
|
|
1214
|
NA from A/Puerto Rico/8/1934(H1N1) |
Influenza A virus (A/Puerto Rico/8/1934(H1N1)) |
|
956530
|
|
8486128
|
FLUAVs6gp1 |
J02146 |
NP_040981 |
|
|
neuraminidase |
Protective antigen |
Influenza virus DNA vaccine pIRES/NA expressing NA
Influenza virus DNA vaccine pIRES/NA/IL-2 encoding NA
Influenza virus DNA vaccine pIRES/NA/GM-CSF encoding NA
Influenza virus DNA vaccine pIRES/NA/IL-12p40 encoding NA
Influenza virus DNA vaccine NA-DNA
Influenza virus DNA vaccine pcDNA3.1/NA
Influenza virus DNA vaccine pIRES/HA/IL-12p35 + pIRES/NA/IL-12p40
|
|
272
|
NadA |
Neisseria meningitidis MC58 |
VO_0010980
|
904134
|
|
15677822
|
NMB1994 |
AE002098 |
NP_274986 |
|
|
adhesin/invasin |
Protective antigen |
|
|
4011
|
nanA |
Edwardsiella tarda |
|
|
|
AFP73415
|
|
|
|
|
CDD:271234
CDD:214872 |
NanA |
Protective antigen |
|
|
4162
|
NanA |
Streptococcus pneumoniae |
|
|
|
ARD37933
|
|
|
|
|
|
NanA |
Protective antigen |
|
|
806
|
NAP |
Helicobacter pylori |
VO_0011337
|
|
|
8777456
|
|
|
|
1JI4
|
CDD:223854
CDD:153102 |
neutrophil-activating protein |
Protective antigen |
H. pylori NAP protein vaccine
|
|
618
|
NcDG1 |
Neospora caninum |
VO_0011202
|
13444377
|
U82229.1
|
2149142
|
|
|
|
|
|
dense granule protein |
Protective antigen |
N. caninum NcDG1 protein vaccine
|
|
621
|
NCDG2 |
Neospora caninum |
VO_0011205
|
13446567
|
|
3237325
|
|
|
|
|
CDD:282882 |
dense granule protein 2 |
Protective antigen |
N. caninum NcDG2 Protein Vaccine
|
|
3946
|
ndk |
Haemophilus parasuis |
|
|
|
KEZ22119
|
|
|
|
|
|
Nucleoside diphosphate kinase |
Protective antigen |
|
|
3897
|
NEAT |
Bacillus anthracis |
|
|
|
WP_080489610
|
|
|
|
|
CDD:309946
CDD:132993
CDD:227223
CDD:275380
CDD:275378
CDD:306825 |
NEAT domain-containing leucine-rich repeat protein |
Protective antigen |
|
|
707
|
Nef |
Human immunodeficiency virus 1 |
VO_0011261
|
156110
|
|
28872818
|
HIV1gp9 |
AF033819 |
NP_057857 |
|
|
Nef |
Protective antigen |
DNA vaccine expressing multiple HIV epitopes
|
|
1063
|
nef |
Simian immunodeficiency virus |
|
1490008
|
|
9627209
|
SIVgp7 |
M66437 |
NP_054373 |
3IOZ
|
|
nef protein |
Virmugen |
Simian Immunodeficiency Virus nef mutant vaccine
|
|
1718
|
nef |
Human immunodeficiency virus 2 |
|
|
|
1845210
|
|
|
|
|
CDD:249884 |
nef protein |
Protective antigen |
HIV-2 DNA vaccine
|
|
1270
|
nef from subtype B |
Human immunodeficiency virus 1 |
|
|
|
108860393
|
|
|
|
|
CDD:109523 |
Nef |
Other |
|
|
1246
|
Nef SIV |
Simian immunodeficiency virus |
|
1490008
|
|
9627209
|
SIVgp7 |
M66437 |
NP_054373 |
|
|
nef protein |
Other |
HIV DNA vaccine SIVmac239 Gag-Pol-Nef and mock Env with rAd5 boost
|
|
4605
|
NF2 |
Homo sapiens |
|
4771
|
|
4557795
|
|
AC004882 |
NP_000259 |
|
|
transcript variant 14 |
Protective antigen |
Recombinant Adenovirus-p53 SCH-58500 Vaccine
|
|
571
|
NH |
Leishmania donovani |
VO_0011161
|
|
|
19697561
|
|
|
|
|
CDD:239117 |
nucleoside hydrolase |
Protective antigen |
L. donovani DNA Vaccine encoding NH36 Protein
|
|
4362
|
NH |
Leishmania donovani |
|
|
|
AAG02281
|
|
|
|
|
CDD:239117 |
nucleoside hydrolase |
Protective antigen |
|
|
895
|
nlpD |
|
|
|
|
224483371
|
|
|
|
|
CDD:182796
CDD:29017
CDD:144954 |
NlpD |
Virmugen |
Yersinia pestis nlpD mutant vaccine
|
|
336
|
NmpC |
Salmonella enterica subsp. enterica serovar Typhimurium |
|
|
|
517159
|
|
|
|
|
CDD:174088 |
NmpC protein |
Virmugen |
Salmonella Typhimurium ompD/nmpC mutant vaccine
|
|
4309
|
non-structural protein 1 |
Porcine parvovirus |
|
|
|
AAS93262
|
|
|
|
|
CDD:255001
CDD:289218
CDD:279406
CDD:288933 |
non-structural protein 1 |
Protective antigen |
|
|
4273
|
non-structural protein NS4a |
Yellow fever virus |
|
|
|
NP_776006
|
|
|
|
|
CDD:279666 |
non-structural protein NS4a |
Protective antigen |
|
|
4274
|
non-structural protein NS4b |
Yellow fever virus |
|
|
|
NP_776008
|
|
|
|
|
CDD:279665 |
non-structural protein NS4b |
Protective antigen |
|
|
454
|
NP |
Zaire ebolavirus |
VO_0010912
|
911830
|
|
10314000
|
ZEBOVgp1 |
AY142960 |
NP_066243 |
|
|
mRNA |
Protective antigen |
|
|
515
|
NP |
Influenza A virus H3N2 |
VO_0011111
|
|
|
3722159
|
|
|
|
|
CDD:278907 |
nucleoprotein |
Protective antigen |
Influenza virus DNA vaccine Luc-NP
Influenza virus DNA vaccine d1TTFC-NP encoding NP
|
|
541
|
NP |
Influenza A virus (A/chicken/Henan/12/2004(H5N1)) |
VO_0011134
|
|
|
61698066
|
|
|
|
|
CDD:278907 |
nucleocapsid protein |
Protective antigen |
Influenza virus DNA vaccine encoding NP from Influenza A virus (A/chicken/Henan/12/2004(H5N1))
|
|
544
|
NP |
Influenza A virus (A/chicken/Hubei/489/2004(H5N1)) |
VO_0011137
|
|
|
55233233
|
|
|
|
|
CDD:278907 |
nucleoprotein |
Protective antigen |
Influenza virus DNA vaccine encoding NP from Influenza A virus (A/chicken/Hubei/489/2004(H5N1))
Influenza virus DNA vaccine pHA/NP147–155 encoding NP147-155
|
|
1230
|
NP |
Lymphocytic choriomeningitis virus Armstrong |
|
|
|
61655717
|
|
|
|
|
CDD:279216 |
nucleoprotein |
Protective antigen |
Lymphocytic choriomeningitis virus DNA vaccine pCMV-NP
|
|
1371
|
NP |
Influenza A virus (A/Hong Kong/156/97(H5N1)) |
|
|
|
12038906
|
|
|
|
|
CDD:278907
GOA:O92784
InterPro: IPR002141
UniProtKB/UniProt: O92784 |
Nucleoprotein |
Protective antigen |
Influenza virus DNA vaccine A/NP
|
|
1415
|
NP |
Influenza A virus (A/Vietnam/CL36/2004(H5N1)) |
|
|
|
93008749
|
|
|
|
|
CDD:278907 |
nucleoprotein |
Protective antigen |
Avian influenza virus DNA vaccine pNP
|
|
1416
|
NP |
Influenza A virus (A/turkey/Ireland/1378/1983(H5N8)) |
|
|
|
115279340
|
|
|
|
|
CDD:278907 |
nucleocapsid protein |
Protective antigen |
|
|
1654
|
NP |
Zaire ebolavirus isolate EBOV/H.sapiens-tc/COD/1995/13709 Kikwit |
|
|
|
436409420
|
|
|
|
|
CDD:283221 |
NP |
Protective antigen |
Marburg virus recombinant vector vaccine CAdVax-Panfilo
|
|
1216
|
NP from A/Hong Kong/2/68(H3N2) |
A/Hong Kong/2/68(H3N2) |
|
|
|
61197034
|
|
|
|
|
CDD:144193 |
nucleoprotein |
Other |
|
|
718
|
NP from Influenza A virus (A/nt/60/1968(H3N2)) |
Influenza A virus (A/nt/60/1968(H3N2)) |
VO_0011264
|
|
|
324704
|
|
|
|
|
CDD:278907 |
nucleoprotein |
Protective antigen |
Influenza virus NP protein vaccine (Influenza A virus (A/nt/60/1968(H3N2)))
|
|
528
|
NP from Influenza A virus (A/Puerto Rico/8/34(H1N1)) |
Influenza A virus (A/Puerto Rico/8/1934(H1N1)) |
VO_0011122
|
956531
|
|
8486130
|
FLUAVs5gp1 |
J02147 |
NP_040982 |
|
|
nucleoprotein |
Protective antigen |
AdH5-FluA NP
Influenza virus DNA vaccine pBK-SFV-NP
Influenza virus DNA vaccine pBK-SFV/Enh-NP
Influenza virus DNA vaccine pND-NP encoding NP
Influenza virus DNA vaccine NP DNA
Influenza virus DNA vaccine VR4700 pDNA encoding NP
Influenza virus DNA vaccine pDNAs VR4762 encoding NP
Influenza virus DNA vaccine pcDNA3.1/NP
Influenza virus DNA vaccine pDNA encoding M2 and NP
Influenza virus DNA vaccine pCMV-NP
Influenza virus DNA vaccine pRSV-NP encoding the coding sequence from influenza virus A/PR/8/34.
|
|
514
|
NP from Influenza B virus |
Influenza B virus |
VO_0011110
|
956539
|
|
8486155
|
FLUBVsRNA-5gp1 |
K01395 |
NP_056661 |
|
|
nucleoprotein |
Protective antigen |
|
|
573
|
NP from Lake Victoria marburgvirus |
Lake Victoria marburgvirus |
VO_0011163
|
|
|
332181
|
|
|
|
|
CDD:283221
CDD:274446 |
nucleoprotein |
Protective antigen |
Marburg Virus Nucleoprotein Vaccine
|
|
160
|
NP from Marburg virus Musoke |
Lake Victoria marburgvirus - Musoke |
|
|
|
60624
|
DQ217792 |
|
|
|
CDD:147601
CDD:163153
GOA:P27588
InterPro: IPR008609
UniProtKB/UniProt: P27588 |
nucleoprotein |
Other |
Marburg virus glycoprotein expressed by baculovirus recombinants
Recombinant VEE Replicons expressing MBGV NP
Marburg virus recombinant vector vaccine CAdVax-Panfilo
Marburg virus recombinant vector vaccine MBGV GP/MBGV NP
Marburg Virus Vaccine mVLP QS-21 Adjuvant
|
|
174
|
NP from Marburgvirus Ravn |
Ravn |
VO_0010933
|
|
|
91177744
|
ABE27068 |
|
|
|
CDD:283221 |
nucleoprotein |
Protective antigen |
Recombinant VEE Replicons expressing MBGV GP
Marburg Virus Vaccine mVLP Poly I:C Adjuvant
|
|
4919
|
NP from Tai Forest Ebolavirus |
Tai Forest ebolavirus |
|
9487539
|
|
302315370
|
CIEBOVp1 |
FJ217162 |
YP_003815423 |
|
|
mRNA |
Protective antigen |
Marburg Virus Vaccine Ad26.Filo, MVA-BN-Filo
|
|
1296
|
NP from Zaire Ebola virus |
Ebola virus - Mayinga, Zaire, 1976 |
|
911830
|
|
10314000
|
ZEBOVgp1 |
AF086833 |
NP_066243 |
|
|
mRNA |
Other |
Ebola virus EBOV NP
Ebola virus recombinant adenovirus vector vaccine ADV−GP/NP
rVSV- SEBOV-GP and -VP40
rCMV- EBOV
rVEE-Ebola-NP
|
|
172
|
NP from Zaire ebolavirus |
Zaire ebolavirus |
VO_0010931
|
911830
|
|
10314000
|
ZEBOVgp1 |
AY142960 |
NP_066243 |
|
|
mRNA |
Protective antigen |
Multivalent DNA vaccine for B. anthracis, Ebola virus, Marburg virus, and VEE virus
|
|
4943
|
NRAS |
Homo sapiens |
|
4893
|
|
4505451
|
|
AH001530 |
NP_002515 |
|
|
NRAS proto-oncogene, GTPase |
Protective antigen |
Racotumomab Vaccine
|
|
4575
|
NRP1 |
Homo sapiens |
|
8829
|
|
1844084060
|
|
AF482431 |
NP_001019799 |
|
|
transcript variant 6 |
Protective antigen |
Plasmacytoid Dendritic Cell Vaccine
DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 Peptide-pulsed Alpha-type-1 Polarized Dendritic Cell Vaccine
|
|
556
|
NS1 |
Japanese encephalitis virus |
VO_0011147
|
|
|
18418672
|
|
|
|
|
CDD:279316 |
NS1 protein |
Protective antigen |
Japanese encephalitis virus DNA vaccine encoding NS1 (pUSK-NS1)
Japanese encephalitis virus DNA Vaccine P-JEV
NYVAC-JEV- prM/E/ NS1
|
|
781
|
NS1 |
|
VO_0011312
|
|
|
288848
|
|
|
|
|
CDD:213897
CDD:279316
InterPro: IPR001157
UniProtKB/TrEMBL: Q06371 |
|
Protective antigen |
Dengue DNA Vaccine encoding NS1 Protein
Dengue virus DNA vaccine pcTPANS1 encoding NS1 fused to the tissue plasminogen activator signal sequence
Dengue Virus DNA Vaccine encoding NS1
|
|
4264
|
NS1 |
Japanese encephalitis virus |
|
|
|
AOG16026
|
|
|
|
|
|
NS1 |
Protective antigen |
|
|
4278
|
NS1 |
Tick-borne Encephalitis Virus (TBEV) |
|
|
|
CAA44678
|
|
|
|
|
CDD:213897
CDD:279316
InterPro: IPR001157
UniProtKB/TrEMBL: Q88482 |
unnamed |
Protective antigen |
Encepur
|
|
4338
|
NS1 |
African horse sickness virus |
|
|
|
AKP39984
|
|
|
|
|
CDD:279979 |
NS1 |
Protective antigen |
|
|
684
|
NS1 (non-structural protein 1) |
|
VO_0011259
|
|
|
|
|
|
|
|
CDD:109983 |
non-structural protein NS1 |
Protective antigen |
Yellow Fever NS1 Protein Vaccine
|
|
517
|
NS1 from Influenza virus |
Influenza virus |
|
|
|
505039
|
|
|
|
3EE8
|
CDD:144260
GOA:Q82804
HSSP: P03495
InterPro: IPR000256
InterPro: IPR009068
UniProtKB/TrEMBL: Q82804 |
|
Virmugen |
Influenza virus NS1 mutant vaccine
|
|
4869
|
NS1 Protein |
Human respiratory syncytial virus B |
|
|
|
CBW47561
|
|
|
CBW47561 |
|
CDD:367500
InterPro: IPR005099
UniProtKB/TrEMBL: E0WMQ1 |
NS1 protein |
Protective antigen |
|
|
4852
|
NS2 |
|
|
|
|
AIO08073
|
|
|
|
|
CDD:427145 |
NS2 |
Protective antigen |
|
|
557
|
NS3 |
Japanese encephalitis virus |
VO_0011148
|
|
|
27696332
|
|
|
|
|
CDD:279317
CDD:214692
CDD:284962
CDD:238005
CDD:304359
CDD:238034 |
non-structural protein NS3 |
Protective antigen |
Japanese encephalitis virus DNA vaccine pUJENS3
|
|
4277
|
NS3 |
Tick-borne Encephalitis Virus (TBEV) |
|
|
|
AGL40608
|
|
|
|
|
CDD:214692
CDD:284962
CDD:238005 |
NS3 |
Protective antigen |
|
|
558
|
NS5 |
Japanese encephalitis virus |
VO_0011149
|
|
|
158702649
|
|
|
|
|
CDD:279336 |
NS5 |
Protective antigen |
Japanese encephalitis virus DNA vaccine pUJENS5
|
|
4681
|
NSCLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
271
|
NspA from N. meningitidis MC58 |
Neisseria meningitidis MC58 |
VO_0010979
|
902774
|
|
15676561
|
NMB0663 |
AE002098 |
NP_273705 |
1P4T
|
|
outer membrane protein |
Protective antigen |
N. meningitidis NspA Protein Vaccine
|
|
863
|
nucA |
Haemophilus influenzae strain P860295 |
VO_0012405
|
|
|
4929317
|
|
|
|
|
CDD:211667 |
5'-nucleotidase NucA precursor |
Protective antigen |
Nontypeable H. influenzae NucA Protein vaccine
|
|
4125
|
nuclease |
Streptococcus pyogenes |
|
|
|
ASQ22678
|
|
|
|
|
CDD:225249 |
nuclease |
Protective antigen |
|
|
1236
|
nucleocapsid |
Viral hemorrhagic septicemia virus DK-3592B |
|
|
|
3282333
|
|
|
|
|
CDD:281242 |
nucleocapsid protein |
Protective antigen |
VHSV DNA vaccine pCMV-vhsN encoding nucleocapsid protein N and glycoprotein G
|
|
4289
|
nucleocapsid protein (N) gene of SARS-CoV |
SARS-CoV |
|
|
|
AAZ67049
|
|
|
|
|
CDD:279305 |
nucleocapsid protein |
Protective antigen |
SARS-CoV Ad S/N vaccine
SARS-CoV N + SARS-CoV M DNA vaccine
SARS-CoV pCI-N DNA from vaccine
SARS-CoV N protein DNA vaccine
|
|
1225
|
nucleoprotein |
Lymphocytic choriomeningitis virus |
|
956592
|
|
23334590
|
LCMVsSgp2 |
DQ361065 |
NP_694852 |
|
|
nucleoprotein |
Other |
|
|
4468
|
NUF2 |
Homo sapiens |
|
83540
|
|
117968353
|
|
AL592435 |
NP_113611 |
|
|
transcript variant X3 |
Protective antigen |
URLC10-CDCA1-KOC1 Multipeptide Vaccine
Multipeptide Vaccine S-588210
|
|
884
|
nuoG |
Salmonella enterica subsp. enterica serovar Gallinarum str. 287/91 |
|
6924283
|
|
205353438
|
SG2352 |
AM933173 |
YP_002227239 |
|
|
NADH dehydrogenase subunit G |
Virmugen |
Salmonella Gallinarum nuoG mutant vaccine
|
|
1076
|
NV |
Infectious hematopoietic necrosis virus |
|
1489849
|
|
9628087
|
IHNVgp5 |
L40883 |
NP_042680 |
|
|
non-virion protein |
Virmugen |
Infectious Hematopoietic Necrosis Virus NV mutant vaccine
|
|
4589
|
NY-ESO-1 |
Homo sapiens |
|
1485
|
|
4503119
|
|
AC244107 |
NP_001318 |
|
|
cancer/testis antigen 1B |
Protective antigen |
Fowlpox-NY-ESO-1 Vaccine
ESO-1:157-165(165V) Peptide Vaccine
ESO-1 Reactive Autologous Peripheral Blood Lymphocyte Vaccine
ESO-1 (161-180) Peptide Vaccine
Dendritic Cell-targeting Lentiviral Vector ID-LV305
Autologous Melanoma Lysate/NY-ESO-1-pulsed Autologous Dendritic Cell Vaccine
Autologous Melanoma Lysate-Pulsed Autologous Dendritic Cell Vaccine
ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine
Anti-NY-ESO1 TCR-transduced Autologous CD62L+-derived T-Lymphocytes
Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A
ALVAC-ESO-1 Vaccine
Ag NY-ESO-1
MELITAC 12.1 Peptide Vaccine
|
|
4817
|
ny-eso-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1701
|
oipA |
Helicobacter pylori strain PD529 |
|
|
|
WP_000756902
|
|
|
|
|
CDD:280099 |
outer membrane protein |
Protective antigen |
H. pylori DNA vaccine poipA
|
|
4041
|
omcB |
Chlamydia trachomatis |
|
|
|
ABY76794
|
|
|
|
|
CDD:281500
CDD:307488 |
OmcB |
Protective antigen |
|
|
420
|
omlA |
Chlamydophila abortus |
VO_0011060
|
|
|
62184824
|
|
|
|
|
CDD:308876 |
outer membrane lipoprotein |
Protective antigen |
C. abortus DNA vaccine encoding OmlA
|
|
4095
|
omlA |
Actinobacillus pleuropneumoniae serovar 2 str. S1536 |
|
|
|
CAA73336
|
|
|
|
|
CDD:295696
GOA:O31239
InterPro: IPR001677
UniProtKB/TrEMBL: O31239 |
OmlA |
Protective antigen |
|
|
425
|
omp1 |
Chlamydophila abortus |
VO_0010881
|
|
|
40601
|
|
|
|
|
CDD:279628
GOA:P16567
InterPro: IPR000604
UniProtKB/UniProt: P16567 |
major outer membrane protein |
Protective antigen |
C. abortus DNA vaccine encoding MOMP
|
|
260
|
Omp16 |
Brucella abortus 2308 |
VO_0010973
|
3788229
|
|
489056820
|
BAB_RS24085 |
AM040264 |
WP_002966947 |
|
|
hypothetical protein |
Protective antigen |
B. abortus DNA vaccine encoding RplL and Omp16
|
|
1678
|
omp16 |
Brucella abortus RB51-AHVLA |
|
|
|
479804733
|
|
|
|
|
CDD:225439
CDD:143586 |
outer membrane lipoprotein omp16 |
Protective antigen |
Divalent DNA B. abortus Vaccine pcDNA3.1-L7/L12-Omp16
|
|
259
|
Omp19 |
Brucella abortus 2308 |
VO_0010972
|
3788831
|
|
489054833
|
BAB_RS25135 |
AM040264 |
WP_002964998 |
|
|
hypothetical protein |
Protective antigen |
|
|
4037
|
omp2 |
Chlamydophila abortus |
|
|
|
AAD20337
|
|
|
|
|
CDD:281500
CDD:279661 |
outer membrane protein 2 |
Protective antigen |
|
|
253
|
Omp25 |
Brucella melitensis bv. 1 str. 16M |
VO_0010966
|
1196960
|
|
17987532
|
BMEI1249 |
AE008917 |
NP_540166 |
|
|
hypothetical protein |
Protective antigen |
Brucella melitensis omp25 mutant vaccine
B. melitensis DNA vaccine p-Omp25
|
|
3943
|
omp26 |
Haemophilus parasuis |
|
|
|
ACL32860
|
|
|
|
|
CDD:332039 |
outer membrane protein 26 |
Protective antigen |
|
|
231
|
Omp31 |
Brucella abortus 2308 |
VO_0010939
|
3788834
|
|
489054549
|
BAB_RS23735 |
AM040264 |
WP_002964719 |
|
|
membrane protein |
Protective antigen |
B. melitensis 16M DNA vaccine expressing Omp31
|
|
1054
|
omp31 |
Brucella melitensis ATCC 23457 |
|
7676420
|
|
225853091
|
BMEA_A1674 |
CP001488 |
YP_002733324 |
|
|
outer membrane protein Omp31 |
Virmugen |
B. melitensis DNA vaccine encoding Omp31 boosted with Omp31
Brucella melitensis omp31 mutant vaccine
|
|
1609
|
omp31 |
Brucella melitensis bv. 1 str. 16M |
|
|
|
61229373
|
|
|
|
|
CDD:226163 |
31 kDa outer-membrane immunogenic protein |
Protective antigen |
B. melitensis DNA vaccine pCI-Omp31
B. melitensis DNA vaccine pCIBLSOmp31 encoding BLSOmp31 (fusion protein)
|
|
766
|
ompA |
Chlamydophila psittaci |
VO_0010924
|
|
|
94467392
|
|
|
|
|
CDD:279628 |
|
Protective antigen |
C. psittaci DNA vaccine pcDNA1/MOMP
|
|
285
|
ompA |
Escherichia coli CFT073 |
VO_0010991
|
1039252
|
|
WP_001246526
|
c3389 |
AE014075 |
NP_755264 |
|
CDD:225439
CDD:143586 |
OmpA family protein |
Protective antigen |
E. coli C3389 protein vaccine
|
|
650
|
ompA |
Rickettsia rickettsii |
VO_0011234
|
|
|
112710
|
|
|
|
|
CDD:225751
CDD:299123
CDD:273608
CDD:281750 |
Outer membrane protein A |
Protective antigen |
Rickettsia rickettsii vaccine using M. vaccae expressing R. rickettsii OmpA Protein
|
|
1638
|
OmpA |
Pasteurella multocida strain 95010872 |
|
|
49182347
|
49182348
|
|
|
AAT57676.1 |
|
CDD:236764
CDD:279698
CDD:143586 |
OmpA |
Protective antigen |
P. multocida DNA vaccine pcDNA-OMPH + pcDNA-OMPA
P. multocida DNA vaccine pcDNA-OMPH/OMPA
|
|
1682
|
ompA |
Chlamydia trachomatis serovar E |
|
|
|
129149
|
|
|
|
|
CDD:279628 |
Major outer membrane porin, serovar E |
Protective antigen |
C. trachomatis DNA vaccine pWRG7079::MOMP
|
|
3861
|
OmpA |
Shigella spp. |
|
|
|
AIL39878
|
|
|
|
|
CDD:236764
CDD:143586 |
OmpA |
Protective antigen |
|
|
3874
|
ompA |
Rickettsia raoultii |
|
|
|
ABD34816
|
|
|
|
|
CDD:273608
CDD:281750 |
OmpA |
Protective antigen |
|
|
3997
|
ompA |
Edwardsiella tarda |
|
|
|
ACT33424
|
|
|
|
|
CDD:236764
CDD:279698
CDD:143586 |
outer membrane protein A precursor |
Protective antigen |
|
|
4022
|
OmpA |
Coxiella burnetii |
|
|
|
WP_041952488
|
|
|
|
|
CDD:225439
CDD:143586 |
OmpA family protein |
Protective antigen |
|
|
4027
|
OmpA |
Chlamydophila psittaci |
|
|
|
AIZ00977
|
|
|
|
|
CDD:279628 |
major outer membrane protein |
Protective antigen |
|
|
4053
|
ompA |
Chlamydia trachomatis |
|
|
|
ABV55512
|
|
|
|
|
CDD:279628 |
OmpA |
Protective antigen |
|
|
4089
|
ompA |
Actinobacillus pleuropneumoniae |
|
|
|
ABV82725
|
|
|
|
|
ATCC:27088
CDD:332966
CDD:143586 |
OmpA |
Protective antigen |
A. pleuropneumoniae OmpA vaccine
mixture of Salmonella strains delivering ApxIA, ApxIIA, ApxIIIA and OmpA of A. pleuropneumoniae
|
|
651
|
ompB |
Rickettsia rickettsii |
VO_0011235
|
|
|
6685726
|
|
|
|
|
CDD:289131
CDD:273608
CDD:214872 |
Outer membrane protein B |
Protective antigen |
Rickettsia DNA Vaccine encoding OmpB Protein boosted with Recombinant OmpB
|
|
3991
|
ompC |
Escherichia coli |
|
|
|
AYG18759
|
|
|
|
|
CDD:182543 |
porin OmpC |
Protective antigen |
|
|
4000
|
ompC |
Edwardsiella tarda |
|
|
|
ADM43235
|
|
|
|
|
CDD:328747
CDD:238208 |
Outer membrane protein C precursor Porin OmpC |
Protective antigen |
|
|
969
|
OMPDC |
Toxoplasma gondii ME49 |
|
7899615
|
|
237831731
|
TGME49_059690 |
DS984728 |
XP_002365163 |
|
|
|
Virmugen |
T. gondii OMPDC mutant vaccine
T. gondii OMPDC/UP mutant vaccine
|
|
3969
|
ompF |
Escherichia coli |
|
|
|
APB87310
|
|
|
|
|
CDD:236639
CDD:238208 |
OmpF |
Protective antigen |
|
|
943
|
ompH |
Pasteurella multocida strain X-73 |
|
|
2745957
|
2745958
|
|
|
AAC02243.1 |
|
CDD:225744
CDD:238208 |
outer membrane protein |
Protective antigen |
P. multocida rOmpH Vaccine
|
|
1637
|
ompH |
Pasteurella multocida strain Pm-17 |
|
|
99083557
|
99083558
|
|
|
ABF66676.1 |
|
CDD:225744
CDD:238208 |
outer membrane protein |
Protective antigen |
P. multocida DNA vaccine pcDNA-OMPH + pcDNA-OMPA
P. multocida DNA vaccine pcDNA-OMPH/OMPA
|
|
4034
|
OmpH-like outer membrane protein |
Chlamydophila pneumoniae |
|
|
|
AAP98243
|
|
|
|
|
CDD:225381 |
OmpH-like outer membrane protein |
Protective antigen |
|
|
1649
|
ompL1 |
Leptospira interrogans serovar Copenhageni str. Fiocruz L1-130 |
|
2769678
|
|
45656861
|
LIC10973 |
AE016823 |
YP_000947 |
|
|
outer membrane protein |
Protective antigen |
Leptospira interrogans DNA vaccine ompL1-pcDNA3.1(+)
|
|
3908
|
ompL1 |
Leptospira borgpetersenii serovar Hardjo-bovis str. JB197 |
|
|
|
ABJ75260
|
|
|
|
|
CDD:288277 |
OmpL1 |
Protective antigen |
|
|
864
|
ompP1 |
Haemophilus influenzae strain 4-H-1093 |
VO_0012406
|
|
|
9716645
|
|
|
|
|
CDD:224978 |
outer membrane protein P1 |
Protective antigen |
Nontypeable H. influenzae Outer Membrane Protein P1 vaccine
|
|
485
|
OmpP2 |
Haemophilus influenzae 86-028NP |
VO_0011084
|
3429565
|
|
68248747
|
NTHI0225 |
CP000057 |
YP_247859 |
|
|
outer membrane protein P2 |
Protective antigen |
|
|
482
|
OmpP5 |
Haemophilus influenzae 86-028NP |
VO_0011082
|
3430592
|
|
68249712
|
NTHI1332 |
CP000057 |
YP_248824 |
|
|
outer membrane protein P5 |
Protective antigen |
|
|
994
|
ompR |
Yersinia enterocolitica subsp. enterocolitica 8081 |
|
4716266
|
|
123444180
|
YE4004 |
AM286415 |
YP_001008150 |
|
|
osmolarity response regulator |
Virmugen |
Yersinia enterocolitica ompR mutant vaccine
|
|
1002
|
ompR |
Salmonella enterica subsp. enterica serovar Typhimurium str. SL1344 |
|
|
|
301160045
|
|
|
|
|
CDD:181883
CDD:29071
CDD:29475
UniProtKB/TrEMBL: E1WIS9 |
two-component response regulator OmpR |
Virmugen |
Salmonella Typhimurium ompR mutant vaccine
|
|
3967
|
ompT |
Escherichia coli |
|
|
|
APO18432
|
|
|
|
|
CDD:236813 |
OmpT |
Protective antigen |
|
|
813
|
ompU |
Listonella anguillarum |
VO_0011344
|
|
|
26513901
|
|
|
|
|
CDD:225744
CDD:238208 |
major outer membrane protein OmpU |
Protective antigen |
|
|
3875
|
OmpW |
Rickettsia rickettsii |
|
|
|
WP_014362720
|
|
|
|
|
CDD:225589 |
OmpW family protein |
Protective antigen |
|
|
4067
|
ompW |
Burkholderia pseudomallei |
|
|
|
EBA51732
|
|
|
|
|
|
outer membrane protein, OmpW family |
Protective antigen |
|
|
4091
|
ompW |
Actinobacillus pleuropneumoniae |
|
|
|
ASU14913
|
|
|
|
|
CDD:328747 |
Outer membrane protein W |
Protective antigen |
A. pleuropneumoniae OmpW vaccine
|
|
3999
|
ompX |
Edwardsiella tarda ATCC 15947 |
|
|
|
GAC64620
|
|
|
|
|
|
outer membrane protein X |
Protective antigen |
|
|
3830
|
opJ |
Yersinia pseudotuberculosis |
|
|
|
AAT28340
|
|
|
|
|
CDD:185269 |
outer protein J |
Protective antigen |
|
|
3940
|
oppA |
Haemophilus parasuis |
|
|
|
ACL32119
|
|
|
|
|
CDD:173869
CDD:185059 |
putative oligopeptide transporter, periplasmic-binding protein, OppA |
Protective antigen |
|
|
4075
|
oppA |
Burkholderia pseudomallei |
|
|
|
CRY20041
|
|
|
|
|
|
oligopeptide ABC transporter periplasmic oligopeptide-binding protein |
Protective antigen |
|
|
4147
|
oppA |
Streptococcus pyogenes M1 476] |
|
|
|
BAM31018
|
|
|
|
|
CDD:226636
CDD:173869 |
oligopeptide-binding protein |
Protective antigen |
|
|
843
|
OprF |
Pseudomonas aeruginosa PAO1 |
VO_0012360
|
878442
|
|
15596974
|
PA1777 |
AE004091 |
NP_250468 |
|
|
outer membrane porin F |
Protective antigen |
P. aeruginosa DNA Vaccine encoding OprF
P. aeruginosa DNA vaccine pGACAG-OprF/OprI
P. aeruginosa DNA vaccine pGACAG-OprF/OprI + pGACAG-PcrV + pGACAG-PilA
|
|
3885
|
oprF_3 |
Pseudomonas aeruginosa |
|
|
|
CRR17034
|
|
|
|
|
|
Outer membrane porin F precursor |
Protective antigen |
|
|
845
|
OprI |
Pseudomonas aeruginosa PAO1 |
VO_0012362
|
879851
|
|
15598049
|
PA2853 |
AE004091 |
NP_251543 |
|
|
outer membrane lipoprotein OprI |
Protective antigen |
P. aeruginosa OprI Protein Vaccine
P. aeruginosa DNA vaccine pGACAG-OprF/OprI
P. aeruginosa DNA vaccine pGACAG-OprF/OprI + pGACAG-PcrV + pGACAG-PilA
|
|
3883
|
oprL |
Pseudomonas aeruginosa |
|
|
|
ABX84373
|
|
|
|
|
CDD:225439
CDD:274307
CDD:143586 |
OprL |
Protective antigen |
|
|
113
|
ORF |
|
VO_0010927
|
|
599653
|
599654
|
|
|
CAA86936.1 |
1DI0
|
CDD:237096
CDD:187741
GOA:P61711
InterPro: IPR002180
PDB: 1DI0
PDB: 1T13
PDB: 1XN1
UniProtKB/UniProt: P61711 |
|
Protective antigen |
B. abortus pcDNA-BLS
B. melitensis DNA vaccine pCIBLSOmp31 encoding BLSOmp31 (fusion protein)
|
|
1412
|
ORF |
Infectious pancreatic necrosis virus |
|
|
221910
|
221911
|
|
|
BAA00608.1 |
|
CDD:281092 |
small ORF |
Protective antigen |
IPNV DNA vaccine pEGFP-N1-SegA and pEGFP-N1-VP2
|
|
1281
|
ORF-2 |
Hepatitis E virus |
|
1494410
|
|
9626450
|
HEVgp10 |
L08816 |
NP_056788 |
|
|
capsid protein |
Other |
|
|
1282
|
ORF-2 |
Hepatitis E virus |
|
1494410
|
|
9626450
|
HEVgp10 |
L08816 |
NP_056788 |
|
|
capsid protein |
Other |
|
|
932
|
ORF-A |
Feline immunodeficiency virus |
|
1724707
|
|
9626705
|
FIVgp4 |
M25381 |
NP_040975 |
|
|
hypothetical protein |
Virmugen |
Feline immunodeficiency virus ORF-A mutant vaccine
|
|
1669
|
ORF1 |
Rabbit hemorrhagic disease virus |
|
|
|
515625
|
|
|
|
|
CDD:279283
CDD:165513
GOA:Q86119
InterPro: IPR000317
InterPro: IPR000605
InterPro: IPR001205
InterPro: IPR003593
InterPro: IPR004004
InterPro: IPR004005
InterPro: IPR007094
InterPro: IPR009003
InterPro: IPR014759
UniProtKB/UniProt: Q86119 |
VP60 |
Protective antigen |
RHDV DNA vaccine pcDNA-VP60
rORFV-RHDV-VP60
|
|
4328
|
ORF1 |
Hepatitis E virus |
|
|
|
BAD35096
|
|
|
|
|
CDD:110646 |
ORF1 |
Protective antigen |
|
|
4296
|
ORF1a |
Porcine respiratory and reproductive syndrome virus |
|
|
|
AMN09501
|
|
|
|
|
|
NSP5 |
Protective antigen |
|
|
659
|
ORF2 |
Porcine circovirus type 2 |
VO_0011243
|
|
|
78217439
|
|
|
|
|
CDD:280582 |
ORF2 |
Protective antigen |
PCV2 DNA Vaccine encoding ORF2 Protein
PrV-PCV2-ORF2
|
|
4329
|
ORF2 |
Hepatitis E virus |
|
|
|
AAA03191
|
|
|
|
|
CDD:281067 |
ORF2 |
Protective antigen |
|
|
1418
|
ORF5 |
Porcine reproductive and respiratory syndrome virus |
|
|
|
14250961
|
|
|
|
|
CDD:109986 |
GP5 envelope protein |
Protective antigen |
PRRSV DNA vaccine pCA-U-optiGP5
PRRSV DNA vaccine pCA-GP5
PRRSV DNA vaccine pIRESorf5/IFNγ
PRRSV DNA vaccine pIRESorf5/IL-2
|
|
4301
|
ORF6 |
Equine arteritis virus |
|
|
|
ATX64259
|
|
|
|
|
CDD:109986 |
M |
Protective antigen |
|
|
663
|
ORF67 |
Human alphaherpesvirus 3 |
VO_0011247
|
1487689
|
|
9625941
|
HHV3_gp68 |
AF206304 |
NP_040189 |
|
|
envelope glycoprotein I |
Protective antigen |
Varicella Subunit Vaccine encoding gI and gE glycoproteins
|
|
662
|
ORF68 |
Human alphaherpesvirus 3 |
VO_0011246
|
1487709
|
|
9625942
|
HHV3_gp69 |
AH010255 |
NP_040190 |
|
|
envelope glycoprotein E |
Protective antigen |
Varicella Subunit Vaccine encoding gI and gE glycoproteins
|
|
4528
|
ORF68 |
Human alphaherpesvirus 3 |
|
1487709
|
|
9625942
|
HHV3_gp69 |
AH010255 |
NP_040190 |
|
|
envelope glycoprotein E |
Protective antigen |
|
|
1421
|
ORF7 |
Porcine reproductive and respiratory syndrome virus CH-1a |
|
|
|
14250964
|
|
|
|
|
CDD:110480 |
nucleocapsid protein |
Protective antigen |
PRRSV DNA vaccine pIRESorf7/IL-2
|
|
4303
|
ORF7 |
Equine arteritis virus |
|
|
|
ATX64260
|
|
|
|
|
CDD:307571 |
N |
Protective antigen |
|
|
569
|
ORFF |
Leishmania donovani |
VO_0011159
|
|
|
703122
|
|
|
|
|
|
unknown |
Protective antigen |
L. donovani ORFF Protein Vaccine
|
|
4251
|
ORFV011 |
Orf Virus |
|
|
|
AGY41811
|
|
|
|
|
CDD:177506
CDD:197205
CDD:301585
CDD:197546
CDD:197206 |
ORFV011 |
Protective antigen |
|
|
4252
|
ORFV059 |
Orf Virus |
|
|
|
ALF04630
|
|
|
|
|
CDD:222919 |
ORFV059 |
Protective antigen |
|
|
838
|
OspA |
Borrelia burgdorferi B31 |
VO_0012384
|
1194357
|
|
11496927
|
BB_A15 |
AE000790 |
NP_045688 |
2HKD
|
|
outer surface protein A |
Protective antigen |
B. burgdorferi DbpA and OspA Protein Vaccine
B. burgdorferi OspA Protein Vaccine
B. burgdorferi DNA vaccine encoding strain B31 OspA
|
|
839
|
OspB |
Borrelia burgdorferi B31 |
VO_0012385
|
1194340
|
|
365823348
|
BB_A16 |
AE000790 |
NP_045689 |
|
|
outer surface protein B |
Protective antigen |
B. burgdorferi OspB Protein Vaccine
|
|
840
|
OspC |
Borrelia burgdorferi B31 |
VO_0012386
|
1194415
|
|
11497024
|
BB_B19 |
AE000792 |
NP_047005 |
1GGQ
|
|
outer surface protein C |
Protective antigen |
B. burgdorferi OspC Protein Vaccine
B. burgdorferi DNA vaccine pCMV-ZS7/TPA encoding OspC from Borrelia burgdorferi sensu lato
|
|
3929
|
outer membrane protein 26 |
Helicobacter pylori |
|
|
|
AFX89461
|
|
|
|
|
CDD:280099 |
outer membrane protein 26 |
Protective antigen |
|
|
3933
|
outer membrane protein A |
Haemophilus parasuis |
|
|
|
ACN62162
|
|
|
|
|
CDD:236764
CDD:279698
CDD:143586 |
outer membrane protein A |
Protective antigen |
|
|
3953
|
outer membrane protein D15 |
Haemophilus parasuis str. Nagasaki] |
|
|
|
ACI05267
|
|
|
|
|
CDD:236834
CDD:284624
CDD:279448 |
outer membrane protein D15 |
Protective antigen |
|
|
3951
|
outer membrane protein P2 |
Haemophilus parasuis str. Nagasaki] |
|
|
|
EYE71716
|
|
|
|
|
|
outer membrane protein P2 (OMP P2) |
Protective antigen |
|
|
4235
|
P |
Bovine Respiratory Syncytial Virus |
|
|
|
AAL49406
|
|
|
|
|
CDD:280615 |
phosphoprotein |
Protective antigen |
|
|
4313
|
P |
Human metapneumovirus |
|
|
|
YP_012606
|
|
|
|
|
CDD:280615 |
phosphoprotein |
Protective antigen |
|
|
580
|
P phosphoprotein |
Measles morbillivirus |
VO_0011169
|
1489805
|
|
9626947
|
MeVgp2 |
AB016162 |
NP_056919 |
|
|
mRNA |
Protective antigen |
Measles Virus Vaccine VVP
|
|
944
|
P protein |
Flury-HEP |
|
|
|
291220682
|
|
|
|
3L32
|
CDD:145910 |
phosphoprotein |
Virmugen |
Rabies virus P protein mutant vaccine
|
|
4874
|
P protein |
|
|
|
|
BAA00638
|
|
|
|
|
CDD:280615 |
P protein |
Other |
|
|
171
|
p1 |
Coxiella burnetii |
VO_0010930
|
|
|
ACJ19787
|
AY249911 |
|
|
|
ncbi protein accession number: AAP04425.1 |
outer membrane porin P1 |
Protective antigen |
P1-HspB (fusion of protein 1 and heat-shock protein B)
|
|
594
|
P1 |
Neisseria meningitidis MC58 |
VO_0011180
|
902192
|
|
15676020
|
NMB0088 |
AE002098 |
NP_273150 |
|
|
outer membrane protein P1 |
Protective antigen |
|
|
1073
|
P1 |
|
|
|
27465165
|
27465166
|
|
|
AAN60108.1 |
|
CDD:100109 |
ribosomal protein P1-like protein |
Protective antigen |
pVAX-P1 DNA vaccine
|
|
1694
|
P1 |
Foot-and-mouth disease virus - type O |
|
|
|
15419537
|
|
|
|
|
CDD:286076
CDD:278501
CDD:119412
CDD:301302 |
polyprotein P1 |
Protective antigen |
FMDV DNA Vaccine encoding P1 and non-structural proteins 2A, 3C, and 3D
|
|
4340
|
p10 |
Borna disease virus |
|
|
|
AAX09334
|
|
|
|
|
CDD:115187 |
p10 |
Protective antigen |
|
|
4435
|
P10 |
|
|
|
|
|
|
|
|
|
|
|
|
Mimotope-P10s-PADRE Peptide Vaccine
|
|
4283
|
p15E |
Feline leukemia virus |
|
|
|
NP_955582
|
|
|
|
|
CDD:pfam00429
CDD:197368 |
p15E protein |
Protective antigen |
|
|
4377
|
p23 |
Cryptosporidium parvum |
|
|
|
AEJ22854
|
|
|
|
|
|
p23 |
Protective antigen |
|
|
1634
|
p27 |
Hepatitis delta virus |
|
|
|
226737605
|
|
|
|
|
CDD:279813 |
Large delta antigen |
Protective antigen |
Hepatitis D DNA vaccine pcDNA3p27/Ad5F35p27
|
|
1373
|
p30 |
Toxoplasma gondii |
|
|
894214
|
894215
|
|
|
AAB33440.1 |
|
CDD:332018 |
p30 antigen |
Protective antigen |
T. gondii DNA vaccine pSAG1-ROP2-SAG2
T. gondii DNA vaccine pcDNA3.1-SAG1-ROP2
|
|
747
|
P36/LACK |
Leishmania infantum |
VO_0011284
|
|
|
134085114
|
|
|
|
|
CDD:238121
CDD:293791
InterPro: IPR001680
InterPro: IPR011046
InterPro: IPR015943
InterPro: IPR017986
InterPro: IPR019775
InterPro: IPR019781
InterPro: IPR019782
InterPro: IPR020472
UniProtKB/UniProt: P62884 |
activated protein kinase c receptor (LACK); p36 LACK protein |
Protective antigen |
VVr expressing L. infantum P36/LACK
|
|
1027
|
P36p |
Plasmodium berghei str. ANKA |
|
3424772
|
|
68068733
|
PB000799.01.0 |
CAAI01001447 |
XP_676277 |
|
|
|
Virmugen |
P. berghei p36p mutant vaccine
|
|
1358
|
P39 from Brucella abortus |
Brucella abortus bv. 1 str. 9-941 |
|
|
|
68067499
|
|
|
|
|
CDD:224567 |
Probable sugar-binding periplasmic protein |
Protective antigen |
B. abortus DNA vaccine pcI-p39 encoding P39 (periplasmic-binding protein)
B. abortus DNA vaccine pcDNA3.1-p39-L7/L12 encoding p39-L7/L12 fusion protein
|
|
751
|
P4 |
Leishmania amazonensis |
VO_0011288
|
|
29165286
|
29165287
|
|
|
AAO65599.1 |
|
CDD:280435
CDD:211382 |
P4 nuclease |
Protective antigen |
|
|
4941
|
p52 |
Plasmodium falciparum 3D7 |
|
9221796
|
|
124505231
|
PF3D7_0404500 |
AL844503 |
XP_001351357 |
|
CDD:429455 |
Sporozoite surface protein P36p |
Virmugen |
|
|
27
|
p53 |
Homo sapiens |
|
7157
|
|
|
|
|
|
|
TP53, LFS1, TRP53, tumor protein p53 (Li-Fraumeni syndrome) |
|
|
dVV-L
|
|
4316
|
p54 |
African Swine Fever Virus |
|
|
|
ADD62408
|
|
|
|
|
CDD:114299 |
p54 |
Protective antigen |
|
|
598
|
p67 |
Theileria parva strain Mugaga |
VO_0011183
|
|
|
4106806
|
|
|
|
|
CDD:253298 |
p67 surface antigen |
Protective antigen |
T. parva Subunit p67 Protein Vaccine
|
|
692
|
p7 |
Phleum pratense |
|
|
|
3367732
|
|
|
|
1K9U
|
CDD:238008
CDD:290234
GOA:O82040
InterPro: IPR002048
InterPro: IPR011992
InterPro: IPR018247
InterPro: IPR018248
InterPro: IPR018249
PDB: 1K9U
UniProtKB/UniProt: O82040 |
p7 protein |
Protective antigen |
|
|
4314
|
p72 |
African Swine Fever Virus |
|
|
|
AGW82377
|
|
|
|
|
CDD:282327 |
P72 |
Protective antigen |
|
|
1062
|
P97 |
Mycoplasma hyopneumoniae 232 |
|
3105444
|
|
54020389
|
mhp183 |
AE017332 |
YP_115696 |
|
|
protein p97; cilium adhesin |
Protective antigen |
rAd-P97c
|
|
1640
|
PA |
Bacillus anthracis str. H9401 |
|
12796252
|
|
386733821
|
H9401_5741 |
CP002093 |
YP_006204206 |
|
|
Phosphoesterase PA-phosphatase related protein |
Protective antigen |
|
|
1391
|
PA63 |
synthetic construct derived from Bacillus anthracis |
|
|
|
193873769
|
|
|
|
|
CDD:281492 |
PA63 |
Protective antigen |
B. anthracis DNA vaccine pPA63-Native
|
|
1394
|
PA63-LAMP1 |
synthetic construct derived from Bacillus anthracis |
|
|
|
193873761
|
|
|
|
|
CDD:281492
CDD:213052 |
PA63-LAMP1 |
Protective antigen |
B. anthracis DNA vaccine pLAMP1-PA63
|
|
1397
|
PA83 |
synthetic construct |
|
|
|
40646953
|
|
|
AAR88321.1 |
|
CDD:284994
CDD:281492 |
protective antigen PA83 |
Protective antigen |
B. anthracis DNA vaccine pDNA encoding PA
B. anthracis DNA vaccine PA83 furin
|
|
4509
|
PAEP |
Homo sapiens |
|
5047
|
|
937226996
|
|
AL354761 |
NP_001018058 |
|
|
transcript variant X8 |
Protective antigen |
HLA-Matched Donor Mononuclear Cell-Enriched Leukocytes Apocell Vaccine
|
|
374
|
pagA |
Bacillus anthracis |
VO_0011029
|
|
|
9280533
|
|
|
|
1ACC
|
ATCC:14185
CDD:311565
CDD:281492 |
protective antigen |
Protective antigen |
B. anthracis DNA vaccine PA
B. anthracis DNA vaccine pSecTag PA83 encoding PA
B. anthracis DNA vaccine pIMS-120 encoding PA
B. anthracis DNA vaccine pCPA
B. anthracis DNA Vaccine expressing PA
pCMV/ER-PA83
rLAG- PA-DCpep
|
|
3903
|
pagA |
Bacillus anthracis |
|
|
|
BAD14937
|
|
|
|
|
CDD:281492 |
pagA |
Protective antigen |
|
|
32
|
PagA from B. anthracis str. 'Ames Ancestor' |
Bacillus anthracis str. 'Ames Ancestor' |
VO_0010872
|
2820165
|
|
47566476
|
GBAA_pXO1_0164 |
AE017336 |
YP_016495 |
1ACC
|
|
protective antigen |
Protective antigen |
RV G-PA chimera
Anthrax Spore Vaccine
Recombinant PA domain 1
DAAV using PA and PGA
Recombiant PA domain 1-3
Recombinant PA domain 4
DNA vaccine encoding PA (PA63)
pCLF4
rPA-(γ-d-glutamate)5–20 synthetic peptide conjugate
DNA vaccine encoding PA83 and LF
|
|
164
|
PagA from Bacillus anthracis |
Bacillus anthracis str. 'Ames Ancestor' |
|
2820165
|
|
47566476
|
GBAA_pXO1_0164 |
NC_007322.2 |
YP_016495.2 |
|
|
protective antigen |
|
Multivalent DNA vaccine for B. anthracis, Ebola virus, Marburg virus, and VEE virus
|
|
4570
|
PAGR1 |
Homo sapiens |
|
79447
|
|
13375654
|
|
AC009133 |
NP_078792 |
|
|
PAXIP1 associated glutamate rich protein 1 |
Protective antigen |
PA-1-STK Ovarian Carcinoma Vaccine
|
|
101
|
Pal |
Haemophilus influenzae 86-028NP |
VO_0010915
|
3429820
|
|
68248984
|
NTHI0501 |
CP000057 |
YP_248096 |
|
|
outer membrane protein P6 |
Protective antigen |
Non-typeable H. influenzae rLP4/rLP6 and Moraxella catarrhalis UspA2 protein vaccine
recombinant nontypeable H. influenzae protein P6 with AdDP
|
|
3952
|
palA |
Haemophilus parasuis SH0165 |
|
|
|
ACL31779
|
|
|
|
|
CDD:274307
CDD:143586 |
18K peptidoglycan-associated outer membrane lipoprotein, precursor PalA |
Protective antigen |
|
|
3898
|
PALFn |
Bacillus anthracis |
|
|
|
AKB95640
|
|
|
|
|
CDD:284994
CDD:281492
CDD:285037
CDD:286266
CDD:238144 |
PALFn |
Protective antigen |
|
|
910
|
panC |
Mycobacterium tuberculosis H37Rv |
|
885459
|
|
15610738
|
Rv3602c |
BX842583 |
NP_218119 |
|
|
pantoate--beta-alanine ligase |
Virmugen |
Mycobacterium tuberculosis panCD mutant vaccine
Mycobacterium tuberculosis RD1/panCD mutant vaccine
|
|
911
|
panD |
Mycobacterium tuberculosis H37Rv |
|
885596
|
|
15610737
|
Rv3601c |
BX842583 |
NP_218118 |
|
|
aspartate alpha-decarboxylase |
Virmugen |
Mycobacterium tuberculosis panCD mutant vaccine
Mycobacterium tuberculosis RD1/panCD mutant vaccine
|
|
1352
|
PAP |
Mus musculus |
|
56318
|
|
46575784
|
|
AC127422 |
NP_062781 |
|
|
transcript variant 1 |
Protective antigen |
Prostate cancer DNA vaccine psig-3P-Fc encoding 3P(hPSM, hPAP, or hPSA)-Fc fusion protein
|
|
1305
|
Pap antigen |
Homo sapiens |
|
55
|
|
6382064
|
|
AC020633 |
NP_001090 |
|
|
transcript variant 2 |
Other |
pTVG-HP Plasmid DNA Vaccine
|
|
764
|
par1 |
|
VO_0011301
|
|
|
2209137
|
|
|
|
|
CDD:282940 |
paraflagellar rod component |
Protective antigen |
T. cruzi PAR1 Protein Vaccine
|
|
4381
|
paraflagellar rod protein 3 |
Trypanosoma cruzi |
|
3540497
|
|
71415533
|
|
AAHK01000953 |
XP_809830 |
|
CDD:240364
InterPro: IPR007824
PFAM:PF05149 |
paraflagellar rod protein 3, putative |
Protective antigen |
|
|
1362
|
Paramyosin |
Schistosoma japonicum |
|
|
|
4761226
|
|
|
|
|
CDD:278467
CDD:283846 |
paramyosin |
Protective antigen |
Chinese S. japonicum DNA vaccine pCMV-Sjc97 encoding paramyosin
|
|
4163
|
pavB |
Streptococcus pneumoniae |
|
|
|
EJH25875
|
|
|
|
|
|
pavB protein |
Protective antigen |
|
|
4571
|
PAX3 |
Homo sapiens |
|
5077
|
|
6654638
|
|
AC010980 |
NP_000429 |
|
|
transcript variant PAX3I |
Protective antigen |
PAX3/FKHR Peptide Vaccine
|
|
896
|
pcm |
|
|
|
|
224483370
|
|
|
|
|
CDD:100107 |
Pcm |
Virmugen |
Yersinia pestis pcm mutant vaccine
|
|
4155
|
pcpA |
Streptococcus pneumoniae |
|
|
|
WP_130894716
|
|
|
|
|
CDD:315882
CDD:275383
CDD:227588 |
choline-binding protein PcpA |
Protective antigen |
|
|
844
|
PcrV |
Pseudomonas aeruginosa PAO1 |
VO_0012361
|
882997
|
|
15596903
|
PA1706 |
AE004091 |
NP_250397 |
|
|
type III secretion protein PcrV |
Protective antigen |
P. aeruginosa PcrV Protein Vaccine
P. aeruginosa DNA vaccine pGACAG-PcrV
P. aeruginosa DNA vaccine pGACAG-OprF/OprI + pGACAG-PcrV + pGACAG-PilA
|
|
4206
|
pcsB |
Streptococcus agalactiae |
|
|
|
CAC28144
|
|
|
|
|
CDD:226400
CDD:226451
InterPro: IPR007921
InterPro: IPR009148
UniProtKB/TrEMBL: Q9AKA4 |
PcsB protein |
Protective antigen |
|
|
4815
|
PDCD1 |
Homo sapiens |
|
5133
|
|
167857792
|
|
AC131097 |
NP_005009 |
|
|
transcript variant X1 |
Protective antigen |
MiHA-loaded PD-L1/L2-silenced Dendritic Cell Vaccine
|
|
1387
|
Pdgfrb |
Mus musculus |
|
18596
|
|
226342982
|
|
AC124448 |
NP_001139740 |
|
|
transcript variant 1 |
Protective antigen |
|
|
606
|
PDI |
Neospora caninum |
VO_0011191
|
13441704
|
|
82568727
|
|
|
|
|
CDD:240266
CDD:294274
CDD:239259
CDD:239280
CDD:239293 |
protein disulfide isomerase |
Protective antigen |
N. caninum NcPDI Protein Vaccine
|
|
1077
|
PE2 |
Venezuelan equine encephalitis virus |
|
|
|
229558446
|
|
|
|
|
CDD:190039
CDD:109978 |
PE2 |
Virmugen |
VEE Virus PE2/E1 mutant vaccine
|
|
1078
|
PE2 |
Western equine encephalomyelitis virus |
|
|
|
90811336
|
|
|
|
|
CDD:109979
CDD:190039
CDD:109978
CDD:144979 |
structural polyprotein |
Virmugen |
Western equine encephalomyelitis virus PE2/E1 mutant vaccine
Western equine encephalomyelitis virus PE2/E2 mutant virus
|
|
819
|
PE20 |
Mycobacterium tuberculosis H37Rv |
VO_0012371
|
885537
|
|
57116919
|
Rv1806 |
JLDD01000021 |
YP_177843 |
|
|
PE family protein PE20 |
Protective antigen |
DNA vaccine Rv1806-1807
|
|
397
|
peb1A |
Campylobacter jejuni |
VO_0011045
|
|
|
112360246
|
|
|
|
2V25
|
CDD:183381
EnsemblGenomes-Gn:Cj0921c
EnsemblGenomes-Tr:CAL35041
GOA:Q0P9X8
InterPro: IPR001638
InterPro: IPR018313
PDB: 2V25 |
aspartate/glutamate-binding ABC transporter protein |
Protective antigen |
C. jejuni DNA vaccine pcDNA3.1(+)-peblA
|
|
794
|
PEP1 |
Coccidioides posadasii |
VO_0011325
|
|
|
73915320
|
|
|
|
|
CDD:299705
CDD:278455
CDD:133137 |
aspartyl protease 1 |
Protective antigen |
|
|
123
|
PepA |
Mycobacterium tuberculosis H37Rv |
VO_0010953
|
886924
|
|
15607267
|
Rv0125 |
CP003248 |
NP_214639 |
|
|
serine protease PepA |
Protective antigen |
Mtb72f fusion protein
|
|
4830
|
PEPCK |
Leishmania major strain Friedlin |
|
5649768
|
|
157865574
|
LMJF_11_0260 |
FR796407 |
XP_001681494 |
|
|
|
Protective antigen |
L. major synthetic DNA vaccine IDM2
|
|
4207
|
peptidase M15 |
Streptococcus agalactiae |
|
|
|
ASI65231
|
|
|
|
|
CDD:224600 |
peptidase M15 |
Protective antigen |
|
|
874
|
pfCelTOS |
|
|
811213
|
AB194052.1
|
62954730
|
|
|
|
|
CDD:163532 |
PF cell-traversal protein |
Protective antigen |
P. falciparum pfCelTos protein vaccine
FMP012 with AS01B adjuvant system
|
|
639
|
Pfen |
Plasmodium falciparum 3D7 |
VO_0011223
|
810313
|
|
124802328
|
PF3D7_1015900 |
LN999944 |
XP_001347440 |
|
|
|
Protective antigen |
P. falciparum Pfen Protein Subunit Vaccine
|
|
3944
|
pflA |
Haemophilus parasuis |
|
|
|
AMW15937
|
|
|
|
|
CDD:182994
CDD:302752
CDD:100105 |
pyruvate formate lyase-activating enzyme 1 |
Protective antigen |
|
|
4838
|
PfP0 |
|
|
810860
|
|
EWC88043.1
|
|
|
|
|
CDD:240285
CDD:240221 |
60S acidic ribosomal protein P0 |
Protective antigen |
PfP0 P-BSA
|
|
140
|
Pfs230 |
|
|
812682
|
|
|
|
|
|
|
|
PFB0405w, transmission-blocking target antigen s230 precursor |
Protective antigen |
Plasmodium DNA vaccine encoding Pfs230 using GPI anchor signal sequence
Pfs230D1-EPA/Matrix-M
|
|
4822
|
Pfs25 from P. falciparum 3D7 |
Plasmodium falciparum 3D7 |
|
810460
|
|
124802764
|
PF3D7_1031000 |
LN999944 |
XP_001347587 |
|
|
|
Protective antigen |
Pfs25-IMX313/Matrix-M
NYVAC-Pf7
Pfs25-EPA / AS01
Pfs25-EPA/Alhydrogel
Pfs25 VLP-FhCMB
Pfs25/ Montanide ISA 51
ChAd63/MVA Pfs25-IMX313
|
|
4833
|
Pfs48/45 |
|
|
814212
|
|
AHA91190.1
|
|
|
|
|
CDD:173430 |
Pfs48/45 |
Protective antigen |
Pfs48/45 in Matrix-M
|
|
4883
|
PGAM2 |
Toxoplasma gondii ME49 |
|
7898971
|
|
1084907167
|
TGME49_297060 |
CM002036 |
XP_002371136 |
|
|
|
Protective antigen |
rTgPGAM 2
|
|
955
|
pgk |
Brucella melitensis biovar Abortus 2308 |
|
3788256
|
|
82700518
|
BAB1_1742 |
AM040264 |
YP_415092 |
|
|
phosphoglycerate kinase |
Virmugen |
Brucella abortus pgk mutant vaccine
|
|
978
|
pgm |
Brucella melitensis biovar Abortus 2308 |
|
3788847
|
|
82698981
|
BAB1_0055 |
AM040264 |
YP_413555 |
|
|
phosphoglucomutase |
Virmugen |
Brucella abortus pgm mutant vaccine
|
|
47
|
Pgm phosphoglucomutase |
Yersinia pestis CO92 (strain: CO92, biovar: Orientalis) |
|
1175516
|
|
|
YPO2686 |
|
|
|
|
|
|
Pgm-
|
|
4051
|
pGP4-D |
Chlamydia muridarum str. Nigg |
|
|
|
Q46440
|
|
|
|
|
CDD:235774 |
Virulence plasmid protein pGP4-D |
Protective antigen |
|
|
688
|
phl p I |
Phleum pratense |
|
|
|
473360
|
|
|
|
1N10
|
CDD:165628
CDD:281341
CDD:279671
GOA:P43213
InterPro: IPR005795
InterPro: IPR007112
InterPro: IPR007117
InterPro: IPR007118
InterPro: IPR009009
InterPro: IPR014733
PDB: 1N10
UniProtKB/UniProt: P43213 |
Phl p I allergen |
Protective antigen |
|
|
249
|
PhoP |
Mycobacterium tuberculosis H37Rv |
|
888772
|
|
15607897
|
Rv0757 |
BX842574 |
NP_215271 |
3R0J
|
|
two component system response transcriptional positive regulator PHOP |
Virmugen |
M. tuberculosis phoP mutant SO2
|
|
730
|
PhoP |
Salmonella enterica subsp. enterica serovar Typhi str. Ty2 |
|
1071307
|
|
29142123
|
t1689 |
AE014613 |
NP_805465 |
|
|
DNA-binding transcriptional regulator PhoP |
Virmugen |
Salmonella Typhi phoP mutant vaccine
|
|
1079
|
phoP |
Yersinia pseudotuberculosis IP 32953 |
|
2956268
|
|
51596756
|
YPTB2434 |
BX936398 |
YP_070947 |
|
|
DNA-binding transcriptional regulator PhoP |
Virmugen |
Yersinia pseudotuberculosis phoP mutant vaccine
|
|
836
|
phpA |
Streptococcus pneumoniae |
VO_0012383
|
|
|
NP_358654
|
|
|
|
|
CDD:273578
CDD:282170
CDD:293251 |
histidine motif-containing protein |
Protective antigen |
S. pneumoniae PhpA-79 Protein Vaccine
|
|
4159
|
phtB |
Streptococcus pneumoniae |
|
|
|
KPL42694
|
|
|
|
|
CDD:273578; CDD:282170; CDD:293251; CDD:114603 |
pneumococcal histidine triad protein B |
Protective antigen |
|
|
4156
|
PhtD |
Streptococcus pneumoniae |
|
|
|
WP_000700338
|
|
|
|
|
CDD:273578
CDD:309414 |
pneumococcal histidine triad protein PhtD |
Protective antigen |
|
|
4160
|
phtE |
Streptococcus pneumoniae |
|
|
|
CKA60496
|
|
|
|
|
CDD:331999
CDD:309414 |
pneumococcal histidine triad protein E |
Protective antigen |
|
|
4346
|
PI1 |
Toxoplasma gondii |
|
7901030
|
|
ADJ17341
|
|
|
|
|
CDD:238052 |
serine protease inhibitor 1 isoform beta |
Protective antigen |
|
|
623
|
PiaA |
Streptococcus pneumoniae D39 |
VO_0011207
|
4442863
|
|
WP_000731179
|
SPD_0226 |
CP000410 |
YP_815744 |
|
CDD:328725 |
extracellular solute-binding protein |
Protective antigen |
S. pneumoniae PiaA Protein Vaccine
|
|
1665
|
pilA |
Pseudomonas aeruginosa PAO1 |
|
|
|
15599721
|
|
|
|
|
CDD:227304 |
type 4 fimbrial protein PilA |
Protective antigen |
P. aeruginosa DNA vaccine pGACAG-OprF/OprI + pGACAG-PcrV + pGACAG-PilA
|
|
3878
|
pilA |
Pseudomonas aeruginosa |
|
|
|
AAK68046
|
|
|
|
|
CDD:227304
CDD:278540 |
PilA |
Protective antigen |
|
|
3879
|
pilA |
Pseudomonas aeruginosa |
|
|
|
AAC60462
|
|
|
|
|
CDD:227304
CDD:290278
CDD:278540 |
pilin |
Protective antigen |
|
|
4403
|
PiuA |
|
|
|
|
WP_000724932
|
|
|
|
|
CDD:270428
CDD:278898 |
amino acid ABC transporter substrate-binding protein |
Protective antigen |
|
|
439
|
PknD |
Chlamydophila pneumoniae CWL029 |
VO_0010894
|
895704
|
|
161353778
|
CPn0095 |
AE001363 |
NP_224303 |
|
|
serine/threonine protein kinase |
Protective antigen |
C. pneumoniae DNA vaccine encoding PknD
|
|
48
|
Pla |
Yersinia pestis CO92 |
VO_0010877
|
1172643
|
|
16082686
|
YPPCP1.07 |
AL109969 |
NP_395233 |
2X56
|
|
outer membrane protease |
Protective antigen |
Pla
|
|
796
|
PLB |
Coccidioides posadasii |
VO_0011327
|
|
|
74486661
|
|
|
|
|
CDD:214474
CDD:132842 |
phospholipase B |
Protective antigen |
|
|
922
|
plcB |
Listeria monocytogenes EGD-e |
|
987036
|
|
16802251
|
lmo0205 |
AL591974 |
NP_463736 |
|
|
phospholipase C |
Virmugen |
Listeria monocytogenes actA/plcB mutant vaccine
|
|
4876
|
PLP1 |
|
|
7894496
|
|
EPT30053.1
|
|
|
|
|
CDD:240433 |
perforin-like protein PLP1 |
Protective antigen |
|
|
3955
|
plpA |
Haemophilus parasuis SH0165 |
|
|
|
ACL32115
|
|
|
|
|
CDD:304360
CDD:270316 |
ABC-type metal ion transport system, periplasmic component/outer membrane lipoprotein 1 precursor |
Protective antigen |
|
|
607
|
Ply |
Streptococcus pneumoniae D39 |
VO_0011192
|
4441611
|
|
116515376
|
SPD_1726 |
CP000410 |
YP_817150 |
|
|
pneumolysin |
Protective antigen |
|
|
4404
|
PlyD1 |
|
|
|
|
|
|
|
|
|
|
|
Protective antigen |
S. pneumoniae detoxified PlyD1 Protein Vaccine
|
|
4408
|
PMEL - OBSOLETE |
Homo sapiens |
|
6490
|
|
318037593
|
|
AC025162 |
NP_001186982 |
|
|
transcript variant 3 |
Protective antigen |
HLA-A*0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide Vaccine
gp100:280-288(288V) Peptide Vaccine
|
|
4534
|
PMEL - obsolete |
Homo sapiens |
|
6490
|
|
318037593
|
|
AC025162 |
NP_001186982 |
|
|
transcript variant 3 |
Protective antigen |
Synthetic Melanoma-Associated Antigens Vaccine
|
|
1687
|
Pmel17 |
Mus musculus |
|
20431
|
|
31981217
|
|
AC117232 |
NP_068682 |
|
|
transcript variant X1 |
Protective antigen |
Melanoma DNA vaccine VR1012/mPmel17
Mouse gp100 Plasmid DNA Vaccine
|
|
801
|
pmp1 |
Coccidioides posadasii |
VO_0011332
|
|
|
78364922
|
|
|
|
|
CDD:239311 |
peroxisomal matrix protein |
Protective antigen |
C. posadasii Subunit PMP1 Protein Vaccine
|
|
4033
|
pmp10 |
Chlamydophila pneumoniae |
|
|
|
CRI40334
|
|
|
|
|
CDD:273587
CDD:284879
CDD:214872 |
Probable outer membrane protein pmp10 |
Protective antigen |
|
|
4032
|
pmp2 |
Chlamydophila pneumoniae |
|
|
|
CRI32508
|
|
|
|
|
CDD:273587
CDD:284879
CDD:214872 |
Probable outer membrane protein pmp2 |
Protective antigen |
|
|
4039
|
pmpD |
Chlamydia trachomatis |
|
|
|
AAK69391
|
|
|
|
|
CDD:311484
CDD:309066 |
polymorphic membrane protein D |
Protective antigen |
|
|
4046
|
pmpE |
Chlamydia muridarum str. Nigg |
|
|
|
Q9PL47
|
|
|
|
|
CDD:330218
CDD:311484
CDD:214872 |
Probable outer membrane protein PmpE |
Protective antigen |
|
|
438
|
PmpE/F-2 |
Chlamydia muridarum str. Nigg |
VO_0010893
|
1246432
|
|
497915819
|
TC_RS01330 |
AE002160 |
WP_010229975 |
|
|
autotransporter domain-containing protein |
Protective antigen |
C. muridarum PmpE/F-2 protein vaccine
|
|
436
|
PmpG-1 |
Chlamydia muridarum str. Nigg |
VO_0010891
|
1246433
|
|
497915821
|
TC_RS01335 |
AE002160 |
WP_010229977 |
|
|
Pmp family polymorphic membrane protein autotransporter adhesin |
Protective antigen |
C. muridarum PmpG-1 protein vaccine
|
|
4048
|
pmpH |
Chlamydia muridarum str. Nigg |
|
|
|
Q9PL44
|
|
|
|
|
CDD:273587
CDD:311484
CDD:214872 |
Probable outer membrane protein PmpH |
Protective antigen |
|
|
1271
|
pol |
Human immunodeficiency virus 1 |
|
|
|
7021456
|
|
|
|
|
CDD:278505
CDD:133149
CDD:238823
CDD:278506
CDD:284283
CDD:284281
CDD:278503
CDD:259998
CDD:280240
CDD:279057 |
pol |
Protective antigen |
DNA vaccine expressing multiple HIV epitopes
|
|
1710
|
pol |
Simian-Human immunodeficiency virus strain SHIV-89.6 |
|
|
|
2828038
|
|
|
|
|
CDD:133149
CDD:295487
CDD:278506
CDD:238185
CDD:284283
CDD:284281
CDD:278503
CDD:259998
CDD:280240
CDD:279057
CDD:278951 |
pol |
Protective antigen |
HIV DNA vaccine SHIV-89.6 DNA (DNA/89.6)
|
|
1269
|
pol from subtype B |
Human immunodeficiency virus 1 |
|
|
|
108860386
|
|
|
|
|
CDD:133149
CDD:73152
CDD:200982
CDD:115473
CDD:203523
CDD:209893
CDD:187690
CDD:202092
CDD:207376
CDD:144223 |
Pol |
Other |
|
|
1245
|
Pol SIV |
Simian immunodeficiency virus SIV-mnd 2 |
|
956107
|
|
27311168
|
Siv2gp2 |
AF367411 |
NP_758887 |
|
|
pol protein |
Other |
HIV recombinant vector vaccine FPV-SIVgag/pol-IFN-γ encoding SIV gag and pol
HIV DNA vaccine pHIS-SHIV-B
HIV DNA vaccine SIVmac239 Gag-Pol-Nef and mock Env with rAd5 boost
rMVTT-SIV-gpe
|
|
151
|
POLS_EEVVT Structural polyprotein (p130) |
Venezuelan equine encephalitis virus (strain Trinidad donkey) |
|
|
|
109940317
|
|
|
|
|
GI:109940317;Swissprot:POLS_EEVVT; Swissprot:P09592; |
Structural polyprotein (p130) |
|
Defective adenovirus expressing VEEV E2 glycoprotein
|
|
4900
|
POLY |
Yellow fever virus |
|
1502173
|
|
9627245
|
YFVgp1 |
X03700 |
NP_041726 |
|
|
mRNA |
Protective antigen |
Dengvaxia
|
|
4901
|
POLY |
Dengue virus 2 |
|
1494449
|
|
159024209
|
DENV_gp1 |
KU725663 |
NP_056776 |
|
|
polyprotein |
Protective antigen |
|
|
4902
|
POLY |
Dengue virus 1 |
|
5075725
|
|
9626686
|
DV1_gp1 |
U88536 |
NP_059433 |
|
|
polyprotein |
Protective antigen |
|
|
4903
|
POLY |
Dengue virus 4 |
|
5075729
|
|
12084823
|
DV4_gp1 |
AF326825 |
NP_073286 |
|
|
polyprotein |
Protective antigen |
|
|
1264
|
Polymerase protein |
Human immunodeficiency virus 1 |
|
|
|
6715123
|
|
|
|
|
CDD:133149
CDD:207741
CDD:200982
CDD:73150
CDD:115473 |
polymerase |
Other |
|
|
418
|
pomp90A |
Chlamydophila abortus |
VO_0011058
|
|
|
187438939
|
|
|
|
|
CDD:273587 |
polymorphic outer membrane protein 90A |
Protective antigen |
C. abortus DNA vaccine Pomp90A
|
|
3891
|
popB |
Pseudomonas aeruginosa |
|
|
|
AAC45937
|
|
|
|
|
CDD:227900
CDD:279450 |
PopB |
Protective antigen |
|
|
873
|
PorA |
Campylobacter jejuni subsp. jejuni NCTC 11168 = ATCC 700819 |
|
905550
|
|
218562871
|
Cj1259 |
AL111168 |
YP_002344650 |
|
|
major outer membrane protein |
Protective antigen |
C. jejuni PorA protein vaccine
|
|
3829
|
Porin |
Yersinia pseudotuberculosis |
|
|
|
WP_050103071
|
|
|
|
|
CDD:304382
CDD:290340
CDD:238208 |
porin OmpF2 |
Protective antigen |
|
|
4094
|
potD2 |
Actinobacillus pleuropneumoniae |
|
|
|
ABN73472
|
|
|
|
|
CDD:330233 |
spermidine/putrescine-binding periplasmic protein 1 precursor |
Protective antigen |
|
|
769
|
PotF |
Burkholderia pseudomallei K96243 |
VO_0010922
|
3095748
|
|
53721504
|
BPSS0467 |
BX571966 |
YP_110489 |
|
|
ABC transporter substrate-binding protein |
Protective antigen |
B. pseudomallei Subunit PotF Protein Vaccine
|
|
4076
|
PotF |
Burkholderia pseudomallei |
|
|
|
APZ24542
|
|
|
|
|
CDD:270377 |
spermidine/putrescine ABC transporter substrate-binding protein PotF |
Protective antigen |
|
|
1022
|
poxA |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1255870
|
|
16767593
|
STM4344 |
AE006468 |
NP_463208 |
3G1Z
|
|
lysyl-tRNA synthetase |
Virmugen |
Salmonella Typhimurium poxA mutant vaccine
|
|
4327
|
pp65 |
Human cytomegalovirus |
|
|
|
AAA45994
|
|
|
|
|
CDD:283448 |
pp65 |
Protective antigen |
|
|
4440
|
pp65 |
Mus musculus |
|
18826
|
|
350606354
|
|
AC129591 |
NP_001234913 |
|
|
transcript variant X5 |
Protective antigen |
PEP-CMV Vaccine
|
|
822
|
PPE14 |
Mycobacterium tuberculosis H37Rv |
VO_0012374
|
885069
|
|
57116795
|
Rv0915c |
AL123456 |
YP_177765 |
|
|
PPE family protein PPE14 |
Protective antigen |
|
|
124
|
PPE18 |
Mycobacterium tuberculosis H37Rv |
VO_0010954
|
886073
|
|
57116841
|
Rv1196 |
AL123456 |
YP_177795 |
|
|
PPE family protein PPE18 |
Protective antigen |
Mtb72f fusion protein
|
|
820
|
PPE31 |
Mycobacterium tuberculosis H37Rv |
VO_0012372
|
885072
|
|
WP_003409179
|
Rv1807 |
AL123456 |
YP_177653 |
|
CDD:227938 |
PPE family protein |
Protective antigen |
DNA vaccine Rv1806-1807
|
|
4398
|
PPE42 |
Mycobacterium tuberculosis H37Rv |
|
|
|
YP_177893
|
|
|
|
|
CDD:307116
CDD:279771
CDD:311933 |
PPE family protein PPE42 |
Protective antigen |
ID93/GLA-SE
|
|
802
|
pra |
Coccidioides immitis |
VO_0011333
|
|
|
42742528
|
|
|
|
|
CDD:128986
CDD:282710 |
proline-rich antigen |
Protective antigen |
C. posadasii DNA Vaccine encoding PRA Protein
|
|
4646
|
PRAME |
Homo sapiens |
|
23532
|
|
619328985
|
|
AC246793 |
NP_001278644 |
|
|
transcript variant 2 |
Protective antigen |
DNA Vector pPRA-PSM Vaccine
Anti-PRAME Immunotherapeutic GSK2302032A Vaccine
|
|
559
|
PreM |
Japanese encephalitis virus |
VO_0011150
|
|
|
14600066
|
|
|
|
|
CDD:279856
CDD:279358 |
preM protein |
Protective antigen |
|
|
4263
|
premembrane protein |
Japanese encephalitis virus |
|
|
|
ACI16478
|
|
|
|
|
CDD:279856 |
premembrane protein |
Protective antigen |
|
|
1703
|
PreS2+S (Middle protein) |
Hepatitis B virus strain ayw |
|
|
|
71794216
|
|
|
|
|
CDD:279085 |
|
Protective antigen |
Hepatitis B DNA vaccine pCMV-S2.S encoding the HBV(ayw Strain) envelope protein.
|
|
555
|
PrM |
Japanese encephalitis virus |
VO_0011146
|
|
|
90019439
|
|
|
|
|
CDD:279856 |
PrM |
Protective antigen |
Japanese encephalitis virus DNA vaccine encoding E protein
Japanese encephalitis virus DNA vaccine encoding PrM
NYVAC-JEV- prM/E/ NS1
|
|
592
|
PrM |
West Nile virus |
VO_0011179
|
5714902
|
|
158516888
|
WNVNY99_gp1 |
DQ211652 |
YP_001527877 |
|
|
mRNA |
Protective antigen |
West Nile virus DNA vaccine pCBWN encoding prM and E
ALVAC-WNV-PrM/E (dogs and cats)
|
|
1380
|
prM from Dengue virus 1 |
Dengue virus 1 |
|
|
|
18308046
|
|
|
|
|
CDD:279856
CDD:279358 |
premembrane |
Protective antigen |
Dengue virus DNA vaccine D1ME encoding prM and E
Dengue Virus DNA Vaccine D1ME-VRP
Dengvaxia
|
|
1378
|
prM from Dengue virus 2 |
Dengue virus 2 |
|
|
|
18308058
|
|
|
|
|
CDD:279856
CDD:279358 |
premembrane |
Protective antigen |
Dengue virus DNA vaccine sA encoding prM and E from Dengue Virus 4
Dengue virus DNA vaccine sC encoding prM and E
Dengue virus DNA vaccine sABC encoding prM and E
Dengue virus DNA vaccine 1040D2MEL encoding dengue-2 prM-E-LAMP chimeric protein
Dengue virus DNA vaccine p1012D2ME encoding prM and E from DEN 2 New Guinea C strain
Dengvaxia
|
|
1379
|
prM from Dengue virus 3 |
Dengue virus 3 |
|
|
|
18308070
|
|
|
|
|
CDD:279856
CDD:279358 |
premembrane |
Protective antigen |
Dengvaxia
|
|
784
|
prM from Dengue virus 4 |
|
VO_0011315
|
|
|
18308086
|
|
|
|
|
CDD:279856
CDD:279358 |
premembrane |
Protective antigen |
Dengue Vaccine using Vaccinia Virus expressing prM Protein
Dengue Virus DNA Vaccine expressing prM/E proteins
Dengvaxia
|
|
1323
|
PrM from West Nile Virus |
West Nile virus NY99 |
|
|
|
158516890
|
|
|
|
|
CDD:110567
CDD:201546
VBRC:36388 |
prM protein |
Other |
|
|
378
|
Prn |
Bordetella pertussis Tohama I |
VO_0011033
|
2664290
|
|
33592195
|
BP1054 |
BX470248 |
NP_879839 |
|
|
pertactin autotransporter |
Protective antigen |
B. pertussis DNA vaccine encoding Prn
|
|
4655
|
Prn |
Mus musculus |
|
111368
|
|
506326690
|
|
AL833794 |
NP_001265187 |
|
|
transcript variant 1 |
Protective antigen |
|
|
1248
|
pro |
Human immunodeficiency virus 1 |
|
|
|
19911446
|
|
|
|
|
CDD:133149 |
protease |
Other |
HIV DNA vaccine ALVAC-HIV encoding env, gag, and pro
HIV adnenovirus vector vaccine Ad28 encoding env, gag, and pro
|
|
690
|
PRO2 |
Phleum pratense |
|
|
|
3914432
|
|
|
|
|
CDD:238085 |
Profilin-2 |
Protective antigen |
Phleum pratense Allergy Phl p 12 Subunit Vaccine
|
|
907
|
proC |
Mycobacterium tuberculosis H37Rv |
|
887256
|
|
15607641
|
Rv0500 |
BX842573 |
NP_215014 |
|
|
pyrroline-5-carboxylate reductase |
Virmugen |
Mycobacterium tuberculosis proC mutant vaccine
|
|
4365
|
prohibitin |
Leishmania infantum |
|
5068054
|
|
XP_001464650
|
|
|
|
|
CDD:259799
GOA:A4HX59
InterPro: IPR000163
InterPro: IPR001107
UniProtKB/TrEMBL: A4HX59 |
prohibitin |
Protective antigen |
|
|
4753
|
PROM1 |
Homo sapiens |
|
8842
|
|
224994189
|
|
AC005598 |
NP_001139319 |
|
|
transcript variant X11 |
Protective antigen |
Autologous CD133-Positive BTSC mRNA-Pulsed Autologous Dendritic Cell Vaccine
CD133 Antigen Peptide-pulsed Autologous Dendritic Cell Vaccine
ICT-121 Dendritic Cell Vaccine
|
|
1348
|
Prostate specific antigen |
Mus musculus |
|
53320
|
|
228008369
|
|
AC099606 |
NP_001153178 |
|
|
transcript variant 2 |
Protective antigen |
Prostate cancer DNA vaccine pVax-PSA
Adenovirus-PSA Prostate Cancer Vaccine
|
|
1349
|
Prostate stem cell antigen |
Mus musculus |
|
72373
|
|
21312316
|
|
AC118022 |
NP_082492 |
|
|
prostate stem cell antigen |
Protective antigen |
Prostate cancer DNA vaccine PSCA-HSP encoding PSCA and HSP
Prostate cancer DNA vaccine encoding PSCA
Prostate cancer DNA vaccine pmPSCA encoding PSCA
|
|
1303
|
Prostate-specific membrane antigen |
Homo sapiens |
|
2346
|
|
62548858
|
GIG27 |
AC110742 |
NP_001014986 |
|
|
transcript variant 6 |
Protective antigen |
Prostate cancer DNA vaccine pDOM-PSMA27 encoding PSMA
Prostate cancer DNA vaccine hPSMAt encoding PSMA
Prostate cancer DNA vaccine psig-3P-Fc encoding 3P(hPSM, hPAP, or hPSA)-Fc fusion protein
Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201
Human Prostate-Specific Membrane Antigen Plasmid DNA Vaccine
APC8015F
DNA Vector pPRA-PSM Vaccine
Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101
Dendritic Cell-Recombinant Prostate-Specific Membrane Antigen Vaccine
Recombinant Vaccinia-PSA/PSMA Vaccine
Adenovirus-mediated Human Interleukin-12
|
|
1347
|
Prostate-specific membrane antigen |
Rattus norvegicus |
|
85309
|
|
17105334
|
|
AABR07071938 |
NP_476533 |
|
|
folate hydrolase 1 |
Protective antigen |
Prostate cancer DNA vaccine rPSMAt encoding PSMA
|
|
761
|
protein G4 |
Trypanosoma cruzi |
VO_0011298
|
|
|
52424038
|
|
|
|
|
|
protein G4 |
Protective antigen |
T. cruzi DNA Vaccine encoding G4 Protein
T. cruzi vaccine encoding TcG2 and TcG4
T. cruzi Vaccine TcVac4
|
|
4161
|
prtA |
Streptococcus pneumoniae |
|
|
|
NP_358155
|
|
|
|
|
CDD:310481
CDD:173801
CDD:240123
CDD:310703
CDD:273478 |
cell wall-associated serine proteinase PrtA |
Protective antigen |
|
|
742
|
PSA-2 |
Leishmania major |
VO_0011279
|
5649964
|
|
1129058
|
|
|
|
|
CDD:215061
CDD:275380 |
surface antigen 2 |
Protective antigen |
L. major PSA-2 Protein Vaccine
|
|
605
|
psaA |
Streptococcus pneumoniae |
VO_0011190
|
|
|
NP_359087
|
|
|
|
1PSZ
|
CDD:238557 |
ABC transporter substrate-binding protein - manganese transport |
Protective antigen |
S. pneumoniae RASV synthesizing PsaA
PsaA DNA Vaccine
|
|
4532
|
PSMB9 |
Homo sapiens |
|
5698
|
|
4506205
|
|
AL669918 |
NP_002791 |
|
|
proteasome 20S subunit beta 9 |
Protective antigen |
LMP-2:340-349 Peptide Vaccine
LMP-2:419-427 Peptide Vaccine
MVA-EBNA1/LMP2 Vaccine
|
|
351
|
Psn |
Yersinia pestis KIM10+ |
VO_0011014
|
1147351
|
|
22126288
|
y2404 |
AE009952 |
NP_669711 |
|
|
pesticin/yersiniabactin outer membrane receptor |
Protective antigen |
RASV expressing Y. pestis Psn
|
|
620
|
PspA |
Streptococcus pneumoniae D39 |
VO_0011204
|
4441373
|
|
116515876
|
SPD_0126 |
CP000410 |
YP_815641 |
|
|
surface protein A |
Protective antigen |
S. pneumoniae PspA Protein Vaccine
DNA vaccine expressing PspA
S. pneumoniae pspA-rBCG Vector Vaccine
|
|
4154
|
pspA |
Streptococcus pneumoniae |
|
|
|
AAF27715
|
|
|
|
|
CDD:299863 |
PspA |
Protective antigen |
|
|
4158
|
pspK |
Streptococcus pneumoniae |
|
|
|
AEV46781
|
|
|
|
|
CDD:303028 |
PspK |
Protective antigen |
|
|
613
|
psrP |
Streptococcus pneumoniae ATCC 700669 |
VO_0011197
|
7329552
|
|
221232510
|
SPN23F_17820 |
FM211187 |
YP_002511663 |
|
|
cell wall surface anchored protein |
Protective antigen |
|
|
865
|
PstS1 |
Mycobacterium tuberculosis H37Rv |
VO_0012407
|
885724
|
|
57116801
|
Rv0934 |
AL123456 |
YP_177770 |
1PC3
|
|
phosphate ABC transporter substrate-binding lipoprotein PstS |
Protective antigen |
|
|
818
|
PstS3 |
Mycobacterium tuberculosis H37Rv |
VO_0012370
|
885366
|
|
57116798
|
Rv0928 |
AL123456 |
YP_177768 |
|
|
phosphate ABC transporter substrate-binding lipoprotein PstS |
Protective antigen |
|
|
4737
|
PTPRC |
Homo sapiens |
|
5788
|
|
392306955
|
|
AF492459 |
NP_001254727 |
|
|
transcript variant 4 |
Protective antigen |
Allogeneic AML Antigen-expressing Dendritic Cell Vaccine
|
|
4771
|
PTTG1 |
Homo sapiens |
|
9232
|
|
538260592
|
|
AB505429 |
NP_001269311 |
|
|
transcript variant 2 |
Protective antigen |
Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine
|
|
379
|
PtxA |
Bordetella pertussis Tohama I |
VO_0011034
|
2665068
|
|
33594638
|
BP3783 |
BX470248 |
NP_882282 |
|
|
pertussis toxin subunit 1 |
Protective antigen |
B. pertussis PTx protein vaccine
|
|
384
|
ptxB |
Bordetella pertussis |
VO_0011037
|
|
|
225311180
|
|
|
|
|
CDD:308828
CDD:280986
GOA:C0MPK7
InterPro: IPR003899
InterPro: IPR005138
InterPro: IPR008992
InterPro: IPR016187
InterPro: IPR020063
UniProtKB/TrEMBL: C0MPK7 |
pertussis toxin subunit 2 precursor |
Protective antigen |
B. pertussis PTx protein vaccine
|
|
385
|
ptxC |
Bordetella pertussis |
VO_0011038
|
|
|
225311183
|
|
|
|
|
CDD:308828
CDD:280986
GOA:Q546I1
InterPro: IPR003899
InterPro: IPR005138
InterPro: IPR008992
InterPro: IPR016187
InterPro: IPR020063
UniProtKB/TrEMBL: Q546I1 |
pertussis toxin subunit 3 precursor |
Protective antigen |
B. pertussis PTx protein vaccine
|
|
377
|
ptxD |
Bordetella pertussis |
VO_0011032
|
|
|
225311181
|
|
|
|
|
CDD:286372
GOA:C0MPK8
InterPro: IPR008992
InterPro: IPR015355
UniProtKB/TrEMBL: C0MPK8 |
pertussis toxin subunit 4 precursor |
Protective antigen |
B. pertussis PTx protein vaccine
|
|
386
|
ptxE |
Bordetella pertussis |
VO_0011039
|
|
|
225311182
|
|
|
|
|
CDD:286373
GOA:C0MPK9
InterPro: IPR008992
InterPro: IPR015356
UniProtKB/TrEMBL: C0MPK9 |
pertussis toxin subunit 5 precursor |
Protective antigen |
B. pertussis PTx protein vaccine
|
|
1014
|
PurC/PurD |
Francisella tularensis subsp. holarctica LVS |
|
3952576
|
|
89255807
|
FTL_0396 |
AM233362 |
YP_513169 |
|
|
fusion protein PurC/PurD |
Virmugen |
Francisella tularensis purMCD mutant vaccine
|
|
939
|
purE |
Brucella melitensis bv. 1 str. 16M |
|
|
|
600729
|
BMEI0295 |
NZ_GG703781 |
NP_539212 |
|
CDD:200634 |
5'-phosphoribosyl-5-amino-4-imidazole carboxylase |
Virmugen |
B. melitensis WR201 (16MΔpurEK)
|
|
938
|
purF |
Francisella novicida U112 |
|
4548578
|
|
118498261
|
FTN_1700 |
CP000439 |
YP_899311 |
|
|
amidophosphoribosyltransferase |
Virmugen |
Francisella tularensis purF mutant vaccine
|
|
239
|
purK |
Brucella melitensis bv. 1 str. 16M |
|
|
|
20141763
|
|
|
|
|
CDD:180352
CDD:200773
CDD:194530 |
N5-carboxyaminoimidazole ribonucleotide synthase |
Virmugen |
B. melitensis WR201 (16MΔpurEK)
|
|
937
|
purM |
Burkholderia pseudomallei K96243 |
|
3092877
|
|
53720427
|
BPSL2818 |
BX571965 |
YP_109413 |
|
|
phosphoribosylaminoimidazole synthetase |
Virmugen |
Burkholderia pseudomallei purM mutant vaccine
|
|
1013
|
purM |
Francisella tularensis subsp. holarctica LVS |
|
3952575
|
|
89255806
|
FTL_0395 |
AM233362 |
YP_513168 |
|
|
phosphoribosylaminoimidazole synthetase |
Virmugen |
Francisella tularensis purMCD mutant vaccine
|
|
936
|
purN |
Burkholderia pseudomallei K96243 |
|
3092878
|
|
53718549
|
BPSL0908 |
BX571965 |
YP_107535 |
|
|
phosphoribosylglycinamide formyltransferase |
Virmugen |
Burkholderia pseudomallei purN mutant vaccine
|
|
4004
|
putative exoprotein-precursor |
Edwardsiella tarda EIB202 |
|
|
|
ACY84923
|
|
|
|
|
CDD:328937 |
putative exoprotein-precursor |
Protective antigen |
|
|
4005
|
putative flagellin associated protein |
Edwardsiella tarda EIB203 |
|
|
|
ACY84965
|
|
|
|
|
CDD:235867 |
putative flagellin associated protein |
Protective antigen |
|
|
4150
|
putative protease maturation proteinSpy1390 |
Streptococcus pyogenes M1 GAS |
|
|
|
NP_269488
|
|
|
|
|
CDD:179281 |
putative protease maturation protein |
Protective antigen |
|
|
4134
|
putative secreted protein SPy0019 |
Streptococcus pyogenes |
|
|
|
NP_268436
|
|
|
|
|
CDD:226400
CDD:226451 |
putative secreted protein |
Protective antigen |
|
|
4132
|
putative surface exclusion protein SPy0269 |
Streptococcus pyogenes |
|
|
|
ANC26552
|
|
|
|
|
CDD:330553
CDD:275124 |
putative surface exclusion protein |
Protective antigen |
|
|
4198
|
putative surface-anchored 5-nucleotidase |
Streptococcus equi subsp. Zooepidemicus |
|
|
|
CAW99100
|
|
|
|
|
CDD:223808
CDD:301300
CDD:277317
CDD:280945
EnsemblGenomes-Gn:SZO_08800
EnsemblGenomes-Tr:CAW99100
GOA:C0MEK3
InterPro: IPR004843
InterPro: IPR006146
InterPro: IPR006179
InterPro: IPR008334
InterPro: IPR019931
InterPro: IPR029052
UniProtKB/TrEMBL: C0MEK3 |
putative surface-anchored 5'-nucleotidase |
Protective antigen |
|
|
4145
|
putative transcriptional antiterminator (BglG family)SPy1325 |
Streptococcus pyogenes M1 GAS |
|
|
|
NP_269442
|
|
|
|
|
CDD:226234
CDD:224676
CDD:238129 |
putative transcriptional antiterminator (BglG family) |
Protective antigen |
|
|
490
|
PUUVsSgp1 |
Puumala orthohantavirus |
VO_0011088
|
2943083
|
|
38371721
|
PUUVsSgp1 |
HE801633 |
NP_941984 |
|
|
nucleocapsid protein |
Protective antigen |
Puumala virus PUUVsSgp1 (NP) protein vaccine
|
|
4823
|
PvCelTOS |
|
|
5476572
|
|
VUZ98878.1
|
|
|
|
|
CDD:408441 |
cell traversal protein for ookinetes and sporozoites |
Protective antigen |
Ad-protein PvCelTOS
Ad-MVA PvCelTOS
Ad-VLPs PvCelTOS
|
|
4831
|
PvDBPII |
|
|
5471431
|
|
ACJ54188.1
|
|
|
|
|
CDD:432515
CDD:140204 |
duffy binding surface protein region II |
Protective antigen |
PvDBPII/Matrix-M1
ChAd63 MVA PvDBP
PvRII/ AS02A
PvRII/ Montanide ISA 720
PvRII/​ Alhydrogel
|
|
4836
|
Pvs25 |
Plasmodium vivax |
|
5471385
|
|
156081935
|
PVX_111175 |
AAKM01002769 |
XP_001608460 |
|
|
|
Protective antigen |
P. vivax PVS25 with Montanide ISA-720
Pvs25-IMX313/Matrix-M1
Pvs25 mRNA–LNP
|
|
1028
|
PY01338 |
|
|
|
23485916
|
23485917
|
|
|
EAA20641.1 |
|
|
hypothetical protein |
Virmugen |
|
|
1083
|
Py36 |
Plasmodium yoelii 17XNL |
|
|
|
23479924
|
|
|
|
|
CDD:185624 |
p36 protein |
Virmugen |
P. yoelii p36/p52 mutant vaccine
|
|
1082
|
Py52 |
|
|
|
15193061
|
15193062
|
|
|
AAK91678.1 |
|
|
Py52 |
Virmugen |
P. yoelii p36/p52 mutant vaccine
|
|
354
|
pYV0055 |
Yersinia pseudotuberculosis IP 32953 |
VO_0011016
|
2952948
|
|
51593897
|
pYV0055 |
BX936399 |
YP_068464 |
|
|
yopB; Yop targeting protein |
Protective antigen |
|
|
648
|
RABVgp1 nucleoprotein N |
Rabies lyssavirus |
VO_0011232
|
1489853
|
|
9627198
|
RABVgp1 |
M13215 |
NP_056793 |
|
|
mRNA |
Protective antigen |
Rabies vaccine rVac-N
rORFV-RabG
|
|
4512
|
RANBP2 |
Homo sapiens |
|
5903
|
|
150418007
|
|
AC010095 |
NP_006258 |
|
|
transcript variant X1 |
Protective antigen |
HLA-A*0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide Vaccine
|
|
368
|
RAP-1 |
Babesia bovis T2Bo |
VO_0011026
|
5479143
|
|
156087004
|
BBOV_IV009870 |
AAXT01000002 |
XP_001610909 |
|
|
|
Protective antigen |
|
|
4953
|
Réunion Island isolate, structural polypeptide |
|
|
|
|
|
|
DQ443544.2 |
|
|
|
|
Protective antigen |
CAdVax-CHIK
|
|
4870
|
rcp |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1015
|
RD1 |
Mycobacterium tuberculosis H37Rv |
|
885777
|
|
15610750
|
Rv3614c |
BX842583 |
NP_218131 |
|
|
hypothetical protein |
Virmugen |
Mycobacterium tuberculosis RD1/panCD mutant vaccine
|
|
967
|
relA |
Salmonella enterica subsp. enterica serovar Gallinarum str. 287/91 |
|
6922678
|
|
205353902
|
SG2866 |
AM933173 |
YP_002227703 |
|
|
GDP/GTP pyrophosphokinase |
Virmugen |
Salmonella Gallinarum relA/spoT mutant vaccine
|
|
1067
|
relA |
Mycobacterium avium subsp. paratuberculosis K-10 |
|
2717869
|
|
41407145
|
MAP1047 |
AE016958 |
NP_959981 |
|
|
RelA |
Virmugen |
Mycobacterium avium relA mutant vaccine
|
|
144
|
RESA |
Plasmodium falciparum 3D7 |
VO_0010959
|
813159
|
|
124505681
|
PF3D7_0102200 |
AL844501 |
XP_001350954 |
|
|
RESA, ring-infected erythrocyte surface antigen, Pf155, MAL1P1.13 |
Protective antigen |
P. falciparum vaccine Combination B
|
|
1713
|
rev |
Simian-Human immunodeficiency virus strain SHIV-89.6 |
|
|
|
2828043
|
|
|
|
|
CDD:278833 |
rev |
Protective antigen |
HIV DNA vaccine SHIV-89.6 DNA (DNA/89.6)
|
|
1263
|
rev from HIV 1 |
Human immunodeficiency virus 1 |
|
155908
|
|
9629359
|
HIV1gp6 |
AF033819 |
NP_057854 |
|
|
Rev |
Protective antigen |
HIV recombinant vector vaccine MVA.HIVA encoding env and rev
DNA vaccine expressing multiple HIV epitopes
HIV DNA vaccine pHIS-SHIV-B
HIV priming with DNA vaccine expressing HIV gp160 protein and boosted with Ad5/35 vector expressing the same protein
|
|
1262
|
rev MN isolate |
Human immunodeficiency virus 1 MN |
|
|
|
3511264
|
|
|
|
|
CDD:189539 |
rev protein |
Other |
HIV DNA vaccine APL 400–003 encoding env and rev
HIV DNA vaccine pCMN160
|
|
4080
|
revA |
Borrelia burgdorferi |
|
|
|
NP_051318
|
|
|
|
|
CDD:309195 |
rev protein |
Protective antigen |
|
|
946
|
rfaF |
Neisseria meningitidis MC58 |
|
904029
|
|
15677379
|
NMB1527 |
AE002098 |
NP_274534 |
|
|
ADP-heptose:LPS heptosyltransferase II |
Virmugen |
Neisseria meningitidis rfaF/siaD mutant vaccine
|
|
930
|
rfaL |
Escherichia coli str. K-12 substr. MG1655 |
|
948148
|
|
16131493
|
b3622 |
U00096 |
NP_418079 |
|
|
O-antigen ligase |
Virmugen |
Escherichia coli rfaL mutant vaccine
|
|
957
|
rfc |
Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S |
|
|
|
267993210
|
|
|
|
|
CDD:33116
CDD:186638 |
O-antigen polymerase |
Virmugen |
Salmonella Typhimurium asd/rfc mutant vaccine
|
|
4834
|
RH5 |
Plasmodium falciparum 3D7 |
|
814549
|
|
124505127
|
PF3D7_0323400 |
AL844502 |
XP_001351305 |
|
CDD:240419 |
Reticulocyte-binding protein homolog 5 |
Protective antigen |
ChAd63-MVA RH5
PfRH5 DNA Vaccine
|
|
4634
|
RHD |
Homo sapiens |
|
6007
|
|
189095266
|
|
AB012623 |
NP_001121163 |
|
|
transcript variant X3 |
Protective antigen |
Synthetic Breast Cancer Peptides-Tetanus Toxoid-Montanide ISA-51 Vaccine
|
|
460
|
Rho |
Eimeria tenella |
VO_0011064
|
|
|
84043169
|
|
|
|
|
CDD:304416 |
rhomboid-like protein |
Protective antigen |
E. tenella vaccine rBCG pMV261-Rho
E. tenella vaccine rBCG pMV361-Rho
|
|
860
|
rib |
Streptococcus agalactiae strain BM110 |
VO_0012403
|
|
|
1620648
|
|
|
|
|
CDD:309682
CDD:312387
CDD:323788
CDD:307064 |
surface protein Rib |
Protective antigen |
S. agalactiae Rib Protein Vaccine
|
|
4363
|
ribosomal protein L3 |
Leishmania major |
|
5655063
|
|
AAY51372
|
|
|
|
|
CDD:240267
CDD:294230 |
ribosomal protein L3 |
Protective antigen |
|
|
4364
|
ribosomal protein L5 |
Leishmania major |
|
12982412
|
|
XP_003722581
|
|
|
|
|
CDD:240254
CDD:279233
CDD:238246
CDD:290906
GOA:E9AF09
InterPro: IPR005484
InterPro: IPR005485
InterPro: IPR025607
UniProtKB/TrEMBL: E9AF09 |
putative 60S ribosomal protein L5 |
Protective antigen |
|
|
778
|
Ricin A chain |
|
|
|
|
269979609
|
|
|
|
3BJG
|
CDD:278586 |
ricin A chain |
Protective antigen |
|
|
237
|
RL3382 |
Rhizobium leguminosarum bv. viciae 3841 |
|
4399754
|
|
116253124
|
RL3382 |
NC_008380 |
YP_768962 |
|
|
putative outer membrane protein related to bp26 antigen of Brucella |
|
B. melitensis with deleted bp26 (CGV26)
|
|
4808
|
RNF43 |
Homo sapiens |
|
54894
|
|
770075665
|
|
AC004687 |
NP_001292473 |
|
|
transcript variant 2 |
Protective antigen |
HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 Multipeptide Vaccine
|
|
3948
|
rnfC |
Haemophilus parasuis |
|
|
|
KEZ22306
|
|
|
|
|
|
Nitrogen fixation protein rnfC |
Protective antigen |
|
|
4866
|
ROP16 |
Toxoplasma gondii ME49 |
|
7894782
|
|
237832151
|
TGME49_262730 |
CM002042 |
XP_002365373 |
|
|
|
Protective antigen |
CAV-2-ROP16
|
|
4882
|
ROP17 |
Toxoplasma gondii ME49 |
|
7896648
|
|
237831549
|
TGME49_258580 |
CM002042 |
XP_002365072 |
|
|
|
Protective antigen |
rTgROP17
|
|
4865
|
ROP18 |
Toxoplasma gondii ME49 |
|
7894509
|
|
237836919
|
TGME49_205250 |
CM002041 |
XP_002367757 |
|
|
|
Protective antigen |
CAV-2-ROP18
T. gondii DNA vaccine pIRESneo/ROP18/PLP1
PLG-rROP38-rROP18
rCDPK6 + rROP18 + PLG
|
|
809
|
Rop2 |
Toxoplasma gondii |
VO_0011340
|
|
|
115299638
|
|
|
|
2W1Z
|
CDD:291215
CDD:304357 |
Rop2 protein |
Protective antigen |
T. gondii Subunit Rop2-Hsp83 Fusion Protein Vaccine
T. gondii DNA vaccine pcDNA3.1-SAG1-ROP2
|
|
1374
|
ROP2 |
Toxoplasma gondii RH |
|
|
|
563627
|
|
|
|
|
CDD:291215
CDD:287472
CDD:304357
GOA:Q27007
InterPro: IPR000719
InterPro: IPR011009
InterPro: IPR016815
PDB: 2W1Z
UniProtKB/TrEMBL: Q27007 |
ROP 2 |
Protective antigen |
T. gondii DNA vaccine pSAG1-ROP2-SAG2
|
|
4347
|
Rop2 |
Toxoplasma gondii |
|
|
|
ABI93795
|
|
|
|
|
CDD:291215
CDD:304357 |
Rop2 protein |
Protective antigen |
|
|
4864
|
ROP38 |
Toxoplasma gondii ME49 |
|
7898368
|
|
1085190577
|
TGME49_242110 |
KE138867 |
XP_002366751 |
|
|
|
Protective antigen |
T. gondii DNA vaccine pVAX-ROP38
PLG-rROP38-rROP18
|
|
1635
|
ROP8 |
Toxoplasma gondii |
|
7897075
|
2293518
|
2293519
|
|
|
AAC47797.1 |
|
CDD:291215
CDD:304357 |
ROP8 |
Protective antigen |
T. gondii DNA vaccine ROP8-pVAX-1
T. gondii DNA vaccine encoding multi-epitope ROP8
|
|
4762
|
ROPN1 |
Homo sapiens |
|
54763
|
|
960513918
|
|
AC117381 |
NP_001304703 |
|
|
transcript variant 5 |
Protective antigen |
Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine
|
|
437
|
RplF |
Chlamydia muridarum str. Nigg |
VO_0010892
|
1246168
|
|
497917443
|
TC_RS04070 |
AE002160 |
WP_010231599 |
|
|
50S ribosomal protein L6 |
Protective antigen |
C. muridarum RplF protein vaccine
|
|
682
|
RplL |
Brucella abortus 2308 |
VO_0010908
|
3788918
|
|
489054195
|
BAB_RS21965 |
AM040264 |
WP_002964371 |
|
|
50S ribosomal protein L7/L12 |
Protective antigen |
B. abortus DNA vaccine encoding RplL and Omp16
|
|
1036
|
rpoB |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1255679
|
|
16767407
|
STM4153 |
AF170176 |
NP_463022 |
|
|
DNA-directed RNA polymerase subunit beta |
Virmugen |
Salmonella Typhimurium gyrA/cpxA/rpoB mutant vaccine
|
|
723
|
rpoS |
Salmonella enterica subsp. enterica serovar Typhimurium SL1344 |
|
|
|
301159483
|
|
|
|
|
CDD:180185
CDD:189414
CDD:146937
CDD:146934
CDD:100119
UniProtKB/TrEMBL: E1WAG8 |
RNA polymerase sigma subunit RpoS (sigma-38) |
Virmugen |
Salmonella Typhimurium rpoS mutant vaccine
|
|
4680
|
Rpsa |
Mus musculus |
|
16785
|
|
224994260
|
|
AC110091 |
NP_035159 |
|
|
ribosomal protein SA |
Protective antigen |
Autologous OFA-iLRP RNA-Transfected Dendritic Cell Vaccine
|
|
236
|
RpsL |
Brucella melitensis bv. 1 str. 16M |
VO_0010963
|
1196463
|
|
161511151
|
BMEI0752 |
NZ_GG703780 |
NP_539669 |
|
|
30S ribosomal protein S12 |
Other |
B. melitensis vaccine strain Rev. 1
|
|
3558
|
RPVgp5 F |
Rinderpest virus (strain Kabete O) |
|
3021776
|
|
56410434
|
RPVgp5 |
X98291 |
YP_087124 |
|
|
F protein |
Protective antigen |
v2RVFH
|
|
3559
|
RPVgp6 H |
Rinderpest virus (strain Kabete O) |
|
3021774
|
|
56410435
|
RPVgp6 |
X98291 |
YP_087125 |
|
|
H protein |
Protective antigen |
v2RVFH
|
|
4839
|
RSV F |
Respiratory syncytial virus |
|
1494475
|
|
9629375
|
Rsvgp08 |
U39661 |
NP_044596 |
|
|
mRNA |
Protective antigen |
|
|
4962
|
RSV F protein |
|
|
|
|
|
|
|
|
|
|
|
Protective antigen |
|
|
4881
|
RSV Prefusion F protein based |
|
|
|
|
UED36857
|
|
|
|
|
CDD:395418 |
prefusion RSV F protein |
Protective antigen |
|
|
4851
|
RSV strain A2 |
|
|
|
|
|
|
|
|
|
|
|
Virmugen |
|
|
3836
|
rtxA1 |
Vibrio vulnificus |
|
|
|
ADX36405
|
|
|
|
|
CDD:288492
CDD:289465
CDD:294717
CDD:288550 |
putative RTX-toxin |
Protective antigen |
|
|
4704
|
RUNX1 |
Homo sapiens |
|
861
|
|
49574546
|
|
AF015262 |
NP_001001890 |
|
|
transcript variant X7 |
Protective antigen |
|
|
882
|
ruvB |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1253415
|
|
16765236
|
STM1894 |
AE006468 |
NP_460851 |
|
|
Holliday junction DNA helicase RuvB |
Virmugen |
Salmonella Typhimurium ruvB mutant vaccine
|
|
4395
|
Rv1813c |
Mycobacterium tuberculosis H37Rv |
|
|
|
NP_216329
|
|
|
|
|
CDD:316353 |
hypothetical protein |
Protective antigen |
ID93/GLA-SE
|
|
1064
|
Rv2660c |
Mycobacterium tuberculosis H37Rv |
|
887222
|
|
15609797
|
Rv2660c |
CP009480 |
NP_217176 |
|
|
hypothetical protein |
Protective antigen |
|
|
787
|
RVFVsMgp1 M protein |
Rift Valley fever virus |
VO_0011318
|
956559
|
|
27881464
|
RVFVsMgp1 |
M25276 |
NP_777376 |
|
|
M protein |
Protective antigen |
|
|
788
|
RVFVsSgp2 N protein |
Rift Valley fever virus |
VO_0011319
|
956562
|
|
9632367
|
RVFVsSgp2 |
X53771 |
NP_049344 |
|
|
N protein |
Protective antigen |
Rift Valley Fever Virus DNA Vaccine encoding N Protein
|
|
495
|
S |
Hepatitis B virus strain MonB04-059 |
VO_0011093
|
|
|
128168861
|
|
|
|
|
CDD:279085 |
hepatitis B surface antigen |
Protective antigen |
|
|
1279
|
S |
Hepatitis B virus subtype adr |
|
|
|
267364
|
|
|
|
|
CDD:279085 |
Small envelope protein |
Protective antigen |
Hepatitis B DNA vaccine PLGA–CTAB–DNA encoding the small envelope gene
|
|
1333
|
S |
Hepatitis B virus |
|
|
|
128168861
|
|
|
|
|
CDD:279085 |
hepatitis B surface antigen |
Protective antigen |
Colorectal cancer DNA vaccine pCEA/HBsAg encoding carcinoembryonic antigen and hepatitis B surface antigen
|
|
1702
|
S |
Duck hepatitis B virus strain GD3 |
|
|
|
44829150
|
|
|
|
|
CDD:279085 |
S protein |
Protective antigen |
Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins
|
|
1704
|
S |
Hepatitis B virus strain ayw |
|
|
|
461940451
|
|
|
|
|
CDD:279085 |
small S protein |
Protective antigen |
Hepatitis B DNA vaccine pCMV-S2.S encoding the HBV(ayw Strain) envelope protein.
|
|
1705
|
S |
Duck hepatitis B virus isolate CH6 |
|
|
|
169116569
|
|
|
|
|
CDD:279085 |
large S protein |
Protective antigen |
Hepatitis B virus DNA vaccine encoding HBVgp2 pre-S1/pre-S2/S
|
|
4284
|
S |
Canine coronavirus |
|
|
|
AGE32061
|
|
|
|
|
|
spike glycoprotein |
Protective antigen |
|
|
4292
|
S |
Feline infectious peritonitis virus |
|
|
|
AGZ84526
|
|
|
|
|
CDD:279880
CDD:279881 |
spike protein |
Protective antigen |
|
|
4412
|
S from MERS-CoV |
Middle East respiratory syndrome-related coronavirus |
|
14254594
|
|
667489389
|
G128_gp02 |
|
YP_009047204 |
|
|
spike glycoprotein |
Protective antigen |
MERS-CoV S vaccine adjuvanted with CpG and Alum
MERS-CoV pcDNA3.1-S1 DNA vaccine
MERS England1 S DNA vaccine
MERS-CoV-S rNTD vaccine
MERS-CoV-S rRBD vaccine
|
|
146
|
S nucleocapsid protein from Dobrava-Belgrade virus |
Dobrava-Belgrade orthohantavirus |
VO_0010960
|
2656266
|
|
38505524
|
DOBVsSp1 |
AJ410615 |
NP_942553 |
|
GI:63030019; Accession:AY961618.1 |
nucleocapsid protein |
Protective antigen |
Recombinant DOBV nucleocapsid protein (rDOBV N)
Dobrava-Belgrade virus S nucleocapsid protein vaccine
|
|
1322
|
S protein gene from SARS Urbani |
SARS coronavirus Urbani |
|
|
|
30027620
|
|
|
|
|
CDD:150170
CDD:190049 |
S protein |
Other |
SARS DNA vaccine VRC-8318 encoding the S protein
|
|
789
|
S protein gene of SARS-CoV |
SARS coronavirus |
VO_0011320
|
1489668
|
|
29836496
|
sars2 |
|
NP_828851 |
|
|
E2 glycoprotein precursor |
Protective antigen |
SARS Subunit Spike Protein with subunit boosting Vaccine
SARS-CoV DNA vaccine pcDNA-S encoding S protein
rMV-SARS-CoV-S/Ssol
ADS-MVA vaccine
SARS-CoV CTLA4-S DNA vaccine
MVA/S vaccine
SARS-CoV Ad S/N vaccine
Recombinant spike polypeptide vaccine
SARS-CoV Salmonella-CTLA4-S DNA vaccine
SARS-CoV Salmonella-tPA-S DNA vaccine
SARS-CoV tPA-S DNA vaccine
|
|
491
|
S segment |
Topografov virus |
VO_0011089
|
|
|
4757106
|
|
|
|
|
CDD:279218
GOA:Q9WMG3
InterPro: IPR002214
UniProtKB/TrEMBL: Q9WMG3 |
N protein |
Protective antigen |
Topografov virus N protein vaccine
|
|
3900
|
S-layer protein |
Bacillus anthracis |
|
|
|
WP_047401514
|
|
|
|
|
CDD:278807
CDD:224259
CDD:302596
CDD:302792 |
S-layer protein |
Protective antigen |
|
|
1643
|
S1 |
Bordetella pertussis Tohama |
|
|
|
3152313
|
|
|
|
|
CDD:111768
GOA:Q599G4
HSSP: P04977
InterPro: IPR003898
UniProtKB/TrEMBL: Q599G4 |
toxin subunit S1 |
Protective antigen |
B. pertussis DNA vaccine pcDNA/S1
|
|
1673
|
S1 |
Infectious bronchitis virus |
|
|
|
55501832
|
|
|
|
|
CDD:279880 |
S1 |
Protective antigen |
IBV DNA vaccine pVAX-S1 with GM-CSF adjuvant
Infectious Bronchitis Virus DNA Vaccine encoding S1, N, and M
IBV DNA vaccine pVAX1-16S1/M/N
Ac-CMV-S1 (infectious bronchitis virus)
|
|
4238
|
S1 |
Infectious Bronchitis Virus (IBV) |
|
|
|
ASV64866
|
|
|
|
|
CDD:279880 |
S1 spike glycoprotein |
Protective antigen |
|
|
4239
|
S1 |
Infectious Bronchitis Virus (IBV) |
|
|
|
AAQ63417
|
|
|
|
|
CDD:279880 |
S1 glycoprotein |
Protective antigen |
|
|
4635
|
S100A6 |
Homo sapiens |
|
6277
|
|
7657532
|
|
AX038700 |
NP_055439 |
|
|
transcript variant X1 |
Protective antigen |
Synthetic Peptides E-PRA And E-PSM Vaccine
|
|
4582
|
S100A9 |
Homo sapiens |
|
6280
|
|
4506773
|
|
A12029 |
NP_002956 |
|
|
S100 calcium binding protein A9 |
Protective antigen |
gp100-Reactive Autologous Peripheral Blood Lymphocyte Vaccine
|
|
4873
|
sadf |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
919
|
sadfasfd |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
326
|
SAG1 |
Toxoplasma gondii ME49 |
VO_0011000
|
7900172
|
|
237839159
|
TGME49_234370 |
KE138836 |
XP_002368877 |
1KZQ
|
|
surface antigen SAG1 |
Protective antigen |
T. gondii DNA Vaccine encoding SAG1 Protein
T. gondii DNA vaccine pVitro-SAG1-GRA7
|
|
611
|
SAG1 |
Neospora caninum |
VO_0011196
|
13442867
|
|
4583447
|
|
|
|
|
CDD:282012 |
surface antigen SAG1 |
Protective antigen |
N. caninum DNA vaccine encoding NcSAG1 and NcSRS2, combined with recombinant NcSAG1 and NcSRS2 Proteins
|
|
672
|
SAG1 |
Sarcocystis neurona 3106 |
VO_0011253
|
|
|
295682690
|
|
|
|
|
CDD:252367 |
surface antigen 1 |
Protective antigen |
S. neurona SAG1 Protein Vaccine
|
|
4359
|
SAG1 |
Sarcocystis neurona |
|
|
|
AAO41732
|
|
|
|
|
|
merozoite surface antigen SAG1 |
Protective antigen |
|
|
1375
|
SAG2 |
Toxoplasma gondii |
|
|
8777958
|
8777959
|
|
|
AAF79156.1 |
|
CDD:309286 |
surface antigen P22 |
Protective antigen |
T. gondii DNA vaccine pSAG1-ROP2-SAG2
|
|
4358
|
SAG5 |
Sarcocystis neurona |
|
|
|
ABD47681
|
|
|
|
|
CDD:282012 |
surface antigen 5 |
Protective antigen |
|
|
4862
|
SAG5B |
|
|
|
|
AAB70530.1
|
|
|
|
|
CDD:240383 |
surface antigen 5B |
Protective antigen |
T. gondii DNA vaccine pSAG5B/SAG5C
|
|
4863
|
SAG5C |
|
|
|
|
AAQ63835.1
|
|
|
|
|
CDD:240383 |
SAG5C |
Protective antigen |
T. gondii DNA vaccine pSAG5B/SAG5C
|
|
850
|
sar5 |
Streptococcus agalactiae Compton R |
VO_0012393
|
|
|
5327234
|
|
|
|
|
CDD:273479
CDD:283989
CDD:273478
GOA:Q9XAS7
InterPro: IPR001899
InterPro: IPR005877
UniProtKB/TrEMBL: Q9XAS7 |
BPS protein |
Protective antigen |
S. agalactiae BPS Protein Vaccine
|
|
4167
|
sasA |
Staphylococcus aureus |
|
|
|
AAR15189
|
|
|
|
|
CDD:301310 |
surface protein SasA |
Protective antigen |
|
|
3876
|
sca1 |
Rickettsia typhi str |
|
|
|
ABC41089
|
|
|
|
|
ATCC:VR-144
CDD:281750 |
Sca1 |
Protective antigen |
|
|
295
|
SCFV |
Homo sapiens |
|
652070
|
|
|
|
DQ535056 |
|
|
|
single-chain Fv fragment |
Protective antigen |
|
|
722
|
SCGB2A2 |
Homo sapiens |
|
4250
|
|
4505169
|
|
AF015224 |
NP_002402 |
|
|
transcript variant X1 |
Protective antigen |
|
|
4202
|
sclC |
Streptococcus equi |
|
|
|
AAV70833
|
|
|
|
|
CDD:333130
CDD:307064 |
collagen-like protein C |
Protective antigen |
|
|
4104
|
SCPA |
Streptococcus pyogenes |
|
|
|
AAT86469
|
|
|
|
|
CDD:234635 |
ScpA |
Protective antigen |
|
|
4121
|
scpA |
Streptococcus pyogenes |
|
|
|
ANC27812
|
|
|
|
|
CDD:173801
CDD:239048
CDD:310703
CDD:328787
CDD:291893 |
C5a peptidase protein ScpA |
Protective antigen |
|
|
4136
|
scpA |
Streptococcus pyogenes M1 GAS |
|
|
|
NP_269970
|
|
|
|
|
CDD:173801
CDD:239048
CDD:310703
CDD:328787
CDD:291893 |
C5A peptidase precursor |
Protective antigen |
|
|
4217
|
scpA_4 |
Streptococcus agalactiae |
|
|
|
AMQ15511
|
|
|
|
|
CDD:282500
CDD:173801
CDD:278510
CDD:239048
CDD:283851 |
C5a peptidase precursor |
Protective antigen |
|
|
4220
|
scpB |
Streptococcus agalactiae |
|
|
|
AAB17762
|
|
|
|
|
CDD:173801
CDD:278510
CDD:239048
CDD:283851
CDD:304423 |
SCPB |
Protective antigen |
|
|
4193
|
scpZ |
Streptococcus equi subsp. zooepidemicus MGCS10565] |
|
|
|
ACG62304
|
|
|
|
|
CDD:173801
CDD:278510
CDD:239048
CDD:283851
CDD:304423 |
C5a peptidase precursor ScpZ |
Protective antigen |
|
|
4695
|
SDC1 |
Homo sapiens |
|
6382
|
|
55749480
|
|
AC104792 |
NP_001006947 |
|
|
transcript variant 1 |
Protective antigen |
XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410
Autologous Dendritic Cell-Tumor Fusion Vaccine
|
|
4484
|
SDC1-Obsolete |
Homo sapiens |
|
6382
|
|
55749480
|
|
AC104792 |
NP_001006947 |
|
|
transcript variant 1 |
Protective antigen |
|
|
325
|
sdfa |
|
|
|
|
|
|
|
|
|
|
SRS domain-containing protein; SAG |
|
|
|
4184
|
sdrD |
Staphylococcus aureus |
|
|
|
CAA06651
|
|
|
|
|
CDD:309682
CDD:313621
CDD:316170
CDD:319228
CDD:307064
GOA:O86488
InterPro: IPR001899
InterPro: IPR003367
InterPro: IPR005877
InterPro: IPR008454
InterPro: IPR008966
UniProtKB/TrEMBL: O86488 |
SdrD |
Protective antigen |
|
|
4185
|
seb |
Staphylococcus aureus subsp. aureus COL |
|
|
|
AAL04126
|
|
|
|
|
CDD:279467
CDD:280949 |
Seb |
Protective antigen |
|
|
117
|
SecA2 |
Mycobacterium tuberculosis H37Rv |
VO_0010950
|
885594
|
|
15608958
|
Rv1821 |
BX842577 |
NP_216337 |
1NL3
|
EMBL: AE000516
EMBL: BX842577
GenomeReviews: AE000516_GR
GenomeReviews: AL123456_GR
HSSP: O05885
InterPro: IPR000185
InterPro: IPR001650
InterPro: IPR011115
InterPro: IPR011116
InterPro: IPR011130
InterPro: IPR014018
InterPro: IPR014021
KEGG: mtc:MT1869
KEGG: mtu:Rv1821
Pfam: PF01043
Pfam: PF07516
Pfam: PF07517
PIR: F70720
PRINTS: PR00906
PROSITE: PS01312
PROSITE: PS51196
TIGR: MT1869
TubercuList: Rv1821
UniProt: P66785 |
preprotein translocase subunit SecA |
Virmugen |
M. tuberculosis secA2 mutant
Mycobacterium tuberculosis lysA/secA2 mutant vaccine
|
|
1068
|
senA |
Shigella sonnei Ss046 |
|
3671021
|
|
74314887
|
SSON_P050 |
CP000039 |
YP_313305 |
|
|
OspD3 |
Virmugen |
Shigella sonnei virG/senA/senB/msbB2 mutant vaccine
Shigella sonnei virG/senA/senB mutant vaccine
|
|
1069
|
senB |
Shigella sonnei Ss046 |
|
3668265
|
|
74313104
|
SSON_2665 |
CP000038 |
YP_311523 |
|
|
putative enterotoxin |
Virmugen |
Shigella sonnei virG/senA/senB/msbB2 mutant vaccine
Shigella sonnei virG/senA/senB mutant vaccine
|
|
4938
|
SERA |
|
|
|
|
AAF37557.1
|
|
|
|
|
CDD:185641 |
serine-repeat antigen protein |
Protective antigen |
NYVAC-Pf7
|
|
626
|
SERA-5 |
Plasmodium falciparum |
VO_0011210
|
812668
|
|
238629807
|
|
|
|
3CH2
|
CDD:185641 |
serine repeat antigen 5 |
Protective antigen |
P. falciparum Subunit SE36 Protein Vaccine
|
|
851
|
SfbI |
Streptococcus pyogenes DSM 2071 |
VO_0012394
|
|
511149
|
WP_014407228
|
|
|
CAA48133.1 |
|
CDD:311998
CDD:331285
CDD:308566 |
fibronectin-binding protein SfbI |
Protective antigen |
S. pyogenes SfbI Protein Vaccine
|
|
631
|
Sfs |
Streptococcus equi subsp. equi 4047 |
VO_0011215
|
7696331
|
|
225869898
|
SEQ_0466 |
FM204883 |
YP_002745845 |
|
|
fibronectin-binding protein Sfs |
Protective antigen |
S. equi Subunit EAG, FNZ and SFS Protein Vaccine
|
|
4204
|
sfs |
Streptococcus equi subsp. zooepidemicus MGCS10565] |
|
|
|
ACG61768
|
|
|
|
|
CDD:274741 |
fibronectin-binding protein Sfs-like |
Protective antigen |
|
|
1651
|
SGP |
Sudan ebolavirus strain Boniface |
|
|
1041223
|
1041225
|
|
|
AAB37096.1 |
|
CDD:279888
CDD:197367 |
virion spike glycoprotein precursor |
Protective antigen |
|
|
1656
|
SGP |
Sudan ebolavirus strain Boniface |
|
|
|
1041225
|
|
|
AAB37096.1 |
|
CDD:279888
CDD:197367 |
virion spike glycoprotein precursor |
Protective antigen |
Marburg virus recombinant vector vaccine CAdVax-Panfilo
|
|
4871
|
SH |
|
|
|
|
ASU47779
|
ASU47779 |
|
ASU47779 |
|
CDD:281565 |
small hydrophobic protein |
Protective antigen |
|
|
4101
|
shp |
Streptococcus pyogenes |
|
|
|
ANC27645
|
|
|
|
|
CDD:288407 |
heme binding protein Shp |
Protective antigen |
|
|
945
|
siaD |
Neisseria meningitidis MC58 |
|
903210
|
|
15677983
|
NMB0067 |
AE002098 |
NP_273131 |
|
|
polysialic acid capsule biosynthesis protein SiaD |
Virmugen |
Neisseria meningitidis metH/siaD mutant vaccine
Neisseria meningitidis rfaF/siaD mutant vaccine
|
|
4628
|
sialyl-Tn |
|
|
|
|
|
|
|
|
|
|
|
Protective antigen |
Sialyl Tn-KLH Vaccine
STn-KLH plus Detox Vaccine
|
|
855
|
sib35 |
Streptococcus pyogenes serotype M12 |
VO_0012398
|
|
|
90567992
|
|
|
|
|
CDD:286161 |
immunoglobulin-binding protein 35 |
Protective antigen |
S. pyogenes Sib35 Protein Vaccine
|
|
3860
|
SigA |
Shigella |
|
|
|
AIL42190
|
|
|
|
|
CDD:315649
CDD:280543
CDD:238653
CDD:273608 |
SigA |
Protective antigen |
|
|
905
|
sigE |
Mycobacterium tuberculosis H37Rv |
|
888751
|
|
15608361
|
Rv1221 |
BX842575 |
NP_215737 |
|
|
RNA polymerase sigma factor SigE |
Virmugen |
Mycobacterium tuberculosis sigE mutant vaccine
|
|
1196
|
sigF |
Mycobacterium tuberculosis CDC1551 |
|
922492
|
|
15842877
|
MT3385 |
AE000516 |
NP_337914 |
|
|
RNA polymerase sigma factor SigF |
Virmugen |
Mycobacterium tuberculosis DeltasigF mutant vaccine
|
|
4233
|
sigma C protein |
Avian Reovirus |
|
|
|
AAL83498
|
|
|
|
|
CDD:113356
CDD:282382
CDD:305065
CDD:176481 |
sigma C protein |
Protective antigen |
|
|
299
|
SILV |
Homo sapiens |
|
6490
|
|
318037593
|
|
AC025162 |
NP_001186982 |
|
|
transcript variant 3 |
Protective antigen |
|
|
859
|
Sip |
Streptococcus agalactiae A909 |
VO_0012402
|
3685788
|
|
76788047
|
SAK_0065 |
CP000114 |
YP_328758 |
|
CDD:212030
CDD:331378 |
group B streptococcal surface immunogenic protein |
Protective antigen |
S. agalactiae Sip Protein Vaccine
|
|
1366
|
Sj23 |
Schistosoma japonicum |
|
|
|
124390
|
|
|
|
|
CDD:278750
CDD:239401 |
23 kDa integral membrane protein |
Protective antigen |
Chinese S. japonicum DNA vaccine pVIVO2-IL12-Sj23 encoding Sj23 and IL-12
Chinese S. japonicum DNA vaccine SjC23-Hsp70
Chinese S. japonicum DNA vaccine SjC23
|
|
276
|
skp |
|
VO_0010918
|
|
4574245
|
4574246
|
|
AF109085 |
AAD23967.1 |
|
CDD:225381
CDD:182724 |
outer membrane protein 26 |
Protective antigen |
H. influenzae Omp26 protein vaccine
|
|
3981
|
skp |
Escherichia coli O25b:H4 |
|
|
|
ARH95964
|
|
|
|
|
CDD:182724 |
periplasmic chaperone Skp |
Protective antigen |
|
|
4485
|
SLAMF7 |
Homo sapiens |
|
57823
|
|
543583691
|
|
AL121985 |
NP_001269517 |
|
|
transcript variant 3 |
Protective antigen |
XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410
|
|
716
|
SLC5A5 |
Homo sapiens |
|
6528
|
|
4507035
|
|
AB032811 |
NP_000444 |
|
|
transcript variant X1 |
Protective antigen |
Cancer DNA Vaccine MIDGE/hNIS encoding hNIS protein
|
|
4131
|
slo |
Streptococcus pyogenes |
|
|
|
NP_268546
|
|
|
|
|
CDD:307453 |
streptolysin O precursor |
Protective antigen |
|
|
1093
|
slyA |
Edwardsiella tarda EIB202 |
|
8608031
|
|
269139033
|
ETAE_1684 |
CP001135 |
YP_003295734 |
|
|
transcriptional regulator |
Virmugen |
Edwardsiella tarda aroC/slyA mutant vaccine
|
|
4383
|
Sm14 |
Schistosoma mansoni |
|
|
|
AAM18481
|
|
|
|
|
CDD:278490 |
Sm14 fatty acid-binding protein delta E3 variant |
Protective antigen |
|
|
1368
|
Sm23 |
Schistosoma mansoni |
|
|
|
511890
|
|
|
|
|
CDD:278750
CDD:239401 |
integral membrane protein 23 |
Protective antigen |
S. mansoni DNA vaccine Sm23-pcDNA encoding Sm23
|
|
4384
|
Sm29 |
Schistosoma mansoni |
|
|
|
AAC98911
|
|
|
|
|
CDD:184037 |
Sm29 |
Protective antigen |
|
|
973
|
smpB |
Yersinia pestis CO92 |
|
1173949
|
|
218928269
|
YPO1101 |
AL590842 |
YP_002346144 |
|
|
SsrA-binding protein |
Virmugen |
Yersinia pestis smpB/ssrA mutant vaccine
|
|
745
|
SMT |
Leishmania infantum |
VO_0011282
|
|
|
146104463
|
|
|
|
|
CDD:332925
CDD:332923
CDD:312111
GOA:A4IDL3
InterPro: IPR013216
InterPro: IPR013705
UniProtKB/TrEMBL: A4IDL3 |
putative sterol 24-c-methyltransferase |
Protective antigen |
L. infantum SMT Protein Vaccine
|
|
489
|
SNVsSgp1 |
Sin Nombre orthohantavirus |
VO_0011087
|
2943142
|
|
38371726
|
SNVsSgp1 |
JQ690276 |
NP_941975 |
|
|
nucleocapsid protein |
Protective antigen |
Sin Nombre virus DNA vaccine encoding SNVsSgp1 (NP)
|
|
1369
|
SOD |
Schistosoma mansoni strain NMRI |
|
|
|
161119
|
|
|
|
|
CDD:238186 |
superoxide dismutase |
Protective antigen |
S. mansoni DNA vaccine pcDNA/CTSOD encoding SOD
|
|
4350
|
SOD |
Toxoplasma gondii |
|
7900511
|
|
AAC63943
|
|
|
|
|
CDD:223678 |
superoxide dismutase |
Protective antigen |
|
|
120
|
SodA |
Mycobacterium tuberculosis H37Rv |
|
886174
|
|
15610982
|
Rv3846 |
NC_000962.2 |
NC_000962.2 |
|
EMBL: AE000516
EMBL: AF061030
EMBL: BX842584
EMBL: X52861
Gene3D: G3DSA:3.90.149.10
GenomeReviews: AE000516_GR
GenomeReviews: AL123456_GR
InterPro: IPR001189
KEGG: mtc:MT3960
KEGG: mtu:Rv3846
LinkHub: P17670
PANTHER: PTHR11404
PDB: 1GN2
PDB: 1GN3
PDB: 1GN4
PDB: 1GN6
PDB: 1IDS
Pfam: PF00081
Pfam: PF02777
PIR: S15205
PRINTS: PR01703
ProDom: PD000475
PROSITE: PS00088
TIGR: MT3960
TubercuList: Rv3846
UniProt: P17670
|
SUPEROXIDE DISMUTASE [FE] SODA |
|
M. tuberculosis DNA vaccine pAK4-sod
|
|
995
|
sodA |
Yersinia enterocolitica subsp. enterocolitica 8081 |
|
4716532
|
|
123444307
|
YE4138 |
AM286415 |
YP_001008274 |
|
|
superoxide dismutase |
Virmugen |
Yersinia enterocolitica sodA mutant vaccine
|
|
4058
|
sodB |
Campylobacter jejuni |
|
|
|
AIJ27548
|
|
|
|
|
CDD:223678 |
superoxide dismutase |
Protective antigen |
|
|
475
|
SodB from F. tularensis SCHU S4 |
Francisella tularensis subsp. tularensis SCHU S4 |
VO_0011077
|
3190713
|
|
56707247
|
FTT_0068 |
AJ749949 |
YP_169143 |
3H1S
|
|
superoxide dismutase (Fe) |
Virmugen |
sodB(Ft)
|
|
1005
|
sodC |
Francisella tularensis subsp. holarctica FTNF002-00 |
|
5522867
|
|
156501771
|
FTA_0403 |
CP000803 |
YP_001427836 |
|
|
copper/zinc superoxide dismutase |
Virmugen |
Francisella tularensis sodC mutant vaccine
|
|
3
|
SodC from B. abortus strain 2308 |
Brucella abortus 2308 |
VO_0010856
|
3827840
|
|
489062065
|
BAB_RS28905 |
AM040265 |
WP_002972093 |
2AQM
|
|
superoxide dismutase [Cu-Zn] |
Protective antigen |
Recombinant B. abortus RB51SOD
B. abortus DNA vaccine pcDNA-SOD
B. abortus DNA vaccine expressing BCSP31, SOD and L7/L12
B. abortus DNA vaccine pcDNA3-SOD encoding Cu-Zn SOD
|
|
321
|
sopB |
Salmonella enterica subsp. enterica serovar Typhimurium |
VO_0010999
|
|
|
54036439
|
|
|
|
|
CDD:283555 |
Inositol phosphate phosphatase SopB |
Protective antigen |
Salmonella DNA vaccine encoding SopB Protein
|
|
4758
|
SOX2 |
Homo sapiens |
|
6657
|
|
28195386
|
|
AC117415 |
NP_003097 |
|
|
SRY-box transcription factor 2 |
Protective antigen |
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
|
|
4785
|
SOX6 |
Homo sapiens |
|
55553
|
|
224967050
|
|
AC009869 |
NP_001139283 |
|
|
transcript variant 5 |
Protective antigen |
HLA-A2-Restricted Synthetic Glioma Antigen Peptides Vaccine
|
|
738
|
SP |
Leishmania major |
VO_0011276
|
|
|
23168331
|
|
|
|
|
CDD:299172
CDD:119398 |
signal peptidase type I |
Protective antigen |
L. major DNA Vaccine encoding SP
|
|
4345
|
sp |
Theileria annulata |
|
|
|
CAC87894
|
|
|
|
|
CDD:289191
CDD:281302
CDD:292389
CDD:282057
GOA:Q8WPH7
InterPro: IPR007274
InterPro: IPR022131
UniProtKB/TrEMBL: Q8WPH7 |
surface protein |
Protective antigen |
|
|
4113
|
spa |
Streptococcus pyogenes |
|
|
|
AIG88580
|
|
|
|
|
CDD:288951
CDD:287215 |
Spa |
Protective antigen |
|
|
4126
|
spa |
Streptococcus pyogenes |
|
|
|
ACD81471
|
|
|
|
|
CDD:309682
CDD:331876
CDD:330553
CDD:307064 |
streptococcal protective antigen |
Protective antigen |
|
|
4174
|
spa |
Staphylococcus aureus |
|
|
|
WP_000728763
|
|
|
|
|
CDD:309682
CDD:280394
CDD:331228
CDD:212030 |
immunoglobulin G-binding protein A |
Protective antigen |
|
|
4761
|
SPA17 |
Homo sapiens |
|
53340
|
|
8394343
|
|
AF334810 |
NP_059121 |
|
|
transcript variant X2 |
Protective antigen |
Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine
|
|
288
|
Spa32 |
Shigella flexneri 5a str. M90T |
VO_0010992
|
876502
|
|
13449098
|
pWR501_0160 |
AF348706 |
NP_085314 |
|
|
invasion protein |
Protective antigen |
|
|
287
|
Spa33 |
Shigella flexneri 5a |
|
876456
|
|
13449099
|
pWR501_0161 |
AF348706 |
NP_085315 |
|
|
Type III secretion protein |
Virulence factor |
|
|
1639
|
spaA |
Erysipelothrix rhusiopathiae |
|
|
|
5881768
|
|
|
|
|
|
|
Protective antigen |
E. rhusiopathiae DNA vaccine pcD-ACSC
|
|
602
|
spag-1 |
Theileria annulata |
VO_0011187
|
|
|
161885
|
|
|
|
|
CDD:253298 |
sporozoite surface antigen |
Protective antigen |
T. annulata Subunit SPAG-1 Protein Vaccine
|
|
4772
|
SPANXB1 |
Homo sapiens |
|
728695
|
|
608601818
|
|
AJ457789 |
NP_115850 |
|
|
SPANX family member B1 |
Protective antigen |
Autologous Tumor-associated Peptide Antigen-pulsed Dendritic Cell Vaccine
|
|
786
|
spaP |
Rickettsia prowazekii |
VO_0011317
|
|
|
152498
|
|
|
|
|
CDD:289131
CDD:273608
CDD:214872 |
surface antigen |
Protective antigen |
|
|
4196
|
spaZ |
Streptococcus equi |
|
|
|
ACG61542
|
|
|
|
|
CDD:330553
CDD:307064 |
protective antigen-like protein, fibrinogen- and Ig-binding protein precursor |
Protective antigen |
|
|
4626
|
SPBC17D11.03c hypothetical protein |
Schizosaccharomyces pombe |
|
2539635
|
|
19113169
|
SPBC17D11.03c |
CU329671 |
NP_596377 |
|
|
|
Protective antigen |
rMeV- SCD
|
|
4123
|
speA |
Streptococcus pyogenes |
|
|
|
WP_011285560
|
|
|
|
|
CDD:279467
CDD:280949 |
streptococcal pyrogenic exotoxin SpeA |
Protective antigen |
|
|
4122
|
speB |
Streptococcus pyogenes |
|
|
|
ANC27833
|
|
|
|
|
CDD:316273
CDD:307663 |
strepotococcal cysteine protease (streptopain) protein SpeB |
Protective antigen |
|
|
76
|
Sph |
Escherichia coli |
|
4364224
|
|
116006945
|
pO86A1_p162 |
NC_008460 |
YP_788128 |
|
|
streptomycin resistance protein |
|
Live attenuated ETEC vaccine ACAM2010
Live attenuated ETEC vaccine ACAM2007
|
|
4417
|
spike (S) protein |
Severe acute respiratory syndrome coronavirus 2 |
PR_P0DTC2
|
43740568
|
|
1796318598
|
GU280_gp02 |
LC528232 |
YP_009724390 |
|
|
surface glycoprotein |
Protective antigen |
Johnson & Johnson COVID-19 vaccine
SARS-CoV-2 Vaccine YF-S0
|
|
4304
|
spike protein |
Transmissible gastroenteritis virus |
|
|
|
AAF02707
|
|
|
|
|
CDD:279880 |
spike protein |
Protective antigen |
|
|
968
|
spoT |
Salmonella enterica subsp. enterica serovar Gallinarum str. 287/91 |
|
6924903
|
|
205354656
|
SG3689 |
AM933173 |
YP_002228457 |
|
|
bifunctional (p)ppGpp synthetase II/ guanosine-3',5'-bis pyrophosphate 3'-pyrophosphohydrolase |
Virmugen |
Salmonella Gallinarum relA/spoT mutant vaccine
|
|
4630
|
SPY-1 |
|
|
|
|
|
|
|
|
|
|
|
Protective antigen |
|
|
4120
|
Spy0416 |
Streptococcus pyogenes |
|
|
|
NP_268723
|
|
|
|
|
CDD:309682
CDD:173801
CDD:239048
CDD:310703
CDD:273478 |
putative cell envelope proteinase |
Protective antigen |
|
|
4118
|
Spy0469 |
Streptococcus pyogenes |
|
|
|
NP_268760
|
|
|
|
|
CDD:197609
CDD:331207 |
putative 42 kDa protein |
Protective antigen |
|
|
793
|
SREHP |
Entamoeba histolytica HM-1:IMSS |
VO_0011324
|
3402462
|
|
67463194
|
EHI_116360 |
DS571976 |
XP_648254 |
|
|
|
Protective antigen |
E. histolytica SREHP protein vaccine
|
|
4040
|
srp |
Chlamydia trachomatis |
|
|
|
P18587
|
|
|
|
|
CDD:253365 |
Sulfur-rich protein, serovars L1/L3 |
Protective antigen |
|
|
4213
|
srr-1 |
Streptococcus agalactiae |
|
|
|
AKI95824
|
|
|
|
|
CDD:274741
CDD:275065
CDD:287406
CDD:273478 |
Serine rich repeat protein 1 |
Protective antigen |
|
|
610
|
SRS2 |
Neospora caninum |
VO_0011195
|
13442869
|
|
5579384
|
|
|
|
|
CDD:282012 |
SRS2 surface antigen |
Protective antigen |
N. caninum DNA vaccine encoding NcSAG1 and NcSRS2, combined with recombinant NcSAG1 and NcSRS2 Proteins
RB51/SRS2
RB51-SRS2
RB51--MIC3/GRA2/GRA6/MIC1/SRS2
|
|
615
|
SrtA |
Streptococcus pneumoniae D39 |
VO_0011199
|
4442999
|
|
116515518
|
SPD_1076 |
CP000410 |
YP_816547 |
|
|
sortase |
Protective antigen |
S. pneumoniae SrtA Protein Vaccine
|
|
4103
|
srtA |
Streptococcus pyogenes |
|
|
|
BAB08162
|
|
|
|
|
|
SrtA |
Protective antigen |
|
|
441
|
Ssb |
Chlamydophila pneumoniae CWL029 |
VO_0010896
|
894901
|
|
15618301
|
CPn0386 |
AE001363 |
NP_224586 |
|
|
single-stranded DNA-binding protein |
Protective antigen |
C. pneumoniae DNA vaccine encoding Ssb
|
|
1741
|
SSP2 |
Plasmodium yoelii |
|
3830241
|
|
45645179
|
|
|
|
|
CDD:240420
CDD:238748
CDD:214559 |
Sporozoite surface protein 2 |
Protective antigen |
P. yoelii DNA vaccine encoding PySSP2
|
|
1744
|
SSP2 from P. knowlesi |
Plasmodium knowlesi strain H |
|
7322479
|
|
221058683
|
|
|
|
|
CDD:240420
EnsemblGenomes-Gn:PKH_121770
EnsemblGenomes-Tr:PKH_121770
InterPro: IPR000884
InterPro: IPR002035
UniProtKB/TrEMBL: B3L8N1 |
sporozoite surface protein 2, putative |
Protective antigen |
P. knowlesi DNA vaccine encoding PkCSP, PkSSP2, PkAMA1, and PkMSP1p42
|
|
1306
|
SSP2 from Plasmodium falciparum |
Plasmodium falciparum |
|
|
|
160691
|
|
|
|
|
CDD:185620
CDD:29244
CDD:199489 |
sporozoite surface protein 2 |
Protective antigen |
NYVAC-Pf7
|
|
974
|
ssrA |
Yersinia pestis CO92 |
|
1173948
|
|
|
YPOs04 |
|
|
|
|
|
Virmugen |
Yersinia pestis smpB/ssrA mutant vaccine
|
|
4547
|
ST8SIA1 |
Homo sapiens |
|
6489
|
|
751130502
|
|
AC007544 |
NP_001291379 |
|
|
transcript variant 2 |
Protective antigen |
Monoclonal Antibody GD2 Anti-Idiotype Vaccine
|
|
3973
|
sta |
Escherichia coli |
|
|
|
ATD53746
|
|
|
|
|
CDD:307942 |
heat-stable enterotoxin STa |
Protective antigen |
|
|
4172
|
staphylococcal enterotoxin A |
Staphylococcus aureus |
|
|
|
AAA26681
|
|
|
|
|
CDD:279467
CDD:280949 |
staphylococcal enterotoxin A |
Protective antigen |
|
|
145
|
STARP |
Plasmodium falciparum |
|
|
|
|
|
|
|
|
PlasmoDB:PF07_0006 |
starp antigen |
|
P. falciparam liver-stage peptides and lipopeptides
|
|
1346
|
Steap1 |
Mus musculus |
|
70358
|
|
254553462
|
UNQ6507/PRO23203 |
AC092404 |
NP_081675 |
|
|
six transmembrane epithelial antigen of the prostate 1 |
Protective antigen |
Prostate cancer DNA vaccine pcDNA3-STEAP encoding six-transmembrane epithelial antigen
|
|
4549
|
STEAP1 |
Homo sapiens |
|
26872
|
|
9558759
|
|
AC004969 |
NP_036581 |
|
|
STEAP family member 1 |
Protective antigen |
mRNA-Derived Prostate Cancer Vaccine CV9103
|
|
4137
|
StreptInCor |
Streptococcus pyogenes |
|
|
|
|
|
|
|
|
|
StreptInCor |
Protective antigen |
|
|
3964
|
stx1B |
Escherichia coli O157 |
|
|
|
OWR88953
|
|
|
|
|
CDD:280428
GOA:Q8X4M7
HSSP: P69178
InterPro: IPR003189
InterPro: IPR008992
UniProtKB/TrEMBL: Q8X4M7 |
Shiga toxin Stx1 subunit B |
Protective antigen |
|
|
3974
|
stx2eB |
Escherichia coli |
|
|
|
AAQ63639
|
|
|
|
|
CDD:280428 |
Shiga toxin 2e subunit B |
Protective antigen |
|
|
3865
|
stxB |
Shigella dysenteriae Sd197 |
|
|
|
ABU96047
|
|
|
|
|
CDD:280428 |
StxB |
Protective antigen |
|
|
248
|
StxB1 |
Phage BP-4795 |
|
2641657
|
|
157166026
|
PBV4795_ORF41 |
NC_004813 |
YP_001449278 |
|
|
Shiga toxin 1 subunit B |
|
|
|
225
|
StxB2 |
Enterobacteria phage 933W |
VO_0010938
|
1262010
|
|
9632507
|
ST933Wp41 |
AF125520 |
NP_049501 |
|
|
Shiga toxin 2 subunit B |
Protective antigen |
Shiga Toxin 2 B Subunit Vaccine
rBCG -Stx2B (Escherichia coli )
|
|
3934
|
superoxide dismutase |
Haemophilus parasuis |
|
|
|
AIK91190
|
|
|
|
|
CDD:224943
CDD:238186 |
superoxide dismutase |
Protective antigen |
|
|
258
|
SurA |
Brucella abortus 2308 |
VO_0010971
|
3787419
|
|
489056605
|
BAB_RS19295 |
JMRZ01000012 |
WP_002966738 |
|
|
molecular chaperone SurA |
Protective antigen |
Brucella recombinant SurA protein vaccine
|
|
1019
|
surA |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1251610
|
|
16763482
|
STM0092 |
AE006468 |
NP_459097 |
|
|
peptidyl-prolyl cis-trans isomerase SurA |
Virmugen |
Salmonella Typhimurium surA mutant vaccine
|
|
4390
|
surA test |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4197
|
surface-anchored protein |
Streptococcus equi |
|
|
|
KIS15526
|
|
|
|
|
|
surface-anchored protein |
Protective antigen |
|
|
719
|
Survivin |
Homo sapiens |
|
|
|
2315863
|
|
|
|
1XOX
|
CDD:306999
CDD:237989 |
apoptosis inhibitor survivin |
Protective antigen |
Cancer DNA Vaccine pSURV encoding Survivin
hTERT/Survivin/Melanoma Tumor Cell-Derived mRNA-Transfected Dendritic Cell Vaccine
Survivin Antigen Vaccine DPX-Survivac
Survivin/p53/HER2 Antigen-loaded Autologous Dendritic Cell Vaccine
SVN53-67/M57-KLH Peptide Vaccine
Autologous Renal Cell Carcinoma Tumor Lysate-Pulsed Dendritic Cell Vaccine
HLA-A1, A2, B35-Restricted Survivin Peptides/Montanide ISA-51 Vaccine
hTERT-LAMP mRNA-loaded Autologous Dendritic Cell Vaccine GRNVAC1
hTERT mRNA/Survivin Peptide-double-loaded Autologous Dendritic Cell Vaccine
|
|
1336
|
Survivin |
Mus musculus |
|
11799
|
|
59859890
|
RP23-268N22.2 |
AB036741 |
NP_001012273 |
|
|
transcript variant 3 |
Protective antigen |
Melanoma DNA vaccine VR-S8/VR-IL2/AD-S8 encoding survivin
|
|
743
|
SW3.1 |
Leishmania major |
VO_0011280
|
|
|
4008565
|
|
|
|
|
UniProtKB/TrEMBL: Q9TVI8 |
histone H1 |
Protective antigen |
L. major H1 Protein Vaccine
|
|
4192
|
szm |
Streptococcus equi subsp. Zooepidemicus |
|
|
|
AKL88101
|
|
|
|
|
CDD:273479
CDD:302998
CDD:290581
CDD:295219
CDD:287215
CDD:279132 |
Szm |
Protective antigen |
|
|
4199
|
SzP |
Streptococcus equi subsp. Zooepidemicus |
|
|
|
AAB92635
|
|
|
|
|
|
M-like protein |
Protective antigen |
|
|
603
|
TA17050 merozoite-piroplasm surface antigen Tams1 |
Theileria annulata |
VO_0011188
|
3864438
|
|
84997996
|
TA17050 |
AF214915 |
XP_953719 |
|
|
|
Protective antigen |
T. annulata Tams1 Protein Vaccine
|
|
461
|
TA4 |
Eimeria tenella |
VO_0011065
|
|
|
84783094
|
|
|
|
|
CDD:287966 |
TA4 antigen protein |
Protective antigen |
E. tenella DNA vaccine pcDNA-TA4-IL-2
|
|
4736
|
TAF1B |
Homo sapiens |
|
9014
|
|
974987474
|
|
AC010969 |
NP_001305905 |
|
|
transcript variant 2 |
Protective antigen |
AIM2(-1)/HT001(-1)/TAF1B(-1) Frameshift Peptide Vaccine
|
|
872
|
Tarp |
Chlamydia muridarum str. Nigg |
|
1245826
|
|
497916366
|
TC_RS02355 |
AE002160 |
WP_010230522 |
|
|
peptide ABC transporter substrate-binding protein |
Protective antigen |
C. muridarum Tarp subunit vaccine
|
|
4056
|
tarP |
Chlamydia trachomatis |
|
|
|
ADK74121
|
|
|
|
|
CDD:284902 |
TarP |
Protective antigen |
|
|
4455
|
TARP |
Homo sapiens |
|
445347
|
|
51702236
|
|
AC006033 |
NP_001003799 |
|
|
transcript variant X1 |
Protective antigen |
TARP 29-37-9V Peptide Vaccine
Autologous TARP Peptide-Pulsed Dendritic Cell Vaccine
TARP 27-35 Peptide Vaccine
|
|
711
|
Tat |
Human immunodeficiency virus 1 |
VO_0011262
|
155871
|
|
9629358
|
HIV1gp5 |
AF033819 |
NP_057853 |
|
|
Tat |
Protective antigen |
DNA vaccine expressing multiple HIV epitopes
HIV DNA vaccine pHIS-SHIV-B
|
|
1712
|
tat |
Simian-Human immunodeficiency virus strain SHIV-89.6 |
|
|
|
2828042
|
|
|
|
|
CDD:278940 |
tat |
Protective antigen |
HIV DNA vaccine SHIV-89.6 DNA (DNA/89.6)
|
|
1719
|
tat |
Human immunodeficiency virus 2 |
|
|
|
1845211
|
|
|
|
|
CDD:278940 |
tat protein |
Protective antigen |
HIV-2 DNA vaccine
|
|
661
|
TBEVgp1 polyprotein |
Tick-borne encephalitis virus |
VO_0011245
|
1489719
|
|
9628432
|
TBEVgp1 |
U27495 |
NP_043135 |
|
|
polyprotein |
Protective antigen |
TBEV DNA vaccine encoding E protein
|
|
277
|
Tbp2 |
Haemophilus influenzae 86-028NP |
VO_0010865
|
3430457
|
|
68249580
|
NTHI1169 |
CP000057 |
YP_248692 |
|
|
transferrin-binding protein 2 |
Protective antigen |
|
|
597
|
tbp2 |
Neisseria meningitidis |
VO_0011182
|
|
|
NP_273507
|
|
|
|
|
CDD:307461 |
transferrin-binding protein B |
Protective antigen |
N. miningitidis TBP2 Protein Vaccine
|
|
833
|
tbpA |
Neisseria meningitidis K454 |
VO_0012380
|
|
|
8926211
|
|
|
|
|
CDD:273799
CDD:238657 |
transferrin-binding protein A |
Protective antigen |
N. meningitidis TbpA Protein Vaccine
|
|
3935
|
tbpA |
Haemophilus parasuis |
|
|
|
AAV68905
|
|
|
|
|
CDD:273799
CDD:238657 |
TbpA |
Protective antigen |
|
|
3930
|
tbpB |
Haemophilus parasuis |
|
|
|
AAV68899
|
|
|
|
|
CDD:279621 |
TbpB |
Protective antigen |
|
|
695
|
Tbx21 |
Mus musculus |
|
57765
|
|
247269497
|
RP23-428N4.9 |
AL606664 |
NP_062380 |
|
|
T-box 21 |
Protective antigen |
|
|
4676
|
TBXT |
Homo sapiens |
|
6862
|
|
394953947
|
|
AL627443 |
NP_001257413 |
|
|
transcript variant 2 |
Protective antigen |
Autologous TARP Peptide-Pulsed Dendritic Cell Vaccine
|
|
1331
|
TC-83 |
Venezuelan equine encephalitis virus |
|
|
|
1375089
|
|
|
|
|
CDD:109979
CDD:190039
CDD:201519
CDD:201874 |
structural polyprotein precursor |
Other |
|
|
763
|
Tc00.1047053434931.10 |
Trypanosoma cruzi strain CL Brener |
VO_0011300
|
3532027
|
|
71398801
|
Tc00.1047053434931.1 |
AAHK01004051 |
XP_802646 |
|
|
paraxonemal rod protein PAR2 |
Protective antigen |
T. cruzi PAR2 Protein Vaccine
T. cruzi DNA vaccine encoding PFR2 fused with HSP70
|
|
432
|
TC0439 adherence factor |
Chlamydia muridarum str. Nigg |
VO_0010887
|
1245792
|
|
497916297
|
TC_RS02190 |
AE002160 |
WP_010230453 |
|
|
adherence factor |
Protective antigen |
C. muridarum DNA vaccine encoding TC0439
|
|
430
|
TC0512 outer membrane protein, putative |
Chlamydia muridarum str. Nigg |
VO_0010885
|
1245872
|
|
497916494
|
TC_RS02600 |
AE002160 |
WP_010230650 |
|
|
outer membrane protein assembly factor BamA |
Protective antigen |
C. muridarum DNA vaccine encoding TC0512
|
|
431
|
TC0757 hypothetical protein |
Chlamydia muridarum str. Nigg |
VO_0010886
|
1246122
|
|
497917305
|
TC_RS03850 |
AE002160 |
WP_010231461 |
|
|
hypothetical protein |
Protective antigen |
C. muridarum DNA vaccine encoding TC0757
|
|
433
|
TC0767 hypothetical protein |
Chlamydia muridarum str. Nigg |
VO_0010888
|
1246132
|
|
497917334
|
TC_RS03895 |
AE002160 |
WP_010231490 |
|
|
polysaccharide deacetylase |
Protective antigen |
C. muridarum DNA vaccine encoding TC0767/768
|
|
434
|
TC0768 hypothetical protein |
Chlamydia muridarum Nigg |
VO_0010889
|
1246133
|
|
15835382
|
TC_0768 |
AE002160 |
NP_297141 |
|
|
hypothetical protein |
Protective antigen |
C. muridarum DNA vaccine encoding TC0767/768
|
|
4375
|
Tc24 (Obselete) |
Trypanosoma cruzi |
|
|
|
ABA62611
|
|
|
|
|
CDD:238008
CDD:290234 |
Tc24 protein |
Protective antigen |
T. cruzi Tc24 vaccine
|
|
1292
|
Tc24 from Trypanosoma cruzi |
Trypanosoma cruzi |
|
|
|
77167273
|
|
|
|
|
CDD:238008
CDD:290234 |
Tc24 protein |
Protective antigen |
T. cruzi DNA vaccine encoding TSA-1 and Tc24
|
|
1293
|
Tc52 from Trypanosoma cruzi |
Trypanosoma cruzi |
|
|
|
32395938
|
|
|
|
|
CDD:48493
CDD:198286
CDD:212209 |
thiol transferase Tc52 |
Other |
|
|
4905
|
Tc80 |
Trypanosoma grayi |
|
20379487
|
|
686630079
|
DQ04_00541100 |
JMRU01000054 |
XP_009307485 |
|
|
|
Protective antigen |
T. cruzi vaccine encoding Tc80
T. cruzi vector vaccine encoding Tc80
T. cruzi DNA prime/rTc80 + ODN-CpG boost vaccine
|
|
1603
|
Tc85-11 |
Trypanosoma cruzi strain Peru |
|
|
3599494
|
3599495
|
|
|
AAD13347.1 |
|
CDD:271234
CDD:290570
CDD:304605
CDD:288214 |
surface glycoprotein Tc85-11 |
Protective antigen |
|
|
388
|
TcfA |
Bordetella pertussis |
|
|
|
282766137
|
|
|
|
|
CDD:154874 |
tracheal colonization factor |
Other |
B. pertussis DNA vaccine encoding TcfA
VC-TetC/Tcf
|
|
4867
|
TcG4 |
Trypanosoma grayi |
|
20379573
|
|
686630251
|
DQ04_00581060 |
JMRU01000058 |
XP_009307571 |
|
|
|
Protective antigen |
T. cruzi Vaccine TcVac4
T. cruzi Vaccine TcVac3 encoding TcG2 and TcG4
T. cruzi Vaccine TcVac2
T. cruzi DNA-prime/MVA-boost vaccine encoding TcG2 and TcG4
T. cruzi DNA prime/Protein-boost vaccine encoding TcG2 and TcG4
|
|
732
|
tcpA |
Vibrio cholerae O1 |
VO_0011271
|
|
|
21616882
|
|
|
|
1OQV
|
CDD:283573 |
TcpA |
Protective antigen |
|
|
733
|
TcpF |
Vibrio cholerae O1 biovar El Tor str. N16961 |
VO_0011272
|
2614504
|
|
15640854
|
VC0837 |
AE003852 |
NP_230485 |
|
GDB:5363132 |
toxin co-regulated pilus biosynthesis protein F |
Protective antigen |
|
|
811
|
tcrP |
Coccidioides immitis |
VO_0011342
|
|
|
13508695
|
|
|
|
|
CDD:176673
GOA:Q1E803
InterPro: IPR004360
InterPro: IPR005956
UniProtKB/UniProt: Q1E803 |
human T-cell reactive protein |
Protective antigen |
|
|
1071
|
TcSP2 |
Trypanosoma cruzi |
|
|
323099910
|
|
|
ADX23547.1 |
|
|
|
|
Protective antigen |
|
|
4916
|
TcSSP4 |
|
|
|
|
|
|
|
|
|
|
|
Protective antigen |
|
|
1608
|
TCTS-154 |
Trypanosoma cruzi strain Y |
|
|
|
840708
|
|
|
|
|
CDD:271234
CDD:290570
CDD:304605
CDD:285602
CDD:292450 |
trans-sialidase |
Protective antigen |
|
|
705
|
TERT |
Homo sapiens |
|
7015
|
|
301129200
|
|
AB016767 |
NP_001180305 |
|
|
transcript variant 4 |
Protective antigen |
Cancer Subunit GV1001 Protein Vaccine
Telomerase-specific Type 5 Adenovirus OBP-301 Vaccine
Telomerase: 540-548 Peptide Vaccine
UV1 Telomerase Peptide Vaccine
hTERT/Survivin/Melanoma Tumor Cell-Derived mRNA-Transfected Dendritic Cell Vaccine
hTERT-LAMP mRNA-loaded Autologous Dendritic Cell Vaccine GRNVAC1
hTERT Vaccine V934/V935
hTERT mRNA/Survivin Peptide-double-loaded Autologous Dendritic Cell Vaccine
hTERT I540/R572Y/D988Y Multipeptide Vaccine
Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine
Primary Prostate Cancer Tissue/hTERT/Survivin mRNA-loaded Autologous Dendritic Cell Vaccine
Synthetic hTERT DNA Vaccine INO-1400
Autologous Renal Cell Carcinoma Tumor Lysate-Pulsed Dendritic Cell Vaccine
hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301
Survivin Sur1M2 Peptide Vaccine
|
|
4539
|
TET1 |
Homo sapiens |
|
80312
|
|
156139122
|
|
AL360177 |
NP_085128 |
|
|
transcript variant X10 |
Protective antigen |
MELITAC 12.1 Peptide Vaccine
|
|
4643
|
tetX |
Clostridium tetani E88 |
|
24255210
|
|
499413369
|
CTC_RS14060 |
AF528097 |
WP_011100836 |
|
|
tetanus neurotoxin TetX |
Protective antigen |
|
|
4592
|
TF |
Homo sapiens |
|
7018
|
|
1519313280
|
|
AC080128 |
NP_001054 |
|
|
transcript variant 2 |
Protective antigen |
Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine
|
|
4093
|
tfbA |
Actinobacillus pleuropneumoniae |
|
|
|
AAA21929
|
|
|
|
|
CDD:279621 |
transferrin-binding protein |
Protective antigen |
|
|
4374
|
TFP250 |
Eimeria maxima |
|
|
|
AAO52676
|
|
|
|
|
CDD:294047
CDD:284955
CDD:238011
CDD:289699
CDD:214542
CDD:301595 |
TFP250 |
Protective antigen |
|
|
4894
|
TgADF |
|
|
7893682
|
|
AAC47717.1
|
|
|
|
|
CDD:449582
CDD:200442 |
actin depolymerizing factor |
Protective antigen |
rTgADF
|
|
4855
|
TgCST2 |
Toxoplasma gondii ME49 |
|
7894302
|
|
237836689
|
TGME49_203600 |
CM002041 |
XP_002367642 |
|
|
|
Protective antigen |
ISA 201-rTgCST2
|
|
4670
|
TGFB2 |
Homo sapiens |
|
7042
|
|
208022653
|
|
AC096638 |
NP_001129071 |
|
|
transcript variant 4 |
Protective antigen |
Belagenpumatucel-L
|
|
4875
|
TgNTPase-II |
|
|
29769498
|
|
Q27895.1
|
|
|
|
|
CDD:450142 |
Nucleoside-triphosphatase 2 |
Protective antigen |
|
|
4893
|
TgPF |
Toxoplasma gondii ME49 |
|
7900190
|
|
1084891739
|
TGME49_293690 |
CM002034 |
XP_018638612 |
|
|
|
Protective antigen |
TgPF-OML
|
|
4895
|
TgRACK1 |
|
|
|
|
AAT11121.1
|
|
|
|
|
CDD:238121
CDD:293791 |
receptor for activated C kinase 1 |
Protective antigen |
rTgRACK1
|
|
1344
|
Th |
Mus musculus |
|
21823
|
|
6678337
|
|
AC012382 |
NP_033403 |
|
|
tyrosine hydroxylase |
Other |
|
|
256
|
Tig |
Brucella melitensis bv. 1 str. 16M |
VO_0010969
|
1196780
|
|
17987352
|
BMEI1069 |
AE008917 |
NP_539986 |
|
|
trigger factor |
Protective antigen |
B. melitensis bp26 and TF Nasal Vaccine
|
|
4211
|
tig |
Streptococcus agalactiae |
|
|
|
AFV71595
|
|
|
|
|
CDD:234956 |
Trigger factor |
Protective antigen |
|
|
199
|
Tir |
Escherichia coli O157:H7 str. EDL933 |
VO_0010940
|
960860
|
|
15804222
|
Z5112 |
AE005174 |
NP_290261 |
|
|
translocated intimin receptor protein |
Protective antigen |
E. coli O157:H7 subunit vaccine expressing Esps and Tir
Recombinant Tir Protein Vaccine
|
|
1042
|
TK |
Human herpesvirus 1 |
|
2703374
|
|
9629403
|
HHV1gp034 |
X14112 |
NP_044624 |
1KIM
|
|
thymidine kinase |
Virmugen |
Herpes simplex virus 1 TK mutant vaccine
|
|
1043
|
TK |
Equid herpesvirus 1 Ab4 |
|
|
|
59214
|
|
|
|
1P73
|
CDD:177537
GOA:P69185
InterPro: IPR001889
UniProtKB/UniProt: P69185 |
thymidine kinase |
Virmugen |
Equid herpesvirus TK mutant vaccine
|
|
4566
|
TLR4 |
Homo sapiens |
|
7099
|
|
4507533
|
|
AF177765 |
NP_003257 |
|
|
transcript variant 3 |
Protective antigen |
NY-ESO-1/GLA-SE Vaccine ID-G305AmN
Autologous TriMix-DC Melanoma Vaccine
|
|
4503
|
TLR7 |
Homo sapiens |
|
51284
|
|
7706093
|
|
AC003046 |
NP_057646 |
|
|
toll like receptor 7 |
Protective antigen |
Plasmacytoid Dendritic Cell Vaccine
|
|
4576
|
TLR9 |
Homo sapiens |
|
54106
|
|
8394456
|
|
AC097637 |
NP_059138 |
|
|
toll like receptor 9 |
Protective antigen |
Plasmacytoid Dendritic Cell Vaccine
|
|
591
|
TM-1 |
Mycoplasma gallisepticum |
VO_0011178
|
|
|
7249262
|
|
|
|
|
CDD:283372 |
TM-1 |
Protective antigen |
M. gallisepticum TM-1 Protein Subunit Vaccine
|
|
4148
|
tmbC |
Streptococcus pyogenes |
|
|
|
BAQ53101
|
|
|
|
|
CDD:224658 |
basic membrane family protein |
Protective antigen |
|
|
4595
|
TMEM37 |
Homo sapiens |
|
140738
|
|
116325983
|
|
AC013275 |
NP_899063 |
|
|
transcript variant X1 |
Protective antigen |
PR1 Leukemia Peptide Vaccine
|
|
857
|
TmpB |
Treponema pallidum subsp. pallidum str. Nichols |
VO_0012400
|
2611387
|
|
499184674
|
TP_RS03880 |
AE000520 |
WP_010882214 |
|
|
treponemal membrane protein B |
Protective antigen |
T. pallidum TmpB Protein Vaccine
|
|
4433
|
TNF |
Homo sapiens |
|
7124
|
|
25952111
|
|
AB088112 |
NP_000585 |
|
|
tumor necrosis factor |
Protective antigen |
Ad CMV I kappaB alpha
Allogeneic Dendritic Cell Vaccine COMBIG-DC
Golnerminogene Pradenovec Vaccine
BCG, Cell Wall Skeleton
|
|
4616
|
tnf-alpha |
Oncorhynchus mykiss |
|
100136034
|
|
185135733
|
|
AJ278085 |
NP_001117829 |
|
|
tumour necrosis factor alpha-like |
Protective antigen |
Recombinant Human Fusion Protein L19TNFalpha Vaccine
|
|
700
|
Tnfrsf13b |
Mus musculus |
|
57916
|
|
10946668
|
RP23-55I2.2 |
AL646093 |
NP_067324 |
|
|
transcript variant X1 |
Protective antigen |
|
|
294
|
TNFRSF18 |
Homo sapiens |
|
8784
|
|
4759246
|
|
AL162741 |
NP_004186 |
|
|
transcript variant X1 |
Protective antigen |
Sargramostim Plasmid DNA Melanoma Vaccine Adjuvant
|
|
691
|
Tnfrsf9 |
Mus musculus |
|
21942
|
|
117422435
|
RP23-272N19.6 |
AL607084 |
NP_001070976 |
|
|
transcript variant 1 |
Protective antigen |
|
|
4945
|
TNFSF10 |
Homo sapiens |
|
8743
|
|
300193032
|
|
AC007919 |
NP_001177871 |
|
|
transcript variant 4 |
Protective antigen |
Recombinant Adenovirus 5 Encoding Tumor Necrosis Factor-related Apoptosis-Inducing Ligand Vaccine
|
|
4583
|
TNFSF18 |
Homo sapiens |
|
8995
|
|
157419142
|
|
AL031599 |
NP_005083 |
|
|
TNF superfamily member 18 |
Protective antigen |
GITRL RNA-transfected Autologous Dendritic Cell Vaccine
|
|
885
|
tolA |
Salmonella enterica subsp. enterica serovar Typhimurium SL1344 |
|
|
|
301157338
|
STM0747 |
AE006468 |
NP_459732 |
|
CDD:181920
CDD:200776
UniProtKB/TrEMBL: E1W9P0 |
tolA protein |
Virmugen |
Salmonella Typhimurium tolA mutant vaccine
|
|
3931
|
TolC |
Haemophilus parasuis |
|
|
|
WP_075604781
|
|
|
|
|
CDD:224455 |
TolC family protein |
Protective antigen |
|
|
4807
|
TOMM34 |
Homo sapiens |
|
10953
|
|
21361356
|
|
AL109839 |
NP_006800 |
|
|
transcript variant X2 |
Protective antigen |
HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 Multipeptide Vaccine
|
|
4097
|
tonB2 |
Actinobacillus pleuropneumoniae serovar 2 str. S1537 |
|
|
|
AAR95695
|
|
|
|
|
CDD:330347
CDD:281534 |
TonB2 |
Protective antigen |
A. pleuropneumoniae TonB2 vaccine
|
|
4458
|
TOP2A |
Homo sapiens |
|
7153
|
|
19913406
|
|
AC080112 |
NP_001058 |
|
|
transcript variant X1 |
Protective antigen |
Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907
|
|
750
|
tox |
Corynebacterium diphtheriae |
VO_0011287
|
|
|
38199106
|
|
|
|
|
CDD:280859
CDD:238651
CDD:280860
CDD:279642
GOA:Q6NK15
InterPro: IPR000512
InterPro: IPR022404
InterPro: IPR022405
InterPro: IPR022406
UniProtKB/TrEMBL: Q6NK15 |
Diphtheria toxin precursor |
Protective antigen |
|
|
4580
|
tox1 |
Corynebacterium diphtheriae PW8 |
|
11716682
|
|
376253302
|
CDPW8_0179 |
CP003216 |
YP_005141761 |
|
|
diphtheria toxin |
Protective antigen |
Haemophilus Influenzae B Vaccine
CTP-37-DT Vaccine
Globo H-DT Vaccine OBI-833
|
|
3835
|
toxin-coregulated pili (TCP). |
Vibrio cholerae |
|
|
|
ORR76700
|
|
|
|
|
|
TCP pilus virulence regulatory protein |
Protective antigen |
|
|
4344
|
Tp1 |
Theileria parva |
|
|
|
AIA64008
|
|
|
|
|
|
CD8+ T cell target antigen Tp1 |
Protective antigen |
|
|
4343
|
Tp2 |
Theileria parva |
|
|
|
AIA64020
|
|
|
|
|
|
CD8+ T cell target antigen Tp2 |
Protective antigen |
|
|
4692
|
TP53 - delete |
Homo sapiens |
|
7157
|
|
120407068
|
|
AB118156 |
NP_000537 |
|
|
transcript variant 2 |
Protective antigen |
|
|
858
|
tp92 |
Treponema pallidum subsp. pallidum str. Nichols |
VO_0012401
|
|
|
AAC16524
|
|
|
|
|
CDD:227116 |
putative outer membrane protein |
Protective antigen |
T. pallidum Tp92 Protein Vaccine
|
|
3838
|
tp92 |
Treponema pallidum subsp. pallidum |
|
|
|
AAF61471
|
|
|
|
|
CDD:227116
CDD:284624
CDD:279448 |
Tp92 |
Protective antigen |
|
|
1392
|
TPA-PA63 |
synthetic construct derived from Bacillus anthracis |
|
|
|
193873765
|
|
|
|
|
CDD:281492 |
TPA-PA63 |
Protective antigen |
B. anthracis DNA vaccine pTPA-PA63
|
|
1395
|
TPA-PA63-LAMP1 |
synthetic construct derived from Bacillus anthracis |
|
|
|
193873763
|
|
|
|
|
CDD:281492
CDD:213052 |
TPA-PA63-LAMP1 |
Protective antigen |
B. anthracis DNA vaccine pTPA-P
|
|
291
|
TPBG |
Homo sapiens |
|
7162
|
|
262205665
|
|
AJ012159 |
NP_001159864 |
|
|
transcript variant 1 |
Protective antigen |
Recombinant Human Papillomavirus Nonavalent Vaccine
Recombinant Modified Vaccinia Ankara-5T4 Vaccine
|
|
3848
|
tpf1 |
Treponema pallidum |
|
|
|
WP_010882482
|
|
|
|
|
CDD:223854
CDD:153102 |
DNA starvation/stationary phase protection protein |
Protective antigen |
|
|
1365
|
TPI |
Schistosoma japonicum |
|
|
|
2501312
|
|
|
|
|
CDD:238190 |
Triosephosphate isomerase |
Protective antigen |
Chinese S. japonicum DNA vaccine SjCTPI
Chinese S. japonicum DNA vaccine SjCTPI-Hsp70
|
|
3839
|
tprF |
Treponema pallidum |
|
|
|
AGF43527
|
|
|
|
|
CDD:280810
CDD:280819 |
TprF |
Protective antigen |
|
|
3923
|
tpx |
Helicobacter pylori |
|
|
|
ADZ50126
|
|
|
|
|
CDD:224988
CDD:278975
CDD:239312 |
Thiol peroxidase |
Protective antigen |
|
|
3837
|
TP_RS03795 |
Treponema pallidum |
|
|
|
WP_010882196
|
|
|
|
|
|
vascular adhesin/metalloprotease pallilysin |
Protective antigen |
|
|
4845
|
trans-sialidase(TsF) from Trypanosoma cruzi |
Trypanosoma cruzi strain CL Brener |
|
3537653
|
|
71410253
|
|
AAHK01001396 |
XP_807431 |
|
|
|
Protective antigen |
T. cruzi Tsf-ISPA vaccine
|
|
3868
|
transcription-repair coupling factor |
Rickettsia prowazekii str |
|
|
|
NP_220966
|
|
|
|
|
CDD:224118
CDD:215001
CDD:278688
CDD:238005
CDD:238034
CDD:198050 |
transcription-repair coupling factor |
Protective antigen |
|
|
4182
|
traP |
Staphylococcus aureus |
|
|
|
ADK12000
|
|
|
|
|
CDD:292771 |
target of RNAIII-activating protein |
Protective antigen |
|
|
4353
|
trap |
Babesia bovis |
|
|
|
ACM44016
|
|
|
|
|
CDD:294047
CDD:238119
CDD:214559 |
thrombospondin-related anonymous protein |
Protective antigen |
|
|
138
|
TRAP from P. falciparum |
Plasmodium falciparum 3D7 |
VO_0010920
|
814170
|
|
124513464
|
PF3D7_1335900 |
AL844509 |
XP_001350088 |
|
|
Thrombospondin-related anonymous protein (TRAP), SSP-2, SSP2, Sporozoite specific protein 2, Sporozoite surface protein 2 |
Protective antigen |
P. falciparum DNA and MVA encoding ME-TRAP
ChAd63-MVA ME-TRAP
|
|
3968
|
traT |
Escherichia coli |
|
|
|
AAT94214
|
|
|
|
|
|
TraT |
Protective antigen |
|
|
1360
|
TRP-1 |
Mus musculus |
|
22178
|
|
530537244
|
RP23-372M15.1 |
AF087673 |
NP_001268943 |
|
|
transcript variant X1 |
Protective antigen |
Melanoma recombinant vector vaccine rVVmTRP-1 encoding TRP-1
TRP1(0RF3):1-9 Peptide Vaccine
Recombinant Vaccinia-TRP1 Vaccine
|
|
1342
|
TRP-2 |
Homo sapiens |
|
1638
|
|
193788640
|
|
AL139318 |
NP_001123361 |
|
|
transcript variant 3 |
Protective antigen |
Melanoma DNA vaccine hTRP2 encoding TRP-2
Melanoma DNA vaccine gp75 DNA encoding melanosomal membrane glycoproteins, gp75
TRP-2: 180-188 Peptide Vaccine
SCIB1 DNA vaccine
|
|
709
|
Trp2 |
Mus musculus |
|
104042
|
|
|
|
|
|
|
|
tRNA proline 2 |
Protective antigen |
Melanoma DNA vaccine pUB-TRP-2 encoding a fusion protein linking murine ubiquitin (UB) to the N-terminus of the full-length mTRP-2
rMCMV-TRP2
|
|
4673
|
TRPC1 |
Homo sapiens |
|
7220
|
|
353411934
|
|
AC022291 |
NP_001238774 |
|
|
transcript variant X4 |
Protective antigen |
|
|
908
|
trpD |
Mycobacterium tuberculosis H37Rv |
|
887681
|
|
15609329
|
Rv2192c |
BX842579 |
NP_216708 |
2BPQ
|
|
anthranilate phosphoribosyltransferase |
Virmugen |
Mycobacterium tuberculosis trpD mutant vaccine
|
|
1021
|
trpE |
Bordetella bronchiseptica |
|
|
|
8515760
|
|
|
|
|
CDD:184146
CDD:147064
CDD:187007 |
anthranilate synthase large subunit |
Virmugen |
Bordetella bronchiseptica aroA/trpE mutant vaccine
|
|
890
|
trxA |
Salmonella enterica subsp. enterica serovar Typhimurium SL1344 |
|
|
|
301160436
|
STM3915 |
AE006468 |
NP_462806 |
|
CDD:48496
UniProtKB/TrEMBL: E1WDY2 |
thioredoxin |
Virmugen |
Salmonella Typhimurium trxA mutant vaccine
|
|
757
|
TS |
Trypanosoma cruzi |
VO_0011294
|
|
|
258547365
|
|
|
|
|
CDD:271234
CDD:304605 |
trans-sialidase |
Protective antigen |
T. cruzi DNA Vaccine pGFP-TSA1
T. cruzi DNA vaccine pTS encoding T. cruzi antigens
|
|
735
|
TSA |
Leishmania major |
VO_0011273
|
|
3411093
|
3411094
|
|
|
AAC31146.1 |
|
CDD:140280
CDD:239313 |
thiol specific antioxidant |
Protective antigen |
L. major DNA Vaccine encoding LACKp24, TSA, LmSTI1 and CPa
LEISH-F1+MPL-SE
L. major DNA vaccine encoding TSA, LMSTI1, KMP11, and LACK
|
|
807
|
TSA |
|
VO_0011338
|
|
|
62175539
|
|
|
|
|
CDD:271234
CDD:290570 |
trans-sialidase |
Protective antigen |
T. brucei DNA Vaccine encoding TSA protein
|
|
759
|
TSA-1 |
|
VO_0011296
|
|
|
162315
|
|
|
|
|
CDD:271234
CDD:290570
CDD:304605
CDD:281915 |
trypomastigote surface glycoprotein |
Protective antigen |
T. cruzi DNA Vaccine encoding TSA-1 protein
T. cruzi DNA vaccine encoding TSA-1, ASP-1, ASP-2
T. cruzi DNA vaccine encoding TSA-1 and Tc24
|
|
4387
|
TSP |
Schistosoma japonicum |
|
|
|
ABQ44513
|
|
|
|
|
CDD:278750
CDD:239401 |
TSP |
Protective antigen |
|
|
4376
|
TSSA |
Trypanosoma cruzi |
|
|
|
ACY54510
|
|
|
|
|
|
trypomastigote small surface antigen |
Protective antigen |
|
|
4175
|
TSST-1 |
Staphylococcus aureus |
|
|
|
AAA26682
|
|
|
|
|
CDD:332684 |
toxic shock syndrome toxin-1 |
Protective antigen |
|
|
451
|
TTC |
|
VO_0010909
|
|
|
157829735
|
|
|
|
1A8D
|
CDD:285228
CDD:285226 |
|
Protective antigen |
C. tetani DNA vaccine pcDNA3tetC encoding fragment C
|
|
4070
|
ttsS |
Burkholderia pseudomallei |
|
|
|
WP_004530590
|
|
|
|
|
CDD:274196 |
YscQ/HrcQ family type III secretion apparatus protein |
Protective antigen |
|
|
4212
|
tuf |
Streptococcus agalactiae |
|
|
|
KUH47811
|
|
|
|
|
|
elongation factor Tu |
Protective antigen |
|
|
474
|
TUL4 |
Francisella tularensis |
VO_0011076
|
|
|
148688
|
|
|
|
|
|
17 kDa major membrane protein (TUL4) precursor |
Protective antigen |
F. tularensis vaccine X4072(pTUIA-15)
|
|
3962
|
tul4 |
Francisella tularensis |
|
|
|
AMD39429
|
|
|
|
|
|
Tul4 |
Protective antigen |
|
|
4529
|
Tumor Associated Antigen |
|
|
|
|
|
|
|
|
|
|
|
Protective antigen |
Light-Emitting Oncolytic Vaccinia Virus GL-ONC1 Vaccine
|
|
183
|
TviA |
Salmonella enterica subsp. enterica serovar Typhi str. CT18 |
|
1250863
|
|
16763124
|
STY4662 |
NC_003198.1 |
NP_458741.1 |
|
|
Vi polysaccharide biosynthesis protein |
|
|
|
729
|
TviB |
Salmonella enterica subsp. enterica serovar Typhi str. Ty2 |
VO_0011269
|
1067316
|
|
29144603
|
t4352 |
AE014613 |
NP_807945 |
|
|
VI polysaccharide biosynthesis UDP-glucose/GDP-mannose dehydrogenase |
Protective antigen |
S. typimurium Vi4072
|
|
177
|
Ty2 |
Salmonella enterica subsp. enterica serovar Typhi Ty2 |
|
1070398
|
|
29144781
|
t4545 |
NC_004631.1 |
NP_808123.1 |
|
|
hypothetical protein |
|
|
|
1335
|
Tyrosinase |
Homo sapiens |
|
7299
|
|
4507753
|
|
AH003020 |
NP_000363 |
|
|
transcript variant X1 |
Protective antigen |
Melanoma DNA vaccine TA2Mâ„¢ encoding tyrosinase peptides
Adenovirus Encoding Tyrosinase/MART-1/MAGEA6-transduced Autologous Dendritic Cell Vaccine
Tyrosinase-KLH Vaccine
Vaccinia-Tyrosinase Vaccine
Xenogeneic Tyrosinase DNA Vaccine
Alpha-type-1 Polarized Dendritic Cells
Autologous TriMix-DC Melanoma Vaccine
27-35(27L):MART-1 peptide vaccine
Autologous Lymphoma Cell/Allogeneic Dendritic Cell Electrofusion Hybrid Vaccine
HLA-A2-Binding TYR/MART-1/gp100 Multipeptide-Pulsed Autologous Dendritic Cell Vaccine
NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine
Recombinant Fowlpox-Tyrosinase Vaccine
Synchrotope TA2M Plasmid DNA Vaccine
Synchrovax SEM Plasmid DNA Vaccine
MELITAC 12.1 Peptide Vaccine
|
|
1377
|
Tyrosinase from Mouse |
Mus musculus |
|
22173
|
|
959092340
|
|
AC122517 |
NP_001304326 |
|
|
transcript variant 2 |
Protective antigen |
Melanoma DNA vaccine xenogeneic DNA encoding murine tyrosinase
|
|
293
|
TYRP1 |
Homo sapiens |
|
7306
|
|
4507757
|
RP11-3L8.1 |
AF001295 |
NP_000541 |
|
CDD:144010
CCDS:CCDS34990.1
HGNC:12450
HPRD:00283
MIM:115501 |
transcript variant X1 |
Protective antigen |
B16 melanoma DNA vaccine pCMV-hTRP-1 encoding TRP-1
Bcl-Xs Adenovirus Vaccine
|
|
4789
|
Tyrp1 |
Mus musculus |
|
22178
|
|
530537244
|
|
AF087673 |
NP_001268943 |
|
|
transcript variant X1 |
Protective antigen |
B16 melanoma DNA vaccine pCMV-hTRP-1 encoding TRP-1
B16 melanoma DNA vaccine pSin-hTRP-1 encoding TRP-1
B16 melanoma DNA vaccine pSin-mTRP-1
|
|
1345
|
Ubiquitin |
Mus musculus |
|
|
|
55118
|
|
|
|
|
CDD:176398
GDB:120478
GDB:133775
GOA:P0CG49
InterPro: IPR000626
InterPro: IPR019954
InterPro: IPR019955
InterPro: IPR019956
UniProtKB/UniProt: P0CG49 |
ubiquitin |
Protective antigen |
Melanoma DNA vaccine pUB-TRP-2 encoding a fusion protein linking murine ubiquitin (UB) to the N-terminus of the full-length mTRP-2
|
|
1621
|
ubiquitin |
Sus scrofa |
|
|
164707
|
164708
|
|
|
AAA31133.1 |
|
CDD:294102
CDD:176398
CDD:214563 |
ubiquitin copy 1 |
Protective antigen |
PRRSV DNA vaccine pCA-U-optiGP5
|
|
1029
|
UIS3 |
Plasmodium yoelii yoelii str. 17XNL |
|
3830198
|
|
83315853
|
PY03011 |
AABL01000850 |
XP_730972 |
2VWA
|
|
|
Virmugen |
P. yoelii UIS3 mutant vaccine
|
|
894
|
UIS4 |
Plasmodium yoelii yoelii str. 17XNL |
|
3853948
|
|
82753006
|
PY00876 |
AABL01000235 |
XP_727503 |
|
CDD:158776
CDD:152003 |
upregulated in infective sporozoites 3 |
Virmugen |
|
|
1031
|
UL0 |
Gallid herpesvirus 1 |
|
3239037
|
|
148828637
|
GaHV1_gp60 |
X97256 |
YP_182395 |
|
|
protein UL0 |
Virmugen |
Gallid herpesvirus 1 UL0 mutant vaccine
|
|
4556
|
UL122 |
Human betaherpesvirus 5 |
|
3077563
|
|
52139286
|
HHV5wtgp107 |
AY446894 |
YP_081561 |
|
|
regulatory protein IE2 |
Protective antigen |
Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
|
|
4326
|
UL123 |
Human cytomegalovirus |
|
|
|
P03169
|
|
|
|
|
CDD:284701 |
55 kDa immediate-early protein 1 |
Protective antigen |
|
|
4555
|
UL123 |
Human betaherpesvirus 5 |
|
3077513
|
|
52139287
|
HHV5wtgp108 |
AY446894 |
YP_081562 |
|
|
regulatory protein IE1 |
Protective antigen |
Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
|
|
1016
|
UL23 |
Suid herpesvirus 1 |
|
2952559
|
|
51557518
|
SuHV1_gp35 |
BK001744 |
YP_068352 |
|
|
thymidine kinase |
Virmugen |
Pseudorabies virus glycoprotein E/G/UL23 mutant vaccine
|
|
1041
|
UL23 |
Felid herpesvirus 1 |
|
8658565
|
|
270339476
|
FeHV-1_gp39 |
M26660 |
YP_003331558 |
|
|
thymidine kinase |
Virmugen |
Feline herpesvirus 1 UL23 mutant vaccine
|
|
1044
|
UL23 |
Bovine herpesvirus 1 |
|
1487380
|
|
9629852
|
BoHV1_gp21 |
Z78205 |
NP_045336 |
|
|
thymidine kinase |
Virmugen |
Bovine herpesvirus 1 UL23 mutant vaccine
|
|
1045
|
UL23 |
Gallid herpesvirus 1 |
|
3239035
|
|
57790948
|
GaHV1_gp17 |
L36139 |
YP_182352 |
|
|
thymidine kinase |
Virmugen |
Gallid herpesvirus 1 UL23 mutant vaccine
|
|
500
|
UL27 |
Herpes simplex virus type 2 |
VO_0011097
|
|
|
1869850
|
|
|
|
|
CDD:223014
GOA:P08666
InterPro: IPR000234
UniProtKB/UniProt: P08666 |
glycoprotein B |
Protective antigen |
Herpes simplex virus type 2 DNA vaccine encoding GB
Herpes simplex virus DNA vaccine ∆gB-2 encoding gB
Herpes simplex virus DNA vaccine encoding gD and gB from HSV-2 strain Curtis
|
|
1653
|
UL27 |
Gallid alphaherpesvirus 1 |
|
3239023
|
|
57790952
|
GaHV1_gp21 |
|
YP_182356 |
|
|
envelope glycoprotein B |
Protective antigen |
|
|
502
|
UL27 from Herpes simplex virus type 1 |
Human herpesvirus 1 |
VO_0011099
|
2703455
|
|
9629408
|
HHV1gp041 |
X14112 |
NP_044629 |
2GUM
|
|
envelope glycoprotein B |
Protective antigen |
Herpes simplex virus DNA vaccine gB-DNA encoding gB
Herpes simplex virus DNA vaccine gBDNA encoding gB
Herpes simplex virus DNA vaccine pSIN-gB encoding gB
Herpes Simplex Virus Type 1 DNA Vaccine encoding 5gP
|
|
961
|
UL29 |
Human herpesvirus 1 |
|
2703458
|
|
9629410
|
HHV1gp41.5 |
X14112 |
NP_044631 |
|
|
single-stranded DNA-binding protein |
Virmugen |
Herpes simplex virus 1 UL29 mutant vaccine
|
|
393
|
UL44 |
Bovine alphaherpesvirus 1 |
VO_0011043
|
4783424
|
|
9629830
|
BoHV1_gp105 |
KC756965 |
NP_045314 |
|
|
envelope glycoprotein C |
Protective antigen |
Bovine herpesvirus 1 DNA vaccine pRSV-gC
Bovine herpesvirus 1 DNA vaccine AdCMVgC
|
|
655
|
UL44 |
Suid alphaherpesvirus 1 |
VO_0011239
|
2952505
|
|
51557513
|
SuHV1_gp30 |
BK001744 |
YP_068347 |
|
|
envelope glycoprotein C |
Protective antigen |
Pseduorabies Subunit Glycoprotein C Vaccine
|
|
506
|
UL44 from HSV-1 |
Human alphaherpesvirus 1 |
VO_0011103
|
2703410
|
|
820945274
|
HHV1gp00p31 |
AJ421498 |
YP_009137119 |
|
|
envelope glycoprotein C |
Protective antigen |
Herpes simplex virus type 1 DNA vaccine encoding GC
Herpes Simplex Virus Type 1 DNA Vaccine encoding 5gP
|
|
508
|
UL44 from HSV-2 |
Human alphaherpesvirus 2 |
|
1487331
|
|
820945196
|
HHV2p31 |
KX574886 |
YP_009137196 |
|
|
envelope glycoprotein C |
Protective antigen |
|
|
1030
|
UL47 |
Gallid herpesvirus 1 |
|
3239064
|
|
57790998
|
GaHV1_gp67 |
EU104855 |
YP_182402 |
|
|
tegument protein VP13/14 |
Virmugen |
Gallid herpesvirus 1 UL47 mutant vaccine
|
|
389
|
UL49 |
Bovine alphaherpesvirus 1 |
VO_0011040
|
1487397
|
|
9629826
|
BoHV1_gp05 |
GU591892 |
NP_045310 |
|
|
tegument protein VP22 |
Protective antigen |
Bovine herpesvirus 1 DNA vaccine tgD-VP22
|
|
1024
|
UL50 |
Suid herpesvirus 1 |
|
2952537
|
|
51557490
|
SuHV1_gp07 |
BK001744 |
YP_068324 |
|
|
deoxyuridine triphosphatase |
Virmugen |
Pseudorabies virus UL50 mutant vaccine
|
|
1756
|
UL83 |
Human herpesvirus 5 |
|
|
|
270355835
|
|
|
|
|
CDD:283448 |
tegument protein pp65 |
Protective antigen |
Human cytomegalovirus DNA vaccine VCL-CB01 encoding phosphoprotein 65 and gB
|
|
4476
|
UL83 |
Human betaherpesvirus 5 |
|
3077579
|
|
52139256
|
HHV5wtgp077 |
AY446894 |
YP_081531 |
|
|
tegument protein pp65 |
Protective antigen |
VCL-CB01 Vaccine
Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
CMV pp65 Peptide-pulsed Autologous Dendritic Cell Vaccine
CMVpp65/gB Plasmid Vaccine ASP0113
|
|
4660
|
UL83 |
Human betaherpesvirus 5 |
|
3077579
|
|
52139256
|
HHV5wtgp077 |
AY446894 |
YP_081531 |
|
|
tegument protein pp65 |
Protective antigen |
|
|
4813
|
UL97 |
|
|
|
|
|
|
|
|
|
|
|
|
Adenovirus RSV-TK
|
|
970
|
UP |
Toxoplasma gondii ME49 |
|
7900273
|
|
237830025
|
TGME49_110640 |
DS984727 |
XP_002364310 |
|
|
|
Virmugen |
T. gondii OMPDC/UP mutant vaccine
|
|
1393
|
UQ-PA63 |
synthetic construct derived from Bacillus anthracis |
|
|
|
193873767
|
|
|
|
|
CDD:176398
CDD:214563
CDD:281492 |
UQ-PA63 |
Protective antigen |
|
|
800
|
URE |
Coccidioides immitis |
VO_0011331
|
|
|
73808050
|
|
|
|
|
CDD:294200 |
urease |
Protective antigen |
C. immitis Subunit URE Protein Vaccine
|
|
804
|
ureB |
Helicobacter pylori |
VO_0011335
|
|
|
WP_000724295
|
|
|
|
|
CDD:184438 |
urease subunit alpha |
Protective antigen |
H. pylori vaccine encoding UreB
SL3261- UreA and UreB
|
|
403
|
ureC |
Actinobacillus pleuropneumoniae serovar 2 |
|
|
|
303253439
|
|
|
|
|
CDD:183894
CDD:30031 |
urease subunit alpha |
Virmugen |
Actinobacillus pleuropneumoniae ureC and apxIIA double mutant deletion vaccine
|
|
666
|
US3 |
Suid herpesvirus 1 |
|
2952561
|
|
126802155
|
SuHV1_gp65 |
BK001744 |
YP_068384 |
|
|
serine/threonine protein kinase US3 |
Virmugen |
Pseudorabies virus US3 mutant vaccine
|
|
505
|
US4 |
Human alphaherpesvirus 2 |
VO_0011102
|
1487356
|
|
820945216
|
HHV2p11 |
JN561323 |
YP_009137216 |
|
|
envelope glycoprotein G |
Protective antigen |
Herpes simplex virus type 2 vaccine using phage displaying GG protein
|
|
501
|
US5 |
Human alphaherpesvirus 1 |
VO_0011098
|
2703406
|
|
820945295
|
HHV1gp00p10 |
AY240646 |
YP_009137140 |
|
|
mRNA |
Protective antigen |
Herpes simplex virus type 1 DNA vaccine encoding GD
|
|
390
|
US6 |
Bovine alphaherpesvirus 1 |
VO_0011041
|
1487406
|
|
9629886
|
BoHV1_gp41 |
KU198480 |
NP_045370 |
|
|
envelope glycoprotein D |
Protective antigen |
Bovine herpesvirus 1 DNA vaccine tgD-VP22
Bovine herpesvirus 1 DNA vaccine AdCMVgD
Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDFL encoding gD
Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD
|
|
499
|
US6 |
Human alphaherpesvirus 2 |
VO_0011096
|
1487358
|
|
820945218
|
HHV2p09 |
KX574902 |
YP_009137218 |
|
|
envelope glycoprotein D |
Protective antigen |
|
|
656
|
US6 |
Suid alphaherpesvirus 1 |
VO_0011240
|
2952521
|
|
51557553
|
SuHV1_gp68 |
BK001744 |
YP_068387 |
|
|
envelope glycoprotein D |
Protective antigen |
Pseudorabies DNA Vaccine encoding glycoprotein D
|
|
392
|
US7 |
Bovine alphaherpesvirus 1 |
VO_0011042
|
4783432
|
|
9629887
|
BoHV1_gp127 |
KU198480 |
NP_045371 |
|
|
envelope glycoprotein I |
Protective antigen |
Bovine herpesvirus 1 GPI protein vaccine
|
|
1706
|
US7 |
Human herpesvirus 1 strain McKrae |
|
|
|
388525000
|
|
|
|
|
CDD:223033
CDD:279953 |
gI |
Protective antigen |
Herpes Simplex Virus Type 1 DNA Vaccine encoding 5gP
|
|
391
|
US8 |
Bovine herpesvirus 1 |
|
1487407
|
|
9629888
|
BoHV1_gp42 |
AJ004801 |
NP_045372 |
|
|
envelope glycoprotein E |
Virmugen |
Bovine herpesvirus 1 US8 (gE) mutant vaccine
|
|
507
|
US8 |
Human alphaherpesvirus 1 |
VO_0011104
|
2703448
|
|
820945298
|
HHV1gp00p07 |
AJ626470 |
YP_009137143 |
|
|
mRNA |
Protective antigen |
Herpes simplex virus type 1 DNA vaccine encoding GE
Herpes Simplex Virus Type 1 DNA Vaccine encoding 5gP
GSK1437173A
|
|
46
|
V antigen |
Yersinia pestis Antiqua |
VO_0010876
|
4118094
|
|
108793672
|
YPA_CD0030 |
CP000311 |
YP_636823 |
|
CDD:113558
InterPro: IPR005413 |
V antigen, antihost protein/regulator |
Protective antigen |
AdsecV
|
|
1408
|
V antigen from Y. pestis |
Yersinia pestis biovar Microtus str. 91001 |
|
2767532
|
|
45478553
|
YP_pCD52 |
AE017043 |
NP_995380 |
|
|
V antigen LcrV |
Protective antigen |
|
|
810
|
vacA |
Helicobacter pylori |
VO_0011341
|
|
|
WP_123946465
|
|
|
|
|
CDD:111576
CDD:309066 |
autotransporter vacuolating cytotoxin VacA |
Protective antigen |
H. pylori VacA protein vaccine
|
|
43
|
VACVgp196 |
Vaccinia virus |
|
1486323
|
|
|
VACVgp196 |
|
|
|
|
|
|
IMV-EEV
|
|
41
|
VACVgp200 |
Vaccinia virus |
|
1486327
|
|
|
VACVgp200 |
|
|
|
|
|
|
IMV-EEV
|
|
714
|
VEGFA |
Homo sapiens |
|
7422
|
|
76781480
|
RP1-261G23.1 |
AF092126 |
NP_001020537 |
2VPF
|
|
transcript variant 1 |
Protective antigen |
URLC10-TTK-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine
VEGFR-2 DNA Vaccine VXM01
hVEGF26-104/RFASE Peptide Vaccine
LY6K/VEGFR1/VEGFR2 Multipeptide Vaccine
PAX3/FKHR Peptide Vaccine
Cancer VEGFA protein vaccine
|
|
4424
|
VHL |
Homo sapiens |
|
7428
|
|
4507891
|
|
AC034193 |
NP_000542 |
|
|
transcript variant 3 |
Protective antigen |
VHL-42: 65-76(V74G) Peptide Vaccine
VHL-59: 116-128 Peptide Vaccine
VHL14 Peptide Vaccine
VHL16 Peptide Vaccine
VHL2 (Y12M) Peptide Vaccine
Von Hippel-Lindau Peptide Vaccine
(H115D)VHL35 Peptide Vaccine
FrSh61 (MEA) VHL33 Peptide Vaccine
|
|
891
|
vicK |
Streptococcus equi subsp. zooepidemicus MGCS10565 |
|
6760966
|
|
195978500
|
Sez_1395 |
CP001129 |
YP_002123744 |
|
|
TCS sensor kinase VicK |
Virmugen |
Streptococcus equi vicK mutant vaccine
|
|
1051
|
vif |
Feline immunodeficiency virus |
|
1724709
|
|
9626704
|
FIVgp3 |
M25381 |
NP_040974 |
|
|
hypothetical protein |
Virmugen |
Feline immunodeficiency virus vif mutant vaccine
|
|
1256
|
vif |
Human immunodeficiency virus 1 |
|
155459
|
|
9629361
|
HIV1gp3 |
AF033819 |
NP_057851 |
|
|
Vif |
Other |
|
|
1714
|
vif |
Simian-Human immunodeficiency virus strain SHIV-89.6 |
|
|
|
2828039
|
|
|
|
|
CDD:278957 |
vif |
Protective antigen |
HIV DNA vaccine SHIV-89.6 DNA (DNA/89.6)
|
|
998
|
virB2 |
Brucella melitensis biovar Abortus 2308 |
|
3827981
|
|
83269021
|
BAB2_0067 |
AM040265 |
YP_418312 |
|
|
type IV secretion system protein VirB2 |
Virmugen |
B. abortus and B. melitensis mutants with unmarked deletion of asp24, virB2, or manBA
|
|
194
|
virG |
Shigella sonnei Ss046 |
|
3670887
|
|
74314980
|
SSON_P143 |
CP000039 |
YP_313398 |
|
icsA; S0192 |
IcsA/VirG |
Virmugen |
Shigella sonnei virG/senA/senB/msbB2 mutant vaccine
Shigella sonnei virG/senA/senB mutant vaccine
|
|
4050
|
Virulence plasmid protein pGP3-D |
Chlamydia muridarum |
|
|
|
WP_010231988
|
|
|
|
|
CDD:283197 |
Virulence plasmid protein pGP3-D |
Protective antigen |
|
|
233
|
VjbR |
Brucella melitensis 16M |
|
1198888
|
|
17989461
|
BMEII1116 |
NC_003318 |
NP_542094 |
|
|
TRANSCRIPTIONAL ACTIVATOR, LUXR FAMILY |
Virmugen |
Microencapsulated B. melitensis vjbR mutant vaccine
|
|
1208
|
vjbR |
Brucella abortus S19 |
|
6326704
|
|
189022339
|
BAbS19_II01090 |
CP000888 |
YP_001932080 |
|
|
LuxR family regulatory protein; VjbR |
Virmugen |
Brucella abortus S19 vjbR mutant vaccine
|
|
415
|
VP1 |
Canine parvovirus |
VO_0011055
|
1489587
|
|
|
CPVgp3 |
|
|
|
|
|
Protective antigen |
Canine parvovirus DNA vaccine pGT36VP1
|
|
1290
|
VP1 |
Human coxsackievirus B3 |
|
|
|
254973291
|
|
|
|
|
CDD:278501
CDD:119412 |
VP1 |
Protective antigen |
Coxsackievirus DNA vaccine pCMV/VPl encoding VP1
|
|
1667
|
VP1 |
Duck hepatitis A virus strain ZJ serotype 1 |
|
|
|
129307224
|
|
|
|
|
|
VP1 protein |
Protective antigen |
Duck hepatitis virus 1 DNA vaccine pSCA/VP1
|
|
4241
|
VP1 |
Chicken Anemia Virus |
|
|
|
ABJ90436
|
|
|
|
|
CDD:282072 |
VP1 |
Protective antigen |
|
|
4310
|
VP1 |
Porcine parvovirus |
|
|
|
AFR43265
|
|
|
|
|
CDD:285583
CDD:279128 |
VP1 protein |
Protective antigen |
|
|
414
|
VP2 |
Canine parvovirus |
VO_0011054
|
1489588
|
|
|
CPVgp4 |
|
|
|
|
|
Protective antigen |
Canine parvovirus CPMV-PARVO1 protein vaccine
|
|
673
|
VP2 |
Rotavirus sp. |
VO_0011254
|
|
|
431460
|
|
|
|
|
CDD:282884 |
|
Protective antigen |
Rotavirus VP2/VP 6 Protein Vaccine
HSVT[VP7/6/2]
|
|
1413
|
VP2 |
Infectious pancreatic necrosis virus |
|
|
|
262212663
|
|
|
|
|
CDD:280020 |
VP2 |
Protective antigen |
IPNV DNA vaccine pEGFP-N1-SegA and pEGFP-N1-VP2
|
|
1636
|
VP2 |
Infectious bursal disease virus strain GX |
|
|
|
32482035
|
|
|
|
|
CDD:280020 |
VP2 |
Protective antigen |
IBDV DNA vaccine pCAGoptiVP2/rVP2
Infectious Bursal Disease Virus DNA Vaccine expressing VP2
rMDV-IBDV-VP2
rFPV-IBDV-VP2
FP-IBDV-VP2
|
|
4242
|
VP2 |
Chicken Anemia Virus |
|
|
|
AIU44252
|
|
|
|
|
CDD:251643 |
VP2 |
Protective antigen |
|
|
4248
|
VP2 |
Feline panleukopenia virus |
|
|
|
CAA38911
|
|
|
|
|
CDD:279128
GOA:P24840
InterPro: IPR001403
InterPro: IPR013607
InterPro: IPR016184
PDB: 1C8E
PDB: 1C8F
PDB: 1C8G
PDB: 1FPV
UniProtKB/UniProt: P24840 |
VP2 |
Protective antigen |
|
|
4254
|
VP2 |
Bluetongue virus |
|
|
|
AGS78451
|
|
|
|
|
CDD:279269 |
VP2 |
Protective antigen |
|
|
4298
|
VP2 |
Porcine rotavirus |
|
|
|
AJC68690
|
|
|
|
|
CDD:282884 |
VP2 protein |
Protective antigen |
|
|
4308
|
VP2 |
Porcine parvovirus |
|
|
|
AGZ94859
|
|
|
|
|
CDD:279128 |
VP2 |
Protective antigen |
|
|
4336
|
VP2 |
African horse sickness virus |
|
|
|
CDJ98824
|
|
|
|
|
CDD:279269 |
VP2 |
Protective antigen |
Plant Produced AHSV VP2 vaccine
Plant Produced AHSV Serotype 5 VLPs Vaccine
|
|
4240
|
VP2, VP3, and VP4 |
Infectious Bursal Disease Virus (IBDV) |
|
|
|
AAA52086
|
|
|
|
|
CDD:280020
CDD:280022
CDD:280021 |
VP2 |
Protective antigen |
|
|
1721
|
VP2-VP4-VP3 |
Infectious bursal disease virus strain 3529/92 serotype 1 |
|
|
|
452029936
|
|
|
|
|
CDD:280020
CDD:280022
CDD:280021 |
polyprotein |
Protective antigen |
IBDV DNA vaccine pCAGVP243-IL-18
rFPV-IBDV-VP 2.4.3
|
|
1739
|
VP22 |
Gallid herpesvirus 2 strain CVI988/Rispens |
|
|
|
33090005
|
|
|
|
|
CDD:309800 |
VP22 |
Protective antigen |
REV DNA vaccine VP22/gag and VP22/env
|
|
168
|
VP24 |
Lake Victoria marburgvirus |
|
920943
|
|
13489281
|
MARVgp6 |
NC_001608.2 |
NP_042030.1 |
|
|
VP24 protein |
|
Recombinant VEE Replicons expressing MBGV GP
|
|
4258
|
VP24 |
Ebola virus |
|
|
|
SCD11538
|
|
|
|
|
CDD:283933 |
VP24 |
Protective antigen |
|
|
12
|
VP24 from Reston ebolavirus |
Reston ebolavirus |
VO_0010860
|
955193
|
|
22789228
|
REBOVgp7 |
AF522874 |
NP_690586 |
|
|
mRNA |
Protective antigen |
|
|
17
|
VP24 from Zaire ebolavirus |
Zaire ebolavirus |
VO_0010866
|
911828
|
|
10313998
|
ZEBOVgp6 |
AY142960 |
NP_066250 |
|
|
mRNA |
Protective antigen |
VRP expressing VP24
|
|
166
|
VP30 |
Lake Victoria marburgvirus |
|
920942
|
|
13489280
|
MARVgp5 |
NC_001608.2 |
NP_042029.1 |
|
|
VP30 protein |
|
Recombinant VEE Replicons expressing MBGV GP
|
|
4259
|
VP30 |
Ebola virus |
|
|
|
SCD11537
|
|
|
|
|
CDD:314419 |
VP30 |
Protective antigen |
|
|
14
|
VP30 from Reston ebolavirus |
Reston ebolavirus |
VO_0010862
|
955196
|
|
22789227
|
REBOVgp6 |
AF522874 |
NP_690585 |
|
|
mRNA |
Protective antigen |
|
|
18
|
VP30 from Zaire ebolavirus |
Zaire ebolavirus |
VO_0010867
|
911826
|
|
10313997
|
ZEBOVgp5 |
AF272001 |
NP_066249 |
2I8B
|
|
mRNA |
Protective antigen |
VRP expressing VP30
|
|
167
|
VP35 |
Marburg marburgvirus |
VO_0010929
|
920948
|
|
158539110
|
MARV_gp2 |
NC_001608.2 |
YP_001531154 |
|
|
mRNA |
Protective antigen |
Recombinant VEE Replicons expressing MBGV GP
|
|
4260
|
VP35 |
Ebola virus |
|
|
|
SCD11532
|
|
|
|
|
CDD:280298 |
VP35 |
Protective antigen |
|
|
15
|
VP35 from Reston ebolavirus |
Reston ebolavirus |
VO_0010863
|
955189
|
|
22789224
|
REBOVgp2 |
AF522874 |
NP_690581 |
|
|
mRNA |
Protective antigen |
NP
|
|
16
|
VP35 from Zaire ebolavirus |
Zaire ebolavirus |
VO_0010864
|
911827
|
|
10313992
|
ZEBOVgp2 |
AF272001 |
NP_066244 |
3FKE
|
|
mRNA |
Protective antigen |
VRP expressing VP35
|
|
643
|
VP4 |
Bovine rotavirus |
VO_0011227
|
|
|
172054621
|
|
|
|
|
CDD:189541 |
VP4 |
Protective antigen |
Rotavirus VP4/VP7 Protein Vaccine
|
|
660
|
VP4 |
Human poliovirus 1 |
VO_0011244
|
|
|
68532656
|
|
|
|
|
CDD:280403 |
VP4 |
Protective antigen |
|
|
675
|
VP4 |
Murine rotavirus |
VO_0011255
|
|
|
475695
|
|
|
|
|
CDD:189541 |
VP4 |
Protective antigen |
|
|
162
|
VP40 |
Lake Victoria marburgvirus |
|
920947
|
|
13489278
|
MARVgp3 |
NC_001608.2 |
NP_042027.1 |
|
|
VP40 protein |
|
Marburg virus-like particles
Recombinant VEE Replicons expressing MBGV GP
Heterologous MARV Protein VLP
Marburg Virus Vaccine mVLP Poly I:C Adjuvant
Marburg Virus Vaccine mVLP QS-21 Adjuvant
|
|
13
|
VP40 from Reston ebolavirus |
Reston ebolavirus |
VO_0010861
|
955192
|
|
22789225
|
REBOVgp3 |
AF522874 |
NP_690582 |
1ES6
|
|
mRNA |
Protective antigen |
|
|
19
|
VP40 from Zaire ebolavirus |
Zaire ebolavirus |
VO_0010868
|
911825
|
|
10313993
|
ZEBOVgp3 |
AF272001 |
NP_066245 |
1ES6
|
|
mRNA |
Protective antigen |
VRP expressing VP40
rVSV- SEBOV-GP and -VP40
|
|
4256
|
VP5 |
Bluetongue virus |
|
|
|
AEP83825
|
|
|
|
|
CDD:279272 |
VP5 |
Protective antigen |
|
|
4271
|
VP5 protein |
Rotavirus |
|
|
|
CAA78091
|
|
|
|
|
CDD:144538
GOA:Q88301
InterPro: IPR002148
UniProtKB/TrEMBL: Q88301 |
VP5 protein |
Protective antigen |
|
|
638
|
VP6 |
Murine rotavirus |
VO_0011222
|
|
|
268080815
|
|
|
|
|
CDD:279341 |
VP6 |
Protective antigen |
Rotavirus VP6 Protein Vaccine
HSVT[VP7/6/2]
|
|
677
|
VP6 |
Rotavirus A |
VO_0011257
|
7011372
|
|
210136699
|
RVA_s6gp1 |
DQ838646 |
YP_002302229 |
|
|
VP6 |
Protective antigen |
|
|
678
|
VP6 |
Bovine rotavirus |
VO_0011258
|
|
|
195661002
|
|
|
|
1QHD
|
CDD:279341 |
VP6 |
Protective antigen |
Rotavirus VP4/VP7 Protein Vaccine
|
|
4333
|
VP60 |
Hepatitis C virus |
|
|
|
CAA51524
|
|
|
|
|
GOA:Q86119
InterPro: IPR000317
InterPro: IPR000605
InterPro: IPR001205
InterPro: IPR003593
InterPro: IPR004004
InterPro: IPR004005
InterPro: IPR007094
InterPro: IPR009003
InterPro: IPR014759
UniProtKB/UniProt: Q86119 |
VP60 |
Protective antigen |
|
|
642
|
VP7 |
Bovine rotavirus |
VO_0011226
|
|
|
195661008
|
|
|
|
|
CDD:278842 |
VP7 |
Protective antigen |
Rotavirus VP4/VP7 Protein Vaccine
|
|
676
|
VP7 |
Murine rotavirus |
VO_0011256
|
|
|
475697
|
|
|
|
|
CDD:278842 |
VP7 |
Protective antigen |
HSVT[VP7/6/2]
|
|
4255
|
VP7 |
Bluetongue virus |
|
|
|
AEP83826
|
|
|
|
|
CDD:279268 |
VP7 |
Protective antigen |
|
|
4299
|
VP7 |
Porcine rotavirus |
|
|
|
AET79173
|
|
|
|
|
CDD:278842 |
VP7 protein |
Protective antigen |
Porcine Rotavirus Vaccine rPEDV-PoRV-VP7
|
|
4337
|
VP7 |
African horse sickness virus |
|
|
|
AKP39983
|
|
|
|
|
CDD:279268 |
VP7 |
Protective antigen |
Plant Produced AHSV Serotype 5 VLPs Vaccine
|
|
4297
|
VP8 |
Porcine rotavirus |
|
|
|
AEU04135
|
|
|
|
|
CDD:189541 |
VP8 |
Protective antigen |
|
|
4307
|
VP8/S2 fusion protein |
Bovine coronavirus |
|
|
|
AKS43583
|
|
|
|
|
|
VP8/S2 fusion protein |
Protective antigen |
|
|
1257
|
vpr |
Human immunodeficiency virus 1 |
|
155807
|
|
28872817
|
HIV1gp4 |
AF033819 |
NP_057852 |
|
|
Vpr |
Other |
|
|
1715
|
vpr |
Simian-Human immunodeficiency virus strain SHIV-89.6 |
|
|
|
2828041
|
|
|
|
|
CDD:278923 |
vpr |
Protective antigen |
HIV DNA vaccine SHIV-89.6 DNA (DNA/89.6)
|
|
1258
|
vpu |
Human immunodeficiency virus 1 |
|
155945
|
|
9629366
|
HIV1gp7 |
AF033819 |
NP_057855 |
|
|
Vpu |
Other |
HIV DNA vaccine pHIS-SHIV-B
|
|
1716
|
vpu |
Simian-Human immunodeficiency virus strain SHIV-89.6 |
|
|
|
2828044
|
|
|
|
|
CDD:109608 |
vpu |
Protective antigen |
HIV DNA vaccine SHIV-89.6 DNA (DNA/89.6)
|
|
4079
|
vraA |
Borrelia burgdorferi |
|
|
|
AAC66203
|
|
|
|
|
CDD:283392 |
virulent strain-associated repetitive antigen A (VraA protein) |
Protective antigen |
|
|
3938
|
VtaA5 |
Haemophilus parasuis str. Nagasaki |
|
|
|
EYE71559
|
|
|
|
|
|
VtaA5 |
Protective antigen |
|
|
3937
|
VtaA6 |
Haemophilus parasuis str. Nagasaki |
|
|
|
EYE72607
|
|
|
|
|
|
VtaA6 |
Protective antigen |
|
|
3936
|
VtaA8 |
Haemophilus parasuis str. Nagasaki |
|
|
|
EYE72886
|
|
|
|
|
|
VtaA8 |
Protective antigen |
|
|
3939
|
VtaA9 |
Haemophilus parasuis str. Nagasaki |
|
|
|
EYE71168
|
|
|
|
|
|
VtaA9 |
Protective antigen |
|
|
1007
|
wbtA |
Francisella tularensis subsp. tularensis SCHU S4 |
|
3191939
|
|
56708505
|
FTT_1464c |
AJ749949 |
YP_170401 |
|
|
dTDP-glucose 4,6-dehydratase |
Virmugen |
Francisella tularensis wbtA mutant vaccine
|
|
472
|
WbtI |
Francisella tularensis subsp. holarctica FTNF002-00 |
VO_0011074
|
5522688
|
|
156502002
|
FTA_0635 |
CP000803 |
YP_001428067 |
|
|
DegT/DnrJ/EryC1/StrS family sugar aminotransferase |
Protective antigen |
Francisella tularensis wbtI mutant vaccine
|
|
753
|
WD |
Leishmania amazonensis |
VO_0011290
|
|
38455440
|
38455441
|
|
|
AAR20840.1 |
|
CDD:225201
CDD:238121
CDD:293791 |
antigenic WD protein |
Protective antigen |
L. amazonensis DNA vaccine encoding WD protein
|
|
1098
|
wecA |
Salmonella enterica subsp. enterica serovar Typhimurium |
|
|
|
20140863
|
|
|
|
|
CDD:185074
CDD:133463 |
Undecaprenyl-phosphate alpha-N-acetylglucosaminyl 1-phosphate transferase |
Virmugen |
Salmonella Typhimurium wecA mutant vaccine
|
|
4494
|
WHcAg |
Woodchuck hepatitis virus |
|
2546420
|
|
22256034
|
WhBvgp4 |
J02442 |
NP_671816 |
|
|
core protein |
Protective antigen |
Interferon-gamma-expressing Adenovirus Vaccine ASN-002
|
|
4421
|
WT1 |
Homo sapiens |
|
7490
|
|
1327848674
|
|
AH003034 |
NP_000369 |
|
|
transcript variant H |
Protective antigen |
WT1 124-138 Peptide Vaccine
WT1 126-134 Peptide Vaccine
WT1 247-261 Peptide Vaccine
WT1 Analog Peptide Vaccine
WT1 Peptide Vaccine OCV-501
WT1 Peptide Vaccine WT2725
Autologous CT7/MAGE-A3/WT1 mRNA-Electroporated Langerhans-Type Dendritic Cells
Allogeneic Cellular Vaccine 1650-G
Allogeneic GM-CSF-Based Myeloma Cell Vaccine
Autologous GM-CSF-Secreting Lethally Irradiated Leukemia Cell Vaccine
WT1-A10/AS01B Immunotherapeutic GSK2130579A Vaccine
WT1 235-243 Peptide Vaccine
p.DOM-WT1-126 DNA Vaccine
p.DOM-WT1-37 DNA Vaccine
Recombinant Adenovirus-p53 SCH-58500 Vaccine
Recombinant Anti-WT1 Immunotherapeutic GSK2302024A Vaccine
|
|
4483
|
Xbp1 |
Mus musculus |
|
22433
|
|
411147451
|
|
AB036745 |
NP_001258659 |
|
|
transcript variant 1 |
Protective antigen |
XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410
|
|
4784
|
XBP1 |
Homo sapiens |
|
7494
|
|
118640873
|
|
CH471095 |
NP_001073007 |
|
|
transcript variant 2 |
Protective antigen |
hTERT/Survivin/CMV Multipeptide Vaccine
|
|
4746
|
Xcl1 |
Mus musculus |
|
16963
|
|
6678712
|
|
AC133891 |
NP_032536 |
|
|
chemokine (C motif) ligand 1 |
Protective antigen |
|
|
4781
|
XCL1 |
Homo sapiens |
|
6375
|
|
4506853
|
|
AL031736 |
NP_002986 |
|
|
transcript variant X1 |
Protective antigen |
Autologous HNSCC DNA-transfected Semi-allogeneic Fibroblasts MRC-5 Vaccine
IL-2/Lptn Gene-Modified Allogeneic Neuroblastoma Tumor Cell Vaccine
|
|
342
|
YapF |
Yersinia pestis CO92 |
VO_0011005
|
1173449
|
|
218927800
|
YPO0606 |
CP009973 |
YP_002345675 |
|
|
autotransporter protein |
Protective antigen |
|
|
3866
|
YbgF |
Rickettsia rickettsii |
|
|
|
KDO03483
|
|
|
|
|
|
tol-pal system protein YbgF |
Protective antigen |
|
|
4019
|
ybgF |
Coxiella burnetii |
|
|
|
RQM80114
|
|
|
|
|
CDD:292947
CDD:188247
CDD:276809
CDD:276939 |
tol-pal system protein YbgF |
Protective antigen |
|
|
4757
|
YBX1 |
Homo sapiens |
|
4904
|
|
34098946
|
|
AC098484 |
NP_004550 |
|
|
transcript variant 2 |
Protective antigen |
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
|
|
346
|
YdeN |
Yersinia pestis CO92 |
VO_0011009
|
1175868
|
|
218930092
|
YPO3047 |
AL590842 |
YP_002347967 |
|
|
sulfatase |
Protective antigen |
|
|
348
|
YerA |
Yersinia pestis CO92 |
VO_0011011
|
1172650
|
|
16082696
|
YPCD1.05c |
AL117189 |
NP_395142 |
|
|
secretion chaperone |
Protective antigen |
|
|
3954
|
yfeA |
Haemophilus parasuis SH0165 |
|
|
|
ACL32714
|
|
|
|
|
CDD:238557 |
chelated iron ABC transporter, periplasmic-binding protein |
Protective antigen |
|
|
4016
|
ygbF |
Rickettsia rickettsii |
|
|
|
WP_012150526
|
|
|
|
|
CDD:224643
CDD:276809 |
tol-pal system protein YbgF |
Protective antigen |
|
|
3949
|
ygiW |
Haemophilus parasuis D75 |
|
|
|
EQA00462
|
|
|
|
|
|
ygiW domain protein |
Protective antigen |
|
|
49
|
YopD from Y. pestis CO92 |
Yersinia pestis CO92 |
VO_0010878
|
1172673
|
|
16082716
|
YPCD1.28c |
AL117189 |
NP_395162 |
|
|
secreted effector protein |
Protective antigen |
Recombinant Y. pestis YopD protein vaccine
|
|
339
|
YopD from Y. pestis KIM 10 |
Yersinia pestis |
VO_0011002
|
1149313
|
|
31795494
|
D744_p5050 |
AF053946 |
NP_857949 |
|
|
Yop targeting negative regulator |
Protective antigen |
|
|
1074
|
YopE |
Yersinia pestis KIM 10 |
|
1149129
|
|
31795304
|
YKCD1p59 |
AF053946 |
NP_857762 |
|
|
secreted effector protein |
Protective antigen |
YopE(67-77) Protein Vaccine
|
|
3828
|
yopE |
Yersinia pseudotuberculosis |
|
|
|
AJJ04959
|
|
|
|
|
CDD:286154
CDD:119405 |
outer membrane virulence protein yopE |
Protective antigen |
|
|
51
|
YopH from Y. pestis strain: CO92, biovar: Orientalis |
Yersinia pestis CO92 |
VO_0012359
|
1172712
|
|
16082755
|
YPCD1.67c |
AL117189 |
NP_395201 |
|
|
putative secreted protein-tyrosine phosphatase |
Protective antigen |
Yersinia pestis yopH mutant vaccine
|
|
52
|
YopM |
Yersinia pestis CO92 |
|
1172671
|
|
16082715
|
YPCD1.26c |
AL117189 |
NP_395161 |
|
|
secreted effector protein |
Other |
YopM
|
|
340
|
YopO |
Yersinia pestis Angola |
VO_0011003
|
5798322
|
|
162417777
|
YpAngola_B0072 |
CP000902 |
YP_001604502 |
|
|
protein kinase YopO |
Protective antigen |
|
|
341
|
YPMT1.84 (F1 capsule antigen) |
Yersinia pestis CO92 |
VO_0011004
|
1172839
|
|
16082876
|
YPMT1.84 |
AL117211 |
NP_395430 |
|
|
F1 capsule antigen |
Protective antigen |
Y. pestis F1 antigen Vaccine with Flagellin
|
|
349
|
YPO0420 |
Yersinia pestis CO92 |
VO_0011012
|
1173265
|
|
218927621
|
YPO0420 |
AL590842 |
YP_002345496 |
|
|
lipoprotein |
Protective antigen |
|
|
344
|
YPO0612 |
Yersinia pestis CO92 |
VO_0011007
|
1173455
|
|
218927806
|
YPO0612 |
CP009973 |
YP_002345681 |
|
|
sugar binding protein |
Protective antigen |
|
|
100
|
yscF |
Yersinia pestis CO92 |
VO_0010914
|
|
|
16082743
|
YPCD1.55 |
AL117189 |
NP_395189 |
3ET4
|
CDD:131160 |
needle complex major subunit |
Protective antigen |
Non-typeable H. influenzae rLP4/rLP6 and Moraxella catarrhalis UspA2 protein vaccine
|
|
54
|
YscF from Y. pestis CO92 |
Yersinia pestis CO92 |
VO_0010913
|
1172700
|
|
16082743
|
YPCD1.55 |
AL117189 |
NP_395189 |
|
|
needle complex major subunit |
Protective antigen |
Y. pestis YscF subunit vaccine
Y. pestis YscF Protein Vaccine
|
|
338
|
YscF from Y. pestis KIM 10 |
Yersinia pestis |
VO_0011001
|
1149286
|
|
31795470
|
D744_p5023 |
AF053946 |
NP_857922 |
|
|
type III secretion protein |
Protective antigen |
Y. pestis DNA vaccine YscF-2
|
|
1652
|
ZGP |
Zaire ebolavirus strain Zaire95 |
|
|
1695251
|
1695253
|
|
|
AAB37095.1 |
|
CDD:279888
CDD:333284
CDD:197367 |
virion spike glycoprotein |
Protective antigen |
Ebola Virus Vaccine Ad5-ZGP
|
|
879
|
znuA |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1253412
|
|
161353595
|
STM1891 |
AE006468 |
NP_460848 |
2XY4
|
|
high-affinity zinc transporter periplasmic component |
Virmugen |
Salmonella Typhimurium znuABC mutant vaccine
|
|
228
|
znuA |
Brucella melitensis biovar Abortus 2308 |
VO_0012365
|
3827700
|
|
83269918
|
BAB2_1079 |
AM040265 |
YP_419209 |
|
|
periplasmic solute binding protein |
Virmugen |
Live attenuated B. abortus with deletion of znuA
|
|
880
|
znuB |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1253414
|
|
16765235
|
STM1893 |
AE006468 |
NP_460850 |
|
|
high-affinity zinc transporter membrane component |
Virmugen |
Salmonella Typhimurium znuABC mutant vaccine
|
|
881
|
znuC |
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 |
|
1253413
|
|
39546331
|
STM1892.S |
AE006468 |
NP_460849 |
|
|
high-affinity zinc transporter ATPase |
Virmugen |
Salmonella Typhimurium znuABC mutant vaccine
|
